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Abstract 
Work presented in this thesis centres around the application of the new 
hyperpolarisation technique, SABRE, within nuclear magnetic resonance spectroscopy, 
focusing on optimisation of the technique to characterise small organic molecules. 
While pyridine was employed as a model substrate, studies on a range of molecules are 
investigated including substituted pyridines, quinolines, thiazoles and indoles are 
detailed. 
Initial investigations explored how the properties of the SABRE catalyst effect the 
extent of polarisation transfer exhibited. The most important of these properties proved 
to be the rate constants for loss of pyridine and hydrides as these define the contact time 
of pyridine with the parahydrogen derived hydride ligands in the metal template. The 
effect of changing the temperature, solvent or concentration of substrate or catalyst are 
rationalised. For instance, the catalyst ICy(a) exhibits relatively slow ligand exchange 
rates and increasing the temperature during hyperpolarisation increases the observed 
signal enhancements. 
These studies have revealed a second polarisation transfer template can be used with 
SABRE in which two substrate molecules are bound. This allows the possibility of 
investigation of larger substrates which might otherwise be too sterically encumbered to 
bind. 
Another significant advance relates to the first demonstration that SABRE can be used 
in conjunction with an automated system designed with Bruker allowing the acquisition 
of scan averaged, phase cycled and traditional 2D spectra. The system also allowed 
investigations into the effect of the polarisation transfer field and application of that 
knowledge to collect single-scan 13C data for characterisation. The successful 
acquisition of 1H NOESY, 1H-1H COSY, 1H-13C 2D and ultrafast 1H-1H COSY NMR 
sequences is detailed for a 10 mM concentration sample, with 1H data collected for a 1 
mM sample. 
A range of studies which aim to demonstrate the applicability of SABRE to the 
characterisation of small molecules and pharmaceuticals have been conducted. 
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1 Chapter 1 – Introduction  
A wide range of analytical techniques are used in the field of biomedical and 
pharmaceutical research, including mass spectrometry (MS), and infrared (IR) and ultra-
violet (UV) spectroscopy. While techniques such as IR and UV spectroscopy can prove 
very useful, these are dependent on a response factor. This means that in a sample 
containing two substrates in the same concentration, the signal derived from those 
substrates will not necessarily have the same integral. Nuclear magnetic resonance 
(NMR) responds the same to all signals of the same type and therefore is independent of 
a response factor.1 This means it is a quantitative technique even in complex mixtures. 
NMR also has the ability to distinguish between nuclei of different chemical 
environments based on the effects of electron cloud density of nearby nuclei, and 
advanced pulsed NMR methods have allowed the user to investigate the connectivity of 
NMR active nuclei.  
Within the pharmaceutical industry, NMR has found many applications both in the 
liquid and solid state.1-4 Solid state chemistry is very important in formulation chemistry 
as 80-90 % of commercial drugs are solid.4 It can be used to investigate solid forms of a 
drug in a tablet in the presence of excipients,5 interactions between the drug and 
excipients, stability of active complexes in solid solutions,6 and identification of 
potential impurities or degradation products from long storage.4 While solid state NMR 
is a very important application of NMR within the pharmaceutical industry, only liquid 
state NMR will be discussed from here on as only this type of measurements are 
completed experimentally.  
In the liquid state, NMR is most commonly used in drug discovery. It can be used in the 
identification of metabolites3 but it has a widespread use in the characterisation of 
substrates and impurities in the initial development of potential new drugs.7 It is the 
potential application of SABRE to these pharmaceutical uses of NMR that will be 
considered within this thesis.  
1.1 NMR spectroscopy 
One of the main drawbacks of NMR spectroscopy is the inherent insensitivity. The limit 
of detection for NMR is in the range 10-9 to 10-11 mol however for more sensitive 
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techniques this reaches 10-13 mol for laser-induced fluorescence and MS and 10-12 to  
10-15 mol for Fourier transform infrared and Raman spectroscopy.1 The reasons for this, 
and current methods being used to overcome the insensitivity, are discussed below.  
1.1.1 NMR spectroscopy 
Analysis by NMR requires the presence of nuclei which has a nuclear spin quantum 
number which does not equal 0, such as 1H which has a nuclear spin quantum number 
of a ½.8 In the presence of an external magnetic field, the derived energy states split 
according to this nuclear spin quantum number such that spin ½ nuclei give two energy 
levels, + ½ and - ½, spin 1 nuclei give three energy levels (+1, 0 and -1) and spin 3/2 
nuclei give four energy levels (+ 3/2, + ½, - ½ and – 3/2). The extent to which these 
energy levels are populated is defined by the Boltzmann distribution which is dependent 
on the external field. In this thesis, only 1H and 13C nuclei are considered, both of which 
have a nuclear spin quantum number of ½.  
Collectively, the spins in a certain chemical environment combine to produce a bulk 
magnetisation and as such are considered to be responsive to radiofrequency pulses and 
therefore can be manipulated. A 90º pulse can be used to ‘push’ bulk magnetisation 
away from its relaxed state after which the spins begin to immediately precess in a 
precise manor towards the relaxed state. The frequency of this precession is unique to 
the chemical environment and therefore a number of chemical environments can be 
recorded to produce a Free Induction Decay (FID). This is then processed with a Fourier 
transform function to produce a spectrum, indicating a signal for each chemical 
environment.  
NMR is reliant on the Boltzmann distribution. The spins present in the two observed 
energy levels of a spin ½ nuclei act against each other, and consequently without a 
population difference between the two levels, no signal would be observed. 
Unfortunately, the energy difference between the energy levels of interest in NMR is 
small and therefore the population difference created by the Boltzmann distribution is 
also small. Methods of increasing the energy difference between these states are 
therefore discussed.  
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1.1.2 Increasing sensitivity of NMR through instrumental developments 
One method to increase the sensitivity of NMR is to increase the energy difference 
between the states of interest, such that the Boltzmann distribution of spins allows a 
greater population difference. There are two ways to achieve this, first increasing the 
applied magnetic field and secondly, decreasing the temperature.  
The first NMR spectrum was published in 1951 in a paper by Arnold et al.9 and showed 
the three distinct chemical shifts present in ethanol, shown in Figure 1.1. The paper also 
includes the procedure for methanol, propanol, butanol and pentanol with accurate 
integrations of the associated peaks. 
 
Figure 1.1 First 1H NMR spectrum of ethanol published by Arnold et al.9 
Over the coming years,8,10 significant advances in the field of NMR were published, the 
most significant of which is perhaps the development of superconducting magnetic 
fields,11 before which only iron-cored magnets were used. This allowed spectroscopists 
to work at much higher fields, giving not only greater sensitivity but also better 
resolution.  
The second greatest advance in increasing the sensitivity of NMR spectroscopy after the 
increase in magnetic field strength was the invention of the CryoProbe.12 In a normal 
probe, random thermal motion of electrons in the required conductors can result in a 
noise contribution to any spectrum recorded. In a CryoProbe, these conductors, required 
for the transmit/receive coils and tuning and matching circuits, are cooled with liquid 
nitrogen or liquid helium, along with some other electronic components in some probes, 
to reduce the noise created by these components. This has been shown to increase the 
sensitivity of NMR by three fold.1 
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Other advances in NMR include the invention of high resolution capillary tube NMR. 
While this does not affect the sensitivity of the method, the amount of sample required 
for detection is greatly reduced. A standard NMR tube is 5 mm in diameter however 
probes are now commercially available which accept capillary NMR tubes with 
diameters of 1.7 mm and 1 mm (see Figure 1.2). 
 
Figure 1.2 Photo demonstrating the relative size of some available NMR sample tubes demonstrating 
different diameters. The required sample volumes for each sample tube is written in parenthesis, from left 
to right, 5 mm (600 µL), 1.7 mm (35 µL) and 1 mm (7 µL). Image taken from the publication by 
Molinski (2009).13 
In 2002, Schlotterbeck et al.14 published a paper in which the volume of sample, and 
therefore mass of substrate, was correlated to the signal to noise of signals collected via 
a small range of probes. The results of this investigation are presented in Table 1.1. 
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Probe Vtot Vobs Reported 
S/N 
S/N / µmol 
in Vobs 
Enhancement 
1-mm TXI microliter 5 2.5 276 1104 5.0 
5-mm conventional TXI 550 278 55 220 1.0 
5-mm TXI cryoprobe 550 278 181 651 3.0 
5-mm TXI cryoprobe 
with 1-mm sample 
22 10 195 858 3.9 
Table 1.1 Comparison of probe performance of a 1-mm TXI Microliter probe, a 5-mm TXI probe and a  
5-mm cryoprobe, where Vtot is the total sample volume required, Vobs is the volume pulsed by the probe, 
and S/N refers to the signal to noise ratio. These experiments were carried out on 172 µg (0.5 µmol) 
sample of sucrose in the Vtot, collected with one scan, processed with a line broadening of 1. 
Enhancements are calculated based on results gained from the 5-mm conventional TXI probe. Table 
adapted from a 2002 publication by Schlotterbeck et al.14 
The results presented in Table 1.1 show significantly increased mass sensitivity can be 
achieved by using either a cryoprobe or microliter probe when compared to the 
conventional 5-mm probe.  
1.2 Hyperpolarisation in NMR 
Advances in the practical aspects of NMR spectroscopy such as larger magnets and 
CryoProbes can only increase sensitivity, and compared to other techniques, NMR is 
still relatively insensitive. Methods to create non-Boltzmann distributions are therefore 
being investigated and are discussed below. 
1.2.1 Hyperpolarisation 
Hyperpolarisation is a method by which the sensitivity of NMR is increased not through 
increasing the difference observed in the Boltzmann distribution through increasing the 
magnetic field or decreasing the temperature of the sample, but by forcing the 
population into a non-Boltzmann distribution. The methods by which this condition is 
met are discussed below. 
1.2.2 Brute force 
The idea of hyperpolarisation by brute force was first published in 1958 by Abragam 
and Proctor.15 In brute force NMR, hyperpolarisation is not produced by creating a non-
Boltzmann distribution but rather, the equilibrium Boltzmann distribution of the sample 
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is altered.16 This can take a long time because nuclear relaxation becomes slow at low 
temperatures due to loss of molecular motion.17 This problem can be alleviated by either 
the addition of a relaxant17 or through low field thermal mixing,16 a form of cross-
polarisation transfer.  
The idea of adding a relaxant to hyperpolarise 129Xe was considered in a paper 
published by Krjukov et al.17 in 2005. For xenon nuclei in bulk solid at 77 K and a 
magnetic field of 0.1 T, a typical spin relaxation time is 2.5 hours. If the temperature is 
the reduced to 4.2 K, the relaxation time increases to 60 hours for natural xenon and  
180 hours for isotopically enriched xenon. It is therefore clear to see that to 
hyperpolarise xenon through brute force effectively, it would be advantageous to reduce 
the time required to achieve this. Here, the addition of both oxygen and helium as 
relaxants were considered. However, the observation that the T1 of 
129Xe was reduced 
significantly meant that if xenon gas is to be used as a contrast agent in imaging, the 
relaxant must be removed. This unfortunately proved to be impractical in application. 
The removal of oxygen requires the sample to be heated to 100 K which resulted in 
relaxation of the hyperpolarised xenon due to a strong temperature and field T1 
dependence, before the oxygen could be removed.  
The group then investigated the addition of 3He as a relaxant. At 1.5 K, this had the 
effect to reduce the T1 of xenon from around 2 days to 200 mins at 10 T or 2 min at 1 T. 
The loss of polarisation in xenon was investigated during removal of the 3He relaxant. 
The sample was heated to 30 K to remove the helium resulting in only 37 % of the 
original polarisation present in xenon remaining in the sample. This was partly 
overcome by the addition of 4He prior to removal of 3He. This then had the effect to 
retain 68 % of xenon polarisation after helium removal.  
In a paper published by Gadian et al.16 in 2012, the idea of combining brute force with 
low field thermal mixing was revisited. This is where nuclei that are dipolar-coupled to 
each other exchange polarisation. A major drawback of this method is that exposure to 
the low field must be very quick as the short T1 values typical at low fields would allow 
loss of polarisation. The significant improvement posed in the published Gadian paper 
was to derive the polarisation from a large solvent 1H pool to a small amount of nuclei 
of interest without the use of radiofrequencies. Before each experiment the sample is 
saturated at resonance field, exposed to a higher polarisation field, then transiently 
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reduced to a very low mixing field and restored to resonance field to allow acquisition 
of the required NMR data. The extent of polarisation 1H, 13C, 15N, 23Na and 31P can be 
explored by varying the strength or duration of either the high polarisation field or low 
mixing field.  
Initially, the respective rates of polarisation (Tp) of the various nuclei were investigated. 
In a solution of [1-13C] sodium acetate powder, it was shown that Tp was closer to the 
T1 of 
1H rather than 13C. This idea was repeated on a sample of 2 M [1-13C] sodium 
acetate and 1 M sodium phosphate in which the Tp to 
31P also approaches the T1 of 
1H 
rather than 31P. The effect of this on the signal to noise ratios of the resultant 31P spectra 
are shown in Figure 1.3.  
 
Figure 1.3 31P signals obtained in a single scan at 4.2 K from a sample containing 2 M [1-13C] sodium 
acetate and 1 M sodium phosphate. The bottom scan was completed without low field thermal mixing, 
and the top completed with low field thermal mixing. Picture taken from the publication by Gadian et 
al.16 
It was also observed that the addition of 0.1 mM dysprosium-diethylene triamine 
pentaacetic acid (DTPA) to act as a low-temperature relaxation agent had little effect on 
the T1 values of 
13C or 31P but shortened the T1 of 
1H from 170 s to 90 s and 
consequently shortened the observed Tp values. The addition therefore has a great 
advantage.  
1.2.3 Optical pumping 
Optical pumping is a hyperpolarisation technique by which a non-Boltzmann 
distribution of spins is created. This is created by transferring the angular momentum 
from laser photons to electronic spins and then to nuclear spins, temporarily enhancing 
the nuclear spin polarisation. Circularly polarised light can be used to pump electronic 
spins of gaseous alkali metal vapours into non-equilibrium population distributions.18 It 
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was also observed that the nuclear spin polarisation of noble gases could consequently 
be greatly enhanced through collision and spin exchange with electronically spin 
polarised alkali atoms.19 This is possible because in the gas phase, the electronic spin of 
the alkali metal and nuclear spin of any other material are coupled by dipolar cross-
relaxation.20  
Typical gases to be hyperpolarised using optical pumping are 3He and 129Xe. 3He is 
quicker to hyperpolarise than 129Xe, and due to a higher gyromagnetic ratio, also yield 
greater signal to noise ratios in resultant NMR or MRI. It is consequently useful for 
void space imaging of the lungs.21 On the other hand, 129Xe take a longer time to 
hyperpolarise and has a lower resultant signal to noise but is much more soluble in 
blood.22 It is therefore useful when investigating blood and tissues.23-25 
1.2.3.1 Optical pumping in NMR 
Xenon has a highly polarisable electron cloud and therefore its chemical shift is 
sensitive to its surroundings, resulting in a chemical shift range of over 7000 ppm 
depending on the chemical environment.18 Commonly, NMR studies concerning xenon 
will involve an exchange of some sort, for instance, between red blood cells and 
plasma.23  
In 1996, a paper was published by Bifone et al.23 to discuss the idea of using 
hyperpolarised xenon to investigate human blood solutions. The group reported 
enhancements of 3 orders of magnitude larger than thermal signals. This is shown in 
Figure 1.4, where spectra of thermally polarised and hyperpolarised xenon in human 
blood are compared. 
 
Figure 1.4 129Xe NMR spectra of human blood with thermally polarised (top) and hyperpolarised 
(bottom) 129Xe. Picture reproduced from publication in 1996 by Bifone et al.23 
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The two signals observed in the 129Xe NMR spectra in Figure 1.4 correspond to xenon 
bound to red blood cells (at 216 ppm) and xenon dissolved in saline/plasma mixture 
(192 ppm). This increase in sensitivity of 129Xe NMR and the significant difference in 
chemical shifts between dissolved xenon and bound xenon have therefore allowed the 
real time observation of transfer of xenon to red blood cells.  
Xenon polarised through optical pumping could also undergo low field thermal mixing 
to transfer polarisation into other, less sensitive nuclei, in the same way as was observed 
for the brute force method.26,27 This was considered by Bowers et al.26 in a paper they 
published in 1993 in which polarisation was transferred to 13CO2. The group reported an 
enhancement of 200 fold in the 13C NMR spectrum of isotopically enriched 13CO2, and 
that the direction of the circularly polarised light used to polarise the xenon had a direct 
effect on the resultant NMR spectrum. If the light was right circularly polarised, the 13C 
signal was observed in phase, where if left circularly polarised light is used, the 13C 
signal was observed 180o out of phase. 
This idea was extended in a paper published in 2009 by Lisitza et al.27 Here, 
polarisation was transferred to 1-13C-acetic acid by mixing both substrate and 
hyperpolarised xenon in the gas phase and freezing the mixture by emersion in liquid 
nitrogen. To prevent T1 relaxation the mixture is standardly stored at 0.5 T, and moved 
to a field of 0.1 – 0.5 mT for a short time (0.1-0.3 s). The sample is then transferred 
back to a field of 0.5 T to preserve the polarisation. The sample is then thawed during 
which time the xenon evaporates and acetic acid becomes liquid. The 13C spectrum of 
the 1-13C-acetic acid is collected approximately 5-8 seconds after thawing, and 
compared to a thermal spectrum of the same sample. A maximum signal enhancement 
of 5 fold was observed, with corresponding spectra shown in Figure 1.5. 
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Figure 1.5 13C NMR spectra of 1-13C-acetic acid with thermal distribution (bottom) and hyperpolarised by 
thermal mixing with optically pumped 129Xe. Picture reproduced from the 2009 publication by Lisitza et 
al.27 
Extrapolating to allow for the effect of the 13C T1 during the time between thermal 
mixing and interrogation by NMR, it was calculated that an enhancement of ~10 fold 
was achieved at time of thermal mixing.  
Polarisation is also able to transfer from the hyperpolarised xenon gas through the spin 
polarisation-induced nuclear Overhauser effect (SPINOE). When laser polarised gas is 
dissolved in a solution, cross-relaxation and polarisation transfer is possible through a 
novel manifestation of the nOe effect.18,28 
In a paper published in 2003 by Cherubini et al.,28 the efficiency of thermal mixing and 
the SPINOE effect are compared with reference to polarisation transfer form 
hyperpolarised Xe to 13CS2. To achieve the SPINOE effect, a mixture of hyperpolarised 
xenon and 13CS2 is set to a temperature of 196 K where the mixture is liquid. Maximum 
signal enhancement of the 13C signal was observed 2 min after the liquid had formed. 
To achieve the thermal mixing effect, the mixture of hyperpolarised xenon and 13CS2 
was frozen in liquid nitrogen and moved to a low field appropriate for thermal mixing 
for a short time, then thawed to 196 K and interrogated by NMR. During the course of 
these experiments, it was found that polarisation of 13C by thermal mixing (maximum 
390 fold enhancement) was much more efficient the SPINOE effect (maximum ~70 fold 
enhancement).  
66 
1.2.3.2 Optical pumping in MRI 
Hyperpolarised noble gases also have applications within magnetic resonance imaging 
(MRI). This has been considered in 129Xe imaging of the brain,24 and 3He void space 
imaging of lungs.21  
In 1997, a paper was published by Swanson et al.24 as a discussion into the applicability 
of hyperpolarised 129Xe to brain imaging, primarily to investigate regional cerebral 
blood flow (rCBF), by model of a rat brain. In order for this to be possible, the 
hyperpolarised states of 129Xe must survive transport through the lungs, into the blood 
and then to the brain, and remain long enough after this point to yield useful 
information. The group were successful in obtaining NMR spectra of the rat brain 
proving the xenon had travelled that far, and then in obtaining 129Xe images of the rat 
brain, shown in Figure 1.6. 
 
Figure 1.6 129Xe and 1H MRI images of the rat brain. a) Grey-scale 129Xe image, b) False colour 
supusition of 129Xe image on a 1H spin-echo image and c) 1H spin-echo. Figure reproduced from a paper 
published in 1997 by Swanson et al.24 
The combination of the false colour 129Xe image and 1H spin-echo image shown in 
Figure 1.6b indicates the 129Xe is distributed through the brain tissue, as xenon has a 
greater affinity for brain tissue over blood, and is not observed in the surrounding fat or 
muscle. It is also observed that less signal is observed in the cerebellum compared to the 
cerebrum, possibly due to reduced blood flow in the cerebellum. Complications to bring 
this sort of imaging to the commercial environment still exist due to the large volume of 
xenon required for human measurements, and additions of oxygen to prevent anoxia and 
lower xenon concentrations to reduce anaesthetic effects, will also be required.  
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Two papers published by Spence et al. in 200129 and 200430 report a biotin-derivatized 
caged-xenon biosensor for avidin, a protein found in birds, reptiles and amphibians. An 
example of the sensor developed is shown below in Figure 1.7. 
 
Figure 1.7 Structure and schematic representation of the biosensor molecule designed to bind xenon to a 
protein with high affinity and specificity, proposed in a publication by Spence et al.29 The cage binding 
xenon, cryptophane-A, is shown in black with a purple tether and red biotin ligand.  
The signal corresponding to xenon in the free biosensor is shown to shift upon addition 
of avidin. To ensure the change in chemical shift observed was a result of binding to 
avidin, and not proximity to avidin, the experiment was repeated in the presence of 
avidin bound to native biotin. In this case, no change in the chemical shift was observed 
confirming the change was due to binding. These spectra are presented below in Figure 
1.8. 
 
Figure 1.8 The 129Xe NMR spectra depicting the detection of biotin – avidin binding using xenon NMR. 
The left spectra show binding in the absence of native biotin, and the right spectra show binding in the 
presence of native biotin. Images taken from the publication by Spence et al.30 
This work demonstrates the possibility of using hyperpolarised xenon to act as a 
biosensor, which could be used within imaging. 
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Hyperpolarised 3He has also been used in medical imaging when considering regional 
pulmonary functional and microstructural imaging, as reported by Costella et al.21 in 
2012. The current method for the diagnosis and long term monitoring of asthma is 
relatively insensitive to small changes in airway function and therefore the new method 
of hyperpolarised 3He MRI imaging is considered. This method was successful and 
therefore the group were able to use 3He images to investigate the effect of 
methacholine (a bronchoconstrictor) and salbutamol (an asthma drug) on lung function 
to better understand underlying conditions.  
1.2.4 Dynamic nuclear polarisation 
Dynamic Nuclear Polarisation (DNP) is a hyperpolarisation technique by which the 
nuclei of interest are polarised by the transfer of spin polarisation from electrons. The 
electron is polarised through exposure to microwaves, and transfer to the nuclei of 
interest can occur through one of four mechanisms: the solid effect (SE), the cross effect 
(CE), thermal mixing (TM) or the Overhauser effect (OE).31,32 As the sample is made 
colder, weaker microwave sources are required to polarise the sample. The addition of a 
radical is always required. In the case of chemically-induced DNP (CIDNP), a different 
mechanism is present, called the radical pair mechanism.  
The solid effect, cross effect and thermal mixing are only possible when the sample is 
solid, and therefore does not apply to liquid samples. The Overhauser effect is present 
in liquid samples however it is only efficient at low fields and therefore cannot occur in 
a strong magnet. It is therefore difficult to complete high resolution NMR spectroscopy 
that requires signal averaging using DNP. Two groups have developed methods to 
overcome this barrier, and this work will be discussed below. 
In a paper published in 2003 by Ardenkjaer-Larsen et al.,33 a method for generating 
highly polarised nuclear spins in solution using DNP is proposed and extended upon in 
a second paper in 2004.34 The method involves the sample being cooled using liquid 
helium (~4 K) in a 3.35 T magnet and irradiated with ~94 GHz microwaves to produce 
a solid hyperpolarised by DNP. This is then rapidly dissolved in a suitable solvent 
inside the DNP polarisor such that a solution of molecules with hyperpolarised nuclear 
spins is produced and can consequently be transferred into a high resolution NMR 
spectrometer for interrogation. With a sample of [13C]-urea and a trityl radical dissolved 
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in glycerol, hyperpolarisations of 37 % for 13C and 7.8 % for 15N were obtained using 
this method corresponding to enhancements of 44, 400 and 23, 500 fold respectively.33 
The method was then demonstrated for use within MRI.34 A rat was injected with [13C]-
urea and subsequently imaged. 1 s after injection, the first image revealed heart muscles, 
and 2 seconds later, the collected image included the vascular system of the kidneys. 
These images are presented in Figure 1.9. 
 
Figure 1.9 13C coronal projection images of a rat. The images were acquired (a) 1 s and (b) 3 s after 
injection of 13C-urea. Image taken from a publication by Wolber et al.34 
The dissolution method described above has also been applied to the characterisation of 
small molecules using DNP in a publication by Day et al.35 They reported 
enhancements of ~103-104 fold for the six molecules investigated, namely 
indomethacin, quinine, progesterone, alprenalol, acetaminophen and nicotinamide. A 
complication was observed with this method in that the protonated glassing agents, 
methanol and DMSO, also received significant levels of hyperpolarisation and produced 
large side bands. These have the potential to mask potential substrate signals.  
In 2006, Joo et al.36 also published a method to produce a liquid sample hyperpolarised 
by DNP, termed as ‘Temperature Jump High-Frequency Dynamic Nuclear Polarisation’ 
(TJ-DNP) in the paper. In this case, the sample is cooled to 90 K and hyperpolarised by 
DNP using a 140 GHz microwave source. The sample is then melted rapidly using a 
10.6 µm infrared pulse and interrogated by NMR at 300 K. This method holds the major 
advantage that it can be repeated and therefore, standard high-resolution NMR 
sequences can be acquired using hyperpolarised samples. The paper reports 
enhancement levels similar to those reported by Ardenkjaer-Larsen et al.33 An example 
of the reproducibility of the method and consequent signal averaging achieved using 
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this method is presented in Figure 1.10 for a 1D 13C NMR spectrum of [U-13C]-L-
proline. 
 
Figure 1.10 Left, sixteen spectra of the carbonyl resonance in [U-13C]-L-proline resulting from a series of 
TJ-DNP experiments. These spectra can be averaged (right) to improve the observed signal to noise ratio. 
Image taken from a publication by Joo et al.36 
DNP can be used in biological applications such as the detection and investigation of 
tumours. In a paper published in 2010,37 Wilson et al. reported the use of DNP to probe 
a series of enzymatic pathways. They first investigated if a co-polarised solution of 13C 
bicarbonate and [1-13C] pyruvate were able to divulge information about pH and 
pyruvate metabolism, and importantly, if the presence of one hyperpolarised complex 
did not interfere with the other. During the course of the experiment, it was observed 
that the two complexes did not interfere with each other through studies of images with 
both complexes and images with just pyruvate, however, results of the tumour studies 
were less positive. The pH was calculated based on the integral of the 13C bicarbonate 
and 13C CO2 using the Henderson-Hasselbalch equation, with a normal value expected 
to be between 7.28 and 7.40. The ratio of hyperpolarised lactate to pyruvate was also 
investigated, and was expected to be between 0.20 and 0.52. In a normal mouse, the 
highest levels of lactate were found in the kidneys where lactate is excreted, and most 
abdominal regions having the ratio in the range 0.2-0.3. Studies on mice with tumours 
found that the malignant cells showed higher levels of lactate (ratios in the range 0.43 – 
0.58) and were more acidic with a pH in the range 6.6 to 7.0, in comparison to 
surrounding normal abdominal tissues, however the average of 5 values of each were 
found to not be statistically different from each other. This was explained by the 
difficulty in finding positions which were fully benign or fully malignant. In a second 
experiment, it was also observed that images of four different complexes could be 
obtained through observation of [1-13C] pyruvate, [1-13C] pyruvate hydrate, 13C 
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bicarbonate and 13C carbon dioxide. The ability to investigate more than one 
hyperpolarised species in one image reduces the time required to individually 
hyperpolarise each complex of interest, for instance, 13C bicarbonate can take up to    
3.5 hours to hyperpolarise greater than 95 % of the sample.  
In a paper published in 2011,38 Park et al. reported the use of DNP to understand the 
early response to the chemotheraputic drug, Temozolomide, often used to treat 
remaining tumour cells after surgery. This was completed by looking at the metabolism 
of pyruvate to lactate in the human tumour cells implanted into rats. This new method 
could detect changes in the metabolism of the tumours cells within 2 days and in some 
cases within 1 day, but the standard method of investigation did not show reduction 
until between 5-7 days. This difference could prove to be significant as it provides a 
method to investigate the effect of the drug treatment such that treatment of the tumour 
can be adjusted accordingly as soon as possible. 
These techniques are reasonably well developed and illustrate the potential of 
hyperpolarisation techniques applied to biological systems.  
1.2.5 Parahydrogen induced polarisation 
Parahydrogen induced polarisation (PHIP) is a method of hyperpolarisation that derives 
the hyperpolarised state from one of the spin isomers of hydrogen, parahydrogen.  
1.2.5.1 Parahydrogen applied to NMR spectroscopy 
1H has a nuclear spin quantum number of a ½ and can therefore take the value +½ or     
-½, commonly written as α or β respectively. Therefore, in H2 these values can combine 
to produce four molecular nuclear spin wavefunctions of αα, (αβ - βα), (αβ + βα) and 
ββ, where the normalisation factors have been omitted for simplicity. These four spin 
configurations can be further grouped according to the symmetry of their nuclear spin 
wavefunction with respect to exchange of the nuclei. Exchange of nuclei for αα,         
(αβ + βα) and ββ leads to no change in the sign of the nuclear wavefunction and so can 
be considered symmetric. When dihydrogen is found in these three states it is termed 
orthohydrogen and corresponds to the nuclear triplet. Exchange of the nuclei in the    
(αβ – βα) term leads to a change of sign and therefore is considered to have an 
antisymmetric nuclear wavefunction. This is the singlet state of dihydrogen and is 
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termed parahydrogen. Normal hydrogen contains 75 % orthohydrogen and 25 % 
parahydrogen. 
The strength of the signal that is detected in an NMR experiment is dependent on the 
relative difference between the populations of magnetic energy levels that are probed. In 
the case of normal hydrogen, the four energy states are nearly equally populated at room 
temperature (see Figure 1.11a) according to the Boltzmann distribution resulting in only 
1 in 32,000 protons being observable in a 9.4 T (400 MHz) magnetic field. In the case 
of pure parahydrogen, only one of the four potential spin configurations (αβ-βα) is 
populated leading to a large population difference between the four magnetic states (see 
Figure 1.11b). The selection of this state is discussed in section 1.3.1. This is a non-
Boltzmann spin distribution and so consequently can be termed as a hyperpolarised 
state. 
 
Figure 1.11 Schematic showing the relative populations the wavefunctions available to a) normal 
hydrogen and b) parahydrogen. 
As the magnetic spins of parahydrogen are effectively antiparallel to each other 
meaning it has no net nuclear spin, it is not observable by NMR spectroscopy until its 
symmetry is broken. Traditionally, this means the hydrogen molecule must be 
incorporated into another molecule via for the enhancement to be observed. This can be 
achieved through direct hydrogenation and the result has been called parahydrogen 
induced polarisation (PHIP).39 This hydrogenation is commonly of a metal complex to 
form two chemically distinct hydrides. These two protons can be represented by the 
labels αα, αβ, βα and ββ which exist in four different energy levels when placed in a 
magnetic field.  
When the metal complex has been hydrogenated with normal hydrogen, shown in 
Figure 1.12a, the populations of the four available magnetic states follow the Boltzmann 
distribution, leading to the observation of a small signal in NMR spectroscopy. When 
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the same hydrogenation is completed with parahydrogen, the initial (αβ-βα) state of 
parahydrogen can only populate either the αβ and βα states in the hydrogenation 
product. This leads to a large population difference between magnetic states in the 
product; a hyperpolarised state. This is shown in Figure 1.12b. When this state is 
interrogated by NMR, enhanced signals are observed. 
 
Figure 1.12 Schematic showing the magnetic distribution and NMR signals that result for an H2 addition 
product of a) normal hydrogen and b) parahydrogen. Figure reproduced from a paper published by 
Duckett et al.40 
An important consideration of applying parahydrogen to NMR through PHIP is the 
requirement to use a 45o pulse rather than a 90o pulse.41 This is because the signals 
derived from parahydrogen are maximised using a 45o pulse (see section 1.3.3.2). 
The idea of creating an enhanced nuclear state through hydrogenation with of 
parahydrogen was first postulated in a paper published in 1986 by Bowers and 
Weitekamp42 and was experimentally observed in a publication by the same group in 
1987.43 The effect was termed PASADENA to stand for ‘parahydrogen and synthesis 
allow dramatically enhanced nuclear alignment’. PASADENA occurs when the 
parahydrogen is added to the sample at high fields. The Eisenberg group experimentally 
observed44 the PHIP phenomenon almost concurrently but was misinterpreted as an 
observation of chemically induced dynamic nuclear polarisation (CIDNP). In 1987, the 
group published a second paper45 explaining the observation using the prediction of 
PHIP published by Bowers and Weitekamp42 with new systems. 
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A year later in 1988, Pravica and Weitekamp46 also published a new method of PHIP. In 
this case the parahydrogen was added to the solution outside the NMR spectrometer 
and therefore the magnetic states are created at low field. This was termed ALTADENA 
to stand for ‘adiabatic longitudinal transport after dissolution engenders nuclear 
alignment’. Both methods are followed by interrogation by NMR at high field.  
These are complex phenomena and have been reviewed by Natterer and Bargon,41 
Duckett and Sleigh,47 and more recently by Duckett and Mewis48 and Duckett and 
Blazina.49 
1.2.5.2 Inorganic applications of PHIP 
The enhancement gained through the application of PHIP has allowed the detection of 
very low concentration and short lived complexes and intermediates in inorganic 
chemistry.40,41,47,50 A paper published in 1994 by Duckett et al.51 (with corrections 
published in 199752) discussed the observation of new intermediates in hydrogenation 
catalysed by Wilkinson’s catalyst, achieved through the application of PHIP. Up to the 
point of publication of the paper, the mechanism of Wilkinson’s catalyst, a well-studied 
catalyst for the hydrogenation of olefins, was postulated as shown in Figure 1.13. 
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Figure 1.13 Schematic of the mechanism of the hydrogenation of olefins by Wilkinson’s catalyst as of 
1994. Adapted from a  paper published in 1994 by Duckett et al.51 
Although this mechanism was generally accepted, the geometry of the 6-coordinate 
complex is unknown due to limitations of the methods used, with two isomers 
postulated in literature, shown far right in Figure 1.13. The key finding of the 
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investigation was observed accessibility of the Rh(III)/Rh(I) dimers (shown in Figure 
1.14a) whose stability increased upon decreasing the electron richness of the olefin to be 
hydrogenated. These dimers can form 6-coordinate complexes in which the phosphine 
ligands are cis to each other. The nature of the ligand trans to the second phosphine is 
not concluded in the publication, both isomers are shown in Figure 1.14b. 
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Figure 1.14 Structures of new complexes detected and postulated by Duckett et al.51 in the 1994 
publication concerning new intermediates in the mechanism of hydrogenation by Wilkinson’s catalyst 
where a) is the Rh(III)/Rh(I) dimer H2Rh(PPh3)2(µ-Cl)2Rh(PPh3)(olefin) and b) shows the structures of 
the possible isomers of the RhH2Cl(PPh3)2(olefin) intermediate. 
1.2.5.3 Biological applications of PHIP 
Parahydrogen induced polarisation has also been used in biologically-relevant 
applications, most significantly in the production of contrast agents for MRI,48,53-55 but 
also in detection of biological substrates.56 
A paper published in 2007 by Wood et al.56 discussed the application of PHIP to the 
detection of picomole amounts of biological substrates. This was achieved by the 
addition of parahydrogen to [IrCl(CO)(PPh3)2] to act as a receptor in the presence of the 
substrate of interest in toluene. The reaction followed the scheme in Figure 1.15. 
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Figure 1.15 Reaction of [IrCl(CO)(PPh3)2] with parahydrogen in the presence of pyridine. Image 
reproduced from the 2007 publication by Wood et al.56 
The detection was then considered through the enhanced hydride regions, which will 
change depending on which substrate is bound to the complex, created by shaking the 
sample in the presence of parahydrogen and quickly inserting the sample into the 
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magnet. Using this method, it was found possible to detect 50 pmol of pyridine yielding 
hydrides at -21.03 ppm and -21.82 ppm. The characteristic hydride shifts of other 
biologically relevant molecules were also investigated, shown in Table 1.2. 
Substrate (L) Chemical shift of resultant hydrides ligands (ppm) / (ratio of products) 
pyridine -21.03, -21.82 
benzimidazole -19.22, -22.19 
purine a) -21.28, -22.7 b) -20.86, -21.82 c)-19.57, -21.86 / (100:18.6:0.8) 
adenine a) -21.37, -22.74 b) -20.90 c) -20.69, -22.22 
Table 1.2 Characteristic shifts of signals corresponding to the hydride ligands of [IrCl(H)2(PPh3)2(L)] 
where L corresponds to the stated biologically relevant substrates. For purine and adenine, a, b and c refer 
to different isomers of the resultant iridium complex. Data collated from the 2007 publication by Wood et 
al.56 
In 2008, a paper was published by Reineri et al.54 discussing the production of 
hyperpolarised 13C MRI contrast agents using PHIP. To produce a suitable 13C MRI 
contrast agent via PHIP, the molecule must obey a number of rules. The first is that it 
must contain an unsaturated bond that can be efficiently hydrogenated via a metal 
catalyst, commonly a triple bond. This unsaturated bond must also be adjacent to a 
carbonyl group such that a carbon with a long T1 is polarised, limiting the loss of 
polarisation due to relaxation. The polarisation is transferred to this carbon centre 
through scalar coupling with the protons derived from parahydrogen.  
These ideas were taken a further step by the group when extending the applicability to 
MRI. For clinical use in imaging, it is preferable for the contrast agent to be water 
soluble and non-toxic. In many cases, the catalysts required for hydrogenation are not 
water soluble and the metals required in those catalysts are toxic to humans. The 
substrates to be investigated were therefore designed to contain (oligo)oxyethylenic 
chains such that the hydrogenated product was water soluble, but could be 
hyperpolarised in chloroform where the catalyst is more efficient. The group 
investigated the applicability of two potential new 13C MRI contrast agents: 2-(2-
methoxyethoxy)ethyl phenylpropiolate (asymmetric, Figure 1.16a) and bis[2-(2-
methoxyethoxy)ethyl]acetylenedicarboxylate (symmetric, Figure 1.16b). 
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Figure 1.16 Hydrogenation reactions of 1, 2-(2-methoxyethoxy)ethylphenylpropiolate and 2, bis[2-(2-
methoxyethoxy)ethyl]acetylenedicarboxylate with products termed 1a and 2a respectively. Adapted from 
the 2008 paper published by Reineri et al.54 
Upon PHIP hydrogenation with the catalyst [bis(diphenylphosphino)butane](1,5-
cyclooctadiene)rhodium(I) tetrafluoroborate, the asymmetric substrate, 1, only exhibited 
enhanced 13C NMR signals under ALTADENA conditions and not under PASADENA 
conditions. The symmetric substrate, 2, also exhibited enhanced 13C NMR signals but 
under both PASADENA and ALTADENA conditions. This, together with the 
information that 2a showed a degree of water solubility meant substrate 2a was taken 
further. It was then possible to complete the hydrogenation reaction in chloroform and 
transfer the hyperpolarised substrate into water for in vivo administration, thus saving 
time compared to standard methods of elimination of solvent and catalyst and 
dissolution in water.  
To complete a measurement, the catalyst and substrate 2 were dissolved in a 6:1 
chloroform to acetone mixture and the hydrogenation with parahydrogen completed. 
D2O is then quickly added, and the sample shaken to dissolve the hyperpolarised 
hydrogenated substrate in the water. This is then allowed to settle for a short time before 
the water is moved to a second NMR tube for interrogation by 13C NMR spectroscopy. 
The resultant spectrum is shown in Figure 1.17. 
 
Figure 1.17 Single scan 13C spectrum of 13C labelled substrate 2a (see Figure 1.16) extracted in D2O after 
hydrogenation with parahydrogen. a) was recorded as soon as was practical after the hydrogenation step, 
and b) was  collected after relaxation (5 min). Image taken from the 2008 publication by Reineri et al.54 
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Two 13C signals are observed in Figure 1.17; one corresponding to 2a dissolved in D2O, 
at 165.99 ppm, and one corresponding to 2a dissolved in residual chloroform,       
164.82 ppm. The enhancement of this signal was calculated to be around 100 fold. 
While a significant enhancement, this value might be much higher if the phase 
separation step is optimised to be quicker. The group consequently provided a new 
potential method by which to produce hyperpolarised 13C MRI contrast agents, which 
may be further optimised through selection of substrates with more optimal separation 
before and after hydrogenation.  
1.2.5.4 Comparison of PASADENA and ALTADENA 
A paper published in 2009 by Korchak et al.,57 investigated the effect on resultant NMR 
spectra of completing parahydrogenation of styrene to ethylbenzene with the catalyst 
[1,4-bis(diphenylphosphino)butane](1,5-cyclooctadiene)rhodium BF4, shown in Figure 
1.18, at a set number of magnetic fields. 
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Figure 1.18 Hydrogenation reaction of a) styrene to b) ethylbenzene with [1,4-
bis(diphenylphosphino)butane](1,5-cyclooctadiene)rhodium BF4 including relevant labels. Adapted from 
a publication in 2009 by Korchak et al.57 
Strong PHIP signals can be observed at all fields of parahydrogenation investigated, 
shown in Figure 1.19. It shows the ALTADENA-type spectrum obtained at 0.1 mT is 
characterised by the net polarisation of the two groups having opposite sign gradually 
changes to a PASADENA-type spectrum, characterised by antiphase mutiplets, as the 
field of parahydrogenation is increased. Below 0.2 mT, hyperpolarisation is also 
observed in the aromatic protons, attributed to transfer from the CH2 group through 
scalar coupling.  
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Figure 1.19 1H NMR at 7 T and PHIP spectra collected after parahydrogenation at stated polarisation 
field and acquisition at 7 T. * denotes signals corresponding to bound ethylbenzene. Reproduced from a 
publication in 2009 by Korchak et al.57 
1.2.6 Signal amplification by reversible exchange  
1.2.6.1 Introduction to SABRE 
Signal Amplification By Reversible Exchange (SABRE) is a form of non-hydrogenative 
PHIP. The parahydrogen molecule is not incorporated into the substrate of interest 
unlike conventional PHIP experiments. Instead, the parahydrogen molecule undergoes 
a reversible oxidative addition reaction with a metal centre. This metal centre is also 
able to facilitate the reversible exchange of the substrate of interest, creating a metal 
template through which the parahydrogen and substrate are able to come into temporary 
contact with each other (Figure 1.20). It is through this template that the hyperpolarised 
state is able to transfer from parahydrogen to the substrate. 
 
Figure 1.20 Schematic of the SABRE process showing non-hydrogenative transfer of hyperpolarised 
states from parahydrogen to a substrate via a metal catalyst. Adapted from the publication by Adams et 
al. (2009).58 
A major benefit of SABRE is that the substrate is not hydrogenated during 
interrogation. It has therefore negated the need for unsaturated precursors, as would be 
required for PHIP, and provides a catalytic system as the substrate is not consumed.  
80 
1.2.6.2 Theory behind transfer 
In a paper published by Adams et al (2009),59 the theory behind the spontaneous 
polarisation transfer observed in SABRE was discussed. The paper presented a theory 
based on a simplified model in which polarisation transfer is only considered via scalar 
coupling and chemical shift evolution between parahydrogen-derived hydrides and a 
single substrate molecule containing only one proton pair. A schematic of this is shown 
in Figure 1.21. 
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Figure 1.21 The general structure of a SABRE catalyst (a) and the simplified schematic utilised by the 
theory reported in Adams et al. (2009)59 (b), where M = metal and Sub = substrate. The hydride pairs (H) 
are derived from parahydrogen in each case. 
There are two significant differences between the real life situation and the model. In 
reality, polarisation is transferred into both equatorial sites however this is modelled as 
only one equatorial site. The substrate has also been modelled as a single pair of 
protons. This is because a typical substrate, such as pyridine, can contain five or more 
nuclei thereby creating a large scalar coupling network, which is time consuming to 
model. Within the model, the term spin referred to nuclear spins only and the term 
scalar coupling referred to isotropic spin-spin couplings, often known as J-coupling. 
The model complex is therefore a four-spin system comprising of two spins originating 
from parahydrogen and two spins from bound substrate.  
The results from this theoretical study completed in MATHEMATICATM,60 showed that 
the scalar coupling network between the parahydrogen derived hydrides and pair of 
protons on the substrate across the magnetically active metal centre allows the transfer 
of polarisation within the complex. This transfer is greatly affected by the fine balance 
between the scalar coupling and chemical shift effects of the system. As a result of this, 
the process is therefore both magnetic field and time dependent (based on the lifetime of 
the complex). This model is said to be consistent with results obtained in a later paper 
published by Adams et al.58 
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1.2.6.3 The phosphine ligand vs. the carbene ligand 
In the literature, two main types of catalyst have been investigated in the field of 
SABRE. These have the structure [Ir(L)(COD)(Cl/py)], where L is either a phosphine 
ligand58,61-65 or a carbene ligand.66,67 It is therefore important to consider the differences 
between these two ligands.  
1.2.6.4 Phosphine-based catalysts 
The most common phosphine based SABRE catalyst is Crabtree’s catalyst, shown in 
Figure 1.22.  
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Figure 1.22 Structure of Crabtree’s catalyst. 
Crabtree’s catalyst is a well-known hydrogenation catalyst.68-70 When it was introduced, 
it was found to exhibit a much faster hydrogenation rate than the previously used 
Wilkinson’s catalyst for substrates such as cyclohexene and 1-methylcyclohexene.68 It 
was later observed that Crabtree’s catalyst also showed significantly increased activity 
against sterically hindered alkenes such as 2,3-dimethylbut-2-ene69 for which 
Wilkinson’s catalyst showed no activity. 
The ability to direct the hydrogenation completed using Crabtree’s catalyst in 
homogeneous reactions is discussed in a paper published in 1986 by Crabtree and 
Davis70 It was observed that by the addition of an alcohol group to a 1-
methylcyclohexene ring (see Figure 1.23), the ring is able to take on a configuration 
where the alcohol group can take a pseudoaxial position. 
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Figure 1.23 Generic structure and reaction of the 1-methylcyclohexene rings investigated in a publication 
by Crabtree and Davis,70 using terpinen-4-ol as an example. The side view of the conformation of interest 
is also shown, where a) refers to the product formed by directed hydrogenation and b) refers to the 
product formed by counterdirected hydrogenation. 
The confirmation means one face (with the OH group) is more polar than the other (the 
face without an OH group), leading to an opportunity to direct the hydrogentation using 
solvent. The behaviour of the substrate in the presence of Crabtree’s catalyst in a polar 
solvent will be hard to predict however, in a non-polar solvent such as dichloromethane 
(DCM), it can be predicted that the polar face of the substrate will turn towards the 
catalyst. This leads to a directing effect when considering hydrogenation of such a 
substrate, resulting in hydrogenation on the polar face of the substrate and consequently 
leading to the production of the desired product. Initially, the substrates in Figure 1.24 
were investigated, all of which possess a hydroxyl functional group. 
OH OH OH OH OHOH
1                      2                     3                      4                             5                           6  
Figure 1.24 Structures of selected substrates investigated in a publication by Crabtree and Davis70 This 
group are characterised by the alcohol group being bound directly to the ring. 
The hydrogenation of these substrates using Crabtree’s catalyst was proven to be 
successful. A total yield of a minimum of 97.3 % was found in each case, and of that 
yield, a minimum of 96.2 % was the directed product. A series of substrates with an 
exo-cyclic alcohol group or oxygen based functional group, such as an ether or ketone 
group, were also investigated with varying degrees of success.  
Crabtree’s catalyst is also a known H-D exchange catalyst.71  In a paper published in 
2001 by Ellames et al.,71 The effect of changing the substituents on various ketone and 
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acid derivatives on deuteration by Crabtree’s catalyst was investigated. The basic 
reaction investigated is shown in Figure 1.25. 
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Figure 1.25 Deuteration reaction investigated in the 2001 paper published by Ellames et al.71 
The group found that the exchange of protons mediated by Crabtree’s catalyst is 
maximised through the addition of an sp2 hybridised nitrogen or oxygen atom via a five 
membered metallacycle. In general, if the electron donation to the directing heteroatom 
is increased, the degree of deuterium incorporation increases. It was also observed that 
mono-ortho substitution did not affect the level of deuteration observed to the second 
ortho site and that bulky meta substituents hindered deuterium incorporation. 
The group also presented a simplified mechanism for the exchange process in the 
presence of deuterium oxide (D2O), reproduced in Figure 1.26. 
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Figure 1.26 A simplified mechanism for HD exchange in the presence of deuterium oxide by Crabtree’s 
catalyst, reproduced from a paper published by Ellames et al.71 in 2001.  
It is possible to observe that first the catalyst is activated in the presence of three 
equivalents of deuterium gas, 2 equivalents to hydrogenate the COD to octane, and the 
third to add to the metal centre through an oxidative addition. The deuterium oxide then 
binds to the two vacant sites producing the active catalyst, 
[Ir(PCy3)(D)2(D2O)2(py)]PF6. The mechanism then shows deuteration of the ortho 
position to a directing group, where the deuterium atoms are sourced from D2O. 
1.2.6.5 Crabtree’s catalyst applied to SABRE 
The SABRE phenomenon was first published by Adams et al. in 2009 in Science.58 The 
paper concerned polarisation transfer into pyridine and nicotinamide, indicating 
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enhancements in not only 13C, 15N, but also 1H , 19F and 31P signals, a significant 
advantage over DNP in which 1H enhancement is not routinely available. It also alluded 
to applications within MRI. 
These ideas were investigated in greater detail in a paper of the same year by Atkinson 
et al.61 Here, Crabtree’s catalyst was altered such that the phosphine ligand is changed. 
A series of 8 phospines were investigated to show the catalyst containing a PCy2Ph 
ligand exhibited the greatest polarisation transfer into pyridine, where Crabtree’s 
catalyst exhibited the second greatest polarisation transfer into pyridine. The paper also 
indicated that varying temperature or magnetic field of the polarisation step can have a 
great effect on the extent of polarisation transfer by the SABRE effect.  
SABRE has also been applied to the detection of low concentrations of amino acids and 
peptides,64 and the effect of changing the magnetic field of polarisation on the extent of 
polarisation transfer exhibited by Crabtree’s catalyst also investigated.65 The SABRE 
effect has even been applied to low field NMR in papers published by Gong et al.62 and 
Theis et al.63 In the paper published by Gong et al.62 thermally polarised spectra 
collected on a low field NMR spectrometer have been compared to those collected 
under hyperpolarised conditions using SABRE with Crabtree’s catalyst. The resultant 
spectra are presented in Figure 1.27. 
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Figure 1.27 Comparison of low field NMR spectra with SABRE enhancement (left) and thermal 
polarisation (right). Single-scan 1H FIDs and corresponding spectra (inset) of the indicated volumes of 
pyridine in 0.4 ml methanol solutions. Image taken from the publication by Gong et al.62 
Figure 1.27 shows volumes of pyridine as low as 4.9 nL can be observed using the 
SABRE technique, where it is not observed using thermally polarised conditions. The 
signal intensity observed for the 4.9 µL pyridine sample is also significantly greater in 
the SABRE polarised spectrum. 
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The paper published by Theis et al.63 extended this to include polarisation of 15N 
pyridine. The application of SABRE has allowed the collection of a low field 15N NMR 
spectrum of 15N labelled pyridine in a single scan, but also pyridine with naturally 
abundant nitrogen in 128 averaged scans.  
1.2.6.6 Carbene-based catalysts 
There are also two SABRE papers which consider the carbene-based catalyst, 
[Ir(IMes)(COD)Cl] (IMes(a))66,67 which is a carbene analogue of Crabtree’s catalyst. 
Complexes composed of a carbene ligand tethered to a metal centre are published for 
their activities in alkylation of amines with alcohols,72 hydrogenation,73,74 regioselective 
hydrothiolation of alkynes,75 as potential organic light emitting diodes76 and biological 
activities as antimicrobial and anti-tumour agents.76 
In a 2001 publication by Lee et al.,74 the carbene analogue of Crabtree’s catalyst 
[Ir(COD)(py)(SIMes)]PF6 was synthesised and tested for its hydrogenation activity. Of 
the four simple systems investigated, it was only in the case of 1-methyl-1-cyclohexene 
at elevated temperatures that the new complex offered an improvement over the 
previously employed Crabtree’s catalyst. This was a significant result as Crabtree’s 
catalyst is not thermally stable and therefore the carbene analogues may offer a method 
to investigate hydrogenations at higher temperatures. 
The activity for hydrogenation of carbene analogues of Crabtree’s catalyst was also 
discussed in a 2006 publication by Vazquez-Serrano et al.,73 in which a large number of 
alternative catalysts were considered. The activity of [Ir(COD)(IMes)Cl] in the 
hydrogenation of 1-octene is discussed here due to the catalysts application to SABRE. 
When hydrogenating 1-octene with [Ir(COD)(IMes)Cl], a number of products were 
observed by the group; octane, trans-2-octene, cis-2-octene and a range of unidentified 
internal isomers of octene. A time profile of the reaction is presented in Figure 1.28. 
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Figure 1.28 A time profile of the hydrogenation of 1-octene with [Ir(COD)(IMes)Cl] presented in the 
2006 publication by Vazquez-Serrano et al.73 
The Crabtree’s analogues, [Ir(L)(COD)Cl] and [Ir(L)2(COD)]Cl have also been shown 
to exhibit HD exchange much like Crabtree’s catalyst.77,78 A specific example of this 
type of catalyst exhibiting better efficiency than Crabtree’s catalyst can be found in the 
2010 publication by Nilsson and Kerr.78 Here, the group deuterate the Bayer AG 
anthelmintic drug, niclosamide as shown in Figure 1.29. 
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Figure 1.29 Labelling of niclosamide (Bayer AG) adapted from the 2010 publication by Nilsson and 
Kerr.78 
The application of the catalyst [Ir(COD)(IMes)(PPh3)]PF6 over Crabtree’s catalyst 
resulted in a significant improvement in the extent of deuteration of the substrate. With 
a catalyst concentration of 5 mol% for 1 hour at room temperature under D2 gas, the 
catalyst [Ir(COD)(IMes)(PPh3)]PF6 achieved a minimum of 52 % incorporation of 
deuterium to sites a, b, c and d. Under the same conditions with Crabtree’s catalyst, less 
than 15 % incorporation of deuterium on positions a and b only was observed (labels in 
reference to Figure 1.29). 
An important structural observation has also been made concerning carbene-analogues 
of Crabtree’s catalyst. There are examples in the literature79 of complexes possessing a 
carbene ligand which CH activates to a metal in an intramolecular manor. Of particular 
89 
interest are those where one of the methyl groups in the mesitylene rings of IMes80,81 
binds to a metal. This is illustrated in Figure 1.30. 
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Figure 1.30 Chemical structure and X-ray structure of [Ir(IMes’)(NCMe)3(R)]PF6 taken from a 
publication by Torres et al.80 
1.2.6.7 Carbene-analogues of Crabtree’s catalyst applied to SABRE 
The increase in polarisation transfer to pyridine via SABRE using a carbene-based 
catalyst rather than a phosphine base catalyst was first published by Cowley et al.66 in 
2011. 243 fold enhancements were reported to the ortho position of pyridine in a single 
scan 1H NMR spectrum under 3 bar parahydrogen, and 6, 000 fold 1H signal 
enhancement was observed for pyridine at 3 T in an MRI system. This paper also 
introduced an automised polarisation flow system for use with SABRE. This flow 
system increased accuracy in the application of a magnetic field during the polarisation 
transfer step. The polarisation transfer field which produces the greatest signal 
enhancement in pyridine could therefore be investigated to ± 5 G, observed for pyridine 
polarised with [Ir(IMes)(COD)Cl] to be 70 G.  
This catalyst was also used in a paper published by Lloyd et al.67 to investigate the 
application of SABRE to 2D sequences, achieved through the use of the previously 
mentioned polarisor or ultrafast methods by Lucio Frydman.82,83 These results are 
discussed further in Chapter 5. 
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1.2.7 Only Parahydrogen SpectroscopY (OPSY) 
1.2.7.1 Introduction to OPSY 
The OPSY sequence was first described in a publication by Aguilar et al.84 in 2007. The 
OPSY sequence is designed to select specific magnetic states within an interrogated 
substrate, for instance, double quantum terms (IzSz) can be selected using a double 
quantum filter in the OPSYdq sequence. This is particularly useful when looking at 
SABRE experiments as parahydrogen starts in a singlet state. When a molecule of 
parahydrogen adds to a metal centre in an oxidative manner to create two hydrides, the 
zero quantum (ZQ), single quantum (SQ) and double quantum (DQ) terms evolve. 
When these are combined with other molecular spins, a large number of terms are 
generated across the spin system. Within this spin system, the multiple quantum terms 
(MQ) are able to transfer into the substrate. In a thermal sample (without 
parahydrogen), double quantum terms are not observable by a single 90o pulse due to 
symmetry rules and are not observable by use of a OPSYdq sequence because they are 
present in a very low proportion. Addition of polarisation derived from parahydrogen 
through the SABRE technique means double quantum states are much more prominent. 
This phenomenon allows for the observation of only nuclei which have double quantum 
states derived from parahydrogen, filtering out signals that have not been affected by 
parahydrogen and so has the potential to ‘light up’ specific compounds polarised by 
SABRE within the NMR spectrum. This has been considered further in section 1.3.3. 
1.3 Experimental considerations 
1.3.1 Production of parahydrogen 
The overall wavefunction (Ψoverall) for a homonuclear system can be separated into the 
following five components, the electronic, nuclear, translational, rotational and 
vibrational wavefunctions (Ψe,Ψn, Ψt, Ψr and Ψv, Equation 1.1).  
Ψoverall = Ψe x Ψn x Ψt x Ψr x Ψv 
Equation 1.1 The overall wavefunction of a system can be split into five compnents, the electronic, 
nuclear, translational, rotational and vibrational wavefunctions.  
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According to the symmetry postulate of quantum mechanics, dihydrogen must have an 
antisymmetric overall wavefunction, therefore one of the five wavefunction components 
must also be antisymmetric. In the case of homonuclear diatomics, the vibrational, 
translational and electronic wavefunctions are symmetric however the rotational and 
nuclear wavefunctions can be either symmetric or antisymmetric in nature. As described 
in section 1.2.5.1 (pg 71), parahydrogen has an antisymmetric nuclear wavefunction 
and therefore the rotational wavefunction must be symmetric to ensure the overall 
wavefunction is antisymmetric. This means that parahydrogen can only take even 
values of J (rotational quantum number), and so is able to form the most stable spin 
isomer of hydrogen where J = 0. If normal hydrogen gas is cooled to 20 K in the 
presence of a suitable spin exchange catalyst, the majority of spins fall into the most 
stable spin isomer where J = 0, and so hold a symmetric rotational wavefunction, 
becoming parahydrogen. Further details of the experimental production of 
parahydrogen are included in the Experimental section. 
1.3.2 Description of observed signals 
In a thermally polarised 1H NMR spectrum, it would be expected that the spectrum 
could be phased such that all signals are in absorption. Due to the application of 
parahydrogen through SABRE, this is not the case for many of the spectra presented in 
this thesis. An example of typical hyperpolarised spectrum is shown in Figure 1.31. 
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Figure 1.31 Typical 1H NMR spectra of hyperpolarised quinoline indicating various signal forms. 
Figure 1.31 indicates three different types of signal that could potentially be observed 
when applying parahydrogen to NMR investigations. The first type of signal presents as 
an enhanced version of the thermally polarised signal, in absorption but with a larger 
integral, observed in Figure 1.31 for proton 6. The second type of signal presents as 
180º out of phase relative to thermally polarised signals i.e. in emission, observed in 
Figure 1.31 for protons 2, 4, 5 and 8. There is also a third presentation in which the 
signals appear antiphase. This is shown in Figure 1.31 for proton 7 and to a lesser 
extent, for proton 3. The enhancements quoted throughout this thesis also represent the 
sign of the signals observed. A positive enhancement value indicates the signal was of 
positive phase, and a negative enhancement values indicates the signal was of negative 
phase. In the case of an antiphase signal, the integral of whole peak is taken and 
therefore contains a mixture of both absorption and emission character. The quoted 
enhancement is therefore lower as a result of cance
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1.3.3 NMR described in terms of product operators 
1.3.3.1 Introduction to product operator terms85 
Considering NMR in terms of product operators provides a set of quantum mechanical 
operators which can be used to describe spin states which broadly fit into the traditional 
vector model and extend to where the vector model falls down. In the case of an 
uncoupled, spin-½ nuclei, I, the four product operators, ½Ê, Îx, Îy and Îz are required. 
The first is retained for purely formal reasons and will not be discussed again. The final 
three correspond to the bulk x, y and z magnetisation of a single spin in the rotating 
frame and are termed single spin operators or in-phase operators.  
The application of an RF pulse is considered to be aligned to either the x axis or y axis, 
with such a frequency that it causes a rotation in the magnetisation. When an RF pulse 
is applied to create a rotation of β degrees, it is referred to as βx or βy depending on 
which axis that pulse is applied to. This has the following effects on the above 
mentioned product operators. 
Îx – (βx) → Îx     Îx – (βy) → Îxcosβ - Îzsinβ 
Îy – (βx) → Îycosβ + Îzsinβ   Îy – (βy) → Îy 
Îz – (βx) → Îzcosβ - Îysinβ   Îz – (βy) → Îzcosβ + Îxsinβ 
These states must also be considered with respect to the free precession experienced 
after the application of an RF pulse. This is considered for the frequency of the 
precession, Ω, for a period of time, t.  
Îx – (Ωt) → Îxcos(Ωt) + Îysin(Ωt) 
Îy – (Ωt) → Îycos(Ωt) - Îxsin(Ωt) 
Îz – (Ωt) → Îz 
This idea can then be extended to include a second spin, labelled S, which is coupled to 
the first. The spin S can be described in the same way as the spin I in that four product 
operators, ½Ê, Ŝx, Ŝy and Ŝz, are required, and evolve in the same manor under βx, βy, 
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and Ωt. As the two spins are coupled, 16 product operators are required to describe the 
system, as outlined in Table 1.3. 
 ½Ê Ŝx Ŝy Ŝz 
 
 
2x 
½Ê ½Ê Ŝx Ŝy Ŝz 
Îx Îx 2ÎxŜx 2ÎxŜy 2ÎxŜz 
Îy Îy 2ÎyŜx 2ÎyŜy 2ÎyŜz 
Îz Îz 2ÎzŜx 2ÎzŜy 2ÎzŜz 
Table 1.3 Required product operators required to describe a system containing two coupled spins, I and S. 
This has created nine new terms together with the single spin operators. The 2ÎzŜz term 
is a form of z polarisation. The remaining terms can then be split into terms of 
transverse polarisation, discussed below, and multiple quantum terms which are 
discussed later. 
2ÎxŜz, 2ÎyŜz, 2ÎzŜx and 2ÎzŜy are forms of transverse polarisation, sometimes referred to 
as antiphase operators. These can be detected indirectly as they evolve into observable 
in-phase terms. Manipulation of these terms with respect to β must be considered 
carefully, and as such, β must be separated for each spin to (β)I and (β)S. For instance, 
application of (β)I to S will have no effect if I represents 
1H and S represents 13C. After 
an RF pulse, evolution due to chemical shift must be considered as before, however, 
because the spins are coupled, evolution due to J-coupling (JIS) must also be considered. 
First, this is considered for the single spin operators. 
Îx – (πJISt) → Îxcos(πJISt) + 2ÎyŜzsin(πJISt) Ŝx – (πJISt) → Ŝxcos(πJISt) + 2ÎzŜysin(πJISt) 
Îy – (πJISt) → Îycos(πJISt) - 2ÎxŜzsin(πJISt) Ŝy – (πJISt) → Ŝycos(πJISt) - 2ÎzŜxsin(πJISt) 
Îz – (πJISt) → Îz    Ŝz – (πJISt) → Ŝz  
Second, this is considered for the terms referring to transverse magnetisation, the 
antiphase terms. 
2ÎxŜz – (πJISt) → 2ÎxŜzcos(πJISt) + Îysin(πJISt) 
2ÎyŜz – (πJISt) → 2ÎyŜzcos(πJISt) – Îxsin(πJISt) 
2ÎzŜz – (πJISt) → 2ÎzŜz 
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2ÎzŜx – (πJISt) → 2ÎzŜxcos(πJISt) + Ŝysin(πJISt)  
2ÎzŜy – (πJISt) → 2ÎzŜycos(πJISt) – Ŝxsin(πJISt) 
The terms 2ÎxŜx, 2ÎxŜy, 2ÎyŜy and 2ÎyŜx are multiple quantum coherences between the 
spins. These terms are not directly observable. For a two spin system, there are two 
types of multiple quantum coherence, the double quantum coherence and zero quantum 
coherence, each with an x and y component. The four coherences outlined below can be 
combined to produce the four multiple coherences stated above.  
DQx = ½ (2ÎxŜx - 2ÎyŜy)   DQy = ½ (2ÎyŜx + 2ÎxŜy) 
ZQx = ½ (2ÎxŜx + 2ÎyŜy)   ZQy = ½ (2ÎyŜx - 2ÎxŜy) 
In these cases, evolution under chemical shift must be considered differently. Double 
quantum states evolve under the sum of the two spin frequencies (ΩI+ΩS) and zero 
quantum states evolve under the difference of the two spin frequencies (ΩI-ΩS). 
Multiple quantum states do not evolve under J-coupling between themselves (JIS) in a 
weak coupling regime, but can evolve with respect to a coupling to a third spin.  
DQx – ((ΩI + ΩS)t) → DQxcos((ΩI + ΩS)t) + DQysin((ΩI + ΩS)t) 
ZQx – ((ΩI - ΩS)t) → ZQxcos((ΩI - ΩS)t) + ZQysin((ΩI - ΩS)t) 
In thermally equilibrated NMR, nuclei start with longitudinal z-magnetisation, Iz or Sz. 
They evolve as described below upon interrogation with a 90º pulse.  
Îz – (90ºy) → Îzcos(90) + Îxsin(90) → Îx – (ΩIt) → Îxcos(Ωt) + Îysin(Ωt) – (πJISt) → 
Îxcos(ΩIt)cos(πJISt) + 2ÎyŜzcos(ΩIt)sin(πJISt) + Îysin(ΩIt)cos(πJISt) - 
2ÎxŜzsin(ΩIt)sin(πJISt) 
These four terms can be further separated. The Îy term produces the imaginary FID. The 
amplitude of the Îx term can be rewritten using the following trigonometric identity, 
cosAcosB=½(cos(A+B)+cos(A-B))  
as below such that an in-phase doublet is observed. 
Îxcos(ΩIt)cos(πJISt) = Îx[½cos((ΩI + πJIS)t) + ½cos((ΩI - πJIS)t)] 
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The single quantum coherences (2ÎyŜz and 2ÎxŜz) are not directly observable but evolve 
into observable magnetisation during the acquisition time. This is an important 
observation for consideration of more complicated sequences, for instance the COSY 
and INEPT NMR sequences.  
1.3.3.2 Using product operators to understand parahydrogen induced polarisation 
(PHIP) 
Two coupled magnetically and chemically inequivalent protons derived from one 
parahydrogen molecule, such as those observed in an asymmetric hydrogenation 
product, are present in an ÎzŜz state, not an Îz and Ŝz state. This has a significant result on 
the NMR spectra produced. In this case, both I and S represent parahydrogen derived 
protons. In the case of PASADENA, the hyperpolarised states are prepared at high field 
inside the spectrometer and the 2ÎzŜz state is dominant. In the case of ALTADENA 
where the states are prepared outside the magnet in low field, the states, ½(2ÎzŜz) ± ½(Îz 
- Ŝz), are present.
86 Both these cases share the 2ÎzŜz starting state which will be 
considered further. As both I and S are protons, βIy and β
S
y are equal but have initially 
been separated for ease of understanding of the transformations. 
2ÎzŜz – (β
I
y) → 2ÎzŜz cos(β
I
y) + 2ÎxŜzsin(β
I
y) – (β
S
y) → 2ÎzŜzcos(β
I
y)cos(β
S
y) +                     
2ÎzŜxcos(β
I
y)sin(β
S
y) + 2ÎxŜzsin(β
I
y)cos(β
S
y) + 2ÎxŜxsin(β
I
y)sin(β
S
y) 
 2ÎzŜzcos
2(β) + 2ÎzŜxcos(β)sin(β) + 2ÎxŜzsin(β)cos(β) + 2ÎxŜxsin
2(β) 
Upon application of a 90º pulse, all terms with a cos(β) component become 
unobservable as cos(90) = 0. This leaves the 2ÎxŜxsin
2(β) term which is a multiple 
quantum term and therefore not directly observable. It is therefore necessary to apply a 
pulse which does not equal 90º, however sin(β)cos(β) is maximised when β equals 45º. 
In a 1H NMR spectrum, this leads to the observation of antiphase doublets at both ΩI 
and ΩS. In PASADENA, these are of equal intensity, however in ALTADENA, the 
addition of the Îz and Ŝz states produces complications.
87 
97 
1.3.3.3 Using product operators to understand the 1H OPSY NMR sequences86 
The 1H OPSY NMR sequence is an important sequence in the application of SABRE as 
it allows the observation of states derived from parahydrogen while filtering out 
thermal signals. The 1H OPSYdq NMR sequence is presented in Figure 1.32. 
 
Figure 1.32 The 1H OPSYdq NMR sequence, adapted from a publication by Aguilar et al.84 
As discussed before, the addition of parahydrogen to a complex results in the two 
protons being in the state 2ÎzŜz. After a 90ºx pulse, the state 2ÎyŜy is produced. This 
evolves as a mixture of zero and double quantum states, as presented below, under (ΩI + 
ΩS) and (ΩI - ΩS), as discussed in section 1.3.3.1. 
2ÎyŜy – (ΩIt), (ΩSt) →  2ÎyŜycos(ΩIt)cos(ΩSt) + 2ÎyŜxcos(ΩIt)sin(Ωst) 
                                             + 2ÎxŜxsin(ΩIt)cos(ΩSt) + 2ÎxŜycos(ΩIt)sin(Ωst) 
A second 90º pulse is proceeded and followed by gradient pulses which act to filter out 
thermal polarisation and select the chosen coherence. For instance, in the case of the 1H 
OPSYdq NMR sequence, the second set of gradients are 2 times the size of the first to 
select the double quantum coherences. In the case of the 1H OPSYzq NMR sequence, 
the second set of gradients are not present to select zero quantum coherences.  
1.4 Thesis aims  
The main aim of this research project is to further develop the recently illustrated 
hyperpolarisation technique, SABRE, for use within the pharmaceutical industry. At the 
start of this project, knowledge of the SABRE technique was established and 
published,58,61 and knowledge of the carbene catalyst IMes(a) was established but not 
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yet published. Knowledge of temperature and magnetic field dependence was also 
hinted at within the literature61,65,66 however in depth, experimental investigations into 
these effects had not yet been completed. This project began with a more extensive 
investigation into methods of optimisation for the SABRE technique including different 
carbene catalysts (a task divided across the whole research group), different 
temperatures, different magnetic fields of polarisation and different solvents then had 
previously been completed. For these optimisation investigations, pyridine was used as 
a reference substrate, as this had been shown to exhibit significant polarisation transfer 
in the literature, and therefore allowed the ability to compare my results with those in 
the literature.  
The application of the SABRE technique to high resolution NMR in the pharmaceutical 
industry was also required. Development of commonly used characterisation sequences 
such as the COSY and HMBC have also been investigated. Of particular importance, 
when this approach is to be applied to the pharmaceutical industry, is to understand the 
functional group tolerance of SABRE and limits of detection, ideally to the level of 0.5 
– 50 µg of material. This thesis outlines the progress made toward these goals in three 
years of study. 
Chapter 2 provides a brief description of the methods and terminology included 
throughout this thesis, particularly in reference to a new flow system able to facilitate 
the use of SABRE. It then goes on to discuss the mechanisms involved in activation of 
SABRE catalysts and of the exchange of ligands from the active complex. The chapter 
then goes on to discuss the structural and electronic differences between three carbene 
catalysts investigated including not just the active catalysts, but also the catalytic 
precursors. Preliminary studies into the effect of these structural and electronic 
differences on the extent of polarisation transfer are also reported.  
These concepts are extended in Chapter 3. Here the effect of other variables which alter 
the extent of polarisation transfer into pyridine such as the magnetic field of polarisation 
transfer, temperature of polarisation transfer, concentration of substrate and catalyst, 
and solvent are investigated. The magnetic field and temperature of polarisation transfer 
is also investigated as a function of catalyst. It is reported that each variable has a 
significant effect on the extent of polarisation transfer into pyridine, and these changes 
are found to be different according to which catalyst is investigated. The potential 
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reasons for the different changes on extent of polarisation transfer are discussed 
including the rate constants of ligand exchange, the excess of hydrogen gas available to 
the sample and varying combinations of active complexes. 
In Chapter 4, these concepts are extended to include the new, larger substrate, quinoline. 
This consists of a pyridine ring fused to a benzene ring creating an aromatic substrate 
with seven magnetically inequivalent protons. Initial investigations into quinoline 
revealed the catalysts used as standard did not facilitate polarisation transfer into 
quinoline however, addition of acetonitrile to the system allowing significant 
polarisation transfer into quinoline. The result of this addition on the structure of the 
active species is discussed. The effects of temperature and magnetic field of polarisation 
transfer, concentration and solvent on the extent of polarisation transfer are then 
investigated. The mechanism of polarisation transfer into quinoline is also investigated 
through the interrogation of quinoline analogues and application of selective 1H 
OPSYdq NMR sequences to quinoline.  
Quinoline is again used in order to investigate the application of SABRE to a number of 
NMR sequences as discussed in Chapter 5. It was chosen for this task because in 
contrast to pyridine, it contains two quaternary carbons, which will help in 
understanding the application of SABRE to 2D heteronuclear sequences. Investigations 
range from 1H and 13C 1D sequences to 1H-1H and 1H-13C 2D sequences using a flow 
method which allows automated repolarisation of a sample during acquisition of a data 
set. Those involving 13C are of particular interest due to the lower natural abundance 
and gyromagnetic ratio compared to 1H. The effects of SABRE polarisation on these 
sequences is discussed and covers routes to apply decoupling to 13C sequences and 
sequentially receives data. The application of SABRE to the ultrafast COSY is also 
discussed. 
Chapter 6 then looks at the wider applicability of SABRE. This includes investigating 
how different substrates might react to polarisation transfer via SABRE from the 
basicity of the substrate to the effect of increasing the size of the substrate and therefore 
how far into a given substrate polarisation transfer via the SABRE technique can 
progress. The potential for substrates without a pyridyl group, such as thiazole and 
indole analogues are also discussed and extended in order to look at current 
commercially available drugs. A second potential complication of pharmaceutical NMR 
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is considered in the form of competitive substrates in solution. The reaction of 4-
carboxaldehydepyridine with methanol is also discussed in reference to NMR 
spectroscopy, SABRE hyperpolarisation methods and mass spectroscopy studies.  
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2 Chapter 2 - Catalyst synthesis 
2.1 Introduction 
In October 2009, information about the SABRE technique was limited. Within the 
literature SABRE had only been reported where phosphine-based catalysts had been 
utilised58,61 and work within the research group had just begun into the carbene-based 
catalyst, [Ir(IMes)(COD)Cl] (later published in 2011).66 Crude empirical observations 
that a magnetic field dependence and temperature dependence on polarisation transfer 
through SABRE had been made, but not rationalised. The work presented in this thesis 
illustrates a series of investigations into SABRE that seek to improve the understanding 
of which properties lead to significant polarisation transfer (covered in this chapter) and 
how these properties can be altered to optimise polarisation transfer.  
One of the most important factors when considering an investigation into the SABRE 
technique must be the catalyst itself. This forms a template through which the 
hyperpolarised magnetic states associated with the parahydrogen derived hydride 
ligands are able to transfer their hyperpolarisation into the substrate.  
2.1.1 Required properties of a SABRE catalyst 
The SABRE technique is based on the polarisation transfer of hyperpolarised magnetic 
states from parahydrogen-derived hydride ligands to nuclei associated with a substrate 
ligand, where both are bound to a catalytic metal centre. This substrate then dissociates 
from the metal catalyst such that the hyperpolarised magnetic states are observable in 
the signals associated with the free substrate. Consequently, the chosen catalyst must 
provide a platform to which the substrate of interest is able to weakly bind, such that 
binding occurs to allow polarisation transfer. This binding must be reversible such that 
the hyperpolarised states become present in the free substrate. It is also important for the 
hydride ligands to undergo a reversible exchange with hydrogen, such that the 
hyperpolarised states in the system can be replenished.  
There are a number of factors that must be considered when investigating SABRE 
catalysts. Firstly, as the SABRE catalyst will be used in NMR spectroscopy, it is 
important the catalyst used is present in relatively low concentration such that the 
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signals associated with the catalyst do not interfere with the signals associated with the 
substrate of interest. Secondly, it is also important that the catalyst is not paramagnetic 
in nature as this will provide a method of relaxation for the hyperpolarised magnetic 
states which will be interrogated.88 Thirdly, if the metal nucleus is NMR active, it also 
has the potential to induce large splitting patterns or changes in chemical shifts, which 
may complicate the resulting spectra.89,90 The active versions of current SABRE 
catalysts are unstable when exposed to air, and consequently, a stable precursor that can 
be isolated is used. This brings an additional requirement for the metal to be able to 
undergo an activation reaction, which in all catalysts published to date, has been the 
oxidative addition of dihydrogen gas. To this end, a COD ligand is utilised. The two 
double bonds on the COD ligand undergo hydrogentation, producing octane which does 
not interact with the active catalyst. There are many reports of stable complexes of the 
type [Ir(carbene)(COD)Cl] which can be isolated.80,91-96 
The presence of oxygen gas must also be eliminated owing to its paramagnetic 
properties meaning it may have the ability to enhance the rate of relaxation of 
hyperpolarised states within the reaction mixture.88 
For the initial investigations into the effect of changing the catalyst, a model substrate 
was also required. This substrate required a heteroatom with a lone pair to bind to the 
metal, with nitrogen or oxygen being the first choice. It is also important for the 
chemical shift associated with that substrate to be distinct from those associated with the 
catalyst, tending towards an aromatic system. Additionally, it must also be small to 
reduce any potential problems with binding as a result of steric bulk. This led to the 
selection of pyridine, a 6-membered aromatic ring which contains a nitrogen atom with 
an available lone pair for bonding, and a chemical shift range from 7.2 ppm to 8.6 ppm 
which is base-line-resolved from any signals associated with likely catalysts. 
2.1.2 Literature based SABRE results in which phosphine-based catalysts are used 
When the SABRE phenomenon was first reported by Adams et al. (2009),58 the catalyst 
[Ir(COD)(NCMe)(PCy3)]BF4 was utilised. This underwent a reaction with excess 
substrate and hydrogen in methanol to produce [Ir(H)2(PCy3)(substrate)3]BF4 as the 
active catalytic species. A method was described in which a Young’s tap NMR tube was 
charged with the catalyst, excess substrate and parahydrogen, then shaken to dissolve 
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the gas in the headspace into the solution and then interrogated by 1H NMR 
spectroscopy. This resulted in observation of enhanced free pyridine signals, in which 
the observed 1H NMR signals appeared in emission (in a downward direction). In this 
hyperpolarised NMR spectrum, emission peaks corresponding to the bound ligands of 
[Ir(PCy3)(substrate)3(H)2]BF4 are also observed. This suggests that at low field, 
spontaneous polarisation transfer occurs from parahydrogen to the substrate via 
temporary association with the metal template. Polarisation transfer to 13C, 15N, 19F and 
31P nuclei has also been reported.58  
Polarisation transfer to pyridine through the SABRE technique using such phosphine 
catalysts has been extended further, reported in a paper published by Atkinson et al. 
(2009).61 Here, a number of different phosphine catalysts were investigated. These 
complexes were prepared in situ by the addition of the appropriate phosphine to a 
solution of [Ir(COD)(py)2]BF4. This enabled a series of samples to be prepared, 
containing [Ir(COD)(py)2]BF4, 1 equivalent of the required phosphine (PCy3, PPhCy2, 
PEt3, P
iPr3, P
nBu3, P
tBu3 and P(1-naphthyl)3) and an excess of pyridine in d4-methanol. 
These samples were investigated using states prepared in a magnetic field of               
0.5 x10-4 T, but interrogated at high field. The extent of polarisation transfer into 
pyridine (presented as an enhancement) they achieved when the states were prepared at 
0.5 x10-4 T is presented in Figure 2.1. 
 
Figure 2.1 Plot of the relative absolute signal strengths for the three pyridine proton sites (relative to 
signals for free pyridine at equilibrium). Results represent the average of 5 measurements, each recorded 
immediately after shaking the NMR tube in a 0.5 x10-4 T field. Taken from a publication by Atkinson et 
al. (2009).61 
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It can be deduced from Figure 2.1 that changing the phosphine has a great effect on the 
amount of polarisation transferred to the pyridine via the metal template. The most 
significant polarisation transfer is observed when the strong electron donor and most 
sterically demanding phosphine, PPhCy2 is used, with a maximum observed 
1H NMR 
signal enhancement of around 11 fold was found.  
2.1.3 Progression from phosphine-based SABRE catalysts to carbene-based SABRE 
catalysts 
As described in section 2.1.2, pg 102, phosphine-based iridium catalysts can be 
effective polarisation transfer catalysts for the SABRE technique. Carbenes show 
similar binding motifs to phosphines but are stronger electron donors94 (Chapter 1). The 
carbene analogues were therefore investigated for the ability to transfer polarisation 
through SABRE.  
Phosphines and carbenes are neutral species which both contain a lone pair of electrons. 
This lone pair is able to bind to a metal centre to create a metal-ligand bond. The 
properties of phosphines and carbenes are determined by the electron donating 
properties and steric bulk. The most common scale used to consider the electron 
donating properties of such ligands (L) is the Tolman’s Electronic Parameter (TEP).97 
This method detects the vco by infra-red spectroscopy of the [Ni(CO)3(L)] complex, 
chosen because it is easily formed by a simple reaction and the carbonyl stretching 
frequency is resolved and sharp.97 It also allows a measure of electronic donation which 
is unaffected by the size of the ligand. Interpretation of the TEP works on the principle 
that as the electron donation experienced by the metal increases, the more back bonding 
is experienced by the carbonyl ligands, in turn creating a longer CO bond length. This 
change is detected by infra-red spectroscopy as a change in frequency and as such, the 
lower the observed vco, the greater the electron donation that is experienced by the metal 
from the ligand. Considering the TEP of many different phosphines and carbenes, it is 
possible to observe that in general carbenes show stronger electron donation properties 
than the phophines94 (see Table 2.1). 
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Ligand (L) solvent TEP (cm-1) 
PPh3 CHCl3 2068.9 
PEt3 CHCl3 2061.7 
P(p-MeC6H4)3 CHCl3 2066.7 
P(iPr)3 CH2Cl2 2059.2 
PCy3 CH2Cl2 2056.4 
SIPr CH2Cl2 2052.2 
SIMes CH2Cl2 2051.5 
IPr CH2Cl2 2051.5 
IMes CH2Cl2 2050.7 
ICy CH2Cl2 2049.6 
Table 2.1 Carbonyl stretching frequencies for compounds [(L)Ni(CO)3] (TEP, cm
-1). Copied from a 
publication by Kelly III et al. (2008).94 
Before stable carbenes were discovered, the most common method to compare the steric 
bulk of a phosphine ligand was to use the cone angle.98  
 
Figure 2.2 Definition of the cone angle for phosphines, taken from a publication by Clavier and Nolan 
(2010).98 
This was defined for a metal to phosphine bond length of 2.28 Å, with the outermost 
atoms of the phosphine substituents acting as the perimeter of the cone. While this 
system proved very effective for simple phosphines, as science progressed to more 
complicated ligands such as biarylphosphines, bidentate ligands and N-heterocyclic 
carbenes, this steric parameter has proven difficult to interpret and sometimes 
meaningless.98 In the phosphine ligand, the phosphorus atom is the central component 
to which the substituents are bound, resulting in the expected cone shape however this is 
not the case for the carbene ligand. Here, two cone angles could be considered as a 
result of the planar imidazolium (or 4,5-dihydroimidazolium) centre forcing the 
substituents to be in a certain orientation in reference to the metal.  
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Figure 2.3 Definition of the cone angle for carbenes, taken from a publication by Clavier and Nolan 
(2010).98 
Therefore a new method to define the steric bulk of N-heterocyclic carbenes was 
proposed by Huang et al (1999)99 based on crystallographic data. These are defined with 
a metal to carbene length of 2 Å, considered to be the average metal-carbene bond 
length. This again proved to be too simple a model and so a new steric parameter, the 
per cent buried volume (%Vbur), was proposed by Hillier et al.
100 in 2003.  
 
Figure 2.4 Definition of per cent buried volume, taken from a publication by Clavier and Nolan (2010).98 
Their proposal defined the per cent of buried volume (%Vbur) as the per cent of the total 
volume of a sphere occupied by a ligand, giving an idea of the size of the ligand in 
reference to the co-ordination sphere. The sphere has a defined radius and has the metal 
centre at the core and is calculated using crystallographic data. This also allows for the 
comparison of the steric bulk of carbenes to that of phosphines.  
Data collected from Cavallo et al. (2005)101 and Diez-Gonzalez and Nolan (2007)102 
suggests that there is no significant difference in %Vbur between phosphines and 
carbenes. Using a radius of 3 Å and metal to ligand length of 2 Å, the %Vbur of carbenes 
varies from 23 % for ICy/ITol to 37 % for IAd/ItBu, where for phosphines, it varies 
from 22 % for PMe3 to 48 % for PMes3.
98 Thus, the change from phosphine to carbene 
could significantly increase the electronic donation experienced by the metal centre, 
however changes in the steric bulk can still be controlled by the other substituents used 
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on the ligands. This has been discussed in relation to the carbenes I have experimentally 
explored in section 2.3.2.1, pg 124.  
2.1.4 Literature-based SABRE results in which carbene-based catalysts are used 
Within the literature, work has also been published on the extension of SABRE 
catalysts including a carbene analogue of the initially used phosphine catalysts. To date, 
the only carbene containing SABRE catalyst to be published is IMes(a), which utilised 
the IMes (1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene) ligand. IMes(a) has been 
reported in two communications, the first by Cowley et al. (2011)66 to polarise pyridine 
and the second by Lloyd et al. (2012)67 to polarise quinoline.  
The 2011 paper by Cowley et al.66 reported polarisation transfer to pyridine (0.062 
mmol in 0.6 ml methanol) using IMes(a) (5 mol %) shaken at Earth’s magnetic field at 
298 K, where the system exhibited an enhancement of 266 fold enhancement for the 
ortho position of pyridine. This is a significant improvement compared to the PCy3 
analogue published in Atkinson et al. (2009)61, where an average enhancement of 5 fold 
was observed under the same conditions. This implies the increase in electronic 
donation has affected the exchange rate constants observed in such a way that 
polarisation transfer to pyridine is increased. 
2.2 Experimental considerations 
Throughout this thesis, there are a number of experimental considerations which must 
be taken into account when discussing the research into SABRE. These are outlined 
below. 
2.2.1 Terminology 
2.2.1.1 SABRE using an NMR tube – the shake method (method 1) 
The shake method (method 1) utilises a 5 mm NMR tube fitted with a J Young valve 
(called a Young’s Tap NMR tube from here on). The following details are standard and 
so, unless otherwise stated, are the conditions used for the shake method. The catalyst 
was dissolved in 0.6 ml of deuterated solvent, the substrate added and the sample 
degassed on a high vacuum line via three ‘cool-pump-thaw’ cycles. The standard 
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reagent concentration of catalyst and substrate (ratio of 1:20) was 5 mM catalyst and 
100 mM substrate. In an NMR sample, this equates to 0.0031 mmol of catalyst and 
0.062 mmol of substrate in 0.6 ml of deuterated solvent. To activate the catalyst for 
SABRE, the headspace of the Young’s Tap NMR tube was charged with 3 bar hydrogen 
and shaken. The time of activation depends on the catalyst and substrate of interest. To 
interrogate the active sample using the SABRE technique, the headspace of the Young’s 
Tap NMR tube was charged with 3 bar parahydrogen and shaken for 8 s at a field of 0.5 
G. It was then introduced to the NMR magnet and interrogated by the desired NMR 
method. For a repeat experiment, the headspace was evacuated, and replaced with 3 bar 
of fresh parahydrogen to ensure each experiment begins with the same concentration of 
parahydrogen. After activation, these conditions result in a ratio of 1 to 8.5 catalyst to 
hydrogen (see Experimental). A 1H NMR spectrum was collected with a 90º pulse as 
standard. 
2.2.1.2 SABRE using a flow probe – the flow method (method 2) 
 
Figure 2.5 Schematic of the polarisor used in method 2. Adapted from a publication by Cowley et al. 
(2011).66 
The flow method was developed to allow a solution containing the catalyst and 
substrate to be polarised using parahydrogen within a polarisation chamber outside the 
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main NMR magnet.66 The following details for the preparation of samples to be studied 
in the automated polarisor (method 2) are standard and so, unless otherwise stated, are 
the conditions used for the method 2. The standard reagent concentrations of catalyst 
and substrate (ratio of 1:20) are 5 mM and 100 mM respectively. Samples for method 2 
require 3 ml of deuterated solvent and therefore this equates to 0.0155 mmol of catalyst 
and 0.31 mmol of substrate. This sample was then injected into the mixing chamber of 
the polarisor. Parahydrogen was then introduced into this solution via six inlet tubes at 
a pressure of 3 bar for 6 s (unless otherwise stated). The resulting solution was then 
transferred into a Bruker Avance III series 400 MHz spectrometer that was equipped 
with a flow probe, where the flow cell volume was 200 µl, by a flow of helium gas. 
Unless otherwise stated, a single scan of the nucleus of interest was then recorded. A 1H 
or 13C NMR spectrum was collected with a 90º pulse as standard. Once interrogated, the 
solution was returned to the mixing chamber after which the process can be repeated as 
required.  
The polarisor has been developed during the progression of this thesis and consequently 
three systems have been utilised: the MKI, MKII and MKIII. I am very grateful to 
Bruker for allowing me to use the various polarisors, and allowing me to contribute data 
to help in their development. 
The MKI polariser was the first polarisor to be used, in conjunction with a TXO flow 
probe. This system was automated to the extent that it can be controlled by the pulse 
sequence however sample loading and wash cycle are manually operated. The chamber 
was fixed to the legs of the spectrometer giving the option to move the chamber through 
the stray field of the main NMR magnet allowing limited control over the field 
experienced by the sample during the addition of parahydrogen. This is because the 
field is not consistent over the length of the mixing chamber, as it is controlled by the 
stray field. 
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Figure 2.6 Photo of MKI polarisor. 
The MKII polarisor improved on the MKI as it contains a coil surrounding the mixing 
chamber such that a magnetic field can be generated in the z direction. This coil was 
designed to produce a static direct current field in the range of -150 G to +150 G, 
capable of increments of 1 G. This system is automated to the extent that it can be 
controlled by the pulse sequence however sample loading and wash cycles of the system 
are still manually operated.  
 
Figure 2.7 Photos of MKII polarisor. 
The MKIII polarisor refines the MKII design further however, now a TXI flow probe 
was utilised. This also contains a coil around the polarisation chamber which is capable 
of producing a static direct current field in the range of -150 G to +150 G in the z-
direction however it is capable of increments of 0.01 G. It also possesses different 
valves giving more control over pressures within the system and additional functionality 
such that it is fully integrated with TopSpin, the processing package used on Bruker 
spectrometers, allowing all commands to be completed through the TopSpin interface.  
111 
 
Figure 2.8 Photo of MKIII polarisor. 
2.2.1.3 Comparison of method 1 to method 2 
Table 2.2 outlines the advantages and disadvantages of both method 1 and method 2. 
 Method 1 – Shake Method 2 – Flow 
Instrumentation Young’s TAP NMR tube Mixing chamber and 
modified flow probe 
Average consumables 2 mg catalyst + 7 mg 
substrate + 0.6 ml solvent 
10 mg catalyst + 35 mg 
substrate + 3 ml solvent 
Reproducibility 10 % error 5 % error 
NMR methods Single scan only (includes 
single scan 2D methods) 
Can incorporate standard 
2D methods and phase 
cycles 
Field control Crude (using stray field of 
spectrometer) 
-150 - +150G increments of 
1 (MKII) or 0.01 (MKIII) 
Temperature control Crude (water bath) Not currently possible 
Speed of repeat experiments ~ 3 min ~ 30 s 
Table 2.2 Comparison of the two methods, method 1 and method 2, which can be used in the application 
of SABRE in NMR.  
Each method holds its own advantages and disadvantages. Method 1 uses much less 
substrate and catalyst, and also allows a quick route to check the applicability of 
SABRE to a new substrate or catalyst (Chapter 6) and can be completed with a standard 
NMR probe. It is also possible to complete temperature studies with method 1 (Chapters 
3 and 4), which is currently not possible with method 2 as it is not possible to gain 
temperature control with the polarisor. Method 1 does suffer from some drawbacks 
however. The regeneration period between each hyperpolarised experiment is relatively 
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long (~ 3 mins) and it is very difficult and time consuming to complete 1- or 2D spectra 
which require more than 1 transients.  
Method 2 holds the major advantages that it is automated, can accurately control the 
field of polarisation (Chapter 3), and can be applied to methods which require more than 
one scan (phase cycles and 2D spectra, Chapter 5). Its main drawback, however, is that 
the samples require a 5x larger volume and therefore is comparatively expensive due to 
deuterated methanol consumption, and consumes catalyst much quicker.  
Both method 1 and method 2 should be considered when interrogating a new substrate 
or catalyst as optimisation of polarisation transfer using temperature control can only be 
completed using method 1, but optimisation using polarisation transfer field (PTF) can 
only be completed using method 2. 
2.2.1.4 Considerations when discussing the effect of the magnetic field of polarisation 
The standard unit of magnetic field is tesla (T) however throughout this thesis the unit 
of magnetic field used is gauss (G), where 1 T is equal to 10, 000 G. This is because 
only low polarisation transfer fields are used in the range 0 G to 150 G. In tesla, this is 
equal to 0 T to 0.015 T.  
Whenever a polarisation transfer field (PTF) is quoted, this refers to the magnetic field 
present during the addition of parahydrogen to the sample, the polarisation transfer 
step. In method 1, the field is applied during the time the sample is shaken in the 
presence of parahydrogen. This is typically completed at two fields, Earth’s magnetic 
field (0.5 G) and a higher field measured to be around 65 G which is achieved by 
shaking in the stray field of the spectrometer. In reality, this means the higher field 
utilised in method 1 is highly variable as the shake process causes the sample to cross 
over a range of field values.  
In method 2, the field is applied during the bubbling of parahydrogen through the 
solution. For the MK I polarisor, the field is again applied using the stray field of the 
magnet however, the chamber is now stationary so the magnetic field range experienced 
by the sample is much less than that of method 1. For the MK II and MK III polarisors, 
the magnetic field is induced by a current introduced to the coil surrounding the sample. 
The magnetic field experienced by the sample can therefore be controlled by the amount 
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of current in the coil; this corresponds to the value input by the user. The coil controls 
the field experienced in the vertical (z) direction and has additional turnings at each end 
of the coil to ensure homogeneity over the length of the coil. As the chamber is not 
stored at 0 G, but as close to Earth’s magnetic field as possible considering the required 
proximity to the spectrometer, the stated value is offset slightly. The chamber is used in 
the same position during all experiments and so this field offset is constant. The 
standard method employed to understand the effect of changing the field of polarisation 
is to take a sample of standard concentrations, and interrogate it starting at -150 G and 
increasing the field by 10 G until an experiment at +10 G has been completed, unless 
otherwise stated. The field dependence is not studied to +150 G to save time but a 
spectrum at +10 G is collected to prove it is the same as -10 G, and therefore the 
dependence is symmetrical around 0 G. For each field, six 1H NMR spectra are taken to 
ensure reproducibility. 
2.2.1.5 Effect of changing the sign of magnetic field of polarisation on resultant 1H 
NMR spectra 
Another important factor to consider is the effect of changing the sign of the magnetic 
field of polarisation. A series of experiments were completed using method 2 to 
understand the effect of moving through the zero point.  
  
Figure 2.9 Observed 1H NMR signal of selected quinoline resonances, where quinoline is polarised with 
IMes(c). This data is presented with the field of addition of parahydrogen taking place at -60 G to +60 G 
in increments of +20 G. 
These data presented in Figure 2.9 imply the sign and magnitude of the resultant signal 
after polarisation by SABRE is dependent only upon the magnitude of the applied 
magnetic field, and not upon the sign of the applied magnetic field. The symmetry of 
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the spectra allow us to infer that the stated zero is quite close to true zero because if its 
offset was significant, the difference between -20 G and +20 G would be noticeable. 
2.2.1.6 Calculation of enhancements 
There are a number of ways in which the extent of polarisation has been calculated. The 
most simple of these is to compare signal to noise ratios, most common in the case 
where a thermal spectrum cannot be collected such as for low intensity nuclei like 13C 
or 15N. A second method is to consider a direct signal enhancement. This is achieved by 
comparing the integral of a signal corresponding to thermal distribution and the signal 
corresponding to the hyperpolarised distribution. This is the method used throughout 
this thesis. For calculation of the 1H NMR signal enhancement, the following equation 
was used (Equation 2.1). 
E =
Spol
Sunpol  
Equation 2.1 Equation used to calculate the 1H NMR signal enhancement. 
Equation 2.1 is true where: E = enhancement, Spol = integral of the area under the signal 
of polarised sample and Sunpol = integral of the area under the signal of unpolarised 
(thermally polarised reference) sample. 
Owing to the nature of parahydrogen derived hyperpolarisation, a sample interrogated 
by NMR in the presence of parahydrogen may result in both enhanced adsorption 
signals and enhanced emission signals (see Chapter 1). Consequently, the integral for an 
enhanced emission peak is negative. This sign has been carried through in the equation 
to the resulting calculated enhancement. This means that where a negative enhancement 
is quoted, the peak was in emission.  
The level of hyperpolarisation can also be considered through quoting the percentage of 
nuclei that have been observed. On a superficial level, this is equal to the observed 
signal enhancement (calculated as in Equation 2.1) multiplied by the thermal 
polarisation which is based on the Boltzmann distribution and the magnetic field 
strength of the spectrometer. The thermal polarisation in a 400 MHz spectrometer (9.4 
T) is equal to 0.003 %. It is much easier to appreciate the effects of SABRE through 
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comparison of signal enhancement as the numbers are more accessible and therefore 
this is the method used throughout this thesis. 
2.2.1.7 Catalyst forms 
Throughout this thesis, a number of different catalyst precursor systems have been 
utilised to form the active species [Ir(carbene)(H)2(sub)3]
+. This has been necessary for 
certain substrates which are not able to form the salt of the catalyst prior to activation by 
hydrogenation (Chapter 4). The precursor systems have been labelled as Carbene(a), 
Carbene(b) and Carbene(c), shown in Figure 2.10. In general, Carbene(a) implies the 
catalyst was used directly with no further modifications. Carbene(b) implies the 
catalyst was used as its PF6 salt. Carbene(c) implies the catalyst was used with the 
addition of a stoichiometric amount of acetonitrile to promote activation. 
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Carbene(a) Carbene(b) Carbene(c)  
Figure 2.10 Structures of the generic catalyst precursor systems used throughout this thesis namely 
Carbene(a), Carbene(b) and Carbene(c). 
Upon addition of hydrogen and substrate (usually a nitrogen heterocycle in a 20 fold 
excess), these systems form the active catalysts shown in Figure 2.11. In the case of 
Carbene(b) and Carbene(c), it is both the substrate of interest and acetonitrile which 
can bind to receive polarisation through SABRE.  
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Carbene(a) Carbene(b) Carbene(c)  
Figure 2.11 Structures of each catalyst in its active form after the addition of hydrogen and substrate in a 
20 fold excess. 
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These catalytic systems were used in conjunction with the carbenes outlined in Figure 
2.12. IMes (1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene) was the first carbene 
investigated by the group, and investigations into this carbene began before the research 
into this thesis. As a part of this research project, investigations with the IMes based 
catalyst, and new catalysts based on SIMes (1,3-bis(2,4,6-trimethylphenyl)-4,5-
dihydroimidazol-2-ylidene) and ICy (1,3-bis(cyclohexyl)imidazol-2-ylidene), were 
performed. These are discussed further in Chapter 2.2.5 (pg 122). 
NNNN NN
a b c  
Figure 2.12 Structures of carbenes used within this thesis, namely a) IMes, b) SIMes and c) ICy. 
The structures in Figure 2.10 and Figure 2.12 are combined to describe the catalytic 
precursor system used in each experiment. For instance, if an experiment was completed 
using an NMR tube with [Ir(SIMes)(COD)(NCMe)]PF6 it would be stated as 
‘completed using method 1 with SIMes(b)’. If an experiment was completed using the 
flow system with [Ir(ICy)(COD)Cl] in the presence of a stoichiometric volume of 
acetonitrile, it would be stated as ‘completed using method 2 with ICy(c)’. Each 
catalyst in the precursor and active forms are characterised in (see Experimental) and 
IMes(a), SIMes(a) and ICy(a) are discussed further in Section 2.2.5, pg 122. 
2.2.2 Effect of method 1 on the resultant 1H NMR spectra obtained without 
incorporation of enriched parahydrogen 
 
Figure 2.13 Relative energy difference of magnetic states in an NMR sample at Earth’s magnetic field 
and the high field of an NMR spectrometer. 
117 
Normally, it takes five times the T1 of the nuclei involved for equilibration of the 
magnetic states to be achieved after a large change in magnetic field, such as that 
observed during a shake experiment in method 1. Considering Figure 2.13, the sample 
is shaken at State A, then rapidly transported to State B and interrogated immediately. 
The sample is often interrogated quicker than the time required for equilibration of the 
magnetic states so as to observe maximum polarisation possible before the polarised 
magnetic states relax to thermally polarised levels, resulting in potentially less intense 
signals. To add to this complication, during method 1, the sample is also shaken for 8 s 
prior to being transferred into the spectrometer and therefore sample turbulence may 
also be present during interrogation, potentially affecting the quality of the resultant 
spectra. It is therefore important to understand the effect of the process of method 1 on a 
standard thermal sample on 1H NMR spectra before interpreting results derived from 
parahydrogen experiments. Four samples of IMes(a) with pyridine were investigated 
using method 1, where parahydrogen was replaced with normal hydrogen. As normal 
hydrogen is composed of 25 % parahydrogen (Chapter 1), two additional samples were 
also interrogated using method 1 where the headspace was filled with air.103 
 Gas in 
headspace of 
the NMR tube 
Observed 1H NMR signal reduction 
Ortho Meta Para 
Sample 1 Normal H2 0.14 0.25 0.08 
Sample 2 0.23 0.31 0.19 
Sample 3 0.18 0.22 0.14 
Sample 4 0.22 0.22 0.16 
Sample 5 Air 0.38 0.37 0.35 
Sample 6 0.33 0.32 0.31 
Table 2.3 Effect of method 1 on a sample shaken with normal hydrogen or air. 
The values in Table 2.3 are calculated in the same way as the enhancements where the 
integral of the signal from the spectrum collected after method 1 is divided by the same 
signal in the thermally polarised spectrum. Each sample was investigated with 
parahydrogen after these experiments were completed to ensure the catalyst was active. 
This ensures that these control samples are as close as possible to those investigated 
during polarisation experiments. The resultant signals from this experiment were 
calculated to be an average of 20 % that of the normal thermal trace (ranging from 0.08 
to 0.31). This suggests that any experimentally observed enhancement values of 
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between 0 and +1 cannot confirm or disprove polarisation transfer, as the value could 
result from the interrogation taking place before the 5 times T1 wait for equilibrium in 
the higher field to be reached. Throughout these experiments, no emission peaks were 
observed, suggesting any negative enhancement value must be derived from transfer 
from parahydrogen.  
2.2.3 Reproducibility of NMR spectra when SABRE is implemented 
2.2.3.1 Reproducibility of method 1 
Three samples were prepared from a stock solution of IMes(a) and pyridine in methanol 
to produce samples with exactly the same concentration, across the three NMR tubes. 
Each sample was interrogated after an 8 s shake at 2 G under an atmosphere of 3 bar 
parahydrogen, and the experiment repeated 3 times.  
 Ortho Meta Para 
Sample 1 14.58 
10.15   
10.10 
179.85 
169.33 
154.62 
197.13 
189.19 
203.53 
Sample 2 11.88  
2.49     
19.27 
183.87 
172.95 
185.18 
225.31 
230.02 
219.86 
Sample 3 1.40    
8.90    
16.90 
160.76 
176.06 
162.07 
201.19 
219.22 
194.79 
Table 2.4 Results from reproducibility experiment for method 1 with IMes(a) and pyridine, presented as 
absolute values. 
The ortho signal in all three samples showed antiphase character and consequently, a 
significantly lower enhancement than expected, and varying results. The results based 
on enhancement in the ortho signal have therefore not been included in the calculation 
of errors. The errors quoted here have been calculated in reference to the average of the 
values in question. The results within sample 1 are reproducible to ±8 % for the meta 
position and ±5 % for the para position, within sample 2 to ±5 % for both meta and 
para positions, and within sample 3 to ±6 % for the meta position and ±7 % for the para 
position.  
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There are two potential reasons for the variance of enhancement values observed within 
a single sample. The first is that the sample is shaken by hand and therefore the shake 
time cannot be precisely 8 s for every experiment. The second reason is the sample is 
shaken close to the spectrometer so it can be interrogated as quickly as possible, 
however this could result in unwanted variations field.  
Across the three samples, enhancement to the meta and para positions is reproducible to 
±10 %. The variation across the three samples is potentially due to slightly different 
Young’s Tap NMR tube volumes, and therefore different parahydrogen excesses. The 
idea of hydrogen excess in the sample is discussed further in the Experimental. 
2.2.3.2 Reproducibility of method 2 
A series of thirty 1H NMR spectra were collected of quinoline hyperpolarised with 
IMes(c) using method 2 at a PTF of -50 G, the results of which are shown in Figure 
2.14. 
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Figure 2.14 Graphical representation of the observed 1H signal enhancement in thirty NMR spectra of 
quinoline hyperpolarised with IMes(c) using method 2.  
The spectra were found to be reproducible to within 5 % based on the observed signal 
enhancements for all positions but position 6 which was found to be reproducible to 
within 10 %. This large variation is due to the phase of the signal corresponding to the 6 
position present at the PTF used for this experiment (see Chapters 1 and 4). 
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2.2.4 Mechanism of activation of SABRE catalysts 
Over the course of the research, it was noticed that not all catalytic systems activate in 
the same way. For instance, quinoline does not exhibit polarisation transfer with 
IMes(a), but the addition of acetonitrile to the solution (to produce IMes(c)) or a 
change of catalyst to IMes(b) allows significant polarisation transfer to quinoline. In a 
paper published by Cowley et al.,66 initial studies into the mechanism of activation were 
described. NMR and mass spectroscopy were utilised to find an intermediate in the 
mechanism of activation.  
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Figure 2.15 Mechanism of the activation of [Ir(IMes)(COD)Cl] proposed by Cowley et al.66 
It was decided to test if the same intermediate was observed for [Ir(SIMes)(COD)Cl]. 
[Ir(SIMes)(COD)Cl] was dissolved in methanol with a 2 fold excess of pyridine, and a 
yellow solid was isolated from the solution through evaporation of methanol. This was 
redissolved in chloroform for interrogation by NMR spectroscopy.  
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Figure 2.16 Bottom: 1H NMR spectrum of [Ir(SIMes)(COD)(py)]Cl in CDCl3 and top: the same sample 
with added pyridine. 
Figure 2.16 shows that when the product isolated from the reaction of 
[Ir(SIMes)(COD)Cl] with pyridine is interrogated by 1H NMR, there are clear signals 
due to the bound pyridine. To prove these are not due to residual pyridine, an excess of 
pyridine was added which revealed the free pyridine signals. The signals for free and 
bound pyridine are in distinctly different positions supporting the idea that 
[Ir(SIMes)(COD)(py)]Cl has been formed. This is further supported by a crystal 
structure of [Ir(SIMes)(COD)(2-methylpyridine)]PF6, discussed in section 2.3.2.2 , pg 
126. It can also be observed that after the addition of excess pyridine to the solution, the 
signals corresponding to bound pyridine become broader, suggesting that they are 
exchanging with the excess free pyridine in solution. 
These experiments may go some way to help explain why some substrates do not 
polarise with the IMes(a) but do with IMes(b). If the substrate is either not basic 
enough to displace the chloride ion, or it’s too bulky to form a [Ir(IMes)(COD)(sub)]Cl 
complex, activation of the catalyst might not occur. An example of this is in Chapter 4. 
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2.2.5 Mechanism of reversible exchange of active species 
The mechanisms of pyridine and hydride ligand loss from IMes(a) were discussed in a 
paper by Cowley et al.66 through investigations using density functional theory (DFT). 
Initial investigations were completed by measuring the thermodynamic data 
corresponding to the loss of both ligands, with results presented in Table 2.5.  
 Loss of hydride ligands Loss of pyridine ligands 
Rate constant / s-1 (300 K) 9 11.7 (per mol py) 
∆H≠ / kJ mol-1 79    ± 1 93 ± 3 
∆S≠ / J K-1 mol-1 41    ± 3 97 ± 9 
∆G300
≠ / kJ mol-1 66    ± 0.3 64 ± 2 
Table 2.5 Thermodynamic data collected and published by Cowley et al.66 for the loss of pyridine and 
hydride ligands from IMes(a).  
A density functional theory (DFT) study of the process predicted that the loss of 
pyridine occurs through a dissociative mechanism. The theory was corroborated 
experimentally with the knowledge that the measured ∆Sǂ value was positive for the 
process, and increasing the concentration of pyridine had little effect on the measured 
rate constant for the loss of pyridine.  
The mechanism was found to be much less simple for hydride ligand loss. 
Experimentally, it was observed that the rate constant of hydride ligand loss decreased 
upon increasing pyridine concentration, implying the rate determining step for the 
process occurs after pyridine dissociation. The rate constant also increased with 
increasing hydrogen pressure and therefore addition of H2 to the complex must also be 
involved in the mechanism of hydride ligand loss. These data confirm however that the 
mechanism cannot be dissociative like that observed for pyridine loss. Three potential 
mechanisms of hydride loss were therefore considered by DFT, as outlined in Figure 
2.17. 
[Ir(H)2(IMes)(py)2]Cl 2) [Ir(H)2(IMes)(py)2(MeOH)]Cl
1) [Ir(IMes)(py)2]
+
3) [Ir(H)4(IMes)(py)2]Cl
[Ir(H)2(IMes)(py)3]Cl
- py ?
 
Figure 2.17 Potential intermediates in the route of hydride ligand loss from IMes(a) investigated by DFT 
published in a paper published by Cowley et al.66 
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DFT predicted that the formation of intermediate 1 in Figure 2.17 would be stable 
however its formation would be thermodynamically unfavourable requiring 117 kJ mol-
1 of free energy, and is inconsistent with the experimentally measured kinetic data. DFT 
also predicted that the binding of methanol, such as for intermediate 2 in Figure 2.17, 
would be easy requiring 13 kJ mol-1 of free energy however the subsequent elimination 
of hydrogen would require a further 83 kJ mol-1 of free energy. This makes the 
formation of intermediates 1 and 2 unlikely routes for the loss of hydride ligands.  
This leaves the possibility of intermediate 3 as the viable route for hydrogen 
elimination. According to DFT calculations, the formation of this intermediate is 
favourable, liberating 11 kJ mol-1 of free energy via a barrier of 27 kJ mol-1. It also 
predicted however that the complex solely takes the form [Ir(H)2(ƞ
2-H2)(IMes)(py)2]
+. 
In this complex, the second hydrogen molecule is bound as dihydrogen which relaxes 
much faster than the hydride ligands, and requires a total of 44 kJ mol-1 free energy to 
form from [Ir(H)2(IMes)(py)3]Cl. If this is the route to hydrogen elimination, 
intermediate 3 must be short lived so as to avoid the conversion of parahydrogen to 
orthohydrogen.  
2.3 Effect of changing the carbene ligand on polarisation transfer efficiency 
The first carbene-based SABRE catalyst the group prepared was IMes(a) and this was 
shown to be much more effective than the previously tested phosphine catalysts.61,66 It 
was therefore decided to investigate if the catalyst could be further optimised by 
modification of this carbene. In changing the carbene, it is possible to change the 
flexibility, electronic properties and steric properties of the carbene and therefore, the 
resultant catalyst.  
NNNN NN
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Figure 2.18 Structures of carbene ligands used within this thesis, namely a) IMes, b) SIMes and c) ICy 
IMes(a) is prepared using the carbene, IMes (1,3-bis(2,4,6-trimethylphenyl)imidazol-2-
ylidene, Figure 2.18a), and so a natural progression from this is to look at SIMes (1,3-
bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene, Figure 2.18b). The R groups 
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on the imidazolium centre have remained as mesitylene groups, however the 
imidazolium centre itself is now saturated across the double bond. SIMes is found to 
exhibit a very similar electron donating ability (TEP of SIMes = 2051.5 cm-1)94 to IMes 
(TEP = 2050.7 cm-1)94 however the slightly longer single bond in the imidazolium 
centre of SIMes introduces a little more flexibility and consequently, slightly different 
steric properties. A further carbene, ICy (1,3-bis(cyclohexyl)imidazol-2-ylidene, Figure 
2.18) was also investigated. In this case, the R groups bound to the two nitrogens of the 
imidazolium centre are cyclohexyl groups.  
2.3.1 Synthesis 
All three catalyst precursors, IMes(a), SIMes(a) and ICy(a), were prepared by the same 
method. The hydrochloride salt of each carbene was deprotonated with potassium tert-
butoxide and reacted with [Ir(COD)Cl]2 in THF. This synthesis is based on similar 
results published by S. Wolf et. al.104 After purification by silica gel column 
chromatography with an eluent of 19:1 DCM : acetone, a crystalline yellow solid was 
isolated, corresponding to [Ir(carbene)(COD)Cl]. Further details are given in the 
Experimental. 
2.3.2 Comparison of structural properties 
A comparison of the structural properties of the carbenes (and of those within the 
catalyst precursors and active forms) will allow an understanding of how changing 
certain properties of the carbenes may improve polarisation transfer for certain 
substrates.  
2.3.2.1 Comparison of TEP, cone angle and buried volume of PCy3, IMes, SIMes and 
ICy 
In this section, the electronic and steric properties of the carbenes used in this thesis 
(IMes, SIMes and ICy) have been compared to each other and to PCy3, the most 
commonly used phosphine in SABRE to date.58,61 A number of methods can be used to 
investigate the structural properties of phosphines and carbenes. These include the TEP, 
the vco for iridium, the percent of buried volume (%Vbur), and repulsiveness, as 
described in section 2.1.3, pg 104. 
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All the complexes used in this thesis have an iridium centre, not nickel, and therefore a 
similar parameter for iridium complexes is also considered. The values used in Table 
2.6 are the vco(Ir)
av (cm-1) for the Ir analogue [(NHC)Ir(CO)2Cl],
94 corresponding to the 
average of the two CO stretches observed when [(NHC)Ir(CO)2Cl] is interrogated using 
infra-red spectroscopy. 
The percent of buried volume (%Vbur) values presented in Table 2.6 are from Clavier 
and Nolan98 where it is based on [(NHC)IrCl(COD)] with a sphere radius of 3.5 Å and 
M to ligand bond length of 2 Å. 
In a paper published by D. G. Gusev (2009),105 a descriptor correlating to the ease of 
loss of a CO ligand from a Ni(CO)3(NHC)-type complex is introduced. This is termed 
the ‘repulsiveness’ parameter, r and is calculated from the ∆H and TEP for any carbene. 
The higher r is, the more ‘repulsive’ that carbene is. The parameter r is therefore a 
measure of direct repulsive interactions between the carbene and carbonyl ligands of 
[Ni(CO)3(NHC)]. 
Ligand TEP (cm-1)94,105 vco(Ir)
av (cm-1)94 %Vbur
98  r 105 
PCy3 2056.4 2028 37.1  
IMes 2050.7  2023.1 33.0 1.5 
SIMes 2051.5 2024.6 34.5 1.9 
ICy 2049.6 2023.0 27.3 1.6 
Table 2.6 Comparison of the structural properties of the carbene ligands investigated in this thesis, IMes, 
SIMes and ICy. Values for PCy3 have also been included.  
Considering the TEP values, the strongest electron donor is ICy, followed by IMes, 
followed by SIMes which is the weakest carbene electron donor. The TEP range of the 
three carbenes however is quite small, with the difference between the strongest and 
weakest donors being 1.9 cm-1. Although the absolute differences between the TEP 
values of the three investigated carbenes is small, the group of carbenes are clearly 
higher than the most commonly used phospines (see Table 2.1), with the strongest 
phosphine in the table, PCy3, exhibiting a TEP value of 2056.4 cm
-1.94 The difference 
between the TEPs for the PCy3 ligand and least electron donating carbene, the SIMes 
ligand, is 4.9 cm-1, 2.5 times larger than the range of the carbenes. This trend is 
continued when looking at the vco values for the iridium complex [(NHC)IrCl(COD)], 
where the strongest donor is ICy and weakest is SIMes. Again, a small range is 
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observed (1.6 cm-1), which is just under half the range observed within the carbenes  
(3.4 cm-1).  
A slightly different trend is observed when considering the repulsiveness factor, 
described by Gusev (2009).105 IMes is the least repulsive, followed by ICy, then SIMes 
which is the most repulsive of the three carbenes. This means SIMes loses CO most 
easily from the [Ni(CO)3(L)] complex when compared to ICy and IMes.  
Analysis of the buried volume shows SIMes is the most sterically hindering carbene, 
followed by IMes then ICy as the smallest carbene. As a comparator, the %Vbur of the 
phosphine (PCy3) used in Adams et al. (2009)
58 and Atkinson et al. (2009)61 is 37.1% 
when calculated with a M-P length of 2 Å, the standard metal to carbene length used for 
the other ligands considered.98 This reduces to 31.8 % when calculated with a M-P 
length of 2.8 Å, the standard metal to phosphine length.98 This implies the investigated 
carbenes have less steric bulk than the most commonly used phosphine in SABRE, but 
also that the carbenes are more electron rich. 
2.3.2.2 Comparison of IMes(a), SIMes(a) and ICy(a) 
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Figure 2.19 Structures of a) IMes(a), b) SIMes(a) and c) ICy(a). 
The active species of SABRE catalysts cannot be isolated and therefore the properties of 
the isolatable precursor systems are considered first. The structures of IMes(a), 
SIMes(a) and ICy(a) shown in Figure 2.19, are most easily considered when looking at 
the X-ray crystal structures. A crystal of SIMes(a) was grown for X-ray diffraction 
analysis. The structure of this complex has been reported by Kelly et al. (2008)94 with 
cell lattice parameters; a, b and c unit cell lengths of 15.4063(12) Å, 11.8278(10) Å and  
15.0331(12) Å respectively with α, β and γ unit cell angles of 90º, 107.0260(10)º and 
90º respectively and unit cell volume of 2619.3(4) Å3. The SIMes(a) crystal grown as 
part of this research were analysed to reveal cell lattice parameters; a, b and c unit cell 
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length of 15.3964(22) Å, 11.8206(13) Å and 15.0337(16) Å with α, β and γ unit cell 
angles of 89.995(14)º, 107.000(13)º and 90.099(13)º and unit cell volume of 
2616.34(65) Å3. The unit cell data collected matched very closely to that published and 
so a full diffraction study was not completed.  
The crystal structures shown in Figure 2.20 were obtained from Kelly et al.94 along with 
the corresponding bond length data and bond angle data. 
  
Figure 2.20 The crystal structures of IMes(a), SIMes(a) and ICy(a) copied from a publication by Kelly et 
al.94 
Catalyst Cl-Ir-CNHC CNHC-Ir-Ccis-cod(av) CNHC-Ir-Ctrans-cod(av) 
IMes(a) 89.82(14)º 94.45(3)º 161.6(3)º 
SIMes(a) 91.87(9)º 93.5851(19)º 161.585(22)º 
ICy(a) 88.5(3)º 91.7(7)º 162.9(8)º 
Table 2.7 Selected angles for [(NHC)Ir(COD)Cl] from a publication by Kelly et al.94 where cis and trans 
are relative to the carbene. 
The angles shown in Table 2.7 imply each structure adopts a distorted square planar 
arrangement, with both Cl-Ir-CNHC and C-NHC-Ir-Ccis-cod(av) angles being close to 90º, 
but the C-NHC-Ir-Ctrans-cod(av) angles are quite distorted from the archetypal 180º. This 
distortion is a result of the bidentate COD ligand.  
Catalyst Ir-CNHC Ir-Cl Ir-Ccis-cod(av) Ir-Ctrans-cod(av) 
IMes(a) 2.055(5) Å 2.3527(14) Å 2.118(7) Å 2.1845(8) Å 
SIMes(a) 2.041(3) Å 2.3550(9) Å 2.121(4) Å 2.181(6) Å 
ICy(a) 2.090(13) Å 2.357(3) Å 2.1015(18) Å 2.169(21) Å 
Table 2.8 Selected bond lengths for [(NHC)Ir(COD)Cl] in Å, from a publication by Kelly et al.94 where 
cis and trans are relative to the carbene. 
Considering the Ir-CNHC bond, this is approximately equal in IMes(a) and SIMes(a) 
suggesting the bond strength is approximately the same, however the same bond in 
ICy(a) is slightly longer suggesting a weaker bond. These bond lengths broadly 
                 IMes(a)       SIMes(a)                                ICy(a) 
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correlate to the %Vbur presented in Table 2.6, where a shorter bond length corresponds 
to a larger %Vbur. The opposite trend is observed with both Ir-COD bond lengths, where 
those in the ICy(a) are slightly shorter and therefore stronger than those in IMes(a) and 
SIMes(a).  
In these distorted square planer complexes, the chloride ion is always positioned trans 
to one of the COD bonds as a result of the bidentate nature of the COD ligand. This 
means the Ir-Cl bond length remains broadly the same across the three carbene 
complexes.  
1H and 13C NMR data was collected for each catalyst precursor, and selected data are 
presented in Table 2.9. 
Catalyst 
precursor 
COD protons (ppm) Imidazolium 
protons (ppm) 
Carbene carbon 
(ppm) CH CH2 
IMes(a) 3.99, 3.08 1.68, 1.30 7.22 179.3 
SIMes(a) 3.94, 3.21 1.63, 1.31 3.95 206.0 
ICy(a) 4.46, 3.04 Under multiplet 7.16 176.5 
Table 2.9 Selected NMR data for the catalytic precursors IMes(a), SIMes(a) and ICy(a) in methanol. 
The data presented in Table 2.9 indicates the significant changes observed in the NMR 
data corresponding to each catalyst. The most significant difference between each 
catalytic precursor is the signal corresponding to the carbene carbon resonance. As 
expected, the strongest electron donator, ICy, has the lowest 13C carbene resonance of 
the three systems, and SIMes, the weakest electron donator has the highest 13C carbon 
resonance. Another significant difference is observed in the 1H signals corresponding to 
the imidazolium protons. SIMes(a) contains a saturated backbone and therefore the 
signals corresponding to these four protons are observed at around 4 ppm as opposed to 
the two analogous protons in IMes(a) and ICy(a) which are observed at around 7 ppm. 
These differences indicate there are significant differences between the three catalyst 
precursors. 
A crystal of [Ir(SIMes)(COD)(2-methylpyridine)]PF6 was also grown for X-ray 
diffraction analysis, shown in Figure 2.21.  
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Figure 2.21 Crystal structures of SIMes(a) ([Ir(SIMes)(COD)Cl] taken from a publication by Kelly et 
al.94 and [Ir(SIMes)(COD)(2-methylpyridine)]PF6 collected as part of this thesis. The PF6 counter ion for 
the latter has been omitted for clarity. Presented with C in black, N in blue, Ir in yellow, H in peach and 
Cl in green. 
This crystal structure supports the information derived in section 2.2.4, pg 120 about the 
mechanism of activation for the catalysts. A comparison of the crystal structure of 
[Ir(SIMes)(COD)(2-methylpyridine)]PF6 with that of [Ir(SIMes)(COD)Cl] (SIMes(a)) 
was completed.  
Catalyst X-Ir-CNHC CNHC-Ir-Ccis-cod(av) CNHC-Ir-Ctrans-cod(av) 
[Ir(SIMes)(COD)Cl] 91.87(9)º (X=Cl) 93.5851(19)º 161.585(22)º 
[Ir(SIMes)(COD)(2-
methylpyridine)]PF6 
97.55(11)º (X=N) 91.36(12)º 160.4(12)º 
Table 2.10 Selected angles for [Ir(SIMes)(COD)Cl] (SIMes(a)) from a publication by Kelly et al.94 and 
[Ir(SIMes)(COD)(2-methylpyridine)]PF6 collected as part of this thesis, where cis and trans are relative 
to the carbene. 
[Ir(SIMes)(COD)(2-methylpyridine)]PF6 also adopts a distorted square planar 
arrangement however, now the distortion is much greater than that observed in 
SIMes(a). The N-Ir-CNHC angle is distorted by over 7º compared to 2º distortion for the 
analogous Cl-Ir-CNHC angle of SIMes(a). The CNHC-Ir-Ctrans-cod(av) angle is also slightly 
more distorted.  
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Catalyst Ir-CNHC Ir-X (Å) Ir-Ccis-cod(av) Ir-Ctrans-cod(av) 
[Ir(SIMes)(COD)Cl] 2.041(3) Å 2.3550(9) (X=Cl) 2.121(4) Å 2.181(6) Å 
[Ir(SIMes)(COD)(2-
methylpyridine)]PF6 
2.078(3) Å 2.116(3) (X=N) 2.138(3) Å 2.165(3) Å 
Table 2.11 Selected bond lengths for [Ir(SIMes)(COD)Cl] (SIMes(a)) from a publication by Kelly et al.94 
and [Ir(SIMes)(COD)(2-methylpyridine)]PF6 collected as part of this thesis, where cis and trans are 
relative to the carbene. 
In contrast, the Ir-CNHC, Ir-Ccis-cod(av) and Ir-Ctrans-cod(av) bond lengths are broadly 
similar for the two complexes, however the Ir-N bond in [Ir(SIMes)(COD)(2-
methylpyridine)]PF6 is much shorter than the analogous Ir-Cl bond in SIMes(a). This 
could provide a reason for the more severe distortion from the square planar 
arrangement exhibited by [Ir(SIMes)(COD)(2-methylpyridine)]PF6, as the chlorine 
atom has been replaced with a much bulkier substituent with a shorter bond to iridium. 
The Ir-N bond has also been measured in [Ir(SIMes)(COD)(py)]PF6 by Lee et al.
74 to be 
2.107 Å, shorter than the analogous bond length observed for [Ir(SIMes)(COD)(2-
methylpyridine)]PF6. Pyridine has a pKa of 5.2 and 2-methylpyridine has a pKa of 
5.97.106,107 It would therefore be expected for 2-methylpyridine to exhibit a shorter bond 
length however due to the steric hinderence of the ortho substituent, the pyridine-
iridium bond length is shorter and therefore stronger. 
This section has shown that small changes in the carbene ligand used to produce 
precursors to active SABRE catalysts can have a significant effect on the steric and 
electronic properties of that complex.  
2.3.2.3 Comparison of the active hydrogenation products of IMes(a), SIMes(a) and 
ICy(a) 
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Figure 2.22 Structures of the active hydrogenation products of IMes(a), SIMes(a) and ICy(a). 
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As polarisation does not transfer into the substrate through the catalytic precursor, but 
through the hydrogenation product, it is prudent to also investigate the properties of 
these compounds.  
An important observation to make at this point is the time required for a catalyst to 
hydrogenate from the precursor to the fully active form. In the case of IMes(a) and 
SIMes(a), full activation of the catalyst occurs within 5 minutes of addition of hydrogen 
and a short shake to incorporate the hydrogen gas into the solution is all that is required. 
However in the case of ICy(a), this time is increased to around 18 hours.  
In 2011, Cowley et al.66 published a crystal structure of the active form of the carbene-
based SABRE catalyst, [Ir(H)2(IMes)(py)3]PF6, with the ORTEP plot shown in Figure 
2.23. 
 
Figure 2.23 X-ray crystal structure of [Ir(H)2(IMes)(py)3]
+. Structure taken from a publication by Cowley 
et al. 2011.66 
Catalyst 
precursor 
Hydride 
ligands 
(ppm) 
Bound pyridine (ppm) Imidazolium 
protons 
(ppm) 
Carbene 
carbon 
(ppm) 
Position to 
hydrides (eq.) 
ortho meta para 
IMes(a) -22.52 cis             (1) 8.09 7.00 7.69 7.18 180.9* 
trans         (2) 8.34 7.14 7.79 
SIMes(a) -22.69 cis             (1) 7.97 6.97 7.66 3.9 208.6 
trans         (2) 8.32 7.12 7.76 
ICy(a) -22.49 cis             (1) 8.31 7.27 7.94 7.22 197.6 
trans         (2) 8.75 7.47 8.00 
Table 2.12 Selected NMR data for the active catalysts in methanol, where ‘eq’ indicates the number of 
equivalents observed. The carbene value * for IMes(a) is quoted for [Ir(IMes)(py)2(H)2Cl] in DCM. 
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The first important observation to be made from Table 2.12 is that each catalyst takes 
the same form when activated. This is evident by the fact that the pyridine ligands 
bound cis and trans to the hydride ligands are in the same proportion in each case. The 
different chemical environments observed in the precursor systems are also observed in 
the active catalysts. The chemical shifts of the hydride ligand resonances are also 
dependent on the electron donation properties of the carbene. As the carbene donates 
more electrons to the metal centre, it in turns shares this between the other ligands, 
including the hydride ligands. The differences between the catalytic systems also extend 
to produce different bound signals for the pyridine protons. It is predicted that these 
differences will have a significant effect on the extent of polarisation transfer observed 
with each catalyst. 
2.3.3 Comparison of ligand exchange rate constants and activation parameters of 
IMes(a), SIMes(a) and ICy(a) 
A
B
C
i
ii  
Figure 2.24 The reaction co-ordinate for the dissociative reaction for loss of ligand. 
A series of 1D EXSY experiments were completed to enable the calculation of the 
pyridine and hydride ligand exchange rate constants in the active forms of IMes(a), 
SIMes(a) and ICy(a) as a function of temperature. The associated rate constants of 
ligand exchange were determined by application of the Dynafit108 programme. These 
data are expected to provide us with a better understanding of the effect the carbene 
ligand has on catalyst activity.  
In this case, the measured rate constant corresponds to the transformation from bound 
ligand (hydride/substrate) to free ligand, A to C in Figure 2.24. When calculating ∆H≠, 
∆S≠ and ∆G≠, the rate constant data used should refer to the rate constant of reaching the 
transition state (B) which is twice the measured rate constant. This is because once the 
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molecule has reached point B, it is possible for it to fully disassociate to form C, or re-
associate to form A. Consequently, the Eyring plots for activation parameters of both 
hydride ligand and pyridine loss are calculated using a graph of ln(2xmeasured 
rate/temperature) vs 1/temperature.109 In all cases, the raw rate constants are measured 
as per mole of iridium catalyst, and not per mole of hydride ligand or pyridine.  
The measured rate constants for loss of pyridine and hydride ligands can be very 
informative however the thermodynamic parameters for the loss of pyridine ligands are 
much more reliable than those for the loss of hydride ligands. This is because the 
mechanism for the loss of pyridine ligands is independent of hydride ligand loss 
however the mechanism for hydride ligand loss is partly dependent on the loss of 
pyridine ligands. This was discussed in section 2.2.5. 
2.3.3.1 Thermodynamic activation parameters observed for the loss of pyridine trans 
to the hydride ligands from hydrogenated IMes(a), SIMes(a) and ICy(a) 
 PCy3 IMes(a)
66
 SIMes(a)  ICy(a)  
vco(Ir)
av (cm-1)94 2028.0 2023.1 2024.6 2023.0 
%Vbur
98  37.1 33.0 34.5 27.3 
Raw Rate constant 
/ s-1 (300 K) 
3.666 23.4 44.8* 1.1 
∆H≠ / kJ mol-1 97.4 (± 9)61 93 (± 3) 75.6 (± 0.4) 94.3 (± 1.1) 
∆S≠ / J K-1 mol-1 84 (± 31)61 97 (± 9) 44.6 (± 1.5) 77.6 (± 3.7) 
∆G300
≠ / kJ mol-1 72.2* 64 (± 2) 62.3 (± 0.05) 71.1 (± 0.04) 
Table 2.13 Activation parameters for the loss of pyridine when IMes(a), SIMes(a) and ICy(a) precursors 
are used. Data for IMes(a) was quoted in a publication by Cowley et al. (2011).66 * denotes value was 
calculated either by extrapolation in the case of SIMes(a) or using published data in the case of PCy3. 
Full exchange rate constant data can be found in the Appendix, sections 9.1.5 and 9.1.6. 
For IMes(a), the raw rate constant for pyridine loss quoted in the publication by Cowley 
et al. (2011)66 has been doubled as the rate constant is quoted per mole of pyridine, 
where the data here is quoted as per mole of iridium catalyst. For SIMes(a), the raw rate 
constant has been calculated from the Eyring plot for that system as the rate constant is 
too fast to measure by NMR methods. Looking at the enthalpies for the activation of 
loss of pyridine, it is possible to see that the value for IMes(a), ICy(a) and PCy3 are 
similar to each other. SIMes(a) has a significantly lower enthalpy, and therefore 
requires less energy than for either IMes(a), ICy(a) and PCy3. These values appear to 
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show a weak correlation to the vco(Ir)
av. In all cases, the loss of pyridine is entropically 
favourable. The greatest increase in entropy is of activation of loss of pyridine is found 
for IMes(a), then ICy(a) and PCy3, then SIMes(a). The Gibbs free energy at 300 K is 
also positive in all cases, suggesting pyridine loss is not spontaneous. Within the 
carbenes, the Gibbs free energy values quoted are consistent with the observed rate 
constants for loss of pyridine and %Vbur, where ICy(a) shows the slowest rate constant 
of loss and highest Gibbs free energy. The phosphine, PCy3, shows a slow rate constant 
of exchange and also one of the highest Gibbs free energies. These data do not appear to 
correlate to the electron donation as the vco(Ir)
av for IMes(a) and ICy(a) are near 
identical, however the related Gibbs free energies are significantly different.  
2.3.3.2 Thermodynamic activation parameters observed for the loss of hydride ligands 
from hydrogenated IMes(a), SIMes(a) and ICy(a) in the presence of pyridine 
 PCy3 IMes(a)
66
 SIMes(a)  ICy(a)  
vco(Ir)
av (cm-1)94 2028.0 2023.1 2024.6 2023.0 
%Vbur
98  37.1 33.0 34.5 27.3 
Raw Rate constant / 
s-1 (300 K) 
 9 36.18* 0.213 
∆H≠ / kJ mol-1  79 (± 1) 74.9 (± 0.2) 88.7 (± 0.6) 
∆S≠ / J K-1 mol-1  41 (± 3) 40.3 (± 0.7) 43.4 (± 2.0) 
∆G300
≠ / kJ mol-1  66.4 (± 0.3) 62.8 (± 0.02) 75.7 (± 0.02) 
Table 2.14 Activation parameters for the loss of hydride ligands when IMes(a), SIMes(a) and ICy(a) 
precursors are used. Data for IMes(a) was quoted in a publication by Cowley et al. (2011).66 * denotes 
the value was calculated by extrapolation. 
Full exchange rate constant data can be found in the Appendix, sections 9.1.5 and 9.1.6. 
For SIMes(a), the raw rate constant at 300 K has been calculated from the Eyring plot 
for that system as the rate constant is too fast to measure by NMR methods. Looking at 
the enthalpies of activation of loss of hydrogen, it is possible to see that the values for 
IMes(a) and SIMes(a) are similar. It can also be observed that ICy(a) has a 
significantly higher enthalpy, meaning the loss of hydrogen requires significantly more 
energy than for either IMes(a) or SIMes(a). These data appear to show a weak 
correlation to the vco(Ir)
av. In all cases, the loss of hydrogen is entropically favourable as 
this increases the disorder in the system. The greatest increase in entropy is observed for 
the loss of hydrogen from SIMes(a) with ICy(a) following, then IMes(a) however the 
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values cannot be considered statistically different from each other. The Gibbs free 
energy at 300 K is also positive in all cases, suggesting activation of the loss of 
hydrogen is not spontaneous for any of the catalysts. The largest barrier is observed for 
ICy(a) and this is reflected in the small observed rate constant for loss of hydrogen. The 
Gibbs free energy values appear to show a correlation to the %Vbur values. These data 
do not appear to correlate to the electron donation as the vco(Ir)
av, as IMes(a) and ICy(a) 
are near identical, however the related Gibbs free energies are significantly different. 
2.3.4 Comparison of polarisation transfer efficiency into pyridine of IMes(a), 
SIMes(a) and ICy(a) 
Now that the structural and electronic differences between the three catalytic precursors 
have been compared and contrasted, it is prudent to investigate the effect these 
differences have on the ability of each catalyst to transfer hyperpolarised states from 
parahydrogen-derived hydride ligands to the substrate. In the case of ICy(a), 
polarisation transfer is only considered after a minimum activation time of 18 hours. For 
IMes(a) and SIMes(a), polarisation transfer is considered after a minimum activation 
time of 5 minutes. 
It is known that changing the ligand from a phosphine to a carbene had the effect of 
significantly increase the extent of polarisation transfer to pyridine using SABRE. The 
phosphine in question, PCy3 has a higher TEP value than the investigated carbenes, and 
also has more steric bulk. It might therefore be possible to predict that reducing the 
steric bulk and increasing the electron donation will increase polarisation transfer to 
pyridine through SABRE. Polarisation transfer to pyridine using IMes(a), SIMes(a) 
and ICy(a) was initially compared using method 1. 
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Catalyst precursor IMes(a) SIMes(a) ICy(a) 
Electronic and steric 
properties 
vco(Ir)
av (cm-1)94 2023.1 2024.6 2023.0 
%Vbur
98 33.0 34.5 27.3 
Rate constant of ligand 
loss (s-1) (300 K) 
Hydride ligand 9 36.2 0.2 
Pyridine 23.4 44.8 1.1 
Obs. 1H NMR pyridine 
signal enhancement 
Ortho -160 -107 -37 
Meta 68 46 24 
Para -142 -68 -34 
Table 2.15 Typical observed 1H NMR signal enhancement to pyridine when IMes(a), SIMes(a) and 
ICy(a) are used as precursors in method 1 hyperpolarised at 2 G.  
Based on results observed for the polarisation of pyridine with the PCy3 phosphine 
based catalyst61 and IMes(a),66 it had been predicted that a decrease in steric bulk and 
increase in electronic donation of the carbene ligand may increase observed polarisation 
transfer to pyridine. This has been proven to be wrong. IMes(a) has exhibited the 
greatest 1H NMR signal enhancements in the spectrum of pyridine, although ICy(a) has 
a greater electron donation and the lowest steric bulk.  
It can be observed from the data in Table 2.15 that the maximum enhancement to 
pyridine is observed when IMes(a) is used, then SIMes(a) then ICy(a). ICy(a) shows a 
significantly slower pyridine and hydride ligand exchange rate constant at 300 K than 
both IMes(a) and SIMes(a) and this may be the reason for the lower amount of 
polarisation transfer observed. IMes(a) shows the most significant polarisation transfer 
however, it exhibits the middle rate constant for pyridine and hydride ligand exchange 
at 300 K. This suggests an optimum exchange rate constant for both pyridine and 
hydride ligands exist to promote maximum polarisation transfer. This could further 
suggest that an optimum contact time is required i.e. the time both hydride ligands and 
pyridine are bound to the iridium centre at the same time.  
The trends in the observed 1H NMR signal enhancement can also be compared 
according to the TEP, vco(Ir)
av, %Vbur and repulsivness factor r. The trend for the two 
descriptors of electron donation, TEP and vco(Ir)
av, are the same with the carbene ICy 
showing the strongest donation, followed by IMes, then SIMes. Considering the trend in 
observed rate constants of loss of pyridine and hydride ligands, the slowest rate constant 
of loss of ligands is observed in the strongest electron donor of the carbenes 
investigated, ICy(a), which in turn shows the least observed polarisation transfer to 
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pyridine. Also, the fastest rate constant of loss of ligands is observed in the weakest 
electron donor of the carbenes investigated, SIMes(a), however, it does not show the 
greatest observed polarisation transfer. The middle rate constants of loss of ligands 
observed in IMes(a) corresponds to the middle electron donation, resulting in the 
highest polarisation transfer into pyridine. This trend is also extended into the %Vbur 
with ICy exhibiting the least steric bulk, followed by IMes, with SIMes exhibiting the 
highest steric bulk. Considering the repulsiveness factor, r, a trend with polarisation 
transfer cannot be derived.  
Looking at all factors considered here, no single factor can be named that has a sole 
impact on the level of polarisation transfer into pyridine. There is no factor that can be 
infinitely increased or decreased to observe maximum polarisation transfer into a 
pyridine, and consequently, a balance must be achieved. It is assumed this will be true 
for all substrates considered.  
The theory predicts that the extent of polarisation transfer is dependent on the chemical 
shift difference and J-coupling network of the system (see Introduction). Changing the 
electron donation properties of the carbene has the effect to change the chemical shifts 
and couplings of the pyridine and hydride ligands and this, combined with the changing 
contact times as a result of different exchange rates, could be the reason for different 
levels of polarisation transfer into pyridine. Further investigations into the theory of 
polarisation transfer by SABRE are required to investigate this further. 
2.4 Summary 
Within this chapter, the fundamental properties of some SABRE catalysts have been 
discussed, comparing the structural and electronic properties and understanding how 
these have an effect on the catalysts ability to complete polarisation transfer. More 
specifically, the chapter looks at three carbene-based catalysts, IMes(a), SIMes(a) and 
ICy(a) and compares them to the analogous phosphine-based catalyst which uses a 
PCy3 ligand in place of the carbene. The most significant difference between the 
phosphine and carbenes is the electron donation properties of that ligand, with the 
carbenes exhibiting significantly larger electron donation properties. The carbenes also 
exhibit significantly shorter metal to ligand (M-C) bonds when compared to the same 
bond of the phosphine ligand (M-P). It might be assumed that the shorter metal to 
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ligand bond would result in a higher steric bulk of the ligand, however due to the 
orientation of the carbene based ligands to that of the phosphine based ligands, the 
buried volumes of the two do not vary significantly from each other.  
This analysis was also extended to include the active complex. Some of the most 
significant information here can be obtained through comparing the rate constants of 
ligand loss and the associated thermodynamic parameters. The observed rate constants 
of loss of pyridine and hydride ligands do not appear to correlate to the electron 
donation or buried volume properties when all four catalysts are considered. 
Correlations can however be derived when considering the carbene catalysts alone. For 
both pyridine and hydride ligand loss, increasing the electron donation of the carbene 
had the result to increase the enthalpy of ligand loss. It can also be stated that the more 
sterically encumbered a carbene is, the lower the Gibbs free energy required for ligand 
loss. In the case of loss of hydride ligands, the entropy term also decreases as the 
carbene becomes larger. It is observed that all ligand loss processes investigated are 
entropically favourable due to the increase in disorder of the system.  
These data were then used to compare the polarisation transfer efficiency of the 
considered polarisation transfer catalysts. Of the three carbene based catalysts, IMes(a) 
has the middle value for Gibbs free energy and rate constants of hydride and pyridine 
ligand loss, electronic donation and buried volumes. It has therefore been postulated 
that an optimum contact time is required to facilitate maximum polarisation transfer into 
pyridine and assumed therefore that will be true for all substrates. 
The data presented in this chapter indicate that the hyperpolarisation properties of a 
potential SABRE catalyst cannot be predicted. The efficiency of a new catalyst must be 
decided by measurement, and can be optimised by changing the magnetic field and 
temperature of the polarisation step, discussed in the following chapter.  
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3 Chapter 3 - Investigation of SABRE effect 
3.1 Introduction 
In order to gain the most from the newest hyperpolarisation technique SABRE, it is 
important to understand how to optimise the method such that the maximum signal 
enhancement can be observed. There are a number of variables that can be altered to 
affect the extent of polarisation transfer into a substrate which includes the catalyst used 
(discussed in Chapter 2), the magnetic field in which the hyperpolarisation step takes 
place, the temperature at which the hyperpolarisation step takes place, and the 
concentration of the catalyst or substrate. From an applicability point of view, it is also 
important to understand the effect of varying the solvent used, as not all substrates are 
soluble in methanol. This chapter details the experiments completed to investigate these 
effects.  
3.2 Effect of magnetic field during the polarisation transfer step on polarisation 
transfer efficiency 
The effect of changing the magnetic field in which the hyperpolarised states are 
prepared is well known for parahydrogen induced polarisation (PHIP)43,45,46 formally 
known as PASADENA and ALTADENA (further discussed in Chapter 1). There are a 
number of publications where this situation has been found relevant to the SABRE 
technique.61,65,66 
The predicted theory behind the polarisation transfer mechanism of SABRE has been 
previously described in Chapter 1.59 This shows how the extent of polarisation transfer 
is dependent on the fine balance between scalar coupling and chemical shift effects. It is 
the chemical shifts dependence on the magnetic field that induces this behaviour.  
The first experimental paper in which the idea of changing the magnetic field of 
polarisation was published in 2009 by Atkinson et al.61 Here, a sample of 
[Ir(PCy3)(H)2(py)3]BF4 with a 24 fold excess of pyridine was prepared in d4-methanol 
and interrogated using method 1 where the polarisation transfer step occurs at two 
magnetic fields, the Earth’s magnetic field (0.5 G) and a higher field during which the 
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sample was shaken across the range 5 G to 100 G. The results from this experiment are 
outlined in Table 3.1. 
Magnetic field 
of polarisation 
Observed 1H NMR signal enhancement 
Ortho Meta Para 
0.5 G -72 110 -47 
5 G – 100 G -0.3 1.6 -0.2 
Table 3.1 Results reported in a publication by Atkinson et al. (2009)61 upon changing the field of 
polarisation on a sample of pyridine polarised by SABRE using [Ir(PCy3)(H)2(py)3]BF4. 
It can be observed that changing the field of polarisation has had a great effect on the 
level of polarisation transfer observed to pyridine. Preparing the states by shaking the 
sample in the range of fields varying from 5 G to 100 G had the effect to significantly 
reduce the observed 1H NMR signal enhancement. These experiments outlined a non-
rigorous idea of the magnetic field dependence of polarisation transfer using SABRE.  
The effect was also investigated in a publication by Cowley et al. (2011)66 using the 
carbene-based SABRE catalyst IMes(a). For this purpose, a flow system (method 2) 
was employed, giving a great advantage over the shake method employed published in 
Atkinson et al. (2009),61 as it was possible to investigate the enhancement observed 
when the sample is polarised at discrete fields.  
 
Figure 3.1 Intensity of the 1H NMR signal enhancement of the para proton resonance of pyridine when 
polarised using IMes(a) at the indicated fields from 0 G to 150 G, in increments of 5 G. Image taken from 
the supplementary information of the publication by Cowley et al. (2011).66  
It is possible to observe in Figure 3.1 that a maximum level of polarisation was 
transferred to pyridine at 70 G. This is significantly different to the results observed 
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with [Ir(PCy3)(H)2(py)3]BF4 and pyridine, where polarisation transfer into pyridine 
decreased upon increase in magnetic field of polarisation. There are two possible 
reasons for this difference. The main reason for this observed difference is the use of a 
different catalyst in each case however this difference could also be due to the different 
methods of interrogation used to investigate the dependence. In the publication by 
Atkinson et al. (2009),61 the higher field is investigated by shaking the NMR tube 
across a range of field values, and in the publication by Cowley et al. (2011),66 an 
automised polarisor is used to allow investigation at discrete magnetic fields. 
The magnetic field dependence of SABRE was also considered in a publication by 
Dücker et al. (2012)65 in a study which investigated polarisation transfer to a number of 
pyrazoles (Figure 3.2) by the catalyst [Ir(COD)(PCy3)(py)]
+, activated in the presence 
of hydrogen and substrate to form [Ir(PCy3)(sub)3(H)2]
+. The choice of catalyst 
therefore means 1 equivalent of pyridine is present in all samples. 
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Figure 3.2 Structures of pyridine and the pyrazole-based substrates investigated in the publication by 
Dücker et al. (2012)65 labelled as a) pyridine, b) pyrazole, c) 1-methylpyriazole, d) 3-methylpyrazole, e) 
3-phenylpyrazole, f) 3-(3-bromophenyl)pyrazole, g) indazole, h) 3,5-dimethylpyrazole and i) 3,5-
diphenylpyrazole. 
The field dependence results published in Dücker et al.65 differ from those previously 
reported, as the measurements were made on a 300 MHz rather than 400 MHz 
spectrometer. These results were collected by the shake method (method 1) in the stray 
field of the spectrometer, resulting in errors from inhomogeneous field effects.  
When Dücker et al.65 examined polarisation transfer to pyridine, they found the 
maximum 1H NMR signal enhancement was observed at 130 G. This value is different 
142 
to that previously reported by Cowley et al. (2011)66 of 70 G. This is a result of the 
different catalysts used in each case. Atkinson et al. (2009)61 reported on polarisation 
transfer to pyridine with the same catalyst as used by Dücker et al.,65 however only two 
magnetic fields were investigated, 0.5 G and a range of 5 G to 100 G, and they observed 
a decrease in polarisation transfer efficiency with increase in magnetic field.  
When Dücker et al.65 investigated pyrazole itself, a maximum enhancement of ~150 
fold was found at 140 G. Although the absolute enhancement is much less than that 
observed for pyridine, the profile of an enhancement vs field graph is similar for the two 
substrates. This trend was continued with the other substrates including 1-
methylpyrazole, 3-methylpyrozole and 3-phenylpyrazole (in which no polarisation was 
noted into the phenyl ring). Preliminary investigations into 3-(3-bromophenyl)pyrazole 
exhibited near identical results to 3-phenylpyridine and therefore a full magnetic field 
dependence profile was not completed. For the remaining substrates, very low or no 
polarisation was observed, and therefore studies on the dependence with magnetic field 
were not completed. 
3.2.1 Effect of magnetic field during the polarisation transfer step on polarisation 
transfer efficiency into pyridine 
In Chapter 2, method 1 was used to explore the polarisation transfer efficiency of 
IMes(a), SIMes(a) and ICy(a) to pyridine. To optimise the enhancement values 
obtained, the 1H NMR signal enhancement was monitored as a function of polarisation 
transfer field (PTF) for each catalyst. Changing the PTF during a shake in method 1 is 
inaccurate and difficult to reproduce as it involves the sample being shaken in the stray 
field of the spectrometer magnet. A more rigorous study was therefore completed using 
method 2 detailed in Chapter 2 and Experimental. It should be noted that samples using 
ICy(a) were activated in an ampoule prior to being injected into the mixing chamber of 
the polarisor (see Experimental). This is completed by sealing the sample in an ampoule 
under an atmosphere of H2, shaking and storing at room temperature overnight. This is 
because ICy(a) has comparatively long activation times which cannot be 
accommodated by the mixing chamber.  
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Substrate Catalyst 
Polarisation 
field of max. 
pol. transfer / G 
Observed 1H NMR signal enhancement 
Ortho Meta Para 
N  
IMes(a) -70 -322 -241 -535 
SIMes(a) -90 -83 -63 -103 
ICy(a) -60  -8 -5 -9 
Table 3.2 1H NMR signal enhancement of pyridine observed for IMes(a), SIMes(a) and ICy(a) using 
method 2, quoted at the magnetic field which resulted in the maximum observed 1H NMR signal 
enhancement. 
The field value for the maximum observed 1H NMR signal enhancement for each 
catalyst considered is presented in Table 3.2. It can be seen that they differ only slightly 
from each other. It is assumed this difference must be as a result of each catalyst 
producing slightly different J-Couplings between the hydride ligands and bound 
pyridine ligands however this coupling is not observable in 1H NMR spectra. 
3.2.2 Effect of magnetic field during the polarisation transfer step on polarisation 
transfer efficiency into deuterated pyridines 
A series of experiments were completed to further understand the polarisation transfer 
process employed in SABRE by using the two deuterated pyridines, 3,4,5-d3-pyridine 
and 2,6-d2-pyridine, with structures shown in Figure 3.3. These experiments were 
completed using SIMes(a). 
a) N
D
D
D
         b)   ND D  
Figure 3.3 Structures of a) 3,4,5-d3-pyridine and b) 2,6-d2-pyridine. 
The first deuterated pyridine to be investigated by method 2 using SIMes(a) was 3,4,5-
d3-pyridine. The initial intention of investigating this substrate was to focus polarisation 
transfer into one site, thereby causing a build-up in that position and consequently a 
higher enhancement. The production of a hyperpolarised single signal also has a great 
advantage in MRI experiments as it prevents ghosting. 
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Figure 3.4 Relative 
1
H NMR signal strength of the ortho proton resonance of 3,4,5-d3-pyridine polarised 
by SIMes(a). These data are presented as a function of the magnetic field of polarisation which varies 
from -150 G to +10 G in increments of +10 G. 
The maximum level of polarisation transfer in 3,4,5-d3-pyridine using SIMes(a) was 
achieved at a magnetic field of polarisation of -80 G. The corresponding enhancement 
was -177 fold for the ortho proton resonance of 3,4,5-d3-pyridine. This means that the 
level of polarisation transfer to the ortho proton resonance increases by nearly 2 fold, 
through deuteration of the 3, 4 and 5 proton resonances, relative to h5-pyridine, as 
predicted. No signals were observed for the 3, 4 or 5 proton resonances. 
2,6-d2-pyridine (Figure 3.3b) was then investigated. The deuteration of both ortho sites 
was predicted to block polarisation transfer into the substrate if transfer involved J 
coupling between the hydride ligands and the ortho protons. It was therefore predicted 
that polarisation transfer into the 3, 4 and 5 protons would not occur.  
The results from the experiments showed the polarisation transfer efficiency into the 
para proton increased when the polarisation transfer step was completed towards 0 G 
magnetic field (Figure 3.5).  
a) b) c)  
Figure 3.5 Relative 
1
H NMR signal strength of the a) ortho, b) meta and c) para proton resonance of 2,6-
d2-pyridine polarised with SIMes(a). These data are presented as a function of the magnetic field of 
polarisation which varies from -150 G to +10 G in increments of +10 G. 
145 
The data was collected for a second time however the magnetic field of polarisation was 
then decreased from 10 G to -150 G. Now, a different trend was observed (Figure 3.6). 
a) b) c)  
Figure 3.6 Observed 
1
H NMR signal of a) ortho, b) meta and c) para proton resonance of 2,6-d2-pyridine 
polarised with SIMes(a). This data is presented with the field of addition of parahydrogen taking place at 
-150 G to +10 G in increments of +10 G, but collected from +10 G to -150 G.  
The para position of 2,6-d2-pyridine now exhibits a maximum polarisation level at -60 
G. The reason for this change proved to be due to deuteration of the ortho sites. This 
was revealed by comparison of thermal 
1
H NMR spectra taken before and after these 
measurements as shown in Figure 3.7.  
 
Figure 3.7 Thermal 
1
H NMR spectra of 2,6-d2-pyridine recorded before (top) and after (bottom) the 
investigation using SIMes(a) with method 2. 
It is clear that the 2,6-d2-pyridine is changed dramatically. Further investigations 
revealed 
1
H/
2
H exchange is too rapid in the presence of SIMes(a) to be able to probe the 
effect of deuterating the ortho positions of pyridine. This is a known reaction of this 
type of catalyst, discussed in Chapters 1 and 2.
77,78
  
3.3 Effect of temperature during the polarisation transfer step on polarisation 
transfer efficiency 
The concept that changing the temperature during the polarisation transfer step can 
result in a change in the polarisation transfer efficiency of a system was first reported 
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experimentally in a publication by Atkinson et al. (2009),61 where polarisation transfer 
to pyridine was investigated at 25 ºC (298 K) and 80 ºC (353 K) with 
[Ir(COD)(PCy3)(py)3(H)2]BF4. They showed that at 0.5 G, the level of polarisation 
transfer to all three sites of pyridine decreased by increasing the temperature to 80 ºC.  
This effect was also investigated in a publication by Cowley et al. (2011)66 for both 
[Ir(COD)(PCy3)(py)3(H)2]BF4 and IMes(a) catalysts with the polarisation transfer step 
taking place at 25 ºC (298 K) and 45 ºC (318 K). Now, an increase in polarisation 
transfer efficiency was observed to pyridine with [Ir(COD)(PCy3)(py)3(H)2]BF4 with 
increase in temperature, but a decrease for IMes(a). 
In each report, the polarisation transfer to pyridine was only investigated at two 
temperatures. It is therefore important to investigate the effect more precisely, looking 
at a larger number of temperatures, both above and below room temperature. 
It is assumed that the reason why catalysts exhibit different polarisation transfer 
properties using SABRE is due to each catalyst having a different rate constant of 
hydride ligands and substrate loss. Consequently, the effect of changing the temperature 
at which the polarisation step occurs will be significant. Theory59 suggests the extent of 
polarisation transfer is dependent on the lifetime of the complex [Ir(carbene)(py)3(H)2]
+ 
(see Chapter 1). This time is known as the contact time.59 It can therefore be assumed 
that changing the temperature at which the polarisation transfer step occurs will affect 
the extent of polarisation transfer through changing the contact time. Generally, an 
increase in temperature will make exchange rates faster and decreasing the temperature 
will slow the exchange rates (see Appendix). 
Temperature Hydride ligand loss (s-1) Pyridine loss (s-1) 
ºC K IMes(a) SIMes(a) ICy(a) IMes(a) SIMes(a) ICy(a) 
0 273 0.3 2 0.006 0.5 2 0.03 
20 293 4 17 0.09 9 21 0.5 
30 303 12 49 0.3 31 62 2 
40 313 33 131 1 105 166 7 
50 323 85 330 3 330 420 21 
Table 3.3 Predicted rate constants of hydride and pyridine ligand loss calculated from thermodynamic 
data in Chapter 2 for IMes(a), SIMes(a) and ICy(a) at the indicated temperatures. 
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It can be predicted that IMes(a) exhibits exchange rate constants closest to the optimum 
(Table 3.3) as it exhibits the highest level of polarisation transfer at 300 K of the three 
catalysts. The effect of changing the temperature of addition of parahydrogen to a 
SABRE catalyst was investigated using method 1. To complete these experiments the 
sample must first be put under a parahydrogen atmosphere but not shaken. It is then 
stored at the desired temperature for three minutes with as little disturbance as possible. 
The NMR tube is then quickly wiped dry, shaken for 8 s and interrogated by NMR. The 
temperature dependence of polarisation transfer via SABRE to pyridine with IMes(a), 
SIMes(a) and ICy(a) was investigated. 
3.3.1 Effect of changing the temperature of polarisation transfer efficiency into 
pyridine using IMes(a) 
IMes(a) was the first catalyst to be investigated with respect to a temperature 
dependence.  
IMes(a) and pyridine Temperature / ºC 
0 20 30 40 50 
Rate of 
loss (s-1) 
Hydride ligands 0.3 4 12 33 85 
Pyridine 0.5 9 31 105 330 
Pyridine 
resonance 
Ortho -64 -78 -69 -96 -85 
Meta 98 96 101 51 61 
Para -120 -126 -119 -79 -90 
Table 3.4 1H NMR signal enhancement to the ortho, meta and para proton resonances of pyridine in the 
presence of IMes(a) in methanol when the polarisation transfer step occurs at the indicated temperatures 
with the predicted rate constants of hydride and pyridine ligand exchange calculated from thermodynamic 
data in Chapter 2. 
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Figure 3.8 Relative 1H NMR signal enhancement to pyridine resonances obtained with IMes(a) as a 
function of temperature. 
Analysis of these data, presented in Table 3.4 and Figure 3.8, shows that a linear 
dependence is not present. In addition, it varies for each resonance; cooling from room 
temperature to 0 ºC appeared to have little real effect, however increasing the 
temperature has a clear effect. Firstly, the ortho resonance exhibits a small, but 
significant increase in the polarisation transfer level observed when the temperature is 
increased to 30 ºC. Increasing the temperature further to 40 ºC and 50 ºC results in a 
further drop in the polarisation transfer level. Very similar effects are observed for the 
meta and para resonances. This experiment has shown that for the IMes(a) and pyridine 
system, the optimal temperature of the five temperatures investigated is room 
temperature.  
3.3.2 Effect of changing the temperature of polarisation transfer efficiency into 
pyridine using SIMes(a) 
The temperature dependence of SIMes(a) with pyridine was investigated. Both pyridine 
and hydride exchange rate constants for SIMes(a) are known to be faster than the 
exchange rate constants for IMes(a) (Table 3.3). Consequently, it is predicted 
increasing the temperature of polarisation, and therefore increasing the exchange rates 
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further, will decrease polarisation transfer to pyridine, and vice versa. The results from 
this experiment are outlined in Table 3.5 and Figure 3.9. 
SIMes(a) and pyridine Temperature / ºC 
0 20 30 40 50 
Rate of 
loss (s-1) 
Hydride ligands 2 17 49 131 330 
Pyridine 2 21 62 166 420 
Pyridine 
resonance 
Ortho -126 -121 -83 -61 -43 
Meta 86 76 40 27 17 
Para -98 -95 -64 -43 -32 
Table 3.5 Observed 1H NMR signal enhancement to the ortho, meta and para proton resonances of 
pyridine in the presence of SIMes(a) in methanol when the polarisation transfer step occurs at various 
temperatures with the predicted rate constants of hydride and pyridine ligand exchange calculated from 
thermodynamic data in Chapter 2. 
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Figure 3.9 Relative 1H NMR signal enhancement to pyridine resonances obtained with SIMes(a) as a 
function of temperature. 
As predicted, increasing the temperature above room temperature reduces the level of 
polarisation transfer. In contrast, a small increase in the level of polarisation transfer is 
observed when reducing the temperature to 0 ºC. 
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3.3.3 Effect of changing the temperature of polarisation transfer efficiency into 
pyridine using ICy(a) 
It is known that the exchange rate constants for both pyridine and hydrides are much 
slower for ICy(a) than for SIMes(a) and IMes(a) (Table 3.3) and therefore, it is 
predicted that increasing temperature, and therefore increasing the exchange rates, will 
increase polarisation transfer into pyridine. The temperature dependence of polarisation 
of pyridine for ICy(a) is presented in Table 3.6. 
ICy(a) and pyridine Temperature / ºC 
0 20 30 40 50 
Rate of 
loss (s-1) 
Hydride ligands 0.006 0.09 0.3 1 3 
Pyridine 0.03 0.5 2 7 21 
Pyridine 
resonance 
Ortho -3 -6 -9 -11 -13 
Meta 2 6 8 9 10 
Para -3 -6 -10 -11 -14 
Table 3.6 Observed 1H NMR signal enhancement to the ortho, meta and para proton resonances of 
pyridine in the presence of ICy(a) in methanol when the polarisation transfer step occurs at various 
temperatures with the predicted rate constants of hydride and pyridine ligand exchange calculated from 
thermodynamic data in Chapter 2. 
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Figure 3.10 Relative 1H NMR signal enhancement to pyridine resonances obtained with ICy(a) as a 
function of temperature. 
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Polarisation of pyridine with ICy(a) shows a clear dependence on the temperature of 
polarisation (Figure 3.10), where an increase in temperature leads to an increase in 
observed polarisation transfer, as predicted. This is predicted to be a result of the slow 
rate constants of loss of pyridine and hydride ligands from ICy(a). 
3.3.4 Comparison of the effect of temperature on the polarisation transfer efficiency 
into pyridine using IMes(a), SIMes(a) and ICy(a) 
The temperature dependence of the above three catalysts, IMes(a), SIMes(a) and 
ICy(a) were compared.  
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Figure 3.11 Relative 1H NMR polarisation transfer to the ortho, meta and para resonances of pyridine 
when IMes(a), SIMes(a), and ICy(a) are used as the polarisation transfer catalyst in methanol as a 
function of temperature of parahydrogen addition. 
As expected, IMes(a) shows the largest signal enhancement of the three catalysts for the 
meta and para resonances of pyridine, but not the ortho resonance (Figure 3.11). This 
could be due to a small amount of antiphase nature (see Chapter 1) that is observed on 
the ortho position for the duration of this experiment. For IMes(a), the temperature that 
gives the maximum polarisation transfer is a little complicated as a maximum is 
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observed at a different temperature for each position. For SIMes(a), the maximum 
signal enhancement is observed at 0 ºC.  
Calculations were completed to understand if some of the above results could be 
explained though the change in solubility of hydrogen gas in methanol at varying 
temperatures. Although the headspace of a typical NMR tube used in method 1 has an 8 
fold excess of hydrogen gas, when this is extended to consider the number of moles of 
hydrogen dissolved in solution, the catalyst becomes ~310 fold in excess (see 
Experimental, section 8.3.2). It is therefore the act of vigorous shaking which allows 
exchange, and therefore polarisation transfer is minimally dependent on hydrogen 
solubility, as a change in temperature has a very small effect on the catalyst excess. 
These experiments have shown that changing the temperature of polarisation has a 
significant effect on the extent of transfer experienced to the substrate, and the effect is 
different for each catalyst. Changing the temperature of polarisation can also be 
considered as a simple method to increase polarisation transfer into a new substrate 
when conducting initial investigations in a Young’s Tap NMR tube.  
Numerous methods to derive a correlation between exchange rates and the extent of 
polarisation transfer to pyridine have been attempted, including the fastest exchange rate 
constant, the product of the exchange rates and consideration of the contact time of the 
complex, however none of these have been successful.  
3.4 Effect of concentration during the polarisation transfer step on polarisation 
transfer efficiency 
There are two publications61,66 which describe a concentration dependence of SABRE. 
The first is for a phosphine61 system and the second for a carbene66 system. In the 
phosphine study published by Atkinson et al.,61 the concentration of pyridine was kept 
constant at 103 mM (5 µL in 0.6 ml solvent) and the amount of 
[Ir(COD)(PCy3)(py)]BF4 added was varied. This corresponded to a catalyst loading 
from 0.1 mol % to 20 mol %, loadings beyond this point could not be investigated as the 
solution became saturated with catalyst. Each sample was then heated to 318 K, shaken 
for 5 s and interrogated by NMR. The results of this experiment are shown pictorially in 
Figure 3.12. 
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Figure 3.12 Reproduced pictorial description of the results of the catalyst loading study completed in a 
publication by Atkinson et al. (2009).61  
The maximum 1H NMR signal enhancement of 94 fold was observed where the catalyst 
loading was 20 mol % at 318 K at 2 G. This sample was then diluted to halve the 
concentration of both catalyst and pyridine, but keeping the same catalyst loading. This 
lowered the observed 1H NMR signal enhancement to 66 fold. The effect is therefore 
not linear. 
The effect of catalyst loading with IMes(a)  and pyridine has also been reported in the 
publication by Cowley et al.66 For an IMes(a) and pyridine system, the catalyst loading 
was varied from 0.1 mol % to 10 mol %. Higher loadings could not be investigated due 
to saturation of the solution. The results of this experiment are shown pictorially in 
Figure 3.13. 
 
Figure 3.13 Reproduced pictorial description of the results of the catalyst loading study in a publication 
by Cowley et al. (2011).66  
These data indicate a similar result to that presented for [Ir(COD)(PCy3)(py)]BF4: the 
higher the catalyst loading, the higher the observed enhancement. In the case of 
IMes(a), the maximum 1H NMR signal enhancement of 360 fold on the ortho proton 
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was observed at 10 mol % catalyst loading. These results are significantly better than 
those for the phosphine catalyst however the dependence is still not linear. 
It can be assumed that the aim of the two catalyst loading experiments reported was to 
understand the conditions required to gain a maximum signal enhancement for pyridine. 
From a pharmaceutical point of view, there are a number of reasons it would be 
advantageous to understand how low concentrations of substrate could be optimally 
examined. The most simple of these reasons is to limit the amount of substrate used. In 
some cases, particularly in research in a pharmaceutical company, only very small 
amounts of substrate are produced for characterisation. This may be too little for 
interrogation by conventional NMR spectroscopy. Furthermore, the polarisation of low 
concentration substrates may allow the detection of potentially genotoxic impurities.  
The first experiments completed to target this problem concerned changing the 
concentration of catalyst and substrate together, such that their ratio remained the same. 
The idea was then extended to investigate polarisation transfer efficiency when the 
substrate is present in low concentration, but the catalyst concentration remains the 
same. This process allows us to better understand how polarisation transfer efficiency 
into a potentially unknown, very low concentration of substrate could be achieved.  
3.4.1 Effect of concentration when ratio of pyridine to catalyst remains constant on 
polarisation transfer efficiency 
These investigations were initially completed using method 1. Concentrations of       
100 mM pyridine (0.062 mmol, 5 ul) with 5 mM IMes(a) catalyst (0.0031 mmol,     
1.99 mg) in 0.6 ml of deuterated methanol were initially used. A series of samples, both 
more and less concentrated than the standard sample were then investigated, outlined in 
Table 3.7. In order to investigate samples at the lower concentrations, a standard 
concentration solution was diluted with deuterated methanol to produce samples at      
10 %, 1 % and 0.1 % of the standard concentration.  
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 Conc. 
Rel. to 
standard 
IMes(a) Pyridine 
[IMes(a)] 
(mM) 
Mass  
(mg) 
[pyridine] 
(mM) 
Volume    
(µl) 
Sample 1 500 % 25  10 500 25 
Sample 2 300 % 15  6 300 15 
Sample 3 100 % 5  2 100 5 
Sample 4 10 % 0.5 0.2 10 0.5 
Sample 5 1 % 0.05 0.02 1 0.05 
Sample 6 0.1 % 0.005 0.002 0.1 0.005 
Table 3.7 The amounts of IMes(a) and pyridine used in the concentration experiments. Each sample 
contained 0.6 ml d4-methanol. 
For samples 5 and 6, it was not possible to observe any pyridine signals in a thermal 
single scan. For calculation of enhancements in sample 5, the integral of the thermally 
derived signals has been estimated. The thermally polarised signal is proportional to the 
concentration of pyridine and therefore a graph of integral vs pyridine concentration 
was drawn to calculate the integral at the lower concentration (see Experimental). 
Enhancements of hyperpolarised signals have not been calculated for sample 6 as the 
signal strength is barely past the noise level in the spectra. In sample 5 (1% standard 
concentration), pyridine could be observed after interrogation by SABRE, with the 
largest of the signals having a signal-to-noise ratio of ~35, thereby giving a small but 
significant signal. By comparison, sample 4 (10 % standard concentration) yielded 
hyperpolarised signals with a signal-to-noise ratio of ~1650. The calculated 
enhancements for samples 1 to 5 and signal-to-noise ratios of samples 1 to 6 are 
presented in Table 3.8. 
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Sample Conc. Rel. 
to standard 
Day Ortho proton Meta proton Para proton 
Enhan. S/N Enhan. S/N Enhan. S/N 
1 500 % 1 -17 12172 36 16699 -37 14622 
2 -85 15087 61 12768 -75 8791 
3 -95 10898 66 14607 -77 11188 
2 300 % 1 -108 31383 81 13739 -84 11055 
2 -176 23164 90 12211 -132 11047 
3 -151 9310 68 7443 -105 6629 
3 100 % 1 -184 19296 137 10025 -163 6895 
2 -357 8192 114 8595 -225 8962 
3 -272 3271 69 6006 -152 5888 
4 10 % 1 -351 4180 179 1672 -277 1312 
2 -308 1732 151 1281 -229 1149 
3 -324 1601 111 1076 -244 1048 
5 1 % 1 -65* 90 43* 77 -54* 33 
2 -32* 35 22* 21 -43* 19 
3 -12* 11 -8* 8 -15* 7 
6 0.1 % 1 - 2 - 2 - 2 
2 - - - - - - 
3 - - - - - - 
Table 3.8 Showing the 1H NMR signal enhancement levels, and signal to noise ratios, of free pyridine 
proton resonances observed with indicated concentrations of IMes(a) and pyridine (Table 3.7) across 
three days. Columns labelled ‘Enhan’ contain the observed 1H NMR signal enhancement, and columns 
labelled ‘S/N’ contain the signal to noise ratio. *Enhancements for the 1 % sample are calculated based 
on a predicted thermally polarised signal integral (see Experimental).  
It should be noted that for samples 1-4, the thermally polarised spectrum used to 
calculate the enhancement values is recollected each day to take into account the 
potential deuteration of the substrate. These data show that hyperpolarisation is still 
achieved at very low sample concentrations. Even the 1 % sample exhibits significant 
polarisation, thereby enabling the detection of ~0.05 µl of pyridine (~0.049 mg) in a 
single scan (Figure 3.14). It should be noted here the enhancement values in Table 3.8 
for the 1 % sample are predicted and do not take into account the effect of poor signal to 
noise ratios for samples of this concentration. They also do not take potential 
deuteration of the sample over the three days into account due to the method by which 
the thermally polarised integral is calculated (see Experimental). Polarisation transfer 
was also observed in sample 6 (0.1 % standard concentration), enabling the detection of 
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~0.005 µl pyridine however the signal to noise ratio for these signals was too low to 
reliably detect them. This might be improved by the completion of a number of 
averaged scans however method 2 must be used to achieve this.  
 
Figure 3.14 Thermal 1H NMR spectrum of pyridine (top) and a typical hyperpolarised spectrum (bottom) 
polarised with IMes(a) using method 1 at 2 G. The catalyst and substrate are at 1% of the standard 
concentration (0.02 mg IMes(a) and 0.05 µl pyridine). 
The calculated enhancements of samples 1-4 have been represented in graphical form in 
Figure 3.15. 
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Figure 3.15 Graphical representation of the enhancement observed over three days of a concentration 
study where the ratio of IMes(a) to pyridine is kept constant (Table 3.8). 
The higher concentration samples show greater signal enhancement on the second day 
when compared to the first. This suggests that increasing the concentration of catalyst 
results in a longer activation time. The highest concentration sample (sample 1) led to 
the highest signal-to-noise ratios owing to the higher amount of starting materials. 
However, the signal enhancement level is the lowest of the four samples. As the 
concentration of parahydrogen is constant in all samples, there is less parahydrogen per 
catalytic centre the higher the concentration of catalyst which could lead to the drop in 
observed enhancement. Generally speaking, the enhancement is greatest for sample 4 
(10 % standard concentration). This could be as a result of the increased relative 
concentration of parahydrogen. Based on the calculations set out in the Experimental, 
there are 8.5 molecules of hydrogen for every molecule of catalyst at standard 
concentrations and conditions for method 1. When the concentration of catalyst is 
lowered to 10 % of standard concentrations, there are 76.5 molecules of parahydrogen 
per molecule of catalyst.  
This type of catalyst is a known HD exchange catalyst,77,78 a reaction discussed in 
Chapters 1 and 2. Completing the experiment over three days also allowed an 
investigation into the level of pyridine deuteration achieved with IMes(a). This has 
been based on thermal single scan 1H NMR spectra.  
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Figure 3.16 Deuteration level of the ortho position of pyridine when reacted with IMes(a) in d4-methanol 
over a period of 48 hours. For sample numbers, refer to Table 3.7. 
The results depicted Figure 3.16 indicate the level of deuteration is significant over a 
time period of 24 hours. It is therefore pertinent to complete all required experiments as 
quickly as possible after activation. 
This experiment was repeated using method 2, as this could provide a greater net 
enhancement due to the ability to optimise the polarisation transfer through changing 
the magnetic field of polarisation. For a flow probe experiment, concentrations of 100 
mM pyridine (0.31 mmol, 24 µl) and 5 mM IMes(a) catalyst (0.0155 mmol, 9.92 mg) in 
3 ml of deuterated methanol were initially used. In order to investigate the lower 
concentration samples, a standard concentration solution was diluted with deuterated 
methanol to produce samples at 10 %, 1 % and 0.1 % of the standard concentration. The 
results after analysis are presented in Table 3.9. 
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[IMes(a) ] 
(mM) 
[pyridine] 
(mM) 
Conc. Rel. 
to standard 
Observed 1H NMR signal enhancement 
Ortho Meta Para 
5 100 100 % -322 -241 -535 
0.5 10 10 % -178 -124 -162 
0.05 1 1 % -65 -15 -7.2 
0.005 0.1 0.1 % - - - 
Table 3.9 Table showing the extent polarisation transfer achieved in a single scan at the indicated 
concentrations of IMes(a) and pyridine using method 2, polarised in a magnetic field of 75 G. 
The results found are comparable with those found in method 1. As the polarisor is set 
to a magnetic field of 75 G, a larger net signal enhancement is expected. However, there 
is a longer time between the addition of parahydrogen and the measurement so the 
hyperpolarised states have had a greater time to decay. It should be noted that the 
sample at 0.1 % standard concentration resulted in the observation of small peaks 
however the peaks observed were too small to be reliably assigned. 
These data show it is possible to detect a small amount of pyridine in these experiments 
where the catalyst loading remains constant. When investigating low concentration 
impurities, the absolute concentration of that impurity will be unknown and therefore 
adding the correct amount of catalyst will not be possible. A different approach is 
therefore required. 
3.4.2 Effect of concentration when concentration of catalyst remains constant on 
polarisation transfer efficiency 
In the case where an impurity is under investigation, for instance a potentially harmful 
reactant which has not been removed effectively, the concentration of that impurity will 
be unknown, and therefore a specified amount of catalyst will be added. This is likely to 
be in great excess of the impurity of interest. It is known that if IMes(a) is activated 
with a lower than 1:3 catalyst to substrate ratio, the catalyst becomes unstable and is no 
longer able to transfer polarisation. To overcome this, a stoichiometric amount of 
acetonitrile (3 equivalents compared to 1 equivalent of catalyst) is added to act as a 
stabiliser. The acetonitrile is present in all samples to keep the conditions consistent 
across the varying pyridine concentrations. This concept was first investigated using 
method 1 and the results of this study are presented in Table 3.10.  
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Sample [pyridine] 
mM 
Ratio of 
cat. to py 
Ortho proton Meta proton Para proton 
Enhan. S/N Enhan. S/N Enhan. S/N 
1 1000 1 : 200 -7 13771 5 6586 -6 4088 
2 500 1 : 100 -16 15335 10 6752 -14 4670 
3 100 1 : 20 -83 14250 60 7009 -83 5343 
4 10 1 : 2 -273 6271 190 3709 -301 2818 
5 1 1 : 0.2 -21 13 81 10 -209* 407* 
6 0.1 1 : 0.02 - 54+ - 80+ - 33+ 
Table 3.10 Table detailing the signal enhancement levels and signal to noise ratios of free pyridine 
resonances observed with indicated concentrations of pyridine, a standard concentration of IMes(b) and a 
stoichiometric volume of acetonitrile. Columns labelled ‘Enhan’ contain the observed 1H NMR signal 
enhancement, and columns labelled ‘S/N’ contain the signal to noise ratio. *donates the bound pyridine 
signal was not base-line resolved from the free pyridine signal and therefore the value is a combination of 
both signals. +denotes the value refers to the bound pyridine signal alone, not the free signal. 
It was not possible to calculate the enhancements for sample 6 as no free pyridine 
signals were observed in the thermal single scan proton spectrum used for comparison. 
It should be noted that as a result of the high relative concentration of catalyst to 
pyridine, in some cases the pyridine remains bound and therefore the signals for the 
bound resonances are more significant than those of the free pyridine. This is 
particularly evident in sample 6 where no signals corresponding to free pyridine are 
observed, however, those corresponding to bound pyridine are observed. In sample 5, 
the bound signals show greater enhancement and signal to noise ratios than the free 
signals. Samples 1 to 4 show similar enhancement values for both free and bound 
pyridine as expected. Here, the free pyridine signals are the most significant in the 
spectrum.  
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Figure 3.17 Graphical representation of the effect of pyridine concentration on the resultant signal 
enhancement (left) and signal to noise ratios (right) of free pyridine signals when pyridine is 
hyperpolarised with a standard concentration of IMes(b) in the presence of a stoichiometric amount of 
acetonitrile.  
a b 
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In Section 3.4.1 (pg 154), it was observed that a slight drop off in enhancement is 
observed when the concentration of both pyridine and IMes(a) was increased past the 
standard concentration. This was put down to the low relative concentration of 
parahydrogen in the sample compared to the concentration of pyridine. In Table 3.10 
and Figure 3.17, a similar drop off in signal enhancement is observed as pyridine 
concentration is increased however it is much more significant now the relative 
concentration of catalyst has not been increased by the same proportion. A possible 
reason for this is the lower concentration of active sites for polarisation transfer due to 
the lower concentration of catalyst. It can be observed that a drop in concentration from 
100 % standard concentration to 10 % concentration results in a significant increase in 
the level of observed polarisation transfer. This area was therefore investigated more 
closely to understand if a higher maximum can be obtained. The results are presented in 
Table 3.11.  
Sample [pyridine] 
(mM) 
Pyridine conc. 
rel. to standard 
Observed 1H NMR signal enhancement 
Ortho Meta Para 
1 100 100 % -70 62 -78 
2 80 80 % -115 102 -134 
3 60 60 % -111 137 -169 
4 40 40 % -257 193 -265 
5 20 20 % -384 273 -378 
Table 3.11 Table detailing the signal enhancement levels and signal to noise ratios of free pyridine 
resonances observed with indicated concentrations of pyridine, a standard concentration of IMes(a) and a 
stoichiometric volume of acetonitrile.  
Table 3.11 is represented graphically below in Figure 3.18. 
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Figure 3.18 The graphical representation of Table 3.11 investigating the effect of pyridine concentration 
on the resultant signal enhancement of free pyridine signals when hyperpolarised with a standard 
concentration of IMes(a) in the presence of a stoichiometric amount of acetonitrile. 
It is possible to observe the polarisation transfer into pyridine increases as the amount of 
pyridine reduces. With the exception of the enhancement observed on the ortho position 
with an addition of 3 µL pyridine, all points show a near linear correlation, indicating 
that addition of 1 µL pyridine gives the concentration resulting in the maximum 
enhancement.  
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Figure 3.19 The graphical representation of Table 3.10 and Table 3.11 investigating the effect of pyridine 
concentration on the resultant signal enhancement of free pyridine signals when hyperpolarised with a 
standard concentration of IMes(a) in the presence of a stoichiometric amount of acetonitrile. 
Combination of the two sets of data presented in Table 3.10 and Table 3.11 results in a 
clear maximum being observed, when 1 µL of pyridine is added.  
In general it has been seen that lowering the concentration of pyridine, or pyridine and 
catalyst, increases the level of polarisation transfer into pyridine. A possible reason for 
this is the increased relative concentration of parahydrogen (see Experimental, section 
8.3.1). Another factor that can affect the extent of polarisation transfer is the number of 
available catalytic sites within a sample, and so if the concentration of the substrate is 
significantly higher than that of the catalyst, low enhancements are observed. 
Conversely, if the catalyst is in a significantly higher concentration compared to the 
substrate, it is difficult to observe enhancements on the free signals of that substrate, 
however, significant enhancements can be observed on the bound resonances. This is an 
important observation as the substrate is also in lower concentration than that of the 
stabilising additive acetonitrile (0.062 µmol pyridine compared to 9.3 µmol 
acetonitrile), and it is still possible to observe the desired substrate.  
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3.5 Effect of solvent on polarisation transfer efficiency 
All of the work described so far has been completed in a methanol solution. Although 
methanol is suitable for most of the substrates investigated in this thesis, this may not 
always be the case. Indeed in industry, the most common NMR solvents are chloroform 
and DMSO. Polarisation transfer to pyridine through SABRE using IMes(a) was 
therefore investigated in six solvents: methanol, ethanol, DCM, chloroform, DMSO and 
acetone. 
Initial experiments revealed that the catalyst activation time was not the same in all 
solvents. In solvents such as chloroform, activation of the catalyst took much longer. 
For this reason, each sample was activated for the time outlined in Table 3.12. 
Solvent Time for activation after hydrogen addition 
Methanol Mins at room temperature 
Ethanol Mins at room temperature 
DCM Mins at room temperature 
Chloroform Overnight at 25 ºC 
DMSO Overnight at 25 ºC 
Acetone Mins at room temperature 
Table 3.12 Time required to fully activate IMes(a) in the indicated solvents where pyridine is the 
substrate. 
As DMSO and chloroform take a long time to activate fully, these were put under a 
hydrogen atmosphere, shaken and stored at 25 oC overnight. For those which activate 
quickly (methanol, ethanol, DCM and acetone), the addition of hydrogen and initial 
shake were completed ~10 mins before interrogation by SABRE. These were not 
activated at the same time as the DMSO and chloroform samples to minimise proton – 
deuterium exchange to the ortho position of pyridine as much as possible. Polarisation 
transfer was then investigated at three temperatures: room temperature, 40 ºC and 0 ºC. 
This enables us to monitor the effect of increasing and decreasing the ligand exchange 
rates in each case. To achieve this, the head space of the NMR tube was filled with 
parahydrogen but not shaken. The sample was then stored at the desired temperature for 
3 min, after which the NMR tube was quickly wiped dry, and the sample shaken for 8 s 
before interrogation by NMR. The results of these experiments are outlined in Table 
3.13.  
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Solvent Pyridine proton 
resonance 
Temperature / ºC 
0 20 40 
Methanol Ortho -63.5 -77.7 -95.9 
Meta 98.3 95.6 50.8 
Para -120.2 -126.0 -78.5 
Ethanol Ortho -100.3 -135.5 -93.2 
Meta 86.0 116.9 72.1 
Para -90.5 -111.1 -72.3 
DCM Ortho -64.4 -39.2 -28.0 
Meta -24.1 -16.9 -12.4 
Para -65.9 -38.7 -30.6 
Chloroform Ortho -40.8 -40.3 -19.2 
Meta -3.0 -4.2 -2.9 
Para -43.5 -41.3 -20.6 
DMSO Ortho n/a -12.1 -26.0 
Meta n/a 7.6 15.8 
Para n/a -14.4 -33.1 
Acetone Ortho -24.6 -14.5 -9.7 
Meta -10.8 -7.4 -5.2 
Para -24.8 -14.0 -9.7 
Table 3.13 Polarisation transfer to pyridine using IMes(a) under the indicated conditions. The notation 
‘n/a’ denotes the experiments could not be completed due to the temperature being significantly below 
melting point of DMSO. 
Results could not be collected for DMSO at 0 ºC as its melting point is 18 ºC.  
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Figure 3.20 A 3D graphical interpretation in magnitude (ortho only) of Table 3.13, indicating the 
polarisation transfer to pyridine with IMes(a) under the indicated conditions.  
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It can be observed that the greatest signal enhancement can be obtained when using 
ethanol as a solvent. The experiment has also shown that significant polarisation 
transfer occurs in non-polar solvents such as DCM and chloroform. Chloroform shows 
an average enhancement of 40 fold and DCM can get as high as 60 fold when the 
temperature of addition of parahydrogen is lowered to 0 ºC. The different solvent 
systems exhibit different polarities and create different binding modes, and therefore 
have an effect on the observed exchange rates and consequently the level of polarisation 
transfer observed. 
Although interrogation of a sample in ethanol gives the greatest enhancement of the 
solvent investigated, methanol will be used for the majority of the work in this thesis. 
This is because methanol still gives significant polarisation transfer however holds the 
added benefit of being a much cheaper solvent.  
3.6 Summary 
This chapter reports on investigations into a number of variables as potential routes in 
order to optimise the extent of polarisation transfer into a specific substrate. These 
include the magnetic field (PTF), temperature, concentration and solvent present during 
the polarisation transfer step, and how they vary for each of the three previously 
discussed catalysts. It was found that each variable had a significant effect on the level 
of polarisation transfer observed within a system, and results also varied with the 
catalytic system. Taking the effect of changing the PTF on polarisation transfer into 
pyridine, the observed 1H NMR signal enhancement for the para position increased 
from 38 fold at a PTF of 0 G to -103 fold at a PTF of -90 G for SIMes(a) and from 4 
fold at a PTF of 0 G to -9 fold at a PTF of -60 G for ICy(a), where each is quoted for 
the maximum PTF for the stated catalyst. The studies presented in this chapter 
demonstrate that the PTF yielding the maximum signal intensity is different for each 
catalyst. These differ from -90 G to –60 G when considering polarisation transfer into 
pyridine. It will later be shown that this also differs for different substrates (Chapters 4, 
6 and Experimental). It has been postulated that the extent of polarisation transfer is 
based on a fine balance between the difference in chemical shifts of the nuclei of 
interest and the J-coupling of the system59 (Chapter 1) and therefore that the extent of 
polarisation transfer is dependent on the PTF as this affects the relative chemical shifts 
of the nuclei. The J-coupling of the system does not change with external field.  
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The relative chemical shift differences between the key resonances in the catalytic 
template vary by ca ‹1 % as evidenced in (Chapter 2) and Table 3.14.  
Catalyst 1H NMR chemical shifts (ppm) 
Py trans to hydride Hydride ligands Difference 
IMes(a) 8.34 -22.53 30.87 
SIMes(a) 8.32 -22.69 31.01 
ICy(a) 8.75 -22.49 31.24 
Table 3.14 The key chemical shifts and chemical shift differences observed for three SABRE catalysts, 
relevant to the mechanism of polarisation transfer. ‘Py trans to hydride’ refers to the ortho proton only. 
The change in chemical shift difference is small between the three catalysts while the 
difference in the extent of polarisation transfer between the three systems is great, 
varying from ~10 fold for ICy(a) to ~500 fold for IMes(a). It is therefore likely that the 
contact time of the active species is a key variable in the efficiency of polarisation 
transfer. This has been illustrated through determination of the rate constants of the 
systems considered and is supported by the fact that increasing the temperature of the 
ICy(a) system (with relatively slow exchange rate constants) but decreasing the 
temperature of the SIMes(a) system (with relatively fast exchange rate constants) has 
the effect to increase the extent of polarisation transfer. This finding suggests the theory 
related to polarisation transfer needs to be revised to explore the effect of changing 
contact time.  
In the future, it would be preferable to experimentally investigate the effect of changing 
both temperature and field of polarisation concurrently. This is not currently possible as 
our current mixing chamber does not have a temperature control function although this 
is desirable. 
The effect of concentration was investigated for the IMes(a) SABRE catalyst only. It 
was found that decreasing the concentration to one tenth of the standard concentrations 
had the result of dramatically increasing the extent of polarisation transfer observed into 
pyridine. This is explained by the relative excess of parahydrogen gas available to the 
sample. With the catalyst at a standard concentration, an excess of 8.5 fold hydrogen 
gas is present but this is increased to an excess of 77 when the catalyst concentration is 
reduced to one tenth of the standard concentration. Using the SABRE method, in a 0.6 
ml sample, 0.05 µL (1 mM) of pyridine can be detected in a single scan producing S/N 
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ratios of 90, 77 and 33 for the ortho, meta and para resonances of pyridine. This is 
approximately 0.05 mg of substrate, between 10 and 20 times less than that used for 1H 
spectra in standard practice for NMR spectroscopy.  These investigations also revealed 
an additional complication in the form of deuteration of the ortho position of pyridine 
after an extended period of time. 
The solvent has also been shown to play a major role in the efficiency of the SABRE 
catalyst. The relative chemical shifts of any nuclei are related to the solvent and 
therefore the chemical shift differences of the active complex are different depending on 
the solvent used. The solvent also has an effect on the exchange rates experienced by 
the complex due to differing polarities, an effect which is particularly important in 
charged systems such as those investigated here. During these experiments it was found 
possible to obtain enhancements in 1H NMR spectra when the catalyst and solvent were 
dissolved in methanol, ethanol, DCM, chloroform, DMSO and acetone. Of these six, 
maximum signal enhancements were observed in ethanol, with methanol running a 
close second. This indicates that SABRE can be completed in other solvents should they 
be required.  
It has been assumed that the solvent is benign in our systems however it is known that 
acetonitrile, acetone and DMSO can bind to the catalysts. It is also evident in the 
hydride region of the resultant NMR spectra collected for each solvent, that a 
combination of active species may be present. An idea for future work within this 
project would be to characterise these active complexes, and measure the related 
exchange rate constants.  
To conclude, it has been observed that a number of variables can be changed which 
affect the extent of polarisation transfer into a substrate molecule and these must be 
considered when optimising the SABRE effect for a new substrate. 
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4 Chapter 4 - Optimisation of quinoline 
4.1 Introduction 
Up to this point, pyridine and mono-substituted pyridine analogues are the only 
molecules that have been considered as substrates for hyperpolarisation by SABRE. 
Pyridine itself has acted as a good model substrate however it is most commonly found 
in larger structures with a number of substitutions. It was therefore thought prudent to 
investigate a larger system. Quinoline was chosen for this task as it contains a pyridine 
moiety fused to a benzene ring. This gives an aromatic substrate which contains 7 
protons, all of which are magnetically different from each other. The quinoline moiety 
is also found in many current and potential drug molecules, such as in the treatment for 
malaria, arrhythmia, and some bacterial infections and potentially in the treatment of 
Alzheimer’s and as targeted cancer therapies. These are discussed in greater detail in the 
following paragraphs. 
4.1.1 Quinoline analogues as drugs 
4.1.1.1 Quinine and quinidine 
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Figure 4.1 Structures of a) quinine and b) quinidine. Copied from Raheem et al. (2003).110  
Quinine and quinidine (Figure 4.1a and Figure 4.1b respectively) are cinchona 
alkaloids, found in the bark of the cinchona tree.111 They are diastereoisomers of each 
other and consequently, despite being composed of the same parts, each holds 
significantly different pharmaceutical properties.  
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Quinine is one of the oldest anti-malarial drugs originally administered through the 
consumption of ground bark from the cinchona tree, and the drug is still used to treat the 
virus today.111,112 When the synthetic drug, chloroquine (Section 4.1.1.2) was invented, 
quinine was used less frequently however resistance to chloroquine soon became 
apparent, and the use of quinine increased again. As a readily available compound, it is 
commonly used to treat malaria in resource limited settings as it can be difficult to 
maintain a steady supply of the alternative, artemisinin-based combination therapy in 
these areas.  Despite concerns about potential complications such as interactions with 
antiretroviral drugs for HIV treatment or antituberculosis drugs, quinine holds a critical 
role as a malarial treatment due to its safety during pregnancy.111  
Quinine and quinidine are also used for the alleviation of muscle cramps in the UK.113 
In the literature review completed by Corbani et al. (2008),113 a series of trials are 
compared to reveal both quinine and quinidine reduce the frequency of cramps, but not 
intensity or duration, with few side effects.  
Quinidine is used mainly as an antiarrhythmic drug.114,115 It has been proved effective in 
treatment of many arrhythmias, such as atrial fibrillation,116 idiopathic ventricular 
fibrillation, Brugada Syndrome117 and Short QT syndrome.115  
Atrial and ventricular fibrillation is a condition where the muscles in the atria or 
ventricles are uncoordinated, and consequently, do not contract properly. In 1997, a 
study was completed by Innes et al. (1997)116 to compare two combination therapies for 
the treatment of paroxysmal atrial fibrillation (self-terminating, recurrent episodes) in 
emergency departments. Quinidine was a part of the combination drugs in both groups, 
which compared the efficacy of vermapamil and quinidine compared to digoxin and 
quinidine. As a treatment course, the vermapamil or digoxin was administered first and 
is used to control the ventricular rate. This is then followed by the admission of 
quinidine, which is used to convert the arrhythmia to a normal sinus rhythm. The study 
found that the sequential combination of vermapamil followed by quinidine was more 
effective and quicker in converting to normal sinus rhythm, suggesting vermapamil is 
more effective at controlling ventricular heart rate.  
Idiopathic ventricular fibrillation is a form of ventricular fibrillation which presents with 
no obvious heart disease.118 In 1999, a study completed by Belhassen et al.118 was 
conducted to investigated the effect of quinidine on patients suffering with idiopathic 
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ventricular fibrillation. The study was based on 27 patients who presented with a normal 
ECG but suffered with spontaneous ventricular fibrillation or tachycardia which can 
also be induced in an electrophysiology (EP) study. Of these 27 patients, 25 were given 
oral quinidine which had the effect to prevent induction of ventricular fibrillation in    
96 % of patients. Three of these patients developed an intolerance to quinidine however 
a transfer onto disopyramide proved successful.  
In 2005, Haghjoo et al.117 presented a patient who had been administered quinidine as a 
treatment for Brugada Syndrome, a subtype of idiopathic ventricular fibrillation 
resulting in ventricular tachycardia and fibrillation which may have genetic causes.118 
The patient had suffered cardiac arrest twice in 3 months, but showed no evidence of 
structural heart disease and presented a normal resting ECG, but with typical Brugada 
changes in provoked ECG. Consequently, an implantable cardioverter-defibrillator 
(ICD) was implanted, designed to correct sudden ventricular arrhythmias. 10 days after 
implantation, the ICD appropriately and successfully discharged 9 times in 2 days to 
terminate ventricular fibrillation. Oral quinidine was therefore administered to have the 
effect of normalising any previously observed ECG abnormalities, and the patient 
remained free of symptoms and ICD discharges for the 19 month follow up period.  
Short QT syndrome is a genetic disorder which can cause atrial fibrillation and 
ventricular fibrillation and consequently, an increased risk of sudden cardiac death.115 
Admission of quinidine to patients with Short QT symdrome caused a lengthening of 
the QT interval, normalising sinus rhythm.  
4.1.1.2 Chloroquine and hydroxychloroquine 
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Figure 4.2 Structure of a) chloroquine and b) hydroxychloroquine. 
Chloroquine (Figure 4.2a) was first synthesised by Hans Andersag in July 1934.119 The 
drug was patented in 1939, and underwent clinical trials, and was used as a first line 
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antimalarial drug from 1945 for 20 years.119 At this point, chloroquine-resistant strains 
of malaria became prevelant, and consequently chloroquine was used much less 
frequently.112,120 In 1955, hydroxychloroquine (Figure 4.2b) was introduced as a less 
toxic version of chloroquine which still holds the same pharmacological advantages.121 
Hydroxychloroquine has also been used to treat malaria.121-123  
Chloroquine (amoung other drugs) was administered to soldiers in the Second World 
War as a preventative measure against malaria. During this time, the soldiers noticed 
improvements in rashes and inflammatory arthritis, leading to investigations into other 
potential uses of chloroquine and hydroxychloroquine, such as antimicrobial,124 
metabolic,125 cardiovascular, antithrombotic126 and antineoplastic effects.121 
As an antibacterial agent, hydroxychloroquine is most recognised as part of a 
combination treatment with doxycycline for chronic Q-fever endocarditis caused by 
Coxiella burnetti bacteria.121 Chronic Q fever endocarditis is fatal in 25 % to 60 % of 
patients and the recommended treatment in 1999 of tetracycline and quinolone can be 
taken from three years to a lifetime due to the high occurrence of relapses.127 In 1999, 
Raoult et al.127 completed a study investigating the effectiveness of two combination 
therapies, doxycycline with quinolone compared to doxycycline with 
hydroxychloroquine. Of the 14 patients treated with doxycycline and quinolone, 1 
patient died, 1 patient was still being treated, 7 relapsed and 5 were cured with a mean 
duration of treatment to cure being 55 months. Of the 21 patients treated with 
doxycycline and hydroxychloroquine, 1 patient died, 3 were still being treated, and 17 
were cured with a mean duration of treatment to cure being 31 months. No patient who 
was treated for 18 months or longer relapsed, while only 2 who were treated for           
12 months relapsed. This study shows treatment of Q fever endocarditis with 
doxycycline and hydroxychloroquine shortens the treatment period and reduces the 
number of relapses compared to the previous treatment of doxycycline with 
quinolone.127  
Currently, there are no known cures for the human corona virus, the cause of 
approximately one third of common colds. In 2003, a resistant strain of the virus was 
discovered, which was found to be the cause of severe acute respiratory syndrome 
(SARS). Chloroquinine has recently shown the potential to inhibit the replication and 
spread of the virus in vitro.128,129 In 2004, a study was completed by Keyaerts et al.128 to 
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investigate the effect of chloroquine on a cell line infected with SARS-CoV. Results 
showed that the IC50 of the complex for the virus was 8.8 µM. This is around 1,000 fold 
below the human plasma level reached when chloroquine is administered for treatment 
of acute malaria, and in the same range as when chloroquine is used in the treatment of 
rheumatoid arthritis. In 2005, a second study was completed by Vincent et al.129 
investigating the effects of chloroquine on the SARS-CoV virus. The results found in 
this study agreed with those found by Keyaerts et al.128 (discussed above), but were also 
extended to investigate the preventative ability of chloroquine against SARS-CoV. A 
cell line was treated with chloroquine for 24 hrs prior to infection to find the drug was 
able to inhibit SARS-CoV virus. Chloroquine could therefore potentially be used as a 
prophylactic drug during a breakout or for travellers, or as a treatment in established 
infections.  
In 1987, a study was completed by Smith et al.125 to investigate if this side effect could 
be used to treat non-insulin-dependent diabetes mellitus. A control group, and group of 
diabetic patients completed an overnight fast, then drank 200 ml water with 75 g sugar 
dissolved in it. The levels of glucose and insulin were monitored for three hours. 
Chloroquine was then administered for two and a half days and the test repeated on the 
day of the last dose. Chloroquine had little effect on the control group, however, glucose 
tolerance was significantly improved in the diabetes mellitus group. Today, this 
treatment has been largely superseded by other drugs. 
Hydroxychloroquine has also been shown to help prevent thrombosis in patients with 
anti-phospholipid antibodies,130 but also those who also have lupus.126 It has also been 
shown to reduce thromboembolic events in patients undergoing total hip 
replacements.131  
Chloroquine has been shown to have antineoplastic effects. This was first observed 
when the drug was administered as a preventative measure against malaria in Tanzania, 
and a reduced incidence of Burkitts Lymphoma was observed.121,132 Chloroquine has 
also been shown to have antineoplastic effects in vitro against human lung cancer.133 In 
2008, a study completed by Hu et al.134 aimed to investigate the effect of adding 
chloriquine to a regime of Akt inhibitors, in vitro. The group investigated three breast 
cancer cell lines and found that chloroquine alone had a very small effect on the growth 
inhibition factor of these cells, but also low cytotoxicity on normal cells. A different 
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story was true when considering the addition of chloroquine to 11 different Akt 
inhibitors. When comparing the Akt as a monotherapy to the Akt plus 20 µM 
chloroquine, the ratio of the GI50 of normal cells to cancer cells was increased from an 
average of 2.47 to 16.65 across the 11 Akt inhibitors. This shows the potential for 
chloroquine to sensitize cancer cells to Akt inhibitor therapy.  
Antineoplastic effects have also been observed with hydroxchloroquine. It has been 
shown to have antineoplastic effects in vitro in solid tumours of breast cancer135 and 
induce apoptosis in malignant cells of chronic lymphocytic leukemia.136 
4.1.1.3 8-hydroxyquinoline analogues  
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Figure 4.3 Structure of Clioquinol. 
The 8-hydroxyquinolines possess a number of therapeutic properties. The best known 8-
hydroxyquinoline analogue is Clioquinol (Figure 4.3). Clioquinol was originally used in 
as an antiparasitc agent however potential neurotoxicity led to the drug being withdrawn 
in the 1970s as an oral medication but it is still available as a topical treatment.137 More 
recently, clioquinol has received attention as a potential treatment for Alzheimers 
disease.137,138  
Clioquinol may have a positive effect on the progression of Alzheimers disease because 
it can bind copper in the brain.139 It is able to therefore remove copper from the protein 
aggregates in the brain, potentially reversing the aggregation.137,140 When the drug 
underwent pilot phase II clinical trials, it was found that those who were more severely 
affected by Alzheimers Disease showed the most significant benefit, through the 
condition worsening minimally.141 
In 2005, Ding et al.142 published a study to investigate the potential anticancer activity 
of clioquinol against human cancer cells in vitro and in vivo in mice. For the in vitro 
studies, a number of cell lines were investigated to cover a range to tissue origins. These 
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were human B-cell lymphoma lines and breast, ovarian, cervical, bladder and pancreatic 
cancer cells. Treatment of these cells with clioquinol proved to be cytotoxic to the 
cancer cells with a maximum IC50 of 40 µmol/L, where reduced cell viability was 
observed after 72 hours. Clioquinol was also shown to inhibit growth of a human 
ovarian cancer line grafted to mice without clinical observations of toxicity or weight 
loss.  
The gluconjugates of 8-hydroxyquinolines have recently been synthesised as potential 
anti-cancer pro-drugs.143 It was proposed by Oliveri et al.143 that the glucoconjugation 
strategy may have the effect of creating a selective pro-drug as a result of elevated 
glycolysis in tumour cells creating increased uptake into tumour cells over normal cells, 
as well as increasing the drugs solubility in aqueous media.  
Substituted quinolines have been shown to be act as a wide range of biologically active 
drugs. From a pharmaceutical view, this implies a need for a method of rapid 
characterisation of this type of molecule and the side products and reagents potentially 
present in the production of these drugs. Quinoline is therefore a good substrate for 
investigations into hyperpolarisation by SABRE.  
4.1.2 Characterisation of quinoline in methanol 
This chapter is based solely on quinoline and its analogues, and therefore, quinoline has 
been fully characterised in d4-methanol. The assignments used throughout the chapter 
are outlined in Figure 4.4 and Table 4.1. Details of collection are outlined in the 
Experimental, section 8.7.2.1. 
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Figure 4.4 Structure of quinoline with positions labelled. 
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Position 1H shift JHH 
13C shift JCH 
2 8.82 dd, 4.3, 1.7 150.0 dq, 178, 4 
3 7.52 dd, 8.4, 0.8 121.3 dd, 165, 8 
4 8.34 dd, 8.5, 0.8 137.2 dt, 163, 6 
5 7.92 dd, 8.2, 1.3 128.0 d(t), 161, (4.9) 
6 7.60 d(m), 7.0 126.8 dd, 162, 9 
7 7.76 d(m), 7.0 129.9 dd, 161, 9 
8 8.02 dd, 8.3, 4.4 127.8 dd, 161, 7 
9 / / 147.5  
10 / / 128.7  
Table 4.1 The observed 1H and 13C NMR shifts of quinoline in d4-methanol. 
4.2 Initial studies into polarisation transfer efficiency into quinoline 
Quinoline has a significantly different structure to that of pyridine, and therefore may 
also exhibit different trends with respect to changing catalyst, temperature of 
polarisation, magnetic field of polarisation or solvent. These concepts will therefore be 
discussed in reference to quinoline in this section.  
4.2.1 Effect of changing catalyst on polarisation transfer efficiency into quinoline 
Polarisation transfer into quinoline was investigated using IMes(a), SIMes(a) and 
ICy(a), initially using method 1. In the case of IMes(a) and SIMes(a), no evidence of 
polarisation transfer is observed in the standard 1H NMR spectra, however a small 
amount of transfer is observed in the 1H OPSYdq spectra, implying a weak polarisation 
transfer is present. After activation, neither IMes(a) or SIMes(a) show evidence of 
decomposition and both show a single signal around -23 ppm in the 1H NMR spectrum 
suggesting the expected complex, [Ir(carbene)(H)2(sub)3]
+ was formed. For ICy(a), 
polarisation transfer is observed in the 1H NMR spectra, leading to a small enhancement 
in some sites as indicated in Table 4.2.  
Catalyst Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 
ICy(a) -0.2 0.8 -0.2 -0.5 1.5 0.6 -0.8 
Table 4.2 1H NMR signal enhancement for quinoline when polarised using method 1 with ICy(a) at room 
temperature and a PTF of 2 G.  
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Considering all three catalysts, the results exhibit a significantly different trend to that 
observed for pyridine polarised by the same catalysts where all three catalysts promote 
polarisation transfer to pyridine with IMes(a) being most efficient. Quinoline is a much 
bulkier substrate than pyridine and exhibits a different pKa (4.85 for quinoline
144 and 5.2 
for pyridine144,145) which may have a significant effect on the activation step. To 
alleviate this concern, the chloride ion can be displaced to form a catalyst similar in 
structure to Crabtree’s catalyst68 and the first published SABRE catalyst.58 This can be 
achieved in two ways in which the IMes carbene is used as an example however the 
principles apply to all carbenes discussed. Firstly, a reaction of [Ir(COD)(IMes)Cl] with 
silver hexafluorophosphate in the presence of acetonitrile yields the catalyst 
[Ir(COD)(IMes)(NCMe)]PF6 (IMes(b)). Secondly, acetonitrile can be added to the 
catalyst in situ transforming the catalyst from [Ir(COD)(IMes)Cl] to 
[Ir(COD)(IMes)(NCMe)]Cl. This in situ method is termed IMes(c). Further details of 
this can be found in Chapter 2. 
The three catalysts were consequently investigated in the presence of acetonitrile. 
Polarisation transfer into quinoline via SABRE was therefore investigated with IMes(c), 
SIMes(c) and ICy(c) with results shown in Table 4.3. 
Catalyst Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 
IMes(c) -20 30 -24 -31 35 15 -33 
SIMes(c) -4 7 -5 -6 10 4 -8 
ICy(c) -7 9 -8 -11 19 5 -19 
Table 4.3 1H NMR signal enhancement for quinoline when polarised using method 1 with IMes(c), 
SIMes(c) and ICy(c) at room temperature and a PTF of 2 G. 
The addition of a stoichiometric volume of acetonitrile to the catalytic precursors has 
increased the polarisation transfer efficiency of all three catalysts into quinoline. Due to 
these results, the Carbene(c) catalysts were used when considering quinoline for all 
other experiments. It should be noted here that acetonitrile is not a benign addition and 
does receive a small level of polarisation transfer, observed as negatively phased peaks. 
This could be taking polarisation away from quinoline, the desired substrate, and 
therefore polarisation transfer to quinoline with IMes(c) was investigated with 
deuterated acetonitrile. The results are presented in Table 4.4. 
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acetonitrile Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 
Protonated -17 20 -22 -31 37 11 -41 
Deuterated -14 20 -20 -28 31 10 -32 
Table 4.4 1H NMR signal enhancement for quinoline when polarised using method 1 with IMes(c) with 
protonated and deuterated acetonitrile, at room temperature and a PTF of 2 G. 
The replacement of protonated acetonitrile with deuterated acetonitrile did not have the 
effect to increase the extent of polarisation transfer into quinoline using IMes(c). In 
fact, the transfer to each position has either remained constant or decreased a little. This 
could be an effect of changing the coupling network of the active complex. Whenever a 
Carbene(c) catalyst is used, protonated acetonitrile is added as this provides better 
polarisation transfer to quinoline.  
The addition of acetonitrile has also had an effect on the resultant 1H NMR spectrum of 
the active complex, in that the hydride region now shows two hydrides rather than one. 
This is discussed in the following section.  
4.2.2 Characterisation of IMes(c) hydrogenated in the presence of quinoline 
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Figure 4.5 Structures of two potential products formed when IMes(c) reacts with hydrogen in the 
presence of quinoline and acetonitrile. 
If the structure observed in Figure 4.5a is present when IMes(c) is activated with 
hydrogen in the presence of quinoline, a single hydride resonance might be expected. 
After activation, the sample was cooled to 243 K to reduce the effects of quinoline and 
hydride exchange. Figure 4.6 shows the hydride region of the 1H NMR spectrum. It is 
evident that two significantly different signals are observed at -20.4 ppm and -22.5 ppm, 
each with a splitting of 6.1 Hz.  
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Figure 4.6 The 1H NMR signals corresponding to the hydride ligands observed when IMes(c) is activated 
in the presence of quinoline and hydrogen. 
These hydrides were confirmed to be coupled to each other by 1H NOESY NMR 
indicating a single complex is present, where each hydride is trans to a different ligand. 
This is consistent with the structure shown in Figure 4.5b. 
This hypothesis is further confirmed when comparing the integrals of the bound 
quinoline resonances. In order to achieve this, a sample with a 1:4 loading, 
catalyst:quinoline, was prepared for interrogation. Two additional sets of signals 
corresponding to quinoline bound to the metal are observed labelled ‘B’ in Figure 4.7. 
This is consistent with the structure shown in Figure 4.5b. 
 
Figure 4.7 The aromatic region of a 1H NMR spectrum observed at 243 K when IMes(c) is activated in 
the presence of quinoline and hydrogen, with a ratio of 1:4 catalyst to substrate. ‘F’ denotes the signals 
corresponding to free quinoline and ‘B’ denotes the signals corresponding to proton 2 of quinoline bound 
to the catalyst. 
The two signals at 9.41 ppm and 9.36 ppm are in the ratio 1:1 providing extra evidence 
for the production of the complex in Figure 4.5b. This is again further confirmed by 
comparing the integrals of signals corresponding to one bound quinoline resonance and 
of one hydride ligand resonance. These exhibit a 1:1 ratio. The two signals at 9.41 ppm 
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and 9.36 ppm therefore correspond to the 2 position of quinoline when bound to the 
iridium trans or cis to the hydride ligand (confirmed by 1H NOESY NMR), 
respectively. It was previously discussed that acetonitrile also experiences polarisation 
transfer and therefore acetonitrile must bind to the complex. It is therefore thought 
[Ir(IMes)(H)2(quinoline)2(NCMe)]
+ is the active form of the catalyst. Full details of the 
characterisation of IMes(c) in the presence of quinoline can be found in the 
Experimental. 
4.2.3 Rate constants and thermodynamic activation parameters of IMes(c) 
hydrogenated in the presence of quinoline 
In order to further understand the extent of polarisation transfer achieved by SABRE, it 
is important to understand the rate constants for exchange for a given system. In this 
section, the rate constants for loss of quinoline and hydride ligands from the IMes(c) 
catalyst is compared to the rate constants for loss of pyridine and hydride ligands from 
the IMes(a) catalyst. All data has been collected in the same manner as previously 
described (see Experimental) and full exchange rate constant data can be found in the 
Appendix. 
4.2.3.1 Thermodynamic activation parameters observed for the loss of hydride ligands 
from IMes(c) hydrogenated in the presence of quinoline 
Initial attempts to calculate the data relating to hydride ligand loss were unsuccessful 
due to the high level of deuterium incorporation experienced into the hydride ligand 
sites by the sample during the experiment time.77,78 To overcome this, the rate constants 
for hydride loss were calculated in a sample dissolved in CD3OH to eliminate the 
possibility of HD exchange.  
 IMes(c)/quinoline IMes(a)/pyridine 
Raw rate constants / s-1 (300 K) 32 9 
∆H≠ / kJ mol-1 76.3 (± 0.5) 79 (± 1) 
∆S≠ / J K-1 mol-1 44.3 (± 1.8) 41 (± 31) 
∆G300
≠ / kJ mol-1 63.0 (± 0.03) 66.4 (± 0.3) 
Table 4.5 Activation parameters for the loss of hydrides for the IMes(c) and quinoline system compared 
to the same data for the IMes(a) and pyridine system. 
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Table 4.5 shows that the enthalpy of activation for the loss of hydride ligands of both 
systems is very similar indicating their similarity. The loss of hydrogen is entropically 
favourable in both cases as it increases disorder in the system. The ∆G300
≠ of 
IMes(c)/quinoline is lower than that for IMes(a)/pyridine resulting in a higher rate of 
H2 loss.  
4.2.3.2 Thermodynamic activation parameters observed for the loss of quinoline 
ligands from hydrogenated IMes(c) 
 IMes(c)/quinoline IMes(a)/pyridine 
Raw rate constants / s-1 (300 K) 23.9* 23.4 
∆H≠ / kJ mol-1 69.5 (± 0.6) 93 (± 3) 
∆S≠ / J K-1 mol-1 19.0 (± 2.2) 97 (± 9) 
∆G300
≠ / kJ mol-1 63.8 (± 0.07) 64 (± 2) 
Table 4.6 Activation parameters for the loss of substrate for the IMes(c) and quinoline system compared 
to the same data for the IMes(a) and pyridine system. * denotes the value was calculated by 
extrapolation. 
For IMes(a), the raw rate constant for pyridine loss reported in the publication by 
Cowley et al. (2011)66 has been doubled as the rate constant is quoted per mole of 
pyridine, where the data here is quoted as per mole of iridium catalyst. The observed 
rate constant for substrate ligand loss from IMes(a)/pyridine and IMes(c)/quinoline are 
near identical at 300 K. This is reflected in the ∆G300
≠ value, although given the 
dramatic difference in ∆H≠ and ∆S≠, this situation is fortuitous. The reduction in ∆H≠ 
observed by changing systems from IMes(a)/pyridine to IMes(c)/quinoline may be a 
result of the change in bond strength, linked to the pKa of the two substrates. The 
entropy difference may be a result of the bulkiness of each system as a relatively large 
pyridine ligand is replaced by an acetonitrile in IMes(c)/quinoline. 
As polarisation transfer into pyridine occurs to a much higher extent than into quinoline, 
the above thermodynamic data suggests that the efficiency of SABRE depends on the 
lifetime of the complex. The fast exchange of hydrogen in IMes(c)/quinoline therefore 
explains the lower extent of polarisation transfer to quinoline.  
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4.3 Further optimisation of polarisation transfer efficiency into quinoline 
It has been shown in previous chapters that polarisation transfer into a certain substrate 
can be increased through changing certain variables employed during the addition of 
parahydrogen to the sample, shown for pyridine in Chapter 3. These concepts have 
been utilised to investigate polarisation transfer into quinoline. 
4.3.1 Effect of changing temperature during the polarisation transfer step on 
polarisation transfer efficiency into quinoline 
In section 4.2.1 (pg 177), polarisation transfer into quinoline using three different 
catalysts was investigated. The same three catalysts were investigated at different 
temperatures to understand if an increase or decrease in temperature leads to a 
significant increase in the level of polarisation transferred into the substrate. These 
experiments were completed using method 1 according to the protocol explained in the 
Experimental. Previous to the temperature studies completed in this section, it is 
important to point out that the active complexes of IMes(c), SIMes(c), and ICy(c) took 
a similar form, assumed from the observation of two coupled hydrides in the 1H NMR 
spectrum of the active complex.  
4.3.1.1 Effect of temperature during the polarisation transfer step on polarisation 
transfer efficiency into quinoline using IMes(c) 
Polarisation transfer into quinoline using IMes(c) was investigated at five temperatures 
with results presented in Table 4.7 and Figure 4.8. Considering the rate constant of loss 
of both quinoline and hydride ligands, it can be predicted that the extent of polarisation 
transfer into quinoline will decrease when the temperature of polarisation increases, due 
to the relatively high rate constant of hydrogen loss.  
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T / 
oC 
Rate constant of ligand loss (s-1) Observed 1H NMR signal enhancement 
Hydride Quinoline 2 3 4 5 6 7 8 
0 1 1 -23 34 -27 -33 44 21 -41 
22 20 15 -20 30 -24 -31 35 15 -33 
30 46 32 -6 10 -8 -9 13 6 -12 
40 125 79 -2 5 -3 -4 6 3 -5 
50 319 187 -1 2 -1 -2 2 1 -2 
Table 4.7 1H NMR signal enhancement for quinoline when polarised using IMes(c) using method 1 at a 
PTF of 2 G when the polarisation transfer step occurs at the indicated temperatures with the predicted rate 
constants of hydride and pyridine ligand exchange calculated from thermodynamic data in Appendix. 
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Figure 4.8 Graphical representation of the effect of changing the temperature of the polarisation step on 
the 1H NMR signal enhancement of quinoline when polarised with IMes(c) at a PTF of 2 G.  
Table 4.7 and Figure 4.8 show that temperature of addition of parahydrogen has a great 
effect on the level of polarisation transfer into quinoline using IMes(c). An increase in 
temperature from room temperature results in a significant reduction in the extent of 
polarisation transfer into quinoline in all positions. A reduction in the temperature of the 
polarisation step below room temperature has the effect to increase the observed 1H 
NMR polarisation transfer by a small amount in all positions. These data match the 
prediction based on the rate constant of hydrogen loss. With quinoline as the substrate, 
the rate constant of loss of hydride ligand is 32 s-1, nearly 4 times faster than the rate 
constant observed when pyridine is the substrate (9 s-1). This means the contact time for 
the complex is relatively short, and this only shortens upon increase in temperature 
reducing observed polarisation transfer. The increase in enhancement upon dropping the 
temperature of polarisation to 0 ºC is proportionally small and so it is recommended to 
investigate SABRE at room temperature when considering polarisation transfer to 
quinoline using IMes(c). 
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4.3.1.2 Effect of temperature during the polarisation transfer step on polarisation 
transfer efficiency into quinoline using SIMes(c) 
Polarisation transfer into quinoline using SIMes(c) was investigated at three 
temperatures, room temperature, 0 ºC and 40 ºC. To compare the SIMes(c)/quinoline 
system to the IMes(c)/quinoline system, the rate of exchange was experimentally 
determined at one temperature. The quinoline exchange rate constant had to be 
measured at a cold temperature to ensure the required resonance was base line resolved 
from all other signals. The exchange rate constant for hydride ligand loss was also 
completed at a cold temperature due to fast exchange. The results are presented in Table 
4.8. 
Rate constant of ligand loss / s-1 (T/K) IMes(c) SIMes(c) 
Hydride (273) 1.56 2.86 
Quinoline (275) 1.74 0.21 
Table 4.8 Experimentally measured rate constants of ligand loss from IMes(c) and SIMes(c) in the 
presence of quinoline. 
At 273 K, the measured exchange rate constant for loss of hydride ligands from 
SIMes(c) in the presence of quinoline is much faster than the same constant for IMes(c) 
under the same conditions, a rate which has already been shown to be too fast for 
optimal polarisation transfer into quinoline. This therefore suggests that upon cooling 
the temperature of the polarisation step of a SIMes(c)/quinoline sample, the observed 
signal enhancement will increase due to the slower hydrogen loss exchange. The extent 
of this increase might be hampered as a result of the lower relative rate of quinoline 
loss. The results of changing the temperature of the polarisation step on the extent of 
polarisation transfer into quinoline are shown in Table 4.9 and Figure 4.9. 
T / oC Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 
0 -7 14 -10 -13 20 8 -17 
22 -4 7 -5 -6 10 4 -8 
40 -0.2 1 -0.2 -0.3 1 0.6 -0.4 
Table 4.9 1H NMR signal enhancement for quinoline when polarised using SIMes(c) using method 1 at a 
PTF of 2 G when the polarisation transfer step occurs at the indicated temperatures. 
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Figure 4.9 Graphical representation of the effect of changing the temperature of the polarisation step on 
the 1H NMR signal enhancement of quinoline when polarised with SIMes(c) at a PTF of 2 G. 
Table 4.9 and Figure 4.9 show that the effect of temperature on the polarisation transfer 
to quinoline using SIMes(c) is significant. Increasing the temperature of the polarisation 
step above room temperature had the effect to reduce observed polarisation transfer to 
all positions to the extent that no enhancement is observed. Decreasing the temperature 
from room temperature by the same amount had the effect to increase observed 
polarisation transfer by approximately 2 fold to all positions. The increase in 
enhancement upon dropping the temperature of polarisation to 0 ºC is significant in the 
case of SIMes(c)/quinoline and it is therefore recommended that a temperature of 0 ºC 
is used in this case, however this does not improve on the enhancement levels observed 
when polarising quinoline using IMes(c). SIMes(c) is therefore not recommended as 
the catalyst to use for SABRE investigations into quinoline.  
4.3.1.3 Effect of temperature during the polarisation transfer step on polarisation 
transfer efficiency into quinoline using ICy(c) 
Polarisation transfer into quinoline using ICy(c) was investigated at three temperatures, 
0 ºC, room temperature (as stated) and 40 ºC. Results are shown in Table 4.10 and 
Figure 4.10. For this catalyst, a number of hydride and bound quinoline signals were 
observed in near equal proportions. The calculated exchange rate constants from the 
[Ir(ICy)(H)2(Q)2(NCMe)]
+ complex would therefore not be representative of the system 
as a whole.  
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T / oC Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 
0 -7 9 -8 -11 17 4 -17 
20 -7 9 -8 -11 19 5 -19 
40 -3 4 -3 -4 7 2 -7 
Table 4.10 1H NMR signal enhancement for quinoline when polarised using ICy(c) using method 1 at a 
PTF of 2 G when the polarisation transfer step occurs at the indicated temperatures. 
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Figure 4.10 Graphical representation of the effect of changing the temperature of the polarisation step on 
the 1H NMR signal enhancement of quinoline when polarised with ICy(c) at a PTF of 2 G. 
Table 4.10 and Figure 4.10 shows that increasing the temperature from room 
temperature to 40 ºC has resulted in a drop in observed polarisation transfer to all 
positions of quinoline when polarised with ICy(c). The effect of decreasing the 
temperature to 0 ºC does not follow the same trend, showing very similar enhancement 
levels to those observed at room temperature. This could suggest a maximum 
polarisation transfer might be observed between 20 ºC and 0 ºC. If quinoline is to be 
polarised using the ICy(c) catalyst, it would be recommended to polarise at room 
temperature, however this catalyst does not achieve higher levels of polarisation to 
quinoline than IMes(c). 
4.3.1.4 Comparison of the effect of temperature during the polarisation transfer step on 
polarisation transfer efficiency into quinoline using IMes(c), SIMes(c) and 
ICy(c) 
It is important to consider all the three catalysts compared together. To simplify this, 
polarisation transfer to position 2 of quinoline only is considered, shown in Table 4.11.  
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T / oC Observed 1H NMR signal enhancement on position 2 of quinoline 
IMes(c) SIMes(c) ICy(c) 
0 -23 -7 -7 
20 -20 -4 -7 
40 -2 -0.20 -3 
Table 4.11 1H NMR signal enhancement for quinoline when polarised using IMes(c), SIMes(c) and 
ICy(c) using method 1 at 2 G when the polarisation transfer step occurs at the indicated temperatures .  
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Figure 4.11 Graphical representation of observed 1H NMR signal enhancement in the signal for position 2 
of quinoline when polarised using IMes(c), SIMes(c) and ICy(c) using method 1 at a PTF of 2 G and 
various temperatures. 
Figure 4.11 shows that the trend observed by all three catalysts is very similar. 
Increasing the temperature from room temperature to 40 ºC resulted in a decrease in 
observed polarisation transfer to position 2 of quinoline by all catalysts. Decreasing the 
temperature from room temperature to 0 ºC either has little effect on the polarisation 
transfer into position 2, or has the effect to increase the transfer observed.  
In Chapter 3, the temperature dependence of polarisation transfer to pyridine was 
discussed for each catalyst. The dependence on temperature of the para position of 
pyridine and 2 position of quinoline are compared in Figure 4.12. 
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Observed polarisation transfer to the para  position of pyridine
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Figure 4.12 Graphical representation of observed 1H NMR signal enhancement in the signal for the para 
position of pyridine when polarised using IMes(a), SIMes(a) and ICy(a) (left) and of observed 1H NMR 
signal enhancement in the signal for the 2 position of quinoline when polarised using IMes(c), SIMes(c) 
and ICy(c) (right), both using method 1 at a PTF of 2 G and various temperatures. 
The trends observed between the two substrates are similar for all three catalysts. The 
major difference is that of the SIMes and ICy based catalysts, SIMes(a) shows the 
greater enhancement into pyridine and ICy(c) shows the greater enhancement into 
quinoline, however the IMes based catalyst is still better for both substrates. It would 
therefore be recommended to use the IMes based catalysts for interrogation of substrates 
of this type. 
4.3.2 Effect of changing magnetic field during the polarisation transfer step on 
polarisation transfer efficiency into quinoline 
It has been shown in Chapter 3 that the magnetic field at which the polarisation step 
occurs can have a great effect on the resultant observed polarisation transfer. To this 
point, only single ring systems have been investigated and so the polarisation transfer 
into the second fused ring of quinoline is of great interest. Quinoline was polarised with 
IMes(b) using method 2. 
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Figure 4.13 Effect of changing the PTF during polarisation of quinoline polarised using method 2 with 
IMes(b). 
Prior to these measurements, the two maximum PTFs for IMes(a)/pyridine were found 
to be 70 G for the standard 1H NMR spectra and 0 G for 1H OPSYdq NMR spectra.66 
Investigations into IMes(c)/quinoline were expected to give a similar result with the 1H 
NMR spectra exhibiting a maximum at a PTF of around 70 G and 1H OPSYdq NMR 
spectra exhibiting a maximum at a PTF of 0 G. The data presented in Figure 4.13 shows 
that this was a simplified view and care needs to be executed when selecting the PTF.  It 
can be seen that different proton locations show different profiles upon change in 
magnetic field. Position 2 (‘ortho’) shows a maximum at around -50 G and is always of 
negative phase. In contrast, positions 3, 6 and 7 (‘meta’) show a gradual change in 
phase from negatively phased signals, through some antiphase signals separated by JHH, 
into positively phased signals. The point of inflection appears at -50 G, -60 G and -40 G 
for positions 3, 6 and 7 respectively. The remaining positions, 4, 5 and 8 (‘para’), 
appear as in-phase emissive doublets, where the intensities of the two components 
change upon magnetic field. These show a maximum at a magnetic field of 0 G. Owing 
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to the nature of many of the signals observed, it is easier to consider the enhancements 
as a graph, shown in Figure 4.14. 
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Figure 4.14 Graphical representation of the 1H NMR signal enhancement levels of quinoline when 
polarised with IMes(b) at various PTF using method 2. 
It can be observed in Figure 4.14 that no single magnetic field results in a maximum 
observed polarisation transfer to all proton sites in quinoline. For position 2, the proton 
ortho to the binding site in quinoline, the maximum enhancement is observed at a 
magnetic field -50 G. This shows an enhancement of -7 when completed on the MK II 
system. If the same experiment is completed using the MK III, an enhancement of -57 is 
observed.   
4.3.3 Effect of changing concentration on polarisation transfer efficiency into 
quinoline  
The effect of lowering the concentration of the samples was completed using method 1, 
where both lower concentration samples were prepared by dilution of the higher 
concentration sample with d4-methanol. 
Conc. rel. to 
standard 
[IMes(c)] 
(mM) 
[quinoline] 
(mM) 
Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 
100 % 5 100 -20 30 -24 -31 35 15 -33 
10 % 0.5 10 -23 29 -27 -38 47 14 -44 
1 % 0.05 1 -2 3 -2 -3 4 2 -5 
Table 4.12 1H NMR signal enhancement of quinoline when polarised using method 1 with IMes(c) at a 
PTF of 2 G at the indicated concentrations.  
192 
Table 4.12 shows that a 1H NMR signal enhancement is observed to quinoline at the 
low concentration of when 1 mM quinoline is present. This is the equivalent of 0.08 µl 
of quinoline in a 0.6 ml sample. Significant signal enhancement is also observed when 
the concentration is reduced to 10 %. However the increase in signal enhancement 
observed in the IMes(a) and pyridine system through the same change in concentration 
was not observed in the IMes(c) and quinoline system. 
4.3.4 Effect of changing solvent on polarisation transfer efficiency into quinoline 
It has been shown in Chapter 3 that changing the solvent in which the polarisation step 
takes place can also have a great effect on the extent of polarisation transfer into a 
substrate. Polarisation transfer into quinoline has therefore been investigated in a range 
of solvents with results shown in Table 4.13 and Figure 4.15. 
Solvent Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 
Methanol -11.2 20.8 -15.1 -19.1 22.1 12.0 -18.3 
Ethanol -7.8 11.5 -8.1 -9.8 15.1 5.1 -10.6 
DCM 0.0 0.4 -0.1 0.0 0.3 -0.1 -0.5 
Chloroform 0.7 0.2 1.0 1.4 -0.8 0.5 0.9 
DMSO 0.2 0.4 0.4 0.4 0.4 0.4 0.3 
Acetone 0.0 0.5 -0.1 0.1 0.5 0.2 0.0 
Table 4.13 1H NMR signal enhancement when quinoline is polarised with IMes(c) at room temperature 
and a PTF of 2 G in various solvents.  
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Figure 4.15 A 3D representation of Table 4.13 showing the 1H NMR signal enhancement when quinoline 
is polarised with IMes(c) at room temperature and a PTF of 2 G in various solvents. 
It is clear to observe in Table 4.13 and Figure 4.15 the highest enhancement is observed 
in quinoline when methanol is used as a solvent. This differs slightly from the trend 
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observed when considering polarisation transfer into pyridine (Chapter 3), where 
ethanol produces the maximum polarisation transfer. Hydride signals are observed 
around -20 for the IMes(c)/quinoline sample in all six solvents suggesting the catalyst 
was active in all cases. The results gained here were designed to give a preliminary idea 
into the effect of polarisation transfer into quinoline, and are consequently far from 
optimised. While methanol exhibits the greatest level of polarisation transfer in this 
study, if a different solvent were required, it would be possible to optimise polarisation 
into a substrate. 
4.4 Mechanism of polarisation transfer into quinoline using SABRE 
During the course of the investigations into polarisation transfer into quinoline, it was 
observed that similar signal intensities were observed in all positions after application of 
a 90º pulse. More specifically, there is not a significant difference in the extent of 
polarisation transfer between the first ring (positions 2, 3 and 4) and the second ring 
(positions 5, 6, 7 and 8). This is in contrast to the situation observed for the 
phenylpyridines (discussed in Chapter 6), where the level of polarisation transfer into 
the second ring is significantly less than the first ring. Current theory on the SABRE 
effect suggests that the transfer occurs through coupling between the parahydrogen 
derived hydride ligands and the protons of the substrate. The efficiency of this process 
is dependent on the size of the coupling, and it is likely to promote transfer through the 
ortho proton. In the case of quinoline, this is position 2. The polarisation should then 
transfer through its scalar coupling network around the substrate. Due to the small 
coupling constant present between positions 4 and 5 across the ring junction, it is 
thought polarisation transfer should not be possible between these two positions. The 
fact that the coupling constant between positions 4 and 5 is very small is strengthened 
by the thermal COSY of quinoline, presented in Figure 4.16.  
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Figure 4.16 Thermally polarised 1H NMR COSY of quinoline, with the signal intensity increased such 
that any weak couplings can be observed. 
Figure 4.16 shows that a cross peak signal is not present between positions 4 and 5, 
even though several two bond correlations are observed, indicated by the triangles 
(positions 2 and 4), hexagons (positions 5 and 7), and squares (positions 6 and 8). A 
weak W coupling is also observed between positions 4 and 8, circled. This implies there 
are two possible modes of polarisation transfer around the quinoline substrate; firstly 
through the W coupling and secondly through a coupling between the hydride ligands 
and the proton in the 8 position.  
Initial investigations into the mode of polarisation transfer around quinoline began 
through the investigation of various quinoline analogues, allowing us to block certain 
potential pathways. The investigation was then extended to include a series of selective 
1H OPSYdq spectra of the hyperpolarised quinoline, through which it may be possible 
to understand more about the coupling network.  
195 
4.4.1 Polarisation of quinoline derivatives 
4.4.1.1 Naphthalene 
In the literature, naphthalene has been shown to act as a 2 electron donor146,147 and also 
undergoes CH bond activation.148 This is because of the retention of aromaticity within 
the structure. This therefore shows this analogue of quinoline is able to bind to metals 
without the presence of a nitrogen atom, and therefore quinoline might bind through 
two modes, the nitrogen and an eta type bond. This second binding mode might provide 
a route of polarisation transfer into the second ring. Polarisation transfer into 
naphthalene was therefore investigated to understand if this route is viable.  
 
Figure 4.17 Structure of naphthalene. 
The extent of polarisation transfer into naphthalene (Figure 4.17) was investigated using 
method 1 and IMes(b), completed to understand if the quinoline structure was able to 
accept polarisation transfer through an eta type bonding. During this experiment, no 
signals corresponding to the hydride ligands were observed, and no enhancement or 
emission peaks were observed. This suggests polarisation transfer was not present 
through SABRE to naphthalene however this does not exclude the idea this could still 
be possible for quinoline.  
4.4.1.2 Investigation into the effect of changing the position of the nitrogen on 
polarisation transfer efficiency 
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Figure 4.18 Structures of a) quinoline and b) isoquinoline. 
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These investigations began by introducing the small change of moving the nitrogen 
from the 1 position in quinoline, to the 2 position in isoquinoline (see Figure 4.18a and 
b). This was completed to reduce the possibility of polarisation transfer through a 
coupling between the hydride ligands and 8 position of quinoline and therefore, if this 
was the only route of polarisation transfer into the second ring, observed enhancements 
in positions 5, 6, 7 or 8 of isoquinoline will be significantly reduced or not present. The 
results of this experiment are outlined in Table 4.14. 
 Observed 1H NMR signal enhancement 
1 2 3 4 5 6 7 8 
quinoline n/a -25.3 42.8 -35.0 -46.3 53.7 21.8 -47.7 
isoquinoline -44.9 n/a -58.6 16.4* -32.8 16.4* 17.0 -20.3 
Table 4.14 1H NMR signal enhancement when the indicated quinoline analogues are polarised with 
IMes(b) at room temperature and 2 G. * denotes the signals are not base line resolved in the thermally 
polarised or hyperpolarised spectrum. Therefore, the quoted signal enhancement correlates to both signals 
together. 
The results of using isoquinoline as a substrate have shown polarisation is able to 
transfer into the second ring, therefore a coupling between the hydride ligands and the 8 
position is not the sole method of transfer into the second ring. It is however noted that 
the two highest enhancements are observed in the first ring, and transfer into the second 
ring is reduced in comparison. Investigation using the OPSYdq sequence revealed more 
intense signals in the first ring (positions 3 and 4) than the second. It was also observed 
that position 2 showed very little signal.  
Isoquinoline has also been investigated using method 2. A maximum enhancement was 
observed when a PTF of 70 G was employed, resulting in a signal enhancement of 25 
fold on position 1. 
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4.4.1.3 Investigation into the effect of moving a methyl group of methylquinolines on 
polarisation transfer efficiency 
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Figure 4.19 Structures of a) 4-methylquinoline, b) 7-methylquinoline and c) 8-methylquinoline. 
A series of methylquinolines, namely 4-methylquinoline, 7-methylquinoline and 8-
methylquinoline (Figure 4.19) were then investigated. Each methylquinoline has been 
chosen such that the methyl group acts as a block for polarisation transfer.  
In the case of 4-methylquinoline, the placement of the methyl group on the 4 position 
blocks the possibility of polarisation transfer through the W coupling between positions 
4 and 8. Investigation of 7-methylquinoline allows the isolation of positions 5 and 6 
from polarisation transfer through position 8. If these positions are hyperpolarised then 
there must be another mode of polarisation transfer. In the case of 8-methylquinoline, 
the mode of transfer to position 8 is greatly hindered, allowing information about other 
transfer modes around the ring system. The results of the study are presented in Table 
4.15. 
 Observed 1H NMR signal enhancement 
2 3 4 5 6 7 8 Methyl 
Quinoline -20 -30 -24 -31 35 15 -33 n/a 
4-methyl 
quinoline 
-35 9 n/a -46 47 19 -39 4 
7-methyl 
quinoline 
-20 8* -14 -14 8* n/a -15 5 
8-methyl 
quinoline 
0.2 0.2* 0.2 0.3 0.2* 0.3 n/a 0.5 
Table 4.15 1H NMR signal enhancement when the indicated methylquinolines are polarised with IMes(b) 
at room temperature and 2 G. * denotes the signals are not base line resolved in the hyperpolarised 
spectrum. Therefore, the quoted signal enhancement correlates to both signals together. 
The first observation to be made from Table 4.15 is that 8-methylquinoline showed no 
proof of polarisation transfer into the substrate. Analysis of the 1H NMR spectrum 
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revealed 8-methylquinoline does not bind to the IMes(b) complex, believed to be due to 
the steric bulk created by the methyl group on the 8 position. When interrogated using 
method 1, 4-methylquinoline showed enhancements in all positions. Most interestingly, 
the three highest enhancement levels in the substrate are observed in the second ring. 
Although enhancement is observed in the methyl group, this is a relatively small 
enhancement and consequently, coupling from the 3 position, to the methyl then to the 
five position is an unlikely transfer route. This supports the idea that polarisation 
transfer is able to enter the substrate through a coupling between the hydride ligands 
and proton on the 8 position as well as the 2 position. The OPSYdq sequence was also 
investigated using method one to reveal very similar signal intensity to all aromatic 
protons in 4-methylquinoline, with significantly less signal intensity on the signal 
corresponding to the methyl protons. This would suggest a very weak coupling is 
present between the methyl protons and aromatic protons, an idea strengthened by the 
relatively low observed 1H NMR signal enhancement. It is also noted that with the 
exception of proton 3, a greater enhancement is observed in 4-methylquinoline than 
quinoline. This could be a result of the slightly different exchange rates and coupling 
network created by changing the substrate from quinoline to 4-methylquinoline.  
4-methylquinoline was also investigated using method 2. A maximum polarisation 
transfer in the 1H NMR spectrum was observed with a PTF of -50 G and in the 1H 
OPSYdq NMR spectrum was observed with a PTF of 0 G. The same trend was 
observed between the signals at all fields, the only difference was the signal intensity. 
When interrogating 7-methylquinoline using method 1, polarisation transfer is again 
observed to all protons in the substrate (see Table 4.15). An important observation is the 
extent of polarisation transfer observed on the methyl protons, ~5 fold. This has been 
observed previously however, not to a methyl group on a second ring. Considering the 
aromatic protons, polarisation transfer appears to be almost equal to both rings. This 
suggests a route of transfer between the first and second rings must be present which 
does not involve the 8 position, either from protons 4 to 5 or possibly protons 3 to 5 or 4 
to 6. 7-methylquinoline was investigated with the OPSYdq sequence using method one 
to reveal the signal intensity was greatest for positions 3 and 4, then reduced for the 
other aromatic signals, and significantly smaller for the methyl signal. This again 
suggests the methyl group was an unlikely route for polarisation transfer in this 
substrate. These experiments neither confirm nor disprove potential polarisation transfer 
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route involving the coupling between the proton on the 8 position of quinoline and the 
hydride ligands or the W coupling between the 4 and 8 position. They do however 
prove a second route of polarisation transfer into the second ring is active, evidenced 
through the enhanced 5 and 6 positions. The extent of polarisation transfer into 7-
methylquinoline is less than that observed for quinoline. 
While investigations into the methylquinolines have indicated a number of routes must 
be active to polarisation transfer, they have not confirmed precisely what these are.  
4.4.1.4 Phenazine 
N
N
 
Figure 4.20 Structure of phenazine. 
Initial investigations into the polarisation of phenazine, Figure 4.20, started with the 
IMes(b) catalyst. The first shake experiments showed minimal polarisation transfer 
which yielded no enhancement. The presence of two hydride resonances (-21.00 ppm 
and -22.27 ppm) suggests the phenazine has bound to the metal centre and a negative 
peak (Figure 4.21) suggested a weak polarisation transfer must have occurred. 
 
Figure 4.21 1H NMR spectrum of phenazine where bottom is thermally polarised and top is 
hyperpolarised using method 1 with IMes(b) in methanol. 
It is possible the phenazine group binds too strongly and so pyridine was added to the 
sample to see if this would boost polarisation transfer to phenazine through changing 
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the exchange rates. This also gives the opportunity to check the catalyst is active 
through observing polarisation on pyridine. Results from this showed significant 
polarisation transfer to pyridine but no transfer was observed to phenazine. The addition 
of pyridine also resulted in one extra hydride resonance giving three altogether              
(-21.00 ppm, -22.27 ppm and -22.82 ppm). The sample was investigated again on a 
second day. In the 1H NMR shake experiment, pyridine showed enhancements of over 
150 fold, however no polarisation was observed on phenazine. This may be explained 
by the 1H OPSYdq taken. Here, polarisation is observed on signals corresponding to 
pyridine and the two of the three hydrides which are present without the addition of 
pyridine (-21.00 ppm and -22.27 ppm). This might suggest significant levels of 
polarisation cannot transfer to phenazine as it appears to remain on the hydrides in the 
phenazine based complex.  
4.4.2 Investigations in polarisation transfer route into quinoline using the selective 
OPSYdq sequence 
The SABRE method creates Iz and IzSz type magnetisation (discussed in Chapter 1). Up 
to this point, experiments using a 90º pulse have mainly considered, where Iz type 
magnetisation should be the dominant detected signal, or OPSYdq experiments using 
hard 90º pulses where IzSz type magnetisation is selected using gradients. If two shaped 
pulses are used in place of the two hard 90º pulses in the OPSYdq sequence, specific 
IzSz pairs can be probed. In the following experiments, the two resonances are pulsed 
selectively and concurrently. For quinoline, the 21 potential pairs are presented in 
Figure 4.22. 
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Figure 4.22 Labelled structure of quinoline together with the 21 potential IzSz pairs. 
Interrogation of a substrate in this manor allows the interpreter to investigate which 
proton pairs are active routes for polarisation transfer. To achieve this, every proton 
pairs mentioned in Figure 4.22 was investigated. It would also be advantageous to 
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investigate the IzSz pairs involving the bound quinoline and hydride ligands however 
this is not possible. This is because the bound resonances for quinoline are low in 
intensity and hindered by the free quinoline resonances but also because the chemical 
shifts for the signals corresponding to the aromatic region and hydride ligand region are 
too far apart from each other.  
Figure 4.23 illustrates the results obtained when each potential IzSz pair was 
interrogated for quinoline (100 mM) hyperpolarised using method 2 with IMes(c) (5 
mM) at a PTF of 0 G. In each series of plots, the vertically aligned rectangular box 
represents one selected resonance and the square represents the partner selected for that 
spectrum. 
Considering Figure 4.23, a coupling is observed when a signal is present in both the 
rectangle and square (i.e. for both the resonances selected). The first observation to be 
made was that the signals corresponding to the first, pyridyl ring are much more intense 
than those corresponding to the second, phenyl ring.  
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Figure 4.23 A series of selective 1H OPSYdq spectra of quinoline polarised with IMes(c) using method 2. 
The bottom spectrum in each set is a thermal 1H NMR spectrum to act as a reference. The spectra are 
grouped by resonance (the rectangle) and the second selected resonance is indicated by a square. 
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In some cases, signals are observed outside of these two resonances. There are three 
potential explanations for these unexpected signals. The first explanation is based on 
experimental error as a result of the required pulses used not being selective enough 
however the results are not consistent with this concept. For instance, when protons 2 
and 6 are selected, a signal is observed for proton 3. If this was a result of the selective 
pulse on proton 6 being too wide, consequently exciting proton 3 also, a signal would 
also be observed for proton 2. This is not the case. The second explanation could be the 
presence of COSY crosspeaks. This explanation is also not consistent with the spectra 
collected. These could be present in the case where three peaks are observed rather than 
the expected two, however, in most cases, the additional unexpected peaks are the only 
observed peak. The third explanation is that while the selective pulses are selective for 
the signals corresponding to the free quinoline, beneath these signals are others, 
corresponding to the bound quinoline ligands. Exchange of these bound quinoline 
ligands into free quinoline during the timescale of the experiment could explain the 
unexpected signals. The data in Figure 4.23 has also been presented in Table 4.16, 
compared to observed COSY correlations. 
 2 3 4 5 6 7 8 
O  C  O  C  O  C O C  O  C  O   C  O  C  
2 na na √ √ √ w X X X X X X X X 
3 √ √ na na √ √ X X X X X X X X 
4 √ w √ √ na na X X X X X X X w 
5 X X X X X X na na √ √ X w X X 
6 X X X X X X √ √ na na √ √ X w 
7 X X X X X X X w √ √ na na √ √ 
8 X X X X X w X X X w √ √ na na 
Table 4.16 Correlations observed in free quinoline when interrogated using the selective OPSYdq 
sequence, where a ‘√’ denotes a correlation was observed, ‘w’ denotes a weak correlation is observed, ‘X’ 
denotes a correlation was not observed, ‘O’ refers to the selective 1H OPSYdq NMR experiments and ‘C’ 
refers to the 1H COSY NMR spectrum. 
The main piece of information that can be gathered from this experiment is that a 
correlation was not observed between positions 4 and 5, across the two rings, or 
between 4 and 8 through the W coupling observed as a long range coupling in the 1H-1H 
COSY NMR spectrum. This might imply the polarisation transfer is unable to occur 
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between the two rings. If this is the case, polarisation must transfer into the second ring 
via a coupling between the hydride ligands and position 8 in quinoline. 
4.5 Summary 
This chapter focused on developing our understanding of polarisation transfer by 
extension of the substrate to quinoline. The initial investigations revealed no 
polarisation transfer when quinoline was polarised in the presence of IMes(a) in the 
absence of an activator. The addition of such an activator such as acetonitrile has led to 
two new catalytic systems, IMes(b) and IMes(c).  This results that the active species of 
catalyst takes the form [Ir(IMes)(H)2(quinoline)2(NCMe)]
+ rather than 
[Ir(IMes)(H)2(quinoline)3]
+ as is observed in systems without an activator. 
Using method 1, the polarisation transfer efficiencies of IMes(c), SIMes(c) and ICy(c) 
to quinoline were investigated. This revealed that the IMes(c) samples yielded the most 
significant signal intensities at the three temperatures investigated. This catalyst was 
therefore investigated using method 2 in order to understand the effect of changing the 
PTF. Using a 90º pulse on 1H, the maximum signal intensity was obtained when a PTF 
of 50 G is used for the 2 position with IMes(b). Greater enhancements are observed in 
pyridine however this could be due to pyridine containing 5 protons presenting with 
three 1H NMR resonances and quinoline containing 7 magnetically inequivalent 
protons. This means the transferred polarisation is spread over more nuclei. There is 
also the added complication of the acetonitrile added to the quinoline sample. This is 
able to receive polarisation through the SABRE method and therefore could be 
absorbing some of the polarisation from the parahydrogen derived hydride ligands.  
These data therefore call for a need to revise the current theory on SABRE. The 
template of the IMes(c)/quinoline system includes many more spins and two potential 
ligands for magnetisation transfer (quinoline and acetonitrile), making it structurally 
different to the IMes(a)/pyridine system. There are also significant chemical differences 
between the two substrates.  
Comparing the thermodynamic data for the IMes(c)/quinoline and IMes(a)/pyridine 
systems, the rate constants for the loss of substrate ligand are very similar, as are the 
Gibbs free energies, despite significantly different enthalpy and entropy values. This 
could be because quinoline is a bulkier ligand with a lower pKa than pyridine and 
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therefore a weaker Ir-N bond resulting in a lower enthalpy and entropy. The most 
significant difference is observed in the rate constants for the loss of hydride ligands, 
where the rate constant is much larger for the IMes(c)/quinoline system. This may also 
explain the lower signal enhancements observed to quinoline when compared to 
pyridine and is consistent with the effect of temperature on the extent of polarisation 
transfer.  
IMes(c) was also taken through to investigate the effect of changing the solvent using 
method 1 including solvents such as methanol, ethanol, DCM, chloroform, DMSO and 
acetone. The trend observed for quinoline was significantly different to that observed 
for pyridine. Like pyridine, IMes(c) transfers significant polarisation into quinoline in 
both methanol and ethanol however the other four solvents yielded only weak 
polarisation transfer with only one position in one solvent yielding an enhancement.  
During the course of these experiments, it was observed that the level of polarisation 
transfer to 1H using a 90º pulse is near equal to all positions in quinoline. This is 
unexpected due to the very small coupling constants between protons in each ring in the 
substrate. This idea was investigated through polarisation of various quinoline 
analogues using method 1, and a series of selective 1H OPSYdq NMR spectra using 
method 2. These experiments proved to be inconclusive.  
This chapter has further indicated that optimisation of a polarisation system must be 
optimised for each catalyst and substrate system.  
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5 Chapter 5 – Implementing SABRE with advanced NMR methods 
5.1 Introduction 
Up to this point in this thesis, only single scan 1D 1H NMR spectroscopy has been 
considered. While these spectra can yield significant information about a substrate, such 
as the chemical environments of protons in the system and spin-spin coupling constants, 
there is still a significant amount of information that could be obtained using NMR 
spectroscopy. A great deal of information can be gained from advanced 1D 1H 
sequences such as the 1D 1H NOESY, but consideration of other nuclei such as 13C is 
vital in the characterisation of small molecules. Investigations into 2D sequences such 
as the homonuclear 1H-1H COSY and heteronuclear 1H-13C HSQC, HMBC and HMQC 
are also very important as they allow the observation of correlations between nuclei 
within a molecule indicating even quaternary carbons. However, the successful use of 
these sequences often requires high concentration samples and long acquisition times. 
The application of SABRE to these sequences therefore has the potential to significantly 
reduce sample loading and time required for characterisations.  
The model substrate quinoline is used to achieve this goal and the subsequent results are 
described within this chapter. Quinoline was selected because unlike pyridine, it 
represents a more complex system, containing two rings and most importantly for the 
investigations into heteronuclear sequences, two quaternary carbons. 
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Figure 5.1 Labelled structure of quinoline. 
A more detailed characterisation of quinoline can be found in Chapter 4 or 
Experimental. Much of the work in this chapter contributed towards a Journal of 
American Chemical Society publication in 2012, presented in the Appendix.67 Owing to 
the need for signal averaging and phase cycling, the majority of this chapter has been 
completed using method 2. This also allows the possibility to reliably change the PTF.  
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5.2 Development of method 2 applied to 1D NMR sequences 
This section looks into the application of SABRE to 1D NMR sequences for both 1H, 
looking at the NOESY, and 13C, including 1H coupled, 1H decoupled and INEPT 
sequences.  
5.2.1 Method 2 applied to 1D 1H NMR sequences 
In order to compare the results gained through investigations into hyperpolarisation by 
SABRE, a thermally polarised 1H NMR spectrum of quinoline is shown in Figure 5.2. 
 
Figure 5.2 Thermally polarised 1H NMR spectrum of quinoline. 
5.2.1.1 Investigations into the effect of changing exposure time to parahydrogen on 
resultant 1H NMR spectra 
The effect of changing the exposure time to parahydrogen was investigated using a 
standard 1H NMR sequence with a 90o pulse using method 2. The results are shown in 
Figure 5.3. 
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Figure 5.3 Effect of changing the time of addition of parahydrogen on the 1H enhancement observed to 
the indicated positions of quinoline (10 mM) when polarised with IMes(c) (0.5 mM) using method 2.  
Figure 5.3 shows that the longer the time that parahydrogen is added to the sample, the 
greater the extent of observed polarisation transfer. It should also be noted that the 
relative phase of the signal of positions 3 and 7 changes depending on the bubbling 
time. Significantly better signal strengths are observed when a bubbling time of 10 s is 
employed, however it was also observed this resulted in significant ‘blow-off’ of 
solvent such that only two 2D spectra can be collected before further addition of d4-
methanol is required. As a compromise, a bubbling time of 6 s is used for the following 
experiments as this gives sufficient signal without causing too much solvent to be 
evaporated during the course of the experiment.  
5.2.1.2 Method 2 applied to 1H OPSY NMR sequence 
A more full description of the 1H OPSY NMR sequences can be found in Chapter 1. 
When an OPSYdq measurement is completed, double quantum coherences are selected. 
The effect of changing the PTF on the signal intensity of the resulting 1H OPSYdq 
spectra was investigated using method 2, and the results are shown in Figure 5.4.  
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Figure 5.4 Plot of the effect of PTF on the signal intensity in the resultant 1H OPSYdq NMR spectrum of 
quinoline hyperpolarised with IMes(b) using method 2 where the PTF is set to -150 G (bottom) to 0 G 
(top). For clarity, the plot has been split into three sets of equal relative intensity, where the left set shows 
protons 2, 4 and 8, middle set shows protons 5 7 and 6, and right set shows proton 3. 
Figure 5.4 reveals that the maximum signal intensity is observed with a PTF of 0 G. 
This suggests that the level of IzSz type magnetisation in quinoline produced through 
SABRE is maximised with a PTF of 0 G. Similar data was also collected for when the 
related zero quantum and single quantum states are selected through the OPSY 
sequence, and these also both show maximum signal intensity when a PTF of 0 G is 
employed. Based on the contrasting data collected in Chapter 4 where the signal 
intensity of the 1H NMR sequence with a 90o pulse is maximised with a PTF of 50 G, 
the following measurements are recorded with a PTF of 0 G and 50 G.  
5.2.1.3 Method 2 applied to 1H NOESY NMR sequence 
1H NOESY measurements can reveal two important pieces of information. The primary 
use of the 1H NOESY sequence is to ascertain which protons are correlated to each 
other through nuclear Overhauser interactions. A correlation therefore indicates the two 
protons concerned are close in space to each other but not necessarily connected 
through bonds. The second use of the 1H NOESY sequence is to investigate exchange of 
a proton from one environment to another, also called a 1H EXSY. 
Up to this point, spectra have only been completed using one scan, or by averaging of a 
number of scans. In order to work, the 1H NOESY NMR sequence must complete a 
phase cycle and therefore successful investigations into using the NOESY sequence 
would demonstrate a major advance in the application of SABRE. The process of 
introducing a phase cycle to a sequence during the application of SABRE is 
complicated by the requirement to repolarise the sample between each measurement. 
When this is implemented for the NOESY sequence through using a standard loop 
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within the sequence, failure results due to the incorrect incrementation of the phase 
cycle. It was also not possible to complete the two required scans in one transit, as the 
level of polarisation in each scan was significantly different, and therefore many 
artefacts were present. This can be overcome by the explicit coding of 4 sequential 
acquisitions within one pulse sequence file as outlined in the Appendix.  
 
Figure 5.5 Thermally polarised 1D 1H NOESY spectrum of quinoline (100 mM), top, and hyperpolarised 
using method 2 with IMes(c) (5 mM), bottom, presented on the same scale. Position 4 of quinoline was 
selected, and the inset traces show the observed nOe correlations to positions 5 and 3. 
The hyperpolarised 1H NOESY spectrum presented in Figure 5.5 was collected with 4 
scans using method 2, where quinoline (100 mM) was hyperpolarised using IMes(c)    
(5 mM). In this case, signal corresponding to the 4 position was selected by the selective 
pulse in the sequence, showing as the large adsorption signal at 8.38 ppm. The 1H 
NOESY spectrum then also shows signals corresponding to the 5 and 3 positions of 
quinoline as emission peaks at 7.95 ppm and 7.53 ppm. 
 Position of quinoline Ratio of S/N 
4 (8.38 ppm) 5 (7.95 ppm) 3 (7.53 ppm) 4/5 4/3 
Thermal, 8 scans 1131 10 19 113 60 
SABRE, 4 scans 65036 615 1030  106 63 
Table 5.1 Signal to noise ratios relating to the thermally polarised 1D 1H NOESY spectrum of quinoline 
(100 mM) and hyperpolarised spectrum achieved using method 2 with IMes(c) (5 mM). Position 4 of 
quinoline was selected, and nOe correlations to positions 5 and 3 were observed. 
Table 5.1 shows that the signal to noise ratios for the hyperpolarised 1H NOESY NMR 
spectrum are significantly larger than those for the thermally polarised spectrum, 58 
times larger on average, despite being completed with half the number of scans. It 
should also be noted that the ratio between the selected resonance (position 4 on 
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quinoline) and each NOESY peak (positions 5 and 3 on quinoline) is similar for both 
the thermally polarised and hyperpolarised spectra.  
As the signal to noise ratios of the NOESY signals were in the range of several 
hundreds, the 1H NOESY NMR sequence was investigated at a lower concentration. 
Using method 2, a hyperpolarised 1H NOESY NMR sequence was completed using 
quinoline (10 mM) hyperpolarised with IMes(c) (0.5 mM); 10 % of standard 
concentrations. The resultant spectrum is presented in Figure 5.6. 
 
Figure 5.6 Thermally polarised 1D 1H NOESY spectrum of quinoline (10 mM), top, and hyperpolarised 
spectrum achieved using method 2 with IMes(c) (0.5 mM), bottom, presented on the same scale. Position 
4 of quinoline was selected, and the inset traces show the observed nOe correlations to positions 5 and 3.  
While the concentrations of both substrate and catalyst are now 90 % lower than the 
standard concentration, a very similar spectrum is still observed even though the 3 ml 
sample now contains only 4 µl of quinoline. This is the equivalent of 0.8 µl of quinoline 
in a standard 0.6 ml NMR sample. The signal corresponding to the 4 position was again 
selected.   
 Position of quinoline Ratio of S/N 
4 (8.39 ppm) 5 (7.97 ppm) 3 (7.54 ppm) 4/5 4/3 
Thermal, 128 scans 157 2 3 79 52 
SABRE, 4 scans 2642 30 39 88 68 
Table 5.2 Signal to noise ratios relating to the thermally polarised 1D 1H NOESY spectrum of quinoline 
(10 mM) and hyperpolarised with IMes(c) (0.5 mM). Position 4 of quinoline was selected, and nOe 
correlations to positions 5 and 3 were observed. 
At this concentration of quinoline, it was necessary to complete 128 scans before the 
NOESY signals in the thermally polarised spectrum were observable. It can be observed 
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in Table 5.2 that the signal to noise ratios for the hyperpolarised 1H NOESY NMR 
spectrum are larger than those for the thermally polarised spectrum, 15 times larger on 
average, despite being completed with significantly fewer scans. Like the spectra 
completed at the higher concentration, the ratio between the selected resonance 
(position 4 on quinoline) and each NOESY peak (positions 5 and 3 on quinoline) is 
similar for both the thermally polarised and hyperpolarised spectra, however this 
similarity is less clear in the lower concentration spectra. It should also be noted that the 
4 scan hyperpolarised spectrum was also collected in a much quicker time than the 128 
scan thermally polarised spectrum. Both were completed with a mixing time of 1.5 s, 
and the hyperpolarised spectrum required an additional time to allow for addition of 
parahydrogen to the sample taking a total of 24 s. The total time required to collect the 
thermally polarised spectrum was 9 min 53 s, where the hyperpolarised spectrum took a 
total time of 43 s. The application of SABRE has therefore reduced the time required to 
collect the 1H NOESY NMR spectrum of quinoline at a concentration of 10 mM by a 
little over 9 min.  
5.2.2 Method 2 applied to 1D 13C and 13C{1H} NMR sequences 
In order to compare the results gained through investigations into hyperpolarisation by 
SABRE, thermally polarised 1D 13C and 13C{1H} NMR spectra of quinoline are shown 
in Figure 5.7.  
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Figure 5.7 Thermally polarised coupled (top, 9216 scans) and decoupled (bottom, 101 scans) 13C NMR 
spectra of quinoline. 
A 13C{1H} NMR spectrum of quinoline is expected to reveal nine resonances. In a 13C 
NMR spectrum, each of these resonances is split by the associated 1H-13C couplings. In 
order to maximise the signal to noise ratios of the carbon signals, decoupling is 
required. This also has the effect to simplify the resultant spectrum and reduces the 
number of scans required. This is exemplified in Figure 5.7 in which the presented 
decoupled 13C sequence collected with 101 scans exhibits better signal intensity that the 
coupled 13C spectra collected in 9216 scans. An alternative is to work at higher 
concentrations.  
It is well established that a range of substrates can receive 1H polarisation through the 
SABRE technique however, polarisation transfer to 13C has not yet been discussed.  
5.2.2.1 Method 2 applied to utilising 13C magnetisation without 1H decoupling 
The resultant hyperpolarised single scan 13C NMR spectrum is often of poor quality due 
to the concentration of the sample being too low. An example 13C NMR spectrum of a 
100 mM quinoline sample that has been hyperpolarised using method 2 and IMes(b) at 
a PTF of 10 G is shown in Figure 5.8. 
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Figure 5.8 Single scan 13C NMR spectrum of quinoline hyperpolarised with IMes(b) at PTF of 10 G 
using method 2. 
Of the nine carbons present in quinoline, signals corresponding to only two of these are 
clearly observable, both of which exhibit a poor signal to noise ratio. As a result, all 
investigations into the development and optimisation of 1D 13C NMR sequences were 
carried out with a higher concentration of catalyst and substrate with sample 
concentrations of 15 mM IMes(b)/IMes(c) and 300 mM quinoline being used, unless 
otherwise mentioned. Once hyperpolarised using method 2, these higher concentration 
conditions allow the observation of most 13C signals in a single scan.  
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Figure 5.9 A series of single scan 13C NMR spectra of quinoline hyperpolarised with IMes(c) using 
method 2, where the PTF is increased from -150 G (bottom) to 0 G (top) in increments of 30 G. 
Figure 5.9 shows that at when the sample is prepared in a PTF of -150 G, eight of the 
nine 13C resonances expected for quinoline are readily detected. The missing resonance 
corresponds to the carbon centre that is next to the nitrogen in position 2. When the PTF 
is changed to 0 G, the 13C spectrum obtained with a 90o read pulse shows that only six 
of the nine 13C resonances expected for quinoline are readily detected. The signal to 
noise ratio for these six signals is however much better than that achieved in the 
spectrum collected with a PTF of -150 G. These data therefore confirm that as with the 
1H NMR spectra, the resultant spectra are dependent on the PTF.  
The signals for the 13C centres are split with respect to both one bond and two bond 
couplings in the coupled spectrum. The application of SABRE has resulted some of 
these splittings appearing antiphase as a result of the multiple quantum states derived 
from parahydrogen. A very simple schematic of the resultant signals from these 
multiple quantum states is presented in Figure 5.10. Here, the observed nuclei I is 
considered to be split by two other nuclei, the first, S, with a large coupling and the 
second, T, with a small coupling. This situation is analogous to that observed for 
quinoline in Figure 5.9 where I corresponds to a 13C centre, S corresponds to a 1H one 
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bond away implying a large coupling and T corresponds to a 1H two bonds away 
implying a smaller coupling. 
 
Figure 5.10 Schematic of the effect of multiple quantum states on the resultant signal. 
For an Iz state, the signal is split according to both S and T, into inphase magnetisation. 
The magnetic state IzSz yields a signal is antiphase with respect to the large coupling to 
S. The same is true for IzTz, where the signal is antiphase with respect to the small 
coupling to T. This consequently means that for the magnetic state IzSzTz, the resultant 
signal is antiphase with respect to both small and large couplings. The spectra shown in 
Figure 5.9 reflect the sum of these states in differing proportions. A schematic of 
selected combinations are presented in Figure 5.11. 
 
Figure 5.11 Schematic of the effect of selected combinations of multiple quantum states on the resultant 
signal. 
Figure 5.11 represents a simplified schematic of the combination of selected multiple 
quantum states. They are simplified in the sense that they assume both multiple 
quantum states are added together in equal proportion which is unlikely to occur in a 
real system. In Figure 5.9, signals with similar combinations to those observed in Figure 
5.10 and Figure 5.11 can be identified. For example, the signal observed for position 9 
of quinoline when a PTF of -60 G, -30 G or 0 G was used shows an antiphase nature 
with respect to the small coupling, corresponding to an IzTz state. The carbon is a 
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quaternary carbon and therefore shows no large coupling. This state is also observed for 
the signal corresponding to position 4 of quinoline when a PTF of 0 G is used however 
in this case, splittings corresponding to both small and large couplings are observed, 
antiphase with respect to the small coupling. Representative signals with the IzTz state 
are shown in Figure 5.12. 
 
Figure 5.12 13C signals which present with the IzTz state. Left is a quaternary carbon signal and right is a 
CH carbon signal. 
It can also be observed in Figure 5.9 that as the PTF is decreased through to -150 G, the 
profile of the signal corresponding to position 4 changes from presenting with IzTz 
nature to presenting as a combination of Iz and IzTz nature. A similar change in the 
appearance of the signal corresponding to position 3 of quinoline is also observed upon 
changing the PTF. At a PTF of 0 G, the signal presents with IzTz nature to a mixture of 
IzSz with either IzTz of IzSzTz states at a PTF of -150 G.  
It is consequently possible to observe that a spectrum collected through the use of 
SABRE can contain a number of different nuclear magnetic states, and these states can 
present as antiphase to more than one coupling, and to different couplings when using 
different PTFs. This is an important observation when considering decoupling the 
hyperpolarised 13C spectrum.  
5.2.2.2 Method 2 applied to utilising 13C magnetisation with 1H decoupling 
As discussed in the previous section, when 13C is polarised using the SABRE technique, 
the resulting signals can be antiphase. This means standard decoupling is not possible as 
the antiphase signals cancel out and consequently become unobservable, as shown in 
Figure 5.13.  
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Figure 5.13 Schematic depicting the effect of decoupling on antiphase signals. 
This effect is also observed in parahydrogen induced polarisation and means 
decoupling is not possible without further manipulation of the magnetic states present. 
This was first explored by the addition of a delay period between the 90º pulse and data 
acquisition as shown in Figure 5.14.  
 
Figure 5.14 Schematic of the refocused 13C{1H} NMR sequence termed the 13C{1H}_JR NMR sequence. 
τ denotes a delay corresponding to a 1H-13C coupling constant. 
The delay between the pulse and acquisition allows any antiphase signal to refocus into 
in-phase signals, which can consequently be decoupled during acquisition. This 
sequence can be optimised depending on the delay used. For the rest of this thesis, the 
delay is optimised to either a one bond correlation where 1JHC is around 165 Hz, or a 
two bond correlation where 2JHC is around 8 Hz, both optimised for position 3. These 
values were set based on a fully coupled 13C, the data for which is presented in Chapter 
4 or Experimental.  
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Figure 5.15 A series of single scan 13C{1H}_JR NMR spectra optimised for a one bond coupling of 
quinoline hyperpolarised with IMes(c) using method 2 where the PTF is increased from -150 G (bottom) 
to 0 G (top) in increments of 30 G. 
The sequence shown in Figure 5.14 was investigated where the PTF was changed from  
-150 G to 0 G in increments of 30 G.  Figure 5.15 clearly shows that when the sequence 
is optimised to refocus one bond couplings, eight of the nine expected 13C signals can 
be successfully refocused such that they could be decoupled. The signal corresponding 
to position 2 of quinoline is however unobservable. Based on this dependence on PTF 
alone, it is possible to see that the best signal intensity is observed for a PTF of 0 G. The 
data were collected for a sequence that optimised to refocus the smaller two bond 
couplings. The results of this process are shown in Figure 5.16. 
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Figure 5.16 A series of single scan 13C{1H}_JR NMR spectra optimised for a two bond coupling of 
quinoline hyperpolarised with IMes(c) using method 2 where the PTF is increased from -150 G (bottom) 
to 0 G (top) in increments of 30 G.  
Figure 5.16 shows that when the 13C{1H}_JR sequence is optimised to refocus a two 
bond coupling, it is difficult to define a single PTF which yields maximum signal 
intensity. Compared to the sequences optimised for one bond couplings, fewer signals 
are now observed, with a maximum of six signals in any one spectrum. The greatest 
signal intensity is observed when a PTF of -90 G is employed and coincidently, this is 
also the PTF which yielded the greatest number of signals. This was therefore chosen 
for comparison to the spectrum optimised for one bond couplings at a PTF of 0 G 
shown in Figure 5.17. 
221 
 
Figure 5.17 Single scan 13C{1H}_JR NMR spectra optimised for a two bond coupling with a PTF of -90 
G (bottom) and one bond coupling with a PTF of 0 G (top) of quinoline hyperpolarised using method 2 
with IMes(c). 
Figure 5.17 shows that when the 13C{1H}_JR sequence is optimised for two bond 
couplings, only the signal at 121 ppm (C3) has an increased intensity compared to 
optimisation for one bond couplings. The signal intensity for all the other observed 
peaks is greater when the sequence is optimised to refocus one bond couplings. It is also 
possible to observe two more signals when the sequence is optimised for one bond 
couplings. A possible reason for these observations is that the relaxing hyperpolarised 
states do not survive the refocusing time. The delay period, τ is equal to 1/2JCH, and 
therefore if two bond couplings are refocused, τ will equal 0.0625 s (1/(2x8)). This is a 
much longer time than the delay used to correspond to one bond couplings, 0.003 s 
(1/(2x165)).  
While the signals created using the 13C{1H}_JR sequence have been successfully 
refocused to the point where they can be decoupled, the decoupled signals are still not in 
phase with each other. This is because the 13C{1H}_JR sequence allows refocusing with 
respect to J coupled evolution but not with respect to chemical shift evolution. One 
method to overcome this is to present the spectrum in magnitude, an example of which 
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can be seen in Figure 5.37. This can also be rectified through the application of a new 
sequence termed 13C{1H}_JCSR, shown in Figure 5.18. 
 
Figure 5.18 Schematic of the refocused 13C{1H} NMR sequence termed the 13C{1H}_JCSR 13C NMR 
sequence. τ denotes a delay corresponding to a 1H-13C coupling constant. 
This refocuses spin evolution due to chemical shift on 13C, but the 180º pulse on 1H 
allows the state to evolve into an in-phase state. At this point, the 1H-13C couplings can 
be removed by 1H-decoupling and the 13C{1H} NMR spectrum recorded.  
 
Figure 5.19 A series of single scan 13C{1H}_JCSR NMR spectra optimised for a one bond coupling of 
quinoline hyperpolarised with IMes(c) using method 2 where the PTF is increased from -150 G (bottom) 
to 0 G (top) in increments of 30 G. 
223 
Figure 5.19 shows the 13C{1H}_JCSR NMR sequence exhibits most intense signals at a 
PTF of 0 G and the signals have been decoupled however not all the expected signals 
are observed. These spectra were repeated when the sequence was optimised for two 
bond couplings. 
 
Figure 5.20 A series of single scan 13C{1H}_JCSR NMR spectra optimised for a two bond coupling of 
quinoline hyperpolarised with IMes(c) using method 2 where the PTF is increased from -150 G (bottom) 
to 0 G (top) in increments of 30 G. 
Figure 5.20 again shows maximum signal intensity at a PTF of 0 G, similar to the trend 
observed when the sequence is optimised for one bond couplings. As this is the case, 
Figure 5.21 shows the comparison of the spectra resulting from the sequence being 
optimised for both one and two bond couplings both hyperpolarised at a PTF of 0 G. 
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Figure 5.21 Single scan 13C{1H}_JCSR spectra optimised for one bond couplings (top) and two bond 
couplings (bottom), of quinoline hyperpolarised with IMes(c) using method 2 where the PTF is set to 0 
G. 
Figure 5.21 shows that when the 13C{1H}_JCSR sequence is optimised for two bond 
couplings, only the signal at 121 ppm (C3) has an increased intensity compared to 
optimisation for one bond couplings, as it is not observable in that spectrum. However, 
the signal intensity for all the other observed peaks is greater when the sequence is 
optimised to refocus one bond couplings. The two methods of refocusing a 13C 
spectrum in preparation for decoupling are compared to each other in Figure 5.22.  
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Figure 5.22 Optimised 13C{1H}_JR NMR spectrum (top) and optimised 13C{1H}_JCSR NMR spectrum. 
Figure 5.22 shows the signal corresponding to position 2 of quinoline is of similar 
intensity for both sequences however the 13C{1H}_JR spectrum shows more of the other 
signals at greater intensity than the 13C{1H}_JCSR. Again, it would be recommended 
these spectra are presented in magnitude mode for ease of assignment. 
5.2.2.3 Method 2 applied to 13C INEPT NMR sequences 
The INEPT sequence (Insensitive Nuclei Enhanced by Polarisation Transfer) is a 
method by which relatively highly polarised nuclei, most commonly the 1H, is used to 
polarise less sensitive nuclei. It is an integral part of many of the more complicated 
NMR sequences which are used very successfully to characterise materials, including 
the heteronuclear 2D sequences discussed later in this chapter (HMQC/HSQC).8 It was 
therefore decided to investigate the effect of SABRE on INEPT type procedures in 
order to fully understand how it might be optimally used, and to apply these 
observations to later investigations into related 2D heteronuclear experiments.  
Due to the previously discussed complications with proton decoupling within 13C NMR 
spectroscopy, the hyperpolarised INEPT investigations started with a fully coupled 
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INEPT sequence. This is termed ‘INEPTnd’ for the duration of this thesis and the 
sequence is shown in Figure 5.23. 
 
Figure 5.23 Schematic of the standard 13C INEPTnd sequence. τ denotes a delay corresponding to a 1H-
13C coupling constant. 
Two fully coupled thermally polarised 13C NMR spectra (Figure 5.24) collected using 
the standard INEPTnd NMR sequence using the optimal couplings for H3 (165 Hz and 
8 Hz) as for the previously investigated 13C and 13C{1H} sequences. 
 
Figure 5.24 Thermally polarised 13C INEPTnd NMR spectra of quinoline optimised for one bond (top) 
and two bond (bottom) coupling. 
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The 1H-13C INEPTnd NMR spectra optimised for one bond couplings were investigated 
in the range 180 Hz to 150 Hz in increments of 1 Hz, and 161 Hz to 160 Hz in 
increments of 0.1 Hz. It was observed that little change was observed in the resultant 
spectra. The 1H-13C INEPTnd NMR spectra optimised for two bond couplings were 
investigated in the range 20 Hz to 2 Hz in increments of 1 Hz and significant differences 
were observed in the resultant spectra. In the case of these thermally polarised spectra, 
the best results were observed when optimised for a 19 Hz coupling. 
 
Figure 5.25 Thermally polarised 13C INEPTnd NMR spectra of quinoline optimised for two bond 
couplings (8 Hz, top and 19 Hz bottom). 
From this thermally polarised data, it is observed that the 19 Hz coupling results in 
more signals and of greater signal intensity than the spectrum completed at 8 Hz 
however this value is significantly different from the couplings measured for quinoline 
using a thermally polarised 13C{1H} NMR spectrum (see Chapter 4). Future 
hyperpolarised investigations will therefore be considered as optimised for the 
couplings relating to position 3. 
The following hyperpolarised experiments were completed using a higher concentration 
sample of 15 mM IMes(c) and 300 mM quinoline, with a single scan, unless otherwise 
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stated. The effect of the PTF was the first investigated with respect to a hyperpolarised 
13C INEPTnd NMR spectrum. Two PTFs were investigated; 0 G (to maximise 1H-1H 
IzSz-type magnetisation, section 5.2.1.2, pg 208) and -65 G (to maximise 
1H Iz 
magnetisation, Chapter 4), initially optimised for a two bond coupling. The results of 
this experiment are presented in Figure 5.26. 
 
Figure 5.26 Single scan 13C INEPTnd NMR spectra of quinoline optimised for a two bond coupling, 
hyperpolarised using method 2 with IMes(c) at a PTF of -50 G (bottom) and 0 G (top). 
Figure 5.26 shows the signal intensity for the INEPTnd sequence is greatest when a PTF 
of -50 G is employed. This is expected as the 13C magnetisation observed is derived 
from 1H polarisation which exhibits a greater polarisation at a PTF of -50 G for the Iz 
state.  
The first pulse on the 1H channel in a standard INEPTnd sequence is a 90º pulse 
however any IzSz magnetisation will remain unobservable throughout the sequence. In 
order to detect signal derived from the IzSz magnetisation state, a different pulse is 
required.149 This principle was investigated when applying SABRE to the INEPTnd 
sequence, such that the first pulse in the INEPTnd sequence shown in Figure 5.23 is 
shortened to a 45º pulse (as described in the Introduction). The resultant spectra yielded 
similar results however the signal intensity was less than that observed for the spectra 
229 
completed with a 90º suggesting the INEPTnd is maximised for the Iz state. The same 
trend is observed when the experiments are collected with a PTF of 0 G where IzSz 
magnetisation is optimised. This further suggests the sequence is optimised when the 
level of Iz type magnetisation is optimised.  
Until now, the INEPTnd sequence has only been investigated when optimised for a two 
bond coupling, however it is also important to consider the effect when the sequence is 
optimised for a one bond coupling. The effect of changing the PTF when the sequence 
is optimised for one bond couplings is considered first. 
 
Figure 5.27 Single scan 13C INEPTnd NMR spectra of quinoline optimised for a one bond coupling, 
hyperpolarised using method 2 with IMes(c) at a PTF of -50 G (bottom) and 0 G (top). 
Figure 5.27 shows that when the 13C INEPTnd sequence is optimised for one bond 
couplings, greater signal intensity is observed when the PTF is set to -50 G. The 
sequence optimised for one bond couplings was then investigated with respect to the 
initial pulse, with 90º and 45º initial pulses investigated as before. The results in this 
case match those found when the sequence is optimised for two bond couplings, in that 
the greatest signal to noise is observed when the first pulse is 90º. The sequence 
optimised for one bond couplings was also investigated at 0 G again showing the same 
trend that starting the sequence with a 90º pulse gave signals with greater intensity. This 
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suggests the INEPTnd sequence reveals more intense signals when the sample is 
hyperpolarised such that the Iz state on proton is maximised. 
In general the 13C INEPTnd NMR spectra shows greatest signal intensity when the first 
pulse is 90º and the PTF is set to -50 G. The sequence optimised for one bond couplings 
is therefore compared to the same sequence optimised for two bond couplings, both 
under the same conditions. This is shown in Figure 5.28.  
 
Figure 5.28 Single scan 13C INEPTnd NMR spectra of quinoline hyperpolarised with IMes(c) at a PTF of 
-50 G where the first pulse is 90º and the sequence is optimised for two bond couplings (bottom) and one 
bond couplings (top). 
It can be seen that the INEPTnd transfer experiment shows much better signal to noise 
when optimised for two bond couplings. This is unexpected as it would be assumed that 
the increased delay time required for when optimising for two bond couplings compared 
to one bond couplings would allow polarisation decay, as is observed in the thermal 
spectra (Figure 5.24). A possible reason for this is the level of polarised states within the 
quinoline, for instance, under a one bond coupling sequence, polarisation is received 
from only one hyperpolarised proton, however in the two bond coupling sequence, 
polarisation is transferred from two hyperpolarised protons. It is also noting that both 
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couplings are optimised for position 3, in which the most significant difference is 
observed. 
It can be concluded from the previous experiments that, up to this point, the optimal 
conditions for the INEPTnd sequence are to optimise for two bond couplings, polarise 
with a PTF of -50 G and set the first pulse in the sequence to 90º. The spectrum 
resulting from these conditions is compared to the optimal 13C NMR spectrum and 
optimal refocused 13C{1H} NMR spectrum in Figure 5.29. 
 
Figure 5.29 Various hyperpolarised coupled and decoupled 13C NMR spectra of quinoline. a) 13C NMR 
spectrum collected at a PTF of 0 G, b) a refocused 13C{1H} NMR spectrum collected at a PTF of 0 G and 
c) a 13C INEPTnd NMR spectrum optimised for two bond couplings collected at a PTF of -50 G. 
An alternative sequence has been published by Haake et al.150 that is designed to 
maximise polarisation derived from parahydrogen in PHIP. This entails changing the 
phase of the first pulse. The sequence proposed for use with PHIP is presented in Figure 
5.30 and is associated with utilising a proton based IzSz starting state. 
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Figure 5.30 Schematic of the 13C PH_INEPT NMR sequence, adapted from Haake et al.150 which differs 
from the INEPTnd sequence in that the first pulse has a 90º phase change and is a 45º pulse. This is 
adapted for use in this research such that the first pulse can be 90º or 45º, to be termed INEPT_phase. τ 
denotes a delay corresponding to a 1H-13C coupling constant. 
The PH_INEPT NMR sequence in Figure 5.30 differs from the INEPTnd sequence 
presented in Figure 5.23 in that the initial pulse is shorter and has a 90º phase change 
from x to y. The 45º pulse is required in PHIP149 (see Introduction) but not SABRE and 
therefore the phase change to the first pulse has been investigated with both 90º and 45º 
first pulses. The new sequence will be termed INEPT_phase for the duration of this 
thesis, described in Figure 5.30. The effect of changing the value of τ was the first to be 
investigated, with results shown in Figure 5.31. 
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Figure 5.31 Single scan 13C INEPT_phase NMR spectra of quinoline hyperpolarised with IMes(c) at a 
PTF -65 G where the first pulse is 90º and the sequence is optimised for two bond couplings (bottom) and 
one bond couplings (top).  
Comparing the spectra in Figure 5.31, it is possible to observe that a better signal to 
noise is obtained when the sequence is optimised for one bond couplings. This is in 
contrast to the result found for the INEPTnd sequence. The effect of changing the PTF 
was then investigated. Results are shown in Figure 5.32. 
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Figure 5.32 Single scan 13C INEPT_phase NMR spectra of quinoline optimised for one bond couplings 
hyperpolarised using method 2 with IMes(c), the first pulse on 1H is 90º, and PTF occurs at -65 G 
(bottom) and 0 G (top). 
Figure 5.32 shows that more intense signals are observed when PTF is 0 G compared to 
-65 G. This result is expected, as the INEPT_phase sequence is optimised for PHIP 
investigations and so consequently, is optimised for double quantum states and these 
states are maximally transferred at 0 G (see section 5.2.1.1, pg 207). The effect of 
changing the first pulse from 90º to 45º was then investigated, according to the sequence 
suggested by Haake et al.,150 with results shown in Figure 5.33.   
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Figure 5.33 Single scan 13C INEPT_phase NMR spectra of quinoline optimised for a one bond coupling, 
hyperpolarised using method 2 with IMes(c) at a PTF of -65 G and the first pulse on 1H is 90º (bottom) 
and 45º (top). 
Figure 5.33 shows that more intense carbon signals are observed for the 13C 
INEPT_phase NMR spectrum when the first pulse is 90º and the PTF is set to 0 G. This 
dependence was also investigated with a PTF of -65 G and also showed better signal to 
noise when the first pulse was set to 90o. This is unexpected as the INEPT_phase 
sequence is optimised for double quantum states which should also be optimised with a 
45º pulse. The proceeding experiments have shown that the optimal conditions for the 
INEPT_phase NMR sequence are to optimise for one bond couplings, use a PTF of 0 G 
and an initial pulse of 90º. 
These results are counter intuitive however they can be explained by the use of product 
operators. For the INEPT_phase experiment with a 45º pulse, a spectrum is observed 
with an IzSz or IzRz starting state, where I and S correspond to protons and R 
corresponds to 13C. When the initial pulse is replaced with a 90º pulse, no observable 
states are retained with an Iz or IzSz starting state however an IzRz starting state produces 
observable states on 13C.151 This is a double quantum state and so will yield a maximum 
signal intensity with a PTF at 0 G, however, as a 1H-13C double quantum state, will 
require a 90º pulse. More information can be found in the Appendix. 
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The two INEPT sequences investigated to this point have been compared to each other 
in Figure 5.34, showing the spectrum completed under optimal conditions for each 
sequence. The INEPTnd NMR sequence is therefore completed optimised for two bond 
coupling, with a PTF of -65G where the first pulse is 90º (Figure 5.34, bottom), and the 
INEPT_phase NMR sequence is completed optimised for one bond couplings, at a PTF 
of 0 G where the first pulse is 90º (Figure 5.34, top).  
 
 
Figure 5.34 Single scan transfer 13C INEPT NMR spectra of quinoline hyperpolarised with IMes(c) 
showing the optimised INEPTnd (bottom) and optimised INEPT_phase (top) spectra. 
Figure 5.34 shows that neither sequence is preferential over the other. The INEPTnd 
NMR sequence shows better more intense signals for the CH carbons but the 
INEPT_phase NMR sequence shows more intense signals for the quaternary carbons. 
Figure 5.29 indicates the gain observed through using an INEPT sequence over a 13C 
sequence and this gain stands for the INEPT_phase sequence also. It is therefore 
recommended to complete both sequences as part of a characterisation series in order to 
obtain maximum information.  
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5.2.2.4 Method 2 applied to 1H decoupling of the INEPT sequence 
It is also important to consider decoupling the INEPT sequence. As with the 13C 
sequences discussed previously, the application of SABRE creates antiphase signals. 
Consequently, the decoupled INEPT sequence must also include a refocusing section 
between the INEPT transfer and decoupled acquisition to ensure the signals are in phase 
and therefore observable. This was completed with the sequence shown in Figure 5.35. 
 
Figure 5.35 Schematic of the 13C INEPTrd NMR sequence. τ and ∆ denote delays corresponding to a 1H-
13C coupling constant. 
The INEPTrd sequence is based on the INEPTnd sequence in Figure 5.23 however it 
includes a refocusing sequence. Both τ and ∆ are delays based on the same coupling 
constant but manipulated in different ways. The spectra gained as a result of using 
hyperpolarised INEPTrd sequences often appeared with out of phase signals. Each 
individual signal could be phased but there is no point at which they all in phase with 
each other. For this reason, each INEPTrd spectrum is processed with a magnitude 
calculation. The effect of optimising for one bond or two bond correlations was 
investigated first.  
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Figure 5.36 Single scan 13C{1H} INEPTrd NMR spectra of quinoline hyperpolarised with IMes(c) at a 
PTF of 0 G, optimised for two bond couplings (bottom) and one bond couplings (top). These spectra have 
been presented in magnitude mode. 
The most significant observation to be made from Figure 5.36 is that the INEPT 
sequence has been successfully proton decoupled under hyperpolarised conditions. It 
can be observed in Figure 5.36 that the most significant single signal is present when 
the sequence is optimised for two bond couplings. It should also be noted however that 
a greater number of signals of close, but lower intensity are observed when the sequence 
is optimised for one bond couplings. This is therefore considered more successful as a 
greater number of resonances are identified. The sequence was then investigated when 
the sample was polarised at a PTF of -50 G and 0 G. This is presented in Figure 5.37. 
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Figure 5.37 Single scan 13C{1H} INEPTrd NMR spectra optimised for one bond couplings of quinoline 
hyperpolarised using method 2 with IMes(c) at a PTF of -50 G (bottom) and 0 G (top). These spectra 
have been presented in magnitude mode. 
It is possible to observe in Figure 5.37 that the most significant signals are observed 
when a PTF of -50 G is used. This is a very significant result as the INEPTrd collected 
with a PTF of -50 G is the first carbon spectra collected to clearly define all nine 
resonances associated with quinoline. This was repeated when the sequence was 
optimised for two bond couplings to give the same trend of maximum signals at a PTF 
of -50 G.  
It was therefore found that the optimal conditions for the INEPTrd sequence are to 
optimise for one bond couplings and polarise at a PTF of -50 G.  
5.2.2.5 Utilisation of polarisation transfer to two different nuclei to increase 
information gain 
Investigations into SABRE have now shown polarisation transfers into 13C sites as well 
as 1H sites. Therefore, in each hyperpolarised transit between the polarisor and 
spectrometer, the polarisation that is transferred into the nuclei that are not interrogated 
is wasted. After optimisation of the 13C NMR sequences, and most importantly the 
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INEPT sequences, above, the potential to utilise the polarisation transfer into the whole 
substrate to gain both coupled and decoupled 13C spectra in one transit is achievable.  
This might be achieved in one of two ways, either an INEPT sequence followed by a 
13C sequence or a 13C sequence followed by an INEPT sequence. If the INEPT sequence 
is completed first, polarisation from the 1H sites will be transferred to the 13C sites using 
RF pulses and then read out. This might result in a higher signal on the first spectra, but 
removes most of the polarisation from the substrate. It is therefore important to 
interrogate using polarisation on 13C first, then use the INEPT sequences to transfer the 
polarisation still present on 1H to repolarise 13C for the second spectrum. All the spectra 
in this section have been presented after completion of a magnitude calculation for ease 
of interpretation. 
This was first investigated by completing a 13C NMR spectrum followed by an 
INEPTnd sequence in the same transit. The result is shown in Figure 5.38. 
 
Figure 5.38 Showing a 13C NMR spectrum of quinoline hyperpolarised at a PTF of -65 G (bottom) and a 
13C INEPTnd NMR spectrum (top) completed immediately after the first sequence. These spectra have 
been presented in magnitude mode. 
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Figure 5.38 shows two coupled 13C NMR spectra have been successfully recorded 
without requirement of the sample to be repolarised between scans i.e. in a single 
transit. The ability to do this may hold great advantages as it now may be possible to 
take a 13C and 13C{1H} spectrum with only one polarisation step. Initially, this was first 
attempted by completing a 13C{1H} first, followed by a coupled INEPT sequence. The 
result is shown in Figure 5.39. 
 
Figure 5.39 Showing a 13C{1H} NMR spectrum of quinoline hyperpolarised at a PTF of 0 G (bottom) and 
a 13C INEPTnd NMR spectrum (top) completed immediately after the first sequence. These spectra have 
been presented in magnitude mode. 
It can be observed in Figure 5.39 that no 13C signals are observed in the INEPTnd. This 
is because during collection of the first 13C{1H} NMR spectrum, the polarisation present 
on 1H is quenched due to the decoupling sequence. This experiment has therefore 
shown it is important to complete a coupled 13C first, followed by a 13C{1H} INEPTrd 
sequence. The resulting spectra are shown in Figure 5.40. 
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Figure 5.40 Showing: bottom, a 13C NMR spectrum of quinoline hyperpolarised at a PTF of -50 G and 
top, a 13C{1H} INEPTrd spectrum completed immediately after the first sequence. These spectra have 
been presented in magnitude mode. 
The combination of completing a coupled 13C NMR spectrum immediately followed by 
a 13C{1H} INEPTrd NMR sequence was investigated at two PTFs. This is because 
polarisation transfer into 1H is optimal when quinoline is hyperpolarised at a PTF of -50 
G and 13C is optimal when the quinoline is hyperpolarised at a PTF of 0 G, however the 
best result was found at a PTF of -50 G, shown in Figure 5.40. Despite the extra time 
the 1H nuclei have to relax due to acquisition of the 13C sequence, the nine carbons 
present on quinoline are observed, although the signal intensity of positions 3, 4 and 5 is 
weak. The initial acquisition of the 13C sequence has also yielded all nine carbons 
signals together with couplings however the signal for position 2 is weak.  
These experiments have shown the potential to gain even further information from each 
hyperpolarisation step than investigated previously. Here, polarisation transfer into both 
13C and 1H nuclei on a substrate are utilised to gain both coupled and decoupled 13C 
NMR spectra, yielding two different sets of information in one transit from the 
polarisor.  
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5.2.2.6 Hyperpolarised 13C NMR spectra using standard reagent concentrations 
During the optimisation of the sequences used to gain coupled and decoupled 13C 
spectra, the sample concentration used was increased to 3 times the standard reagent 
concentrations. This is impractical for pharmaceutical uses as this concentration equates 
to approximately 40 mg of the relatively small substrate quinoline, and therefore, for 
larger substrates this mass will increase greatly. As the INEPTrd was the only sequence 
to produce all nine of the expected 13C signals correlating to quinoline, this was used to 
investigate the ability of SABRE to gain a 13C spectrum at standard reagent 
concentrations of quinoline (100 mM) and IMes(c) (5 mM). The results are presented in 
Figure 5.41.  
 
Figure 5.41 13C{1H} INEPTrd NMR spectra of quinoline (100 mM) hyperpolarised using method 2 with 
IMes(c) (5 mM) at a PTF of -50 G with 1 scan (bottom), and 8 scans (middle), and 13C{1H} INEPTrd 
NMR spectra of quinoline (300 mM) hyperpolarised using method 2 with IMes(c) (15 mM) at a PTF of   
-50 G with 1 scan (top). These spectra have been presented in magnitude mode, and are scaled relative to 
each other according to the y-axis. 
Figure 5.41 indicates the 13C{1H} INEPTrd spectrum does not produce a spectrum with 
good signal intensity for any of the expected peaks when completed with standard 
reagent concentrations (100 mM substrate and 5 mM catalyst). The number of scans 
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was therefore increased to eight with the result that six of the nine expected signals are 
now observed. To gain a similar level of signal intensity for the 13C{1H} NMR spectrum 
under thermally polarised conditions, 200 scans were required which took ~7 minutes to 
complete, revealing seven of the nine expected carbon resonances of quinoline. Even 
with 8 scans, the hyperpolarised method requires ~4 minutes and therefore is quicker.  
5.3 Development of method 2 applied to 2D NMR sequences 
Investigations into the reproducibility of method two (see Chapter 2) together with the 
success of the INEPT sequence in conjunction with SABRE have led to the possibility 
of completing 2D sequences using SABRE. All 2D sequences inherently require more 
than one scan, as at least one scan per increment in the second dimension is required. It 
is therefore difficult to complete hyperpolarised 2D sequences using method 1 (without 
the use of ultrafast methods discussed in section 5.3.2.1, page 248) due to the fast 
relaxation of the hyperpolarised states, and magnetisation being used up through 
interrogation. Unless otherwise mentioned, all hyperpolarised 2D spectra were collected 
using standard reagent concentrations. 
5.3.1 Method 2 applied to 1H-1H 2D homonuclear NMR sequences 
Investigations into 2D homonuclear sequences extended to proton-proton sequences 
only. In order to compare the results gained through investigations into 
hyperpolarisation by SABRE, a thermally polarised 1H-1H COSY NMR spectrum of 
quinoline is shown in Figure 5.42. 
 
Figure 5.42 Thermally polarised 1H-1H COSY NMR spectrum of quinoline. 
245 
5.3.1.1 Method 2 applied to 1H-1H COSY NMR sequence 
 
Figure 5.43 1H-1H COSY NMR spectrum of quinoline hyperpolarised using method 2 with IMes(c) at a 
PTF of 0 G. 
Figure 5.43 shows a hyperpolarised 1H-1H COSY NMR spectrum recorded using 
method 2 under standard reagent conditions with 64 increments and was collected in   
36 min using the MKII polarisor. The successful application of SABRE to the standard 
COSY sequence resulted in a good spectrum, very similar to that observed in Figure 
5.42. All the expected diagonal signals are observed, although the signal for position 7 
is of reduced intensity. The expected cross peaks corresponding to single bond 
correlations are all observed although again two cross peaks relating to the proton in 
position 7 are of reduced intensity. This sequence was also completed on the MKIII 
polarisor and which resulted in a very similar spectrum but was completed in the 
quicker time of 20 min. As the thermally polarised spectrum also presents with cross 
peaks corresponding to the long range coupling between positions 2 and 4 and can be 
collected in a significantly shorter time, investigations into the standard COSY NMR 
spectrum were not continued. 
5.3.1.2 Method 2 applied to 1H-1H OPSYdq-COSY NMR sequence 
The pulse sequence for the 1H-1H OPSYdq-COSY NMR spectrum was first described 
in a publication by Aguilar et al.84 in 2007 for use within PHIP and extended to use with 
SABRE in a publication by Aguilar et al.86 in 2011.  
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Figure 5.44 1H-1H OPSY-COSY sequence adapted from that proposed in a publication by Aguilar et al.84 
in 2007. 
In the case of the 1H-1H OPSY-COSY sequence, the standard COSY sequence has been 
adapted in that the initial 90º pulse has been replaced by the OPSY sequence. The most 
significant advantage of adding an OPSY sequence selecting double quantum states to 
the beginning of the COSY sequence is that the magnetic states prepared by the 
OPSYdq sequence lead optimally to those responsible for cross peaks in a COSY 
sequence. This has the effect that cross peaks are observed before the diagonal, made 
possible by the use of parahydrogen. 
 
Figure 5.45 1H-1H OPSYdq-COSY NMR spectra of quinoline (100 mM) hyperpolarised with IMes(c) (5 
mM) at a PTF of 0 G (left) and -50 G (right). 
In Figure 5.45, more intense signals are observed when the PTF is set to 0 G. This is 
expected as the double quantum states used in a 1H OPSYdq spectrum are maximised at 
a PTF of 0 G (see section 5.2.1.1, pg 207). When collected using method 2 on the 
MKIII polarisor, the 2D OPSY spectrum takes 20 mins to collect when the solution is 
bubbled with parahydrogen for 6 s before each transient. As the addition of the OPSY 
sequence to the COSY sequence yields additional information, the sequence was 
investigated with lower concentrations of quinoline and catalyst. Figure 5.46 shows the 
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corresponding NMR spectra obtained when of the 1H-1H OPSYdq-COSY sequence was 
completed for a sample of 10 mM quinoline and 0.5 mM IMes(c).  
 
Figure 5.46 1H-1H OPSYdq-COSY NMR spectra of quinoline (10 mM) hyperpolarised with IMes(c) (0.5 
mM) at a PTF of 0 G (left) and -50 G (right), with long range correlations labelled between positions 2 
and 4 (triangles), positions 5 and 7 (hexagons) and positions 6 and 8 (squares). 
Again, in Figure 5.46, the most intense signals are observed when the PTF is set to 0 G, 
particularly the cross peaks in the second ring of quinoline. These are labelled in Figure 
5.46 on the left hand side. The long range correlations between positions 2 and 4 and 
positions 5 and 7 can be observed on the thermally polarised COSY spectrum of a 
sample of 10 mM quinoline (see Experimental), however the correlation between 
positions 6 and 8 are weak. These signals are also much weaker in the thermally 
polarised COSY spectrum than the hyperpolarised OPSYdq-COSY spectrum. As signal 
to noise scales with the square of concentration, these plots illustrate the benefit of these 
methods. 
It has been shown that the OPSYCOSY spectrum can be completed in 20 mins on the 
MKIII polarisor when the parahydrogen is added over 6 s per transient. This time of 
addition of parahydrogen can be shortened such that the time required to complete a 
hyperpolarised OPSYCOSY spectrum can be shortened. Preliminary investigations 
using the 1D OPSYdq NMR sequence showed the bubbling time could not be shortened 
to less than 2 s. When this time of addition of parahydrogen is applied, the spectrum of 
64 increments can be collected in 16 mins. 
A thermally polarised 2D COSY NMR spectrum of a 10 mM sample of quinoline can 
be collected in ~3 minutes. This is significantly quicker than the time required for a 
hyperpolarised 1H-1H OPSYCOSY which takes 16 minutes.  
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5.3.2  Method 2 applied to 1H-13C 2D heteronuclear NMR sequences 
The investigation into the application of SABRE to 2D sequences using method 2 was 
extended to include heteronuclear sequences such as the HSQC, HMBC and HMQC.  
5.3.2.1 Method 2 applied to the 1H-13C HSQC NMR sequence 
In order to compare the results gained through investigations into hyperpolarisation by 
SABRE, a thermally polarised 1H-13C HSQC NMR spectrum of quinoline is shown in 
Figure 5.47. 
 
Figure 5.47 Thermally polarised 1H-13C HSQC NMR spectrum of quinoline. 
Initially, completion of the 1H-13C HSQC NMR spectrum combined with SABRE led to 
the observation of no signals corresponding to correlations between the 1H and 13C 
nuclei. The sequence was then repeated however, the first 90o pulse was changed to a 
45o pulse. This process will unlock any IzSz magnetisation present in the substrate, and 
therefore produce an HSQC spectrum from this. This was initially completed at a PTF 
of 0 G and 60 G, as shown in Figure 5.48.  
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Figure 5.48 1H-13C HSQC NMR spectra of quinoline (100 mM) hyperpolarised using method 2 with 
IMes(c) (5 mM) at a PTF of 0 G (left) and -60 G (right). 
Figure 5.48 shows that different 1H-13C correlations within quinoline are observed when 
the sample is prepared in different fields. At a PTF of 0 G, the sample revealed the 1H-
13C correlations corresponding to positions 4, 5, 6 and 7, and weak correlations for 
positions 2 and 8 also. At a PTF of -60 G, the spectrum revealed intense 1H-13C 
correlations corresponding to positions 3 and 7, and much less intense correlations for 
positions 4, 5 and 8. The PTF was therefore changed again to -30 G, in order to observe 
all correlations. 
 
Figure 5.49 1H-13C HSQC NMR spectra of quinoline (100 mM) hyperpolarised with IMes(c) (5 mM) at a 
PTF of -30 G. 
Figure 5.49 shows that using a PTF of -30 G does not result in an HSQC spectrum 
which reveals all seven of the 1H-13C correlations in quinoline. Instead, 1H-13C 
correlations corresponding to positions 4, 5, 6 and 7 are observed. This therefore means 
no single PTF is able to produce an HSQC spectrum with all 7 1H-13C correlations 
present. A second concern has been identified in the hyperpolarised HSQC spectra. A 
significant proportion of the signal observed in the HSQC NMR spectra has been 
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encoded incorrectly in the f2 direction and consequently resides in the top and bottom 
of the spectra, irrespective of the PTF used. This is shown in Figure 5.50. 
 
Figure 5.50 1H-13C HSQC NMR spectra of quinoline (100 mM) hyperpolarised using method 2 with 
IMes(c) (5 mM) at a PTF of -30 G, expanded to include the observed noise at the top and bottom of the 
spectrum (left). The 3D representation is also included on the right. 
In Figure 5.50, the two images are from the same spectrum however the right hand 
image is a 3D representation, looking at the HSQC spectrum from the 13C axis. This 
gives the opportunity to directly compare the intensity of the signals corresponding to 
the expected correlations (see in the centre of the axis) and the signal observed at the top 
and bottom of the 2D HSQC spectrum (left and right of axis). This 3D representation 
makes it clear that the noise is much more intense than the expected correlations. It is 
therefore clear that much of the potential magnetisation is wasted.   
5.3.2.2 Method 2 applied to the 1H-13C HMBC NMR sequence 
In order to compare the results gained through investigations into hyperpolarisation by 
SABRE, a thermally polarised 1H-13C HMBC NMR spectrum of quinoline is shown in 
Figure 5.51, in which 19 correlations are observed. 
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Figure 5.51 Thermally polarised 1H-13C HMBC NMR spectrum of quinoline. 
Initially, work into development of the HMBC NMR sequence began on the MKII 
polarisor and the two required delays were set to correspond to 160 Hz and 8 Hz. The 
sequence was investigated at two PTFs, with results shown in Figure 5.52.  
 
Figure 5.52 1H-13C HMBC NMR spectra of quinoline (100 mM) hyperpolarised with IMes(c) (5 mM) 
utilising the MKII polarisor at a PTF of 0 G (left) and -60 G (right). 
 Figure 5.52 shows the most intense signals are observed when a PTF of -60 G is used. 
This is expected as the sequence encodes 1H magnetisation according to the proximity 
to 13C and therefore, the greater signal intensity is observed when polarisation to 1H is 
optimised. The hyperpolarised HMBC shows thirteen of the nineteen expected 
correlations at a PTF of 0 G, and fourteen of the nineteen expected correlations at a PTF 
of -60 G. Different correlations are observed depending on the PTF employed. An 
important observation here is that many correlations are observed to H2 and C2, a 
resonance that was difficult to observe in the 1D carbon experiments. At a PTF of 0 G, 
no correlations to either C7 or H7 are observed and when the PTF is changed to -60 G, 
there are still no correlations to the H7, although one correlation to C7 is present. It 
should also be noted that some signal intensity is present on the centre of the f1 
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dimension (140 ppm), indicating that not all the signal was encoded incorrectly. This 
artefact appears to increase proportionally to the encoded signals when changing the 
PTF from 0 G to -60 G. When completed on the MKIII polarisor, each spectrum took 
23 min to complete with a bubbling time of 8 s. This is an improvement on the MKII 
polarisor which requires approximately 30 min to collect the spectrum with a bubbling 
time of 6 s.  
As significant signal intensity is observed when this sequence was used to investigate a 
100 mM sample, the sequence was investigated with a sample of 10 % of the standard 
reagent concentration (10 mM quinoline and 0.5 mM IMes(c)). The results of this 
experiment are shown in Figure 5.53. 
 
Figure 5.53 1H-13C HMBC NMR spectra of quinoline (10 mM) hyperpolarised with IMes(c) (0.5 mM) 
utilising the MKIII polarisor at a PTF of -50 G. 
Figure 5.53 shows significant signal is still present with this lower concentration 
sample, although thirteen of the nineteen expected correlations are observed, less than 
for the more concentrated samples. Compared to the standard concentration sample, 
similar trends are observed in reference to the PTF. It is also possible to observe the 
artefact on the centre of the f1 axis (140 ppm) is still present but significantly less 
intense.  
It was observed that it was not possible to collect a thermally polarised HMBC of a     
10 mM sample of quinoline with the same number of signals at the same intensity in the 
time it is possible to collect a hyperpolarised spectrum. In fact, the number of scans 
must be increased to 16 per 128 increments for the same number of correlations to be 
observed. The result of this is an increase of collection time to around one hour and a 
half (see Experimental). This means that with respect to 1H-13C HMBC spectra, the 
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application of SABRE to a low concentration sample can save a significant amount of 
time. 
5.3.2.3 Method 2 applied to the 1H-13C HMQC NMR sequence 
In order to compare the results gained through investigations into hyperpolarisation by 
SABRE, a thermally polarised 1H-13C HMQC NMR spectrum of quinoline is shown in 
Figure 5.54. 
 
Figure 5.54 Thermally polarised 1H-13C HMQC NMR spectrum of quinoline optimised for two bond 
couplings. 
The thermally HMQC spectrum optimised to investigate two bond couplings is 
presented in Figure 5.54. This differs slightly from the thermally polarised HMBC 
spectrum presented in Figure 5.51 in that the decoupling in position 3 is improved and 
an additional correlation corresponding to the proton in position 4 is observed. There is 
also one less correlation observed correlating to the proton in position 2, compared to 
the thermally polarised HMBC spectrum.  
Initial work into development of the HMQC NMR sequence began on the MKII 
polarisor. In the case of the HMQC, it is possible to change a specific delay to optimise 
the sequence for one bond couplings or two bond couplings. An HMQC sequence was 
therefore recorded using a delay corresponding to a 160 Hz coupling to optimise for one 
bond correlations (see Chapter 4 or Experimental) leading to an HSQC-type spectrum, 
and 8 Hz coupling to optimise for two bond correlations. The HMQC optimised for one 
bond correlations was investigated first.  
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Figure 5.55 1H-13C HMQC NMR spectra of quinoline (100 mM) hyperpolarised using method 2 with 
IMes(c) (5 mM) at a PTF of 0 G (left) and -60 G (right), and optimised for one bond couplings. 
The most significant feature of both the HMQC spectra presented in Figure 5.55 is the 
line of signal that has been encoded incorrectly present on the centre of the f1 direction 
(135 ppm). When considering the less intense signal outside of this artefact, it is 
possible to observe HSQC-type correlations (see Figure 5.47). Different correlations are 
observed depending on the PTF used. The observed correlations are much weaker in 
intensity than the artefacts.  
The HMQC was also investigated when optimised for two bond couplings. The effect of 
changing the PTF was investigated first with results shown in Figure 5.56. 
 
Figure 5.56 1H-13C HMQC NMR spectra of quinoline (100 mM) hyperpolarised using method 2 with 
IMes(c) (5 mM) at a PTF of 0 G (left) and -60 G (right), and optimised for two bond couplings. 
Collection of the HMQC was much more successful when optimised for two bond 
couplings compared to the HMQC optimised for one bond couplings. Figure 5.56 shows 
the level of artefact is significantly reduced when the sequence is optimised for two 
bond couplings with less intense artefacts observed in the spectrum collected with a 
PTF of 0 G and nearly unobservable artefacts in the spectrum collected with a PTF of    
255 
-60 G. Just as with the HMBC, the HMQC sequence also presents with many 
correlations are observed to H2 and C2, a resonance that was difficult to observe in the 
1D carbon experiments. Considering the effect of PTF, a greater number of correlations 
are observed in the HMQC spectrum completed with a PTF of 0 G (thirteen of the 
nineteen expected correlations compared to twelve observed for a PTF of -60 G). These 
signals are also of greater intensity than observed when the PTF is set to -60 G.  
The HMQC was repeated where the first pulse was shortened to 45o pulse to understand 
if the incorrectly encoded signal observed on the centre of the f1 dimension was due to 
unlocked IzSz magnetisation. This was unsuccessful, and the resultant spectrum was not 
different to that collected with an initial 90o pulse. After development, these 
experiments were repeated on the MKIII polarisor. Each spectrum took 22 mins to 
complete with a bubbling time of 8 s, yielding similar results to those observed using 
the MKII polarisor. Again this is quicker than the MKII polarisor which requires 
approximately 30 min for collection of the same data.  
As significant signal intensity is observed when this sequence was used to investigate a 
100 mM sample, the sequence was investigated with a sample of 10 % of the standard 
reagent concentration (10 mM quinoline and 0.5 mM IMes(c)). The results of this 
experiment are shown in Figure 5.57. 
 
Figure 5.57 1H-13C HMQC NMR spectra of quinoline (10 mM) hyperpolarised with IMes(c) (0.5 mM) at 
a PTF of -50 G and optimised for two bond couplings. 
Figure 5.57 shows significant signal is still observed in thirteen of the nineteen expected 
correlations and the experiments also showed the same trend is observed as with the 
standard concentration sample with respect to the PTF used. 
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It was observed that it was not possible to collect a thermally polarised HMQC of a     
10 mM sample of quinoline with the same number of signals at the same intensity in   
22 minutes, the time it is possible to collect a hyperpolarised spectrum. In fact, to 
observe the same number of correlations in a thermally polarised spectrum, the number 
of scans must be increased to 16 per 128 increments which requires around one hour 
and a half to collect (see Experimental). This means that with respect to 1H-13C HMQC 
spectra, the application of SABRE to a low concentration sample can save a significant 
amount of time. 
What is clear from these experiments is that hyperpolarisation via SABRE produces 
significant signal intensity and information pertaining to 13C nuclei can be extracted 
from hyperpolarised 2D 1H-13C heteronuclear NMR sequences however, the sample 
must be repolarised between each scan due to relaxation. This is a major drawback 
when using method 2 to utilise SABRE as a result of the significantly longer time this 
requires. It also requires the sample to be five times larger than a standard NMR sample. 
A method to overcome these issues is to use ultrafast NMR methods. These will be 
discussed as applied to SABRE in the following section. 
5.3.2.4 Investigations into removal of artefacts observed in hyperpolarised 2D NMR 
spectra 
Experimentally, two concepts were employed to reduce the signal intensity or remove 
the observed artefacts on the centre of the f1 direction. The first method used was to set 
the centre of the f1 direction to outside the area of interest. This was investigated using 
the HMBC sequence which up to this point was used with a spectral width of 50 ppm 
centred around 140 ppm in the f1 direction. To move the artefact from the spectral 
range, the spectrum was centred around 155 ppm however this led to the need to 
increase the spectral width to include all correlations. The resultant spectrum is 
presented in Figure 5.58 (left). 
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Figure 5.58 1H-13C HMBC NMR spectra of quinoline (100 mM) hyperpolarised using method 2 with 
IMes(c) (5 mM). The spectrum on the right was collected with an f1 spectral width of 50 ppm centred 
around 140 ppm, and the spectrum on the right was collected with an f1 spectral width of 80 ppm centred 
around 155 ppm. 
Figure 5.58 indicates the resolution in the spectrum presented without artefacts is much 
poorer than the spectrum presented with artefacts. This is because the spectral width has 
been increased but the number of increments used has not, resulting in poorer 
resolution. It should also be noted that the artefacts are observed in the spectrum in 
Figure 5.58 (right) however the centre of the f1 direction is now at 155 ppm and 
therefore not presented in the figure. To overcome this loss in resolution, the number of 
increments was doubled to 128, presented in Figure 5.59. 
 
Figure 5.59 1H-13C HMBC NMR spectra of quinoline (100 mM) hyperpolarised using method 2 with 
IMes(c) (5 mM). The spectra were collected with an f1 spectral width of 80 ppm centred around 155 ppm 
with 64 increments (left) and 128 increments (right). 
Figure 5.59 shows that increasing the number of increments has improved the resolution 
observed in the HMBC spectrum. This has however come at the cost of time and the 
spectrum took twice as long to collect.  
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A second method of removing the artefacts observed was also considered. Up until this 
point, only one scan per increment had been utilised in an attempt to maximise the 
resolution of a spectrum considering the time required for each hyperpolarisation step.  
The spectra were therefore collected with two scans per increment, however to keep the 
collection time the same, the number of increments was reduced to 32. The resultant 
HMBC and HMQC spectra are presented in Figure 5.60. 
 
Figure 5.60 1H-13C HMBC NMR spectrum (left) and 1H-13C HMQC NMR spectrum (right) of quinoline 
hyperpolarised using method 2 with IMes(c) at a PTF of -50 G. In each spectrum, 2 scans were used for 
each of the 32 increments.  
In the case of both the HMBC and HMQC spectra presented in Figure 5.60, the artefacts 
are no longer observable, even with the signal intensity increased greatly (not shown). If 
the artefacts are still present, they cannot be discerned from noise observed in the 
spectrum. The HMBC now presents with two additional peaks along the 8.65 ppm line 
in the f2 direction corresponding with 124 ppm and 136 ppm in the f1 direction, neither 
of which are expected signals. These could be noise but equally could correspond to a 
contaminant in the sample or to bound signals of quinoline. It should also be noted that 
although these spectra were collected in the same time as those which contained 
artefacts, they only have 32 increments and therefore have lower resolution. 
Both the methods discussed have produced presentable spectra where the artefact has 
either been removed or moved away from the area of interest, however to keep the 
required resolution, the spectra take a minimum of twice as long. This acts as a 
significant concern. The reasons behind the presence of the artefact will be discussed 
later in the Summary for this chapter. 
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5.4 Development of method 1 applied to 2D NMR sequences 
Ultrafast methods applied to NMR spectroscopy were first published by Frydman et 
al.82 and are an exciting new area in NMR spectroscopy. Investigating a sample by 2D 
NMR spectroscopy involves collating a number of individual FIDs in such a way that 
the correlations between protons can be extracted. In the case of ultrafast spectroscopy, 
these FIDs are collected at the same time through the application of gradients across the 
NMR tube. The gradients allow the sample to be viewed as a series of discrete levels, 
each of which produces an FID to gain the correlations. This can be collected in around 
1 µs.  
In a paper published by Mishkovsky and Frydman152 in 2009, a number of different 
ultrafast methods are discussed including: real time identification of mixed components 
subject to a continuous flow separation, monitoring of chemical and biophysical 
transformations using ultrafast EXSY NMR spectroscopy, TOCSY NMR spectroscopy, 
HSQC NMR spectroscopy, HMQC NMR spectroscopy, on thermally polarised or 
hyperpolarised (DNP) samples. These have also been extended to 3D spectra.  
In 2012, Queiroz Junior et al.153 published a paper concerning the real-time monitoring 
of the hydrolysis of 2-(4-nitrophenyl)-1,3-dioxolane acetal using ultrafast HSQC NMR 
spectroscopy, the reaction of which is shown in Figure 5.61. 
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Figure 5.61 Acid-catalysed hydrolysis of 2-(4-nitrophenyl)-1,3-dioxolane acetal (reactant). 
The ability to use the ultrafast HSQC NMR sequence allowed the chance to observe the 
hemiacetal, a notoriously short-lived intermediate. 
In 2012, a paper published by Queiroz et al.154 discussed the application of the ultrafast 
COSY to HPLC-NMR spectroscopy. In this case, a mixture of the natural products 
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naringin, epicatechin and naringenin were successfully separated by an HPLC system 
that was coupled to NMR completing continuous ultrafast COSY spectra to monitor 
elution.  
Ultrafast methods have given the opportunity to collect 2D spectra in less than a second. 
This very short time allows us to apply the hyperpolarisation technique SABRE as each 
FID for the 2D spectrum is collected at the same time and therefore the fast relaxation 
of the hyperpolarised states in no longer a factor. The combination of the two 
techniques was therefore investigated. It was therefore decided to implement the 
ultrafast methods by Frydman82 with the SABRE technique using method 1.83,155,156 
5.4.1 Method 1 applied to 1H-1H 2D homonuclear NMR sequences 
The first sample to be investigated contained standard reagent concentrations of 
quinoline (100 mM) hyperpolarised with IMes(c) (5 mM) in 0.6 ml d4-methanol 
completed using method 1. A thermally polarised ufCOSY spectrum was collected and 
compared to those in which the quinoline had been hyperpolarised at a PTF of 0 G and 
~65 G.  
   
Figure 5.62 1H-1H ufCOSY NMR spectra of quinoline (100 mM) (L-R) thermally polarised spectra, 
hyperpolarised using method 1 with IMes(c) (5 mM) at a PTF of 0 G and hyperpolarised with IMes(c) (5 
mM) at a PTF of 65 G, presented with internal projections. 
It can be observed in Figure 5.62 (middle and right) that the addition of the SABRE 
technique to the ufCOSY NMR sequence has resulted in the observation of correlations 
between positions 2 and 3 (shown in blue squares), which are not observed in the 
thermally polarised spectrum, Figure 5.62 left. From the presented spectra, it is not clear 
of the effect that the addition of parahydrogen has had on the intensity of the observed 
signals. This has therefore been considered through the integration of the peaks, where 
the labelling is outlined in Figure 5.63, and the integration data are presented in Table 
5.3. 
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Figure 5.63 A thermally polarised 1H-1H COSY NMR spectrum including labels corresponding to the 
peaks integrated. 
 Integrals relative to thermally polarised ufCOSY 
Signal Peak Thermally polarised 0 G 65 G 
1 Diag 1 31 117 
2 Diag 1 35 78 
3 Cross 1 27 104 
4 Cross 1 55 13 
5 Cross 1 37 77 
6 Cross 1 50 23 
Table 5.3 Showing the increased signal intensity of the 1H-1H ufCOSY NMR spectra of quinoline (100 
mM) hyperpolarised with IMes(c) (5 mM) at 0 G and hyperpolarised with IMes(c) (5 mM) at 65 G, 
compared to the thermally polarised spectrum.  
At a concentration of 100 mM, the ufCOSY spectrum shows nearly all the expected 1H-
1H correlations. The experiment was therefore repeated at the lower concentration of 10 
mM quinoline hyperpolarised with 0.5 mM IMes(c). This is 10 % of the standard 
concentration and correlates to 0.8 µl quinoline hyperpolarised with 0.2 mg IMes(c) in 
0.6 ml d4-methanol, prepared by dilution.  
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Figure 5.64 1H-1H ufCOSY NMR spectra of quinoline (10 mM) (L-R) thermally polarised, 
hyperpolarised using method 1 with IMes(c) (0.5 mM) at a PTF of 0 G and hyperpolarised using method 
1 with IMes(c) (0.5 mM) at a PTF of 65 G, with internal projections. 
When completing the ufCOSY NMR sequence on a 10 mM quinoline sample, the signal 
intensity gain created by hyperpolarisation is clear to see in Figure 5.64. The observed 
signals are much stronger and the hyperpolarised spectra also show more correlations 
within the substrate.  
The signals are strong in these hyperpolarised spectra, and therefore the solution was 
diluted again to create a sample of 1 mM quinoline and 0.05 mM IMes(c), correlating to 
0.08 µl quinoline and 0.02 mg IMes(c). The sample is now at 1 % of the standard 
concentrations. The results are shown in Figure 5.65.  
  
Figure 5.65 1H-1H ufCOSY NMR spectra of quinoline (1 mM) hyperpolarised with IMes(c) (0.05 mM) at 
0 G (left) and hyperpolarised with IMes(c) (0.05 mM) at a PTF of 65 G (right), presented with internal 
projections. 
For a 1 mM sample of quinoline, the thermally polarised ufCOSY showed no signals 
corresponding to quinoline, only solvent signals. The addition of parahydrogen to the 
sample resulted in the observation of some 1H-1H correlations corresponding to 
quinoline however not all the correlations are observed.  
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The successful combination of the hyperpolarisation technique SABRE with Frydman’s 
ultrafast COSY sequence has been demonstrated. The maximum signal intensity for 
both cross peaks and diagonal peaks is produced with a PTF of 65 G. This means that 
measurements needs be collected at only one PTF, the one at which Iz magnetisation is a 
maximum.  
5.5 Summary 
Previous to this chapter, only 1D 1H NMR spectra have been discussed. This chapter 
has extended the concepts gained there to the successful acquisition of more complex 
hyperpolarised spectra requiring phase cycling, such as the NOESY sequence, 
polarisation transfer into 13C and through to 2D sequences.  
Considering 1D spectra involving more complex sequences than the 90º pulse acquire 
sequence have led to the successful acquisition of a 1H NOESY NMR spectrum where 
the sample has a substrate concentration of 10 mM. A significant observation was also 
made when considering the effect of PTF on the 1H OPSYdq spectrum. It was found the 
maximum signal intensity was observed at 0 G unlike the 90º pulse acquire which gives 
a maximum signal intensity at 50 G for quinoline. This led to all new sequences after 
this point being collected at both 0 G and 50 G.  
Extensive work has been carried out concerning the acquisition of 1D 13C NMR spectra. 
Initially, detection of polarisation from 13C was considered. It was found that, like 1H, 
polarisation on 13C nuclei also has a dependence on the PTF used showing maximum 
signal intensity at 0 G. Owing to the addition of parahydrogen, the signals often 
presented as antiphase in the coupled 1C NMR spectrum. This therefore means a 
refocusing sequence must be completed in order for decoupling to be successful. This 
was achieved using two methods; refocusing according to J coupling evolution 
(13C{1H}_JR), and refocusing according to J coupling and chemical shift evolution 
(13C{1H}_JCSR). The addition of these refocusing sequences allowed for successful 
decoupling of the 13C spectrum however the 13C{1H}_JR sequence allowed the 
observation of the most signals and yielded the best signal intensity for those signals. 
This is thought to be due to relaxation of the hyperpolarised states during the second 
delay period of the 13C{1H}_JCSR sequence.  
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Hyperpolarised 13C spectra were also investigated when considering the INEPT transfer 
sequence. This utilises the polarisation present on 1H and uses pulses to transfer this to 
13C for detection. Predictably, this yielded greater signal intensities than those observed 
when interrogating 13C magnetisation. These spectra also presented with antiphase 
peaks and therefore required a refocusing sequence to allow decoupling. This produced 
the first 13C{1H} NMR spectrum collected using SABRE which revealed all nine of the 
expected signals associated with quinoline. 
The successful acquisition of spectra resulting from both 13C and 1H polarisation in the 
form of the 13C NMR sequence and 13C{1H} INEPT NMR sequence have also allowed 
for the idea of sequential acquisition. When using method 2 to apply SABRE, the time 
required to repolarise the sample between acquisitions can be lengthy. Sequential 
interrogation of polarisation on 13C nuclei followed by polarisation on 1H nuclei in on 
hyperpolarisation step has allowed the collection of a coupled and decoupled 13C 
spectrum in one hyperpolarisation step.  
As mentioned in section 5.2.2.3, the thermally polarised INEPTnd sequence exhibited 
greater signal to noise and a greater number of signals when the sequence was optimised 
for 19 Hz couplings compared to 8 Hz couplings. It was therefore investigated if the 
same difference was observed in the hyperpolarised INEPTnd spectra. This work was 
completed using the MKIII polarisor and therefore required a TXI probe. This therefore 
meant the number of scans needed to be increased to 8 to obtain a similar signal to noise 
level as previously reported using TXO probe. The results of this are shown in Figure 
5.66.  
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Figure 5.66 13C INEPTnd NMR spectra of quinoline optimised for two bond couplings (8 Hz, top and 19 
Hz bottom) hyperpolarised using IMes(c). Using a TXI probe, each spectrum was collected using an 
average of 8 scans. 
Figure 5.66 indicates changing the sequence to be optimised for 19 Hz couplings had 
the effect to increase the signal intensity of the observed signals in hyperpolarised 13C 
INEPTnd spectra. It is also possible to observe the signal corresponding to C2, although 
the signal is weak. 
The polarisor was instrumental in the implementation of SABRE to the classic 2D 
sequences such as the COSY, HSQC, HMBC and HMQC. The use of parahydrogen has 
also allowed the application of the OPSYCOSY, which results in the cross peaks of the 
COSY spectrum to be more intense than the diagonal. It was also found that 
development from the MKII polarisor to the MKIII polarisor decreased the amount of 
time required for a 64 increment 2D spectrum significantly. This was reduced further by 
reducing the time of addition of parahydrogen per increment from 6 s to 2 s, resulting in 
the collection of a 2D spectrum in 16 min. This is a great improvement on 
interrogations of low concentration substrates considering 1H-13C spectra such as the 
HMBC and HMQC.  
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Considering the 2D 1H-13C NMR spectroscopy, an artefact was observed on the centre 
of the f2 axis. A possible reason for this is the polarisation within the complex evolves 
into an observable state after the initial states are encoded in the f1 direction. To 
understand this better, a hyperpolarised HMQC was completed without decoupling. 
This was completed to understand the origin of the magnetisation creating the artefact. 
If the artefact shows splitting, it suggests the artefact is derived from magnetisation on 
13C but if it does not, the artefact is derived from magnetisation on 1H. First, the 
hyperpolarised HMQC is presented with the decoupler on in Figure 5.67. 
 
Figure 5.67 1H-13C HMQC NMR spectra of quinoline (100 mM) hyperpolarised with IMes(c) (5 mM) at 
a PTF of -50 G and optimised for two bond couplings with decoupler turned on. Selected signals have 
been expanded for comparison. 
The expansions in Figure 5.67 indicate four signals, two corresponding to the expected 
1H-13C correlations and two corresponding to artefacts. The top left signal presents as a 
singlet, the top right as a doublet and the artefact bottom left presents as a triplet and 
bottom right presents as a doublet. The spectrum was then repeated with the decoupler 
off, presented in Figure 5.68. 
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Figure 5.68 1H-13C HMQC NMR spectra of quinoline (100 mM) hyperpolarised with IMes(c) (5 mM) at 
a PTF of -50 G and optimised for two bond couplings with decoupler turned off. Selected signals have 
been expanded for comparison. 
The signals expanded in Figure 5.67 and Figure 5.68 were chosen to exemplify the 
differences and similarities between the two spectra. In the case of the coupled HMQC, 
not all the signals experienced additional splittings. The expansions corresponding to 
expected signals now have different splittings with the singlet on the top left now 
presenting as a doublet and the doublet on the top right now presents as a triplet. The 
same cannot be said for the expanded artefacts, whose splittings remain the same. We 
can therefore infer that the artefact is derived from 1H magnetisation that is not 13C 
coupled. 
Another potential route to overcome the artefact present in the heteronuclear 2D spectra 
is to apply a gradient across the sample cell such that 2 independent scans can be 
collected across the height of the cell. This means for each transient, 2 scans can be 
collected, and consequently two scans per increment can be used for each 2D spectrum 
without doubling the experiment time. It will be interesting to develop this idea in the 
future. This may indicate a need to change the way data is collected when using SABRE 
hyperpolarised NMR spectroscopy. For instance, a 2D spectrum with a large spectral 
width but poor resolution might be collected to gain a rough idea of the position of 
correlations, followed by a series of small spectra width spectra with good resolution 
chosen to observe the required correlations only. The application of SABRE to 
hyperpolarised 2D 1H-15N spectra is also of great future interest as it would provide the 
potential to bring 15N spectroscopy into the routine of a pharmaceutical chemist. Initial 
investigations into this have been completed by the group however significant 
challenges were revealed with respect to phase coherence of the spectra.  
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The SABRE technique has also been successfully applied to the ufCOSY sequence by 
Frydman using method 1. It has therefore been possible to obtain a hyperpolarised 
COSY of 10 mM quinoline in less than a second.  
This chapter has demonstrated that the SABRE technique can be applied to a number of 
routine and non-routine NMR sequences, yielding a great deal of information. In the 
case of low concentration samples, this information can also be gained much quicker 
than possible with thermally polarised samples. From the work completed in this 
chapter, it is recommended that the following strategies are implemented when 
polarisation a substrate using SABRE hyperpolarised NMR spectroscopy. First 
investigations into a substrate should include a series of 1H NMR spectra acquired with 
90º pulse and 1H OPSYdq NMR spectra collected at a number of PTFs to gain an idea 
of which field each state is transferred maximally. To complete a 13C{1H} spectrum, the 
INEPTrd sequence should be collected at the PTF yielding maximum Iz states. 
Considering acquisition of 2D data, the ultrafast methods are clearly much quicker to 
acquire once optimised however, the optimisation of the ultrafast sequence to detect a 
new substrate takes longer than collection by standard sequences using the flow system. 
Therefore, a 2D OPSYdq NMR spectrum collected at the PTF yielding the maximum 
signal intensity for the 1D OPSYdq NMR spectrum should be collected for 1H-1H 
correlations followed by an HMBC to gain information about 1H-13C correlations as this 
yielded better resolution than the HMQC.  
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6 Chapter 6 – Applying SABRE 
6.1 Introduction 
Modern day drugs have many different substructures, not just those based on pyridine. 
It was therefore thought prudent to investigate derivatives of pyridine and other 
potential substructures. Many important biologically relevant molecules are indole 
analogues.   
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Figure 6.1 Structures of a) tryptophan, b) melatonin and c) serotonin. 
Analogues of the bicyclic heterocycle indole, consisting of a benzene ring fused to a 
pyrrole ring, are found within important molecules such as tryptophan (one of the 20 
standard amino acids in humans and a key precursor to neurotransmitters), melatonin 
(an important antioxidant) and serotonin (5-hydroxytryptamine, 5HT, Figure 6.1). 
Serotonin, an important neurotransmitter, and its analogues are very important 
molecules within the body regulating appetite,157 emesis,158 digestive track 
movements159 and many neurological disorders160 such as depression,157 anxiety,157 
obsessive compulsive disorder,160 autism,160 schizophrenia160 and sudden infant death 
syndrome.160 Drugs with an indole substructure have shown cytotoxic (Cediranib161), 
anti-inflamatory,162 antiviral,162 antimicrobial,162 and antidepressant158 properties.  
The thiazole analogues are also very important. A natural thiazole analogue is vitamin 
B1 (Figure 6.2), an important vitamin in human biology, playing a pivotal role in the 
metabolism of carbohydrates, fats and proteins, and the production of adenosine 
triphosphate. 
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Figure 6.2 Structure of Thiamine, Vitamin B1.  
Many commercial drug molecules are also thiazole analogues, such as Ritonavir163 
(used in combination with other drugs as a antiretroviral), Abafungin (an antifungal 
drug) and Tiazofurin (an antineoplastic drug).164,165 In recent research they have been 
found to be biologically active in many areas including exhibiting anti-inflammatory,165 
analgesic,166 antifungal,167 antibiotic, antimicrobial activity168 and antitumour164 
activities. The substructure has even shown promise in the fight against breast 
cancer.169-171  
In 1999, Pandeya et. al.167 published a paper investigating a series of thiazole containing 
compounds derived from isatin for their antibacterial, antifungal and anti-HIV activities.  
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Figure 6.3 Structures of a) trimethoprim b) sulphamethoxazole and c) 1-[N,N-dimethylaminomethyl]-5-
bromoisatin-3-{1’-[4’’-(p-chlorophenyl) thiazole-2’’-yl] thio semicarbazone.167 
A series of 12 compounds were tested against 28 pathogenic bacteria and the minimum 
inhibitory concentration (MIC) compared to that of trimethoprim (Figure 6.3a) and 
sulphamethoxazole (Figure 6.3b). Of these 12, newly synthesised compounds, 1-[N,N-
dimethylaminomethyl]-5-bromoisatin-3-{1’-[4’’-(p-chlorophenyl) thiazole-2’’-yl] thio 
semicarbazone} (Figure 6.3c) proved to show the most favourable antibacterial activity, 
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showing increased activity against 27 of the 28 bacteria compared to sulphamethoxazole 
and against 18 of the 28 bacteria compared to trimethoprim. 
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Figure 6.4 Structure of Pittsburgh B. 
Another important thiazole analogue is found in the form of benzothiazole in complexes 
such as Pittsburgh B, a fluorescent dye which can emit positrons in the body as a result 
of the presence of 11C. It can therefore be used in positron emission tomography (PET). 
It is able to produce scans of beta-amyloid plaques in neuronal tissues, giving the ability 
to complete investigational studies of Alzheimer’s disease, such as a more quantitative 
premortum tool to understand the effectiveness of potential new drugs. 
Within this chapter, a series of commercial drugs were investigated. These include 
albendazole, mebendazole, anastrazole, bicalutamide, esomeprazole and gefitinib, 
provided by AstraZeneca, shown in Figure 6.5. 
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Figure 6.5 Structures of a) albendazole, b) anastrazole, c) bicalutamide, d) esomeprazole, e) gefitinib and 
f) mebendazole.  
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Albendazole has been shown as an effective treatment against a number of worm 
infestations in a range of mammals.172,173 An infestation of worms in children can result 
in chronic debilitating effects from severe abdominal pain and anemia to stunted growth 
and impaired cognitive development.174 For this reason, the charity Children Without 
Worms174 use Albendazole donated by GlaxoSmithKline (GSK) as a method to treat 
school age children, improving their quality of life. It has also been used in humans to 
treat solitary cysticercus granuloma, such that seizures are reduced, less calcification is 
observed and in some cases, the lesion disappears.175 Albendazole is a benzimidazole 
analogue which contains the nitrogen available for binding to the metal centre.   
Mebendazole, like Albendazole, has been shown effective against parasitic worms,173 
and is also used by Children Without Worms,174,176 where mebendazole is donated by 
Johnson & Johnson. Mebendazole has also been shown effective in keeping a 
carcinoma stable.177 A patient with adrenocortical carcinoma who had experienced 
failure of or intolerance to conventional treatments was prescribed mebendazole as a 
single agent. In the 19 months this treatment was taken, the metastases initially 
regressed and then remained stable from that point, with minimal side effects and good 
quality of life. This has shown the possibility for Mebendazole to control this form of 
carcinoma over an extended period of time. Mebendazole is a benzimidazole analogue 
which contains the nitrogen available for binding to the metal centre.   
Tamoxifen has been one of the main treatments for breast cancer for many years by 
blocking the production of oestrogen however, some of the side effects restrict its use. 
Anastrazole, which works by the same route as tamoxifen, is a drug developed by 
AstraZeneca which has shown great promise over the use of tamoxifen as an adjuvant 
therapy.178-181 A five year study179 of 9,366 post-menopausal women with localised 
breast cancer was completed comparing anastrazole to tamoxifen. The most significant 
results of this were to show anastrazole gave prolonged disease-free survival and 
reduced distant metastases compared to Tamoxifen. Anastrazole also exhibited fewer 
serious side effects than Tamoxifen such as significantly fewer occurrences of vascular 
events (deep vein thrombosis, for example), gynaecological problems and cataracts, 
however increased occurrences of fractures and athralgia. The study suggested 
anastrazole should be the preferred initial treatment for postmenopausal women with 
localised hormone-receptor-positive breast cancer. This was strengthened in a second 
study178 in which patients were switched to anastrazole after two years of tamoxifen 
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treatment, to reduce the side effects experienced by tamoxifen treatment over the course 
of 5 years. This reported a 40 % decrease in the risk of an event (defined as local or 
distant metastases, or contralateral breast cancer) in the group transferred to anastrazole 
compared to those who stayed on tamoxifen. Anastrazole is a triazole analogue with 
carbonitrile functional groups, both of which contain nitrogen available for binding to 
the metal centre. 
Bicalutamide is a drug developed by AstraZeneca which is effective against prostate 
cancer.182,183 As a monotherapy, it has been reported to preserve bone mineral density, 
muscle strength and provide significant health-related quality of life benefits for men 
suffering with prostate cancer and osteoporosis,182 providing an alternative to castration. 
Bicalutamide has also been used in combination therapies to increase the effectiveness 
of both drugs involved compared to either when used as a monotherarpy.184,185 A phase 
II study of sorafenib in combination with bicalutamide184 showed increased 
effectiveness in stabilising the disease however, the same level of side effects were 
observed. This has been used in combination with carbidopa against castration resistant 
prostate tumours, with promising results in vitro and in vivo (in mice).185 Bicalutamide 
contains a carbonitrile functional group which contains nitrogen available for binding to 
the metal centre. 
Esomeprazole is a proton pump inhibitor (PPI) developed by AstraZeneca which is used 
in the treatment of acid reflux and related diseases.186 A randomised controlled 
trial187,188 of 554 patients with well-established gastroesophageal reflux disease who 
responded well to PPIs were split into two groups. The first underwent optimised 
esomeprazole treatment (266 patients) and the second were recommended for 
laparoscopic antireflux surgery (LARS, 288 patients, 248 of whom went through with 
the surgery). During this study, it was found that both methods of treatment achieve and 
maintain remission for the five year period the trail was conducted. The two methods 
were not significantly different from each other and consequently, should patients wish 
to avoid the risks and side effects of surgery, esomeprazole is a viable option. 
Esomeprazole is also used in acid production control in the treatment of chronic gastritis 
and gastric ulcers caused by the bacteria, Helicobacter pylori,189,190 in combination with 
suitable antibiotics. Esomeprazole is a benzimidazole analogue which contains nitrogen 
available for binding to the metal centre.   
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Gefitinib is a drug developed by AstraZeneca which has been FDA approved for 
treatment of locally advanced or metastatic non-small-cell lung cancer since May 
2003.191,192 Clinical trials are also underway to investigate it is effectiveness against 
other cancers such as certain breast cancers181 and head and neck192 cancers. Gefitinib is 
a quinazoline analogue which contains nitrogen available for binding to the metal 
centre.  
It is clear to see from the previous few paragraphs there are many commercially 
available drugs which are nitrogen-containing aromatic analogues (see Figure 6.5). This 
gives them the potential to bind to SABRE catalysts. This gives SABRE the potential to 
investigate the effectiveness and mechanism of drugs within cells or within the body. It 
is important to first understand the extent of this potential and consequently 
investigations will concentrate on the smaller moieties to ensure first polarisation 
transfer is possible and the extent of observed increase in signal intensity. It is also clear 
to see these drugs also include a number of potentially interfering or hindering 
additional functional groups.  
The intention of this chapter is therefore to develop an understanding of the limitations 
of SABRE, but not to optimise it for each of the substrates described here. To become 
applicable as a general method, it is important to understand the tolerances and 
limitations of SABRE with respect to various functional groups, including bulkier 
groups such as the benzoyl moiety. This need introduces a number of further 
complications such as the effect of basicity of the substrate, steric bulk and whether the 
substrate can activate the catalyst.  
A number of investigations were completed to achieve this. Firstly, the tolerance of 
SABRE to different functional groups is described by reference to a series of 4-
substituted pyridines. A study on steric effect then follows, investigating the effect of 
polarisation transfer to various groups outside of the pyridine ring, such as methyl, 
phenyl and benzoyl groups. This is followed by the investigation of polarisation transfer 
to new binding groups such as those found in indole and thiazole, and of polarisation 
transfer to a selection of commercially available drugs. Potential real life complications 
are then investigated, looking into the situation where more than one substrate is present 
or the elimination of impurities that may be found in a reaction mixture.  
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Another potential of SABRE is to investigate the metabolism of some molecules within 
the body. This is observed in DNP by reference to pyruvate, the potential to 
differentiate between normal and cancerous cells in animal and human cancer 
cells.37,38,193,194 The potential for SABRE to complete a similar metabolism is 
investigated by reference to the spontaneous reaction of 4-carboxaldehydepyridine with 
methanol. 
6.2 Investigations into polarisation transfer efficiency to pyridine analogues 
Initial investigations into the general applicability of SABRE began with pyridine 
analogues. Within this section, the effect of changing the basicity of the pyridine 
analogue, the effect of changing the spacer between the pyridine ring and second phenyl 
ring. 
6.2.1 The effect of basicity on the level of observed polarisation transfer in a series of 
para-substituted pyridines 
The basicity (considered through the pKa) of the substrate is an important factor when 
considering polarisation transfer; both binding strength (whether the substrate can 
displace the halide bound to the iridium centre, forming the catalytic salt, see Chapter 2) 
and exchange rates are dependent on it. To investigate the effect of the pKa, it is 
necessary to eliminate both steric and activation effects, and consequently a series of 
para-substituted pyridines were selected. This series of substituted pyridines also 
provides a range of functional groups with which to investigate the tolerance of 
SABRE. These are shown in Figure 6.6.  
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Figure 6.6 List of the 4-substituted pyridines investigated, namely: (a) 4-carbonitrilepyridine, (b) 4-
hydroxypyridine, (c) 4-carboxamidepyridine, (d) 4-carboxaldehydepyridine, (e) isonicotinic acid, (f) 4-
phenylpyridine, (g) 4-methylpyridine and (h) 4-aminopyridine. Each substrate is presented with the pKa 
of the nitrogen position. 106,145,195-202 
In order to complete this study, the substrates were polarised using method 1 and 
IMes(a). Polarisation transfer to pyridines (a) – (h) (Figure 6.6) was investigated for 1H 
NMR at a PTF of 2 G and 65 G and 1H OPSYdq NMR at a PTF of 2 G. This was 
completed at these magnetic fields because in the standard 1H NMR spectrum, 
maximum transfer to pyridine is observed at a PTF of 75 G and maximum transfer for 
the 1H OPSYdq is observed at a PTF of 2 G. The observed enhancements to the ortho 
and meta 1H resonances of these substrates are presented in Table 6.1. The data 
collected for standard 1H spectra is presented as the average of three points. The data 
collected for 1H OPSYdq spectra are a single point only, as the aim of this sequence is 
to prove transfer of double quantum states derived from parahydrogen. This average 
approach is applied to all data in this chapter unless otherwise stated.  
Pyridines (d) and (e) proved unsuitable for comparison because (d) showed a reaction 
with methanol (further investigated in chapter 6.5.1, pg 305) and (e) exhibited low 
solubility in methanol. Although polarisation transfer is observed to both substrates, 
neither is at standard concentration and so cannot be compared to the other substrates 
due to the known concentration dependence of SABRE (see Chapters 3 and 4). 
Polarisation transfer to the phenyl and methyl groups of pyridines (f) and (g) (Figure 
6.6) will be discussed later in this chapter (Section 6.2.2, pg 280). It is also important to 
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note the exchangeable protons in groups such as the amine or hydroxyl group can 
become deuterated due to the experiment being carried out in d4-methanol.  
Para 
substituent 
pKa 
Observed 1H NMR signal enhancement 
1H at 2 G 1H at 65 G 1H OPSYdq at 2 G 
Ortho Meta Ortho Meta Ortho Meta 
-carbonitrile 1.9195 -37 18 -69 1 13 15 
-hydroxy 3.3106,196,198 -49 44 -60 26 8 10 
-carboxamide 3.6199 -69 59 -86 42 6 5 
-phenyl 5.3200 -91 4 -116 7 7 1 
-methyl 6145 -35 25 97 -60 23 22 
-amino 9.2197,199,201 68 112 127 46 19 20 
Table 6.1 1H polarisation observed with a PTF of 2 G and 65 G, and 1H OPSYdq polarisation observed 
with a PTF of 2G for the ortho and meta position of a series of 4-substituted pyridines. 
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Figure 6.7 Showing the observed polarisation to the ortho position of a series of four substituted pyridines 
compared to the pKa of the N-position of those substrates. 
In Figure 6.7, it is possible to observe increasing polarisation transfer to the ortho 
position of the pyridine analogues upon increasing pKa, however after 5.3, a phase 
change of the observed signals is experienced, affecting calculated enhancement. The 
1H OPSYdq is processed in magnitude mode and therefore a phase change cannot be 
observed. The extent of polarisation transfer observed by the 1H OPSYdq NMR spectra 
does not appear to follow a trend.  
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These data are presented in a different way in Table 6.2, through the addition of the 
magnitudes of observed signal enhancement to ortho and meta positions of the 4-
substituted pyridines. 
Para substituent pKa 
Sum of the 1H NMR signal enhancement 
observed on ortho and  meta positions 
1H at 2 G 1H at 65 G 1H OPSYdq at 2 G 
-carbonitrile 1.9195 55 70 28 
-hydroxy 3.3106,196,198 93 86 18 
-carboxamide 3.6199 128 128 11 
-phenyl 5.3200 95 -123 8 
-methyl 6145 60 157 45 
-amino 9.2197,199,201 180 173 39 
Table 6.2 The sum of the observed 1H polarisation with a PTF of 2 G and 65 G, and 1H OPSYdq 
polarisation with a PTF of 2G for the ortho and meta position of a series of 4-substituted pyridines. 
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Figure 6.8 Showing the sum of the modulus of polarisation transfer to both ortho and meta positions of a 
series of four substituted pyridines compared to the pKa of the N-position of those substrates.  
Looking at Figure 6.8, no simple correlation, linear or curved, can be observed. In some 
cases¸ polarisation transfer to the substrate from parahydrogen can result in IzSz-type  
states leading to antiphase signals, particularly with a PTF of 2 G, which greatly effects 
the calculated enhancement. It might also be due to the additional interactions created 
by the different R groups in para-position. For instance, any group containing a 
nitrogen or oxygen may be able to bind to the metal centre, creating a kinetic motif 
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which is not solely dependent on the pKa of the nitrogen centre. While it is unlikely 
polarisation can be transferred when binding occurs through the substituent, this could 
greatly affect the contact time when binding through the N position. To investigate this 
idea, the hydride region of a thermal 1H NMR spectrum of each sample was analysed 
(Figure 6.9). 
 
Figure 6.9 Hydride region of thermal 1H NMR spectra of the named substrates polarised using method 1 
and IMes(a). 
Evidence for the expected singlet hydride corresponding to [Ir(IMes)(H)2(sub)3]Cl is 
observed in all 6 spectra, together with a limited level of deuteration. A smaller peak 
can also be observed next to these corresponding to the HD analogue. In the cases of 4-
hydroxypyridine and 4-carbonitrilepyridine, additional hydrides are observable 
suggesting the nitrogen in the pyridine ring is not the only binding atom in the substrate.  
To investigate this, polarisation transfer to phenol and benzonitrile (Figure 6.10) was 
investigated using method 1 and IMes(a).  
OH N
 
Figure 6.10 Structures of phenol and benzonitrile. 
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These substrates have analogous structures to 4-hydroxypyridine and 4-
carbonitrilepyridine however the nitrogen in the ring is replaced with a carbon to form a 
phenyl derivative rather than a pyridine derivative. Hydrogenation of IMes(a) in the 
presence of these substrates will show if they are able to activate the catalyst and form a 
stable complex, and therefore binding through the OH or CN functional groups.  
In the case of phenol, polarisation transfer was not observed in the standard 1H spectra 
however, signals were observed in the 1H OPSYdq spectra suggesting weak polarisation 
transfer must have occurred. A number of hydrides are also observed. Together, this 
information proves the hydroxyl group is able to activate and stabilise IMes(a) and 
shows a small level of polarisation transfer is possible through this route.  
In the case of benzonitrile, polarisation transfer was observed in the standard 1H spectra 
(in the form of an emission peak) and 1H OPSYdq NMR spectra however this did not 
lead to an enhancement value. A single hydride resonance was observed at -21.15 ppm. 
This proves the nitrile group is also able to activate and stabilise IMes(a) and the 
polarisation transfer is possible through this route.  
While it was not possible to ascertain a simple correlation, this experiment has shown 
that a significant polarisation transfer can be gained with both weak and strong 
interactions between the ligand and metal. It has also shown that the SABRE technique 
is tolerant to many different functional groups such as hydroxyl, carbonitrile, amino, 
amide and phenyl groups. 
6.2.2 Effect of substitution on the level of polarisation transfer to the binding pyridine 
ring and substituents 
In this section, the aim is to explore how steric interactions play a role in the ability of 
SABRE to operate. The challenge in achieving this goal is that it has already been 
shown that basicity plays a role in the modulation of the polarisation level. The two 
effects are therefore clearly linked. The three simple substituted 2-, 3- and 4- 
methylpyridines will be examined first. 
281 
6.2.2.1 Polarisation transfer efficiency trends observed within the methylpyridines 
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Figure 6.11 Labelled structures of a) 2-methylpyridine, b) 3-methylpyridine and c) 4-methylpyridine. 
Using method 1, IMes(a) and SIMes(a) employed at a PTF of 2 G were used to 
examine 2-, 3- and 4-methylpyridine. The results obtained with IMes(a) are discussed 
first (Table 6.3). 
 pKa  ortho meta para methyl 
2-methyl 
pyridine 
5.97106,107 Position - 6 3 5 4 7 
Enhancement - -4 0.5 1 -4 0.2 
3-methyl 
pyridine 
5.68106,107 Position 2 6 - 5 4 7 
Enhancement -66 -82 - 61 -181 -8 
4-methyl 
pyridine 
6.02106,107 Position 2 - 3 - - 5 
Enhancement 151 - -37 - - 12 
Table 6.3 Observed 1H enhancements of 2-, 3- and 4-methylpyridine when polarised with IMes(a).  
In the case of 4-methylpyridine, the ortho and meta positions show some IzSz-type 
character. The greatest signal enhancement to the methyl group is observed in 4-
methylpyridine. It can also be observed that very little polarisation transfer is observed 
into any position of 2-methylpyridine.  
4- and 3- methylpyridine were investigated using SIMes(a) in deuterated methanol and 
reacted in the expected way. For 2-methylpyridine, no activity was observed and 
SIMes(b) was used. This resulted in the observation of polarisation transfer. Results for 
all three methylpyridines are outlined in Table 6.4. 
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 pKa  ortho meta para methyl 
2-methyl 
pyridine 
5.97106,107 Position - 6 3 5 4 7 
Enhancement - -1 0.8 1.2 -0.9 0.6 
3-methyl 
pyridine 
5.68106,107 Position 2 6 - 5 4 7 
Enhancement -17 -14 - 11 -9 2 
4-methyl 
pyridine 
6.02106,107 Position 2 - 3 - - 5 
Enhancement -83 - 8 - - 8 
Table 6.4 Observed 1H enhancements of 3- and 4-methylpyridine when polarised with SIMes(a) and 2-
methylpyridine when polarised with SIMes(b).  
Within the methyl pyridines, a clear trend can be observed. The least hindered substrate, 
4-methylpyridine (pKa = 6.02
106,107), shows greatest enhancement on all positions, then 
3-methylpyridine (pKa = 5.68
106,107) and the most hindered substrate, 2-methylpyridine 
(pKa = 5.97
106,107) shows the least enhancement. The presence of emission peaks in the 
2-methylpyridine spectrum indicates polarisation has transferred to the substrate. In all 
the methylpyridine cases, less polarisation transfer is observed with the SIMes based 
catalysts compared to IMes(a).  
6.2.2.2 Polarisation transfer efficiency trends observed within the phenylpyridines 
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Figure 6.12  Labelled structures of a) 2-phenylpyridine, b) 3-phenylpyridine and c) 4-phenylpyridine. 
Polarisation transfer into the phenylpyridines was investigated in order to investigate 
transfer to a bulkier substrate and transfer into a second aromatic ring. This differs from 
quinoline in that in the phenyl pyridines, the two aromatic rings are separated by a 
single C-C bond. 4-phenylpyridine has a pKa of 5.55, 3-phenylpyridine has a pKa of 4.8 
and 2-phenylpyridine has a pKa of 4.48. All three phenylpyridines were investigated 
using method 1 and IMes(a). No polarisation transfer was observed to 2-phenylpyridine 
using IMes(a) or IMes(b). The polarisation transfer observed with 3- and 4-
phenylpyrine is outlined in Table 6.5. 
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 pKa  Ring 1 (pyridine) Ring 2 (phenyl) 
3-phenyl 
pyridine 
4.8107 Position 2 4 5+9 6 8 10 
Enhancement -67.4 -44.7 22.3 -77.1 3.6 3.4 
4-phenyl 
pyridine 
5.55107 Position 2 - 3 - 6 7+8 
Enhancement -50.8 - 27.9 - 4.3 2.9 
Table 6.5 Comparison of the enhancement observed for 3-phenylpyridine and 4-phenylpyridine. 
In Table 6.5, the enhancement for positions 5 and 9 of 3-phenylpyridine, and 7 and 8 of 
4-phenylpyridine have been calculated as one value. This is because the resonances are 
not base line resolved in the spectra and cannot be separated for integration. In the first 
ring, it can be observed that the highest polarisation is observed in the ‘ortho’ positions 
(2 and 6) of 3-phenylpyridine, showing greater enhancement than the ‘ortho’ position 
(2) of 4-phenylpyridine. The next highest is then the ‘para’ position of 3-
phenylpyridine. The lowest enhancements in the first ring are observed in the ‘meta’ 
positions, however unlike the ‘ortho’ positions, it is now 4-phenylpyridine (position 3) 
showing the greatest enhancement compared to 3-phenylpyridine (position 5). This 
trend is continued into the second ring where the ‘ortho’ position of 4-phenylpyridine 
(6) shows greater enhancement than that of 3-phenylpyridine (8), however this 
enhancement is significantly lower than those observed in the first ring. The trend 
switches again when looking at the ‘meta’ and ‘para’ positions of the second ring, with 
3-phenylpyridine exhibiting greater enhancement. Generally speaking, greater 
polarisation transfer is observed within 3-phenyl pyridine. The 1H OPSYdq spectra 
show greater polarisation transfer into the first ring than the second for both 3- and 4-
phenylpyridine. 
An investigation followed to find a method to increase the polarisation transferred into 
the second ring. This work was completed with 3-phenylpyridine using method 2 
IMes(a). The polarisation transfer was investigated with a PTF of 60 G where the 
length of time parahydrogen is added to the sample (bubbling time) is altered. The 
results are represented graphically in Figure 6.13.  
284 
-60
-50
-40
-30
-20
-10
0
10
0 2 4 6 8 10 12 14 16 18 20
Bubbling time / s
O
b
s
e
rv
e
d
 e
n
h
a
n
c
e
m
e
n
t
Proton 2
Proton 6
Proton 4
Proton 8
Proton 5+9
Proton 10
 
Figure 6.13 Graphical representation of the effect of changing bubbling time on the polarisation transfer 
to 3-phenylpyridine. 
The bubbling time of parahydrogen was increased from 2 seconds to 20 seconds. An 
increase in polarisation transfer to 3-phenylpyridine can be observed up to a bubbling 
time of 10 s, however after this time, the polarisation transfer either decreases or 
stabilises for different protons. This did not have the effect of significantly increasing 
polarisation transfer into the second ring.  
6.2.2.3 Polarisation of 3-benzoylpyridine and 4-(4-chlorobenzoyl)pyridine 
3-benzoylpyridine and 4-(4-chlorobenzoyl)pyridine (Figure 6.14) were interrogated to 
extend the investigation of polarisation transfer into a second aromatic ring. In the case 
of these two substrates, the second ring is separated from the first by a carbonyl group.  
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Figure 6.14 Structure of 3-benzoylpyridine and 4-(4-chlorobenzoyl)pyridine. 
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3-benzoylpyridine was hyperpolarised by method 1 and IMes(a). Results are outlined in 
Table 6.6.  
3-benzoylpyridine Observed 1H NMR signal enhancement 
2 4 5 + 10 6 9 11 
Polarised at 2 G -52.2 34.0 14.7 -53.2 1.6 2.6 
Polarised at ~65 G -53.8 -39.0 2.4 -46.6 1.9 0.7 
Table 6.6 Observed 1H NMR polarisation transfer to 3-benzoylpyridine polarised with IMes(a) at a PTF 
of 2 G and 65 G.  
In Table 6.6, the enhancement for positions 5 and 10 of 3-benzoylpyridine have been 
calculated as one value. This is because the resonances are not base line resolved in the 
spectra and cannot be separated for integration. It is possible to see polarisation transfer 
was achieved in this system, including into the second ring. Changing the PTF to ~65 G 
did not increase polarisation transferred into the second ring.  
4-(4chlorobenzoyl)pyridine was hyperpolarised using method 1 and IMes(a).  
4-(4-chlorobenzoyl)pyridine Observed 1H NMR signal enhancement 
2 3 7 8 
Polarised at 2 G -64.7 46.3 -0.8 2.4 
Polarised at ~65 G -46.8 0.4 0.9 0.7 
Table 6.7 Observed 1H NMR polarisation transfer to 4-(4-chlorobenzoyl)pyridine polarised with IMes(a) 
with a PTF of 2 G and 65 G. 
It is possible to see polarisation transfer was achieved in this system, including a small 
amount into the second ring. Changing the PTF to ~65 G did not increase polarisation 
transfer into the substrate. The polarisation transfer observed into H(3) with a PTF of 
~65 G was comparable to that for H(2) at the same PTF, but the signal exhibited 
significant antiphase (IzSz-type) behaviour and consequently, has a low calculated 
enhancement.  
Investigations into the two substrates, 3-benzoylpyridine and 4-(4-
chlorobenzoyl)pyridine have shown polarisation can transfer across a fairly large spacer 
with no protons between the pyridine and phenyl rings.  
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6.3 Polarisation of substrates without a pyridine subunit 
In the previous chapters, pyridine (and substituted pyridines) and quinoline (and 
substituted quinolines) are the only substrates that have been considered. In this section, 
polarisation transfer to the indole subunit, the thiazole subunit and to commercially 
available drugs is investigated. 
6.3.1 Investigation into the polarisation of indole 
Indole analogues are important biologically (see Section 6.1), and so an investigation 
into whether it would be possible to hyperpolarise indole was undertaken. It also gives 
us the opportunity to investigate polarisation to a 5-membered N-heterocyclic ring, and 
if polarisation is possible where an NH is present. Two substrates were investigated; 
indole and 1-methylindole (Figure 6.15). 
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Figure 6.15. Structures of a) indole and b) 1-methylindole. 
Both substrates were initially investigated using method 1 and IMes(a) however, in 
both cases, no polarisation was observed in either the 1H NMR spectrum or 1H OPSYdq 
NMR spectrum.  
The investigation was then extended to include IMes(c). With this new catalyst, 
polarisation transfer is now observed in the form of emission peaks in the 1H and 
significant peaks in the 1H OPSYdq for indole, however an enhancement is not 
observed (Table 6.8). No transfer is observed in the case of 1-methylindole.  
Indole 2 3 4 5 6 7 
Enhancement -0.03 0.15 -0.52 0.49 0.69 -0.51 
Table 6.8. Observed 1H polarisation transfer to indole in the presence of IMes(c). 
It was thought the low level of polarisation transfer observed could be due to the 
proton/methyl group present on the nitrogen atom, which limits the substrate from 
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binding. Potassium tert-butoxide was added to the indole and IMes(c) sample to attempt 
to deprotonate the proton on the nitrogen in indole and consequently make binding to 
the metal through the nitrogen more accessible, however no evidence for polarisation 
transfer was observed. During this experiment, it was found catalyst did not decompose 
upon addition of the base. This was confirmed by adding the base to a standard pyridine 
and IMes(a) sample, in which the catalyst did not decompose, however the addition 
resulted in greatly reducing the expected polarisation transfer into pyridine in this 
system.  
6.3.2 Investigation into the polarisation of thiazole 
NS
 
Figure 6.16 Structure of thiazole. 
The structure of thiazole is shown in Figure 6.16. Investigations of this structure will 
show the effect of reducing the binding ring from 6-membered to 5-membered while 
maintaining the binding motif in the ring. Unlike indole, there is an additional sulfur 
atom within the ring, and consequently, the nitrogen does not have a proton bound to it, 
hindering its ability to bind to the metal catalyst. It is known that iridium can accept 
both hard and soft donors203 and therefore investigations into thiazole will also give the 
opportunity to determine if the iridium centre in [Ir(IMes)(H)2(sub)3]
+ prefers hard (N) 
or soft (S) donors.  
6.3.2.1 Investigation into the polarisation of 2-aminothiazole 
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Figure 6.17 Structure of 2-aminothiazole. 
2-aminothiazole (Figure 6.17) was the first thiazole analogue to be investigated using 
method 1 and IMes(a). Polarisation transfer is observed to the two 1H resonances, 
proton 4 and proton 5, in 2-amino thiazole which exhibited an average enhancement of  
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-19 and -41 fold respectively. SABRE is therefore tolerant to the amino functional 
group and the presence of a sulphur atom in the ring. When polarisation transfer to 13C 
is examined, one 13C resonance is observed which appears with a S/N ratio of 5.46. This 
corresponds to the quaternary carbon which is bound to the amino group at 170.31 ppm. 
The quaternary carbon is more prominent than the other carbons in the system due to a 
long T1. This data set revealed a second important piece of information; an amount of 
polarisation is also transferred to the OH proton of methanol (enhancement of -0.51). A 
typical 1H NMR spectrum is presented in Figure 6.18.  
 
Figure 6.18 Thermal 1H NMR spectrum of 2-aminothiazole (top) with a typical hyperpolarised spectrum 
of 2-aminothiazole (bottom) polarised with method 1 and IMes(a). 
In the hydride region of the corresponding 1H NMR spectrum, the dominant signal 
appears at -23.0 ppm. This suggests the complex of the form [Ir(IMes)(H)2(sub)3]Cl is 
present, where each bound 2-amino thiazole is bound through the nitrogen. Two further 
pairs of hydrides observed in the hyperpolarised 1H OPSYdq NMR spectrum, indicating 
the presence of two complexes with inequivalent hydrides, with relative intensities of 
~5% (-21.58 ppm and -22.38 ppm, JH-H = 6.15 Hz) and ~2% (-21.70 ppm and                 
-22.59 ppm, JH-H = 6.83 Hz) compared to the dominant singlet hydride. 
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2-aminothiazole has a significantly different structure compared to pyridine as it is 
based around a 5-membered ring, where pyridine is a 6-membered ring. While pyridine 
shows a maximum observed 1H NMR enhancement with a PTF of -70 G,66 it was 
thought 2-aminothiazole may exhibit a different trend owing to the different coupling 
network through the 5-membered ring. Therefore, 2-aminothiazole was tested next 
using method 2 and IMes(a), varying the PTF in the range -150 G to +10 G in 
increments of 10 G. Results are shown in Figure 6.19. 
 
Figure 6.19 Observed 1H NMR signal enhancement of 2-aminothiazole hyperpolarised at a PTF of -150 G 
to +10 G in increments of 10 G using method 2 and IMes(a). 
It is possible to observe the maximum enhancement for both proton environments in    
2-aminothiazole polarised with IMes(a) is obtained with a PTF of -60 G. This is slightly 
offset when compared to the magnetic field dependence of pyridine. 
These experiments prove that a thiazole analogue is able to bind to the iridium catalyst 
and can accept polarisation from parahydrogen via the metal template. It also shows 
this polarisation transfer is subject to a field of polarisation dependence which is similar 
to that of pyridine.  
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6.3.2.2 Investigation into the polarisation of 2-amino-4-methyl thiazole, 2-amino-4-
phenyl thiazole and 2-amino-4-(4-chlorophenyl) thiazole 
S
N
NH2
 
Figure 6.20 Structure of 2-amino-4-methyl thiazole. 
Transfer of polarisation to 2-aminothiazole could occur when the substrate is bound to 
the iridium centre by either nitrogen of sulphur atoms. The addition of substituents on 
the 4 position of 2-aminothiazole will give an insight into the binding preferences of 
IMes(a). This was first investigated by polarisation of 2-amino-4-methyl thiazole 
(Figure 6.20) using method 1 and IMes(a). Weak polarisation transfer was observed in 
the thiazole proton only, and not methyl group of 2-amino-4-methylthiazole, shown in 
Table 6.9. However, weak double quantum polarisation transfer was observed to both 
thiazole and methyl proton signals. Using IMes(c) increases the observed enhancement 
on the thiazole proton by 6 fold. 
 Observed 1H NMR signal enhancement 
Thiazole (~6.1 ppm) Methyl (~2.1 ppm) 
2-amino-4-methyl thiazole -0.43 0.64 
2-amino-4-methyl thiazole + NCMe -2.60 0.12 
Table 6.9 Observed 1H NMR signal enhancement for 2-amino-4-methyl thiazole. 
As polarisation transfer is observable on both methyl and thiazole protons, the methyl 
group may provide a method of polarisation transfer to the thiazole proton. 
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Figure 6.21 Structures of (a) 2-amino-4-phenyl thiazole and (b) 2-amino-4-(4-chlorophenyl) thiazole. 
In the cases of 2-amino-4-phenyl thiazole (Figure 6.21a) and 2-amino-4-(4-
chlorophenyl) thiazole (Figure 6.21), no enhancement was observed with a 90o pulse, 
regardless of whether IMes(a) or IMes(c) was employed. The use of the 1H OPSYdq 
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NMR sequence yielded weak polarisation transfer into the phenyl ring of both 
substrates. A series of experiments were designed to prove these signals are truly 
signals derived from double quantum states, and not thermal breakthrough. This was 
completed with 2-amino-4-(4-chlorophenyl) thiazole as it showed slightly greater signal 
in the 1H OPSYdq spectrum compared to 2-amino-4-phenyl thiazole.  
First, a 1H OPSYdq sequence was completed without the presence of parahydrogen, 
where no peaks were observed. Second, the crusher gradients of the 1H OPSYdq were 
increased from 60 % to 80 % during a hyperpolarised experiment, increasing the 
selectivity of the filter. The signals on the phenyl ring were still observable, suggesting 
they derived from double quantum states, not thermal breakthrough. A third test is to 
investigate the field dependence of this transfer. 2-amino-4-(4-chlorophenyl)thiazole 
was consequently interrogated using method 2 and IMes(c), varying the PTF in the 
range -140 G to 0 G with increments of 20 G, shown in Figure 6.22. 
  
Figure 6.22 Observed NMR signal enhancement of 2-amino-4-(4-chlorophenyl)thiazole polarised with 
IMes(c). This data is presented with a PTF of -140 G (bottom) to 0 G in increments of 20 G. The left 
shows the effect on 1H NMR spectra and the right shows the effect on the 1H OPSYdq NMR spectra. 
It appears that a small dependence is observed in the 1H NMR spectra (Figure 6.22, left) 
but this has not led to an enhancement of the signal, with the largest peak having an 
absolute integral of only 75 % of the same signal in the thermal trace. As this could 
result from turbulence within the signal reducing the lock (see Chapter 2), and no 
antiphase (IzSz-type) or emission (negative phase) peaks are observed, it is not possible 
to prove if this 25 % drop in signal intensity is due to polarisation transfer. A different 
dependence is observed in the 1H OPSYdq NMR spectra (Figure 6.22, right) however, 
with significant signal observed in the signals corresponding to the phenyl ring, and 
none observed in the shift that would correspond to the proton in the thiazole ring. Not 
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only that, but the 1H OPSYdq NMR spectra appear to show a field dependence with a 
maximum observed with a PTF of -80 G. The experiment was repeated with a PTF in 
the range -100 G to -60 G in increments of 5 G to double check these results. The same 
trends were observed for both 1H NMR spectra and the 1H OPSYdq NMR spectra. This 
suggests the signals must derive from double quantum states and are not due to 
selectivity issues with the OPSY sequence, as thermal breakthrough would not exhibit a 
dependence on magnetic field of polarisation. This suggests that polarisation does 
transfer from parahydrogen to the 4-substituted 2-aminothiazoles via SABRE however, 
the interaction is weak. This consequently suggests transfer to this range of substrates 
may be optimised by the use of a different SABRE catalyst.  
6.3.2.3 Investigation into the polarisation of benzothiazole 
N
S
2
4
5
6
7
 
Figure 6.23 Structure of benzothiazole. 
Initially, the polarisation transfer to benzothiazole was investigated using method 1 and 
IMes(a). This resulted in the observation of significant polarisation transfer to most 
positions however the observed enhancement on position 2 is significantly less than the 
other positions (Table 6.10). Benzothiazole was also investigated using IMes(c), as it 
was thought this might alter the system enough to encourage a more equal spread of 
polarisation transfer around the system. In most positions, this had the effect to 
significantly increase the polarisation transfer observed, particularly to position 2.  
Benzothiazole Observed 1H NMR signal enhancement 
Position 2 4 5 6 7 
IMes(a) 9.6 79.9 46.8 63.8 72.0 
IMes(c) 95.9 114.1 49.5 105.6 103.0 
Table 6.10 Observed 1H NMR signal enhancement for benzothiazole using method 1 and IMes(a) and 
IMes(c).  
Polarisation transfer to this substrate has proved to be strong and consequently further 
investigations have been completed. First, the effect of changing the PTF was 
investigated using method 2 and IMes(c). 
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Figure 6.24 Effect of changing field of hydrogen addition on polarisation transfer to benzothiazole using 
method 2 and IMes(c). a) shows all 1H resonances, b) shows signals corresponding to the proton 2, c) to 
protons 4 and 7 and d) to protons 5 and 6.  
This experiment revealed the maximum polarisation transfer is experienced at with a 
PTF of -60 G (Figure 6.24) for benzothiazole. This is the same as 2-aminothiazole and 
quinoline (Section 6.3.2.1, pg 287, and Chapter 4 respectively). Significant polarisation 
transfer was also observed into all positions of benzolthiazole. 
PTF Observed 1H NMR signal enhancement 
2 4 5 6 7 
0 G -13 -30 16 25 -31 
-60 G -84 -62 -23 -12 -61 
Table 6.11 Observed polarisation transfer to benzothiazole using IMes(c) and method 2 with a PTF of 0 
G and -60 G. 
As transfer was so significant, polarisation transfer to 13C was also investigated. At 
standard concentration, it was possible to obtain a completed 13C spectra after 8 scans, 
hyperpolarised with a PTF of -60 G. 
a) 
c) 
b) 
d) 
-140 G 
-140 G 
-140 G 
+10 G 
+10 G 
+10 G 
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Figure 6.25 13C spectra of benzothiazole after 8 scans hyperpolarised with a PTF of -60 G. 
Investigations into these thiazole analogues have shown polarisation transfer is 
achievable to a five membered ring which contains a binding nitrogen and sulfur. 
Investigations suggest [Ir(IMes)(H)2(sub)3]
+ prefers hard donor ligands, as polarisation 
transfer to the 5 position should be much more prominent in the 4-substituted-2-
aminothiazoles if binding through the sulfur was dominant.  It is observed, however, 
that unlike pyridine analogues, weak polarisation is observed with the presence of a 
substituent adjacent to the binding nitrogen. It is thought the reduced steric hinderence 
of the 5-membered thiazole compared to the 6-membered pyridine have allowed this 
transfer.  
6.3.3 Polarisation of commercial drugs 
A series of commercial drug molecules, discussed in the introduction of this chapter, 
were also investigated. This was completed to gain an idea of the real life potential of 
the application of SABRE to the pharmaceutical industry. 
The polarisation of albendazole, anastrazole, bicalutamide, esomeprazole, gefitinib and 
mebendazole (shown in Figure 6.5) was investigated using method 1 and IMes(a). 
Albendazole and mebendazole were found to be insoluble in methanol, and a screen of 
other solvents revealed they were also insoluble in ethanol, water, acetone, 
dimethylsulphoxide (DMSO), chloroform and dichloromethane (DCM) at standard 
concentration. They were consequently not investigated any further. Gefitinib was 
found to have limited solubility in methanol and so at standard concentration, not all the 
substrate was in solution. This substrate was therefore investigated in chloroform in 
which solubility was much better, although an increase in temperature to 40 oC was 
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required for all the substrate to dissolve. Use of the SABRE technique on this sample 
resulted in the observation of a small level of polarisation transfer into the substrate 
however this did not result in enhancement of the signals within the 1H NMR spectrum. 
Esomeprazole exhibited no polarisation transfer when interrogated with a standard 1H 
NMR sequence, however utilisation of the 1H OPSYdq sequence revealed a small level 
of polarisation transfer into the substrate. Esomeprazole was therefore investigated 
using IMes(c) which resulted in an increase in polarisation transfer observed within the 
1H OPSYdq sequence but no evidence of polarisation transfer was observed within the 
standard 1H sequence.  
Neither of the final two commercial drugs investigated, bicalutamide and anastrazole, 
showed evidence of polarisation transfer. In the case of anastrazole, significant 
antiphase hydrides were observed in the standard hyperpolarised 1H NMR spectrum 
which also show large signals within the 1H OPSYdq spectrum. This suggests the metal 
catalyst creates a very stable complex when bound to anastrazole.  
This work has indicated some potential future complications. Many of these drugs 
showed solubility issues but also, many drugs have more than one binding site, which 
may cause stable complexes or dimers.  
6.4 Effect of polarisation transfer efficiency in complex mixtures 
6.4.1 Effect of polarisation transfer efficiency to competing substrates 
One of the long term goals for this technique is to use it for the identification of small 
amounts of contaminant such as potentially genotoxic impurities in a pharmaceutical 
mixture. It is therefore important to understand the behaviour of the system when more 
than one substrate is present. 
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 Catalyst Substrate 1 Substrate 2 Overall sub. 
Conc.  Conc. (mM) Conc. (mM) Conc. (mM) 
1 5 100  100 
2 5  100 100 
3 5 100 100 200 
4 5 50  50 
5 5  50 50 
6 5 50 50 100 
Table 6.12 Outlining the concentrations of catalyst and substrate for each sample in 0.6 ml d4-methanol 
for a standard competition study between two substrates. 
This was designed such that the two substrates are tested as the sole substrate at 
standard concentration and then investigated in competition with each other. The 
various combinations on concentrations were completed to create groups of where 
either the concentration of each substrate was kept constant, or the ratio of catalyst 
concentration to overall substrate concentration was kept constant. 
During these experiments, the two substrates had to be chosen carefully. Most 
importantly, the spectra of each substrate within the competition study had to be fully 
base line resolved from each other meaning the observed polarisation can be easily 
assigned to the correct substrate. The catalyst required for particular substrates must 
also be considered, for instance, to investigate sterics with a larger substrate such as 
quinoline, IMes(a) would not be suitable and IMes(b) or IMes(c) would be required. 
All competition studies were completed using method 1.  
6.4.1.1 Competition between pyridine and 2-aminothiazole 
The first competition study to be investigated was between pyridine and                        
2-aminothiazole (Figure 6.26). This is because the proton spectra of both substrates are 
baseline resolved from each other and both polarise when the catalyst IMes(a) is used. 
N
N
S
H2N
a) b)  
Figure 6.26 Structures of a) pyridine and b) 2-aminothiazole. 
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The samples were prepared according to Table 6.12. 
 Pyridine Thiazole Overall 
sub. conc. 
(mM) 
Observed 1H NMR signal enhancement 
No. (mM) (mM) Ortho Meta Para T4 T5 
1  100 100    -10.6 -14.5 
2 100  100 -69.8 86.5 -121.8   
3 100 100 200 -50.0 41.2 -57.1 -2.5 -3.9 
4  50 50    -10.2 -15.7 
5 50  50 -198.2 174.6 -199.6   
6 50 50 100 -114.4 85.0 -119.2 -5.9 -10.4 
Table 6.13 Observed 1H NMR signal enhancement for the competition study between pyridine (ortho, 
meta and para) and 2-aminothiazole (T4 and T5) using IMes(a). 
It can be seen that adding a second substrate has a great effect on the polarisation 
transfer to both substrates (Table 6.13). Comparing samples 1, 2 and 3, it is possible to 
see that the combination of the two substrates reduces the polarisation transfer to both 
substrates, although the enhancement observed 2-aminothiazole is reduced by a greater 
per cent than for pyridine. This trend is continued for samples 4, 5 and 6, where 
enhancement is less for both substrates after combination of the two substrates. 
When comparing the samples where the overall substrate concentration is the same for 
all three samples, a different trend is observed. The polarisation transferred to               
2-aminothiazole (samples 1 and 6) drops after combination of the two substrates, but the 
polarisation transferred to pyridine (samples 2 and 6) appears to increase. It is also 
possible to draw a conclusion on the comparison of samples 1 with 4, 2 with 5, and 3 
with 6. This gives the general trend that reducing the concentration increases 
polarisation transfer.  
While it is clear from this experiment that both substrates polarise when in the presence 
of each other, it is difficult to understand which substrate is preferred, if one is preferred 
at all. This could be explained by looking at the polarisation transfer to each substrate 
individually. When these substrates are tested without a competitor, the observed 
polarisation transfer is greatly different between pyridine and 2-aminothiazole 
(comparing samples 1 and 2 and samples 4 and 5, Table 6.13). To overcome this hurdle, 
the experiment was repeated with two substrates that exhibit similar levels of 
polarisation transfer to each other before competition. 
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6.4.1.2 Competition between 2-aminothiazole and quinoline 
Looking through all the substrates tested up until this time, 2-aminothiazole and 
quinoline (Figure 6.27) show the most similar levels of polarisation transfer (an average 
enhancement factor of around 30 for both, see section 6.3.2.1, pg 287, for                     
2-aminothiazole and Chapter 4 for quinoline). The signals for each substrate are base 
line resolved from each other however IMes(c) is required to polarise quinoline. 
Consequently, to keep consistency, IMes(c) was used for all six samples. 
N
N
S
H2N
a) b) Nc)  
Figure 6.27 Structures of a) pyridine, b) 2-aminothiazole and c) quinoline. 
 Thia Quin Overall 
sub. conc. 
(mM) 
Observed 1H NMR signal enhancement 
No. (mM) (mM) T4 T5 Q2 Q3 Q4 Q5 Q6 Q7 Q8 
1 100  100 -1 -2 - - - - - - - 
2  100 100 - - -26 44 -32 -49 66 14 -56 
3 100 100 200 -0.2 -0.3 -1 -2 -1 1 -2 1 1 
Table 6.14 Results from the competition study between 2-aminothiazole (Thia, T4 and T5) and quinoline 
(Quin, Q2, Q3, Q4, Q5, Q6 and Q7). 
The use of IMes(c) to polarise 2-aminothiazole appears to promote a side reaction, 
which is not understood. As 2-aminothiazole polarises with IMes(a) giving an average 
enhancement of 30 fold, the observed side reaction must be a result of the additional 
acetonitrile resulting in a significant reduction in polarisation transfer. Due to this 
complication leading to a drop in observed polarisation transfer, the second half of the 
experiment was not completed. 
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Figure 6.28 The hydride region of the reaction of hydrogen with 2-aminothiazole with IMes(a) (bottom) 
or IMes(c) (top). 
The hydride region (Figure 6.28) shows a different profile to that expected. This may 
suggest that a significant amount of acetonitrile is binding to the catalyst, perhaps 
pushing the 2-aminothiazole into the trans position, therefore hindering polarisation 
transfer to that substrate. If this was the case, the polarisation would be expected to 
transfer into the acetonitrile however, while some polarisation is observed, a large 
amount appears to remain on the ‘new’ hydrides (Figure 6.29).  
 
Figure 6.29 The 1H NMR spectrum of 2-aminothiazole hyperpolarised with IMes(c) using method 1, with 
2-aminothiazole and hydride regions depicted. 
When quinoline is also added to the system so the two substrates are in competition, as 
for sample 3 (Table 6.14), polarisation transfer is not observed in quinoline either. It can 
be observed that the hydride region for 2-aminothiazole in the presence of IMes(c) 
looks the same with or without the presence of quinoline (Figure 6.30). This suggests 
that the complex created by the addition of acetonitrile is too strong to allow the binding 
of quinoline.  
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Figure 6.30 The hydride region observed for the following, bottom to top; sample 1 (2-aminothiazole and 
IMes(c)), sample 2 (quinoline and IMes(c)) and sample 3 (quinoline, 2-aminothiazole and IMes(c)) from 
Table 6.14. 
To understand the reason behind this, a new experiment was completed. Here,              
2-aminothiazole was polarised with IMes(a) to result in the expected level of 
polarisation transfer to this substrate. Acetonitrile was then added to the sample and it 
was then interrogated again. This resulted in a significant reduction in polarisation 
transfer to 2-aminothiazole, suggesting the addition of acetonitrile to this substrate is 
problematic.  
This competition study between 2-aminothiazole and quinoline has shown that adverse 
reactions can occur through combination of some substrates resulting in significant 
reduction in observed polarisation transfer.  
6.4.1.3 Competition between 4-methylpyridine and 4-phenylpyridine 
N N
a) b)  
Figure 6.31 Structures of a) 4-methylpyridine and b) 4-phenylpyridine. 
Due to the complications of mixing 2-aminothiazole with acetonitrile (see section 
6.4.1.2, pg 298), it became necessary to investigate substrates where IMes(b) or 
IMes(c) are not required. This has the added advantage of removing further 
complications through addition of a third viable substrate. A much simpler comparison 
was made between 4-methylpyridine and 4-phenylpyridine. Both are base line resolved 
from each other and polarise with IMes(a). The observed polarisation transfer is also 
similar for the pyridine ring in both cases.  
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 Substrate conc. (mM) Observed 1H NMR signal enhancement 
Substituent Total 4-methylpyridine 4-phenylpyridine 
Me Ph ortho meta methyl o-py m-py o-ph m+p-ph 
1 100 - 100 -25 31 14 - - - - 
2 - 100 100 - - - -38 20 0 1 
3 100 100 200 -19 4 2 -22 11 0 1 
4 50 - 50 -60 55 18 - - - - 
5 - 50 50 - - - -105 54 -6 4 
6 50 50 100 -87 24 6 -86 49 0 3 
Table 6.15 Results from the competition study between 4-methylpyridine (ortho, meta and methyl) and  
4-phenylpyridine (o-py and m-py of the pyridyl ring, and o-ph and m+p-ph of the phenyl ring). 
This experiment has led to some interesting results. Comparing samples 1, 2 and 3 
(Table 6.15), it is possible to see that combination of both substrates has reduced the 
observed polarisation on each substrate despite experiencing similar polarisation levels 
without a competitor. Comparing samples 4, 5 and 6, a similar result can be observed, 
with a drop in polarisation in most signals for both substrates when they are in 
competition with each other. This observation excludes the ortho position of                 
4-methylpyridine, however in this instance, the drop in calculated enhancement arises 
from the antiphase nature of the signal when 4-methylpyridine is polarised without a 
competitor. Anitphase (IzSz-type) signals are observed for 4-methylpyridine at both 
investigated concentrations but it is not present when 4-methylpyridine is polarised in 
competition with 4-phenylpyridine.  
In contrast to the first competition study between pyridine and 2-aminothiazole (see 
section 6.4.1.1, pg 296), a different trend is observed when comparing samples 1, 2 and 
6 (Table 6.15), keeping the concentration of overall substrate constant. All positions of 
4-phenylpyridine have increased in observed polarisation transfer. While the ortho 
position of 4-methylpyridine has also greatly increased in observed polarisation transfer, 
this could be due to a low calculated enhancement for sample 1 (due to the antiphase 
presentation of the signal). The observed enhancement of the other two signals within  
4-methylpyridine dropped. This might suggest that in this situation, it is preferential to 
transfer polarisation to 4-phenylpyridine. This is an unexpected result as                       
4-phenylpyridine is the larger substrate and consequently, sterics would suggest           
4-methylpyridine would bind preferentially. As greater polarisation is observed on         
4-phenylpyridine, it is thought an interaction exists between the phenyl ring and 
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mesitylene rings on the ‘IMes’ group. It is also possible that by chance, the addition of 
these two substrates together had led to a more optimal exchange rate for 4-
phenylpyridine.  
It can also be observed by comparing samples 1 with 4, 2 with 5 and 3 with 6 (Table 
6.15) that lowering the concentration of substrate by 2 fold has again significantly 
increased the observed polarisation transfer in all cases investigated in this study. 
6.4.2 Utilisation of the 1H OPSYdq NMR sequence 
As outlined in the introduction, the overall aim of this project is to develop the SABRE 
technique such that it can be utilised for characterisation in a pharmaceutical setting or 
for the detection of small amounts of genotoxic impurities. In such cases, the samples 
used may be a part of a complex mixture and so the ability to separate out a single set of 
resonances may prove useful. The OPSY sequence has the ability to probe nuclear spins 
which are scalar coupled to parahydrogen-derived nuclei or have at some point been 
scalar coupled to them at a metal centre and subsequently dissociated from that metal 
complex. This therefore means only those resonances which are polarised by 
parahydrogen are detectable.  
To begin an investigation into this, a sample of IMes(a) and pyridine in methanol was 
prepared with a series of other substrates whose chemical shifts are in a similar vicinity 
to the shifts of pyridine, but will not become hyperpolarised. In this case, toluene,        
1-methylindole, 2-amino-4-(4-chlorophenyl) thiazole and 8-methylquinoline were 
added. Under normal thermal conditions, this leaves a complicated spectrum (Figure 
6.32, bottom).  
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Figure 6.32 The 1H NMR spectra of a mixture of compounds with (bottom) the thermal 1H NMR 
spectrum and (top) the 1H OPSYdq NMR spectrum hyperpolarised with IMes(a) by method 1. 
It can be seen in Figure 6.32 that the OPSYdq sequence has filtered out the peaks of the 
interferents showing clearly the position of the pyridine signals. In this particular case, 
the pyridine signals can be picked out by a simple hyperpolarised 1H NMR spectrum as 
the substrate and interferents are of approximately the same concentration. However, if 
the compound to be hyperpolarised is a contaminant in very low concentration, such as 
a genotoxic impurity, this method may enable its observation.  
This experiment also included the removal of solvent peaks, such that hyperpolarised 
experiments could be completed in protonated solvents. An experiment was completed 
where the catalyst and pyridine were dissolved in 90 % protonated methanol and 10 % 
deuterated methanol (required to gain a lock on the spectrometer).  
 
Figure 6.33 1H NMR spectra of pyridine completed in 90 % protonated methanol. Top, thermal 1H NMR 
spectrum and, bottom, 1H OPSYdq NMR spectrum. 
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Comparing single scan thermal 1H NMR spectrum and single scan hyperpolarised 1H 
OPSYdq NMR spectrum, the effect has been to increase the intensity of the pyridine 
signals by between 5 and 18 times, and reduce the intensity of the methanol signals by 
111 times (calculated by integration). This has provided a method of significantly 
reducing solvent signals without a solvent suppression sequence, and has been achieved 
by using only one scan. 
6.5 Reaction of 4-carboxaldehydepyridine with methanol 
During a literature search, a study by Plater et al.204 was found which reported a 
spontaneous reaction of an aldehyde with methanol (Figure 6.36). The group were 
aiming to crystallise the quinoline analogue with a bound aldehyde (Figure 6.34a) in 
methanol, but the crystal structure returned to show the solvent methanol had 
spontaneously reacted with the compound to produce the quinoline analogue with a 
bound hemiacetal (Figure 6.34b).  
N
O
MeOH
N
O OH
a) b)  
Figure 6.34 Spontaneous reaction reported in a publication by Plater et al.204 
It was also observed that a reaction of this type could be furthered by the addition of a 
strong acid. During a literature search to understand the spontaneous reaction described 
above, it was observed that the addition of a suitable acid, such as triflic acid (TfOH, 
pKa = -15),
205 sulphuric acid (pKa = -9),
206 hydrochloric acid (pKa = -7),
207 or p-toluene 
sulphonic acid (pKa = -2.8),
208 can force a further reaction with a second equivalent of 
alcohol to a new acetal product.  
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a) b)  
Figure 6.35 Reaction reported in a publication by de la Fuente and Dominguez.205 
In the 2009 paper205, a method to produce azepine rings by reductive cyclisation used 
the step outlined in Figure 6.35 as a protection step. The production of an acetal was 
also employed by Chavarot et al. (1997)209 in the synthesis of an adenine-
pyridinaldoxime-acridine conjugate. Here, the reaction is not acid catalysed but 
proceeds by reaction with trimethylsilyl chloride (TMSCl) and methanol. 
It was therefore decided to investigate the potential for SABRE to investigate these 
reactions with reference to 4-carboxaldehydepyridine.  
6.5.1 The spontaneous reaction of 4-carboxaldehydepyridine with methanol 
N
O H
N
MeO OH
H
 
Figure 6.36 Spontaneous reaction of 4-carboxaldehydepyridine in the presence of methanol. 
The reaction of 4-carboxaldehydepyridine with methanol was investigated, shown in 
Figure 6.36. First, the expected chemical shifts associated with 4-
carboxaldehydepyridine were recorded (Figure 6.37). 
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Figure 6.37 Thermal 1H NMR spectra of 4-carboxaldehydepyridine in d4-methanol and CDCl3, where 
black circles correspond to 4-carboxaldehydepyridine, and blue circles correspond to the hemiacetal 
product. 
When 4-carboxaldehydepyridine is dissolved in chloroform, three resonances are 
observed, corresponding to the three proton environments in the substrate. If the solvent 
is changed to methanol, it is clear to see the signals corresponding to 4-
carboxaldehydepyridine are not dominant (circled in black). Instead, three signals 
corresponding to a new product are present. These have similar multiplicity and 2:2:1 
intensity however, they correspond to the hemiacetal product (circled in blue). The 
signals corresponding to the hemiacetal product are 18 times more intense than those for 
4-carboxaldehydepyridine based on the integral of the aldehyde/hemiacetal proton. This 
is because methanol is in a large excess as it is the solvent.  
To understand this reaction further, a sample of 4-carboxaldehydepyridine dissolved in 
chloroform-d1 was prepared, and protonated methanol added to the solution. When the 
reaction is completed in d4-methanol, the protons associated with the methoxy group 
and hydroxyl group are NMR invisible due to deuteration. Establishing the same 
equilibrium as observed previously, but reacting with protonated methanol allows the 
observation of all protons on the hemiacetal product, rather than just the pyridyl and 
hemiacetal protons. Completing the reaction in chloroform-d1 means all observed 
hemiacetal product has been produced with protonated methanol.  
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Figure 6.38 1H NMR spectra in chloroform of bottom, 4-carboxaldehydepyridine and top, 4-
carboxaldehydepyridine and protonated methanol. 
It is possible to observe that upon addition of protonated methanol to 4-
carboxaldehydepyridine in chloroform-d1, the hemiacetal product is formed but now the 
signals corresponding to the hemiacetal product are 9 times smaller than those for 4-
carboxaldehydepyridine. The proportion of the product can be increased by increasing 
the amount of protonated methanol. This has also allowed the opportunity to observe 
the signal corresponding to the previously unobservable methoxy group of the 
hemiacetal product. It is therefore possible to characterise both 4-
carboxyaldehydepyridine and the hemiacetal product (see Experimental).  
An investigation was then completed to understand if the reaction was reversible 
through the use of 1H EXSY NMR spectra (Figure 6.39). To complete these 
experiments, protonated methanol was added until the proportion of 4-
carboxaldehydepyridine to hemiacetal product was approximately 1:1. This was 
completed to ensure all potential nOe correlations are observed, and are not missed due 
to low concentration of one of the investigated products.  
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Figure 6.39 Thermal 1H NMR spectrum (bottom) of 4-carboxaldehydepyridine dissolved in chloroform-
d1 with an addition of methanol and 
1H EXSY spectra of the same sample with various mixing times (d8) 
where the 4-(CH(OMe)(OH))py of the hemiacetal is excited (top three). The * symbol denotes the excited 
resonance. 
The 1H EXSY experiments allowed us to confirm a reversible exchange was taking 
place. In Figure 6.39, after excitation of the hemiacetal proton, 4-(CH(OMe)(OH))py, 
nOe interactions (inverted signals) are observed to the pyridyl ring of the hemiacetal, 
but also exchange interactions to the CH(O) of 4-carboxaldehydepyridine. This is 
supported by the fact that the intensity of the exchange peak increases as the mixing 
time is increased. To confirm it is an exchange process, EXSY experiments are also 
completed where the CH(O) of 4-carboxaldehydepyridine is excited, shown in Figure 
6.40.  
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Figure 6.40 Thermal 1H NMR spectrum (bottom) of 4-carboxaldehydepyridine dissolved in chloroform-
d1 with an addition of methanol and 
1H NOESY spectrum of the same sample where the 4-(CH(O))py of 
4-carboxaldehydepyridine is excited (top). The * symbol denotes the excited resonance. 
NOe excitation of the CH(O) proton of 4-carboxaldehydepyridine (Figure 6.40) yields 
nOe interactions into the pyridyl protons of 4-carboxaldehydepyridine and also 
exchange into the hemiacetal. An exchange is observed in both directions, this confirms 
the reaction is reversible.  
A variable temperature study was completed in which the percentage of each compound 
involved in the reversible reaction was monitored as a function of temperature (Table 
6.16). 
T / K Aldehyde (%, black) Hemiacetal (%, blue) 
298 74 26 
308 83 17 
318 87 13 
308 84 16 
298 80 20 
Table 6.16 Percentage of each compound involved in the reversible reaction of 4-
carboxyaldehydepyridine with methanol as a function of temperature. The calculations are based on the 
integrals of the CH(O) of 4-carboxaldehydepyridine and CH(OMe)(OH) of the corresponding hemiacetal.  
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It was observed that an increase in temperature led to an increase in                               
4-carboxaldehydepyridine. This is expected as entropy drives the reaction towards       
4-carboxaldehydepyridine (two molecules compared to one), and consequently, an 
increase in temperature leads to an increase of 4-carboxaldehydepyridine.  
4-carboxaldehydepyridine was also shown to react in a similarly spontaneous manor 
with ethanol, Figure 6.41.  
 
Figure 6.41 1H NMR spectra in chloroform of bottom, 4-carboxaldehydepyridine and top,                        
4-carboxaldehydepyridine and protonated ethanol. 
6.5.2 Monitoring the spontaneous reaction of 4-carboxaldehydepyridine with 
methanol using SABRE 
Polarisation transfer to both 4-carboxaldehydepyridine and the hemiacetal product were 
initially investigated in d4-methanol.  
 Observed 1H NMR signal enhancement 
ortho meta C(O)H C(OCH3)(OH)H 
Aldehyde -200 35 -94 - 
Hemiacetal -179 118 - 16 
Table 6.17 Observed 1H polarisation transfer to 4-carboxaldehydepyridine (aldehyde) and the hemiacetal 
product (hemiacetal) found in a sample of 4-carboxaldehydepyridine dissolved in d4-methanol in the 
presence of IMes(a). 
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Due to the large excess of methanol, the hemiacetal product is dominant over               
4-carboxaldehydepyridine, and consequently the concentrations of each substrate are 
different to each other. It can however be observed that significant polarisation transfer 
is present in both substrates. When d4-methanol is used as a solvent, the additional 
resonances corresponding to the –OH and –OMe groups are deuterated because they 
originate from the deuterated solvent. They are therefore not observable by 1H NMR 
spectroscopy. The experiment was therefore repeated in d1-chloroform where               
4-carboxaldehydepyridine is reacted with protio-methanol.  
 
 
Solvent 
Observed 1H NMR signal enhancement 
4-carboxaldehydepyridine Hemiacetal product 
ortho meta C(O)H ortho meta C(OCH3)(OH)H -OCH3 
Chloroform -198 -127 -106 - - - - 
Chloroform 
and 
methanol 
-176 -10 -47 -41 2 -0.3 1.8 
Table 6.18 Observed 1H polarisation transfer to 4-carboxaldehydepyridine (aldehyde) and the hemiacetal 
product (hemiacetal) found in a sample of 4-carboxaldehydepyridine dissolved in d1-chloroform in the 
presence of IMes(a), with and without the presence of protonated methanol. 
It was important to first investigate polarisation transfer to 4-carboxaldehydepyridine in 
chloroform without the presence of methanol. This proves that direct polarisation 
transfer is possible to 4-carboxaldehydepyridine, and the previously observed 
enhancement is not a result of transfer to the hemiacetal product, which then converts 
into the aldehyde. In d1-chloroform (see Table 6.18), it is possible to observe that the 
polarisation transfer to the ortho and C(O)H protons of 4-carboxaldehydepyridine 
exhibit similar levels of enhancement to those found in methanol (see Table 6.17), 
however the enhancement observed to the meta position is much higher in chloroform 
than methanol. The addition of 0.02 ml protonated methanol to the sample resulted in 
the spontaneous production of the hemiacetal in the ratio 1:0.4                                       
4-carboxaldehydepyridine to hemiacetal. It is possible to observe polarisation transfer to 
the hemiacetal in d1-chloroform also, although the observed enhancement is less than 
that observed in methanol. It is however now possible to observe transfer to the –OMe 
group.  
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These experiments have shown that it is possible to polarise 4-carboxaldehydepyridine, 
and its hemiacetal produced upon reaction with methanol, however the reaction is very 
fast and therefore cannot be monitored using SABRE.  
6.5.3 The acid catalysed reaction of 4-carboxaldehydepyridine with methanol 
In the introduction to this section, 4-carboxaldehydepyridine has also been shown to 
react with a second equivalent of methanol upon the addition of an acid. Initially, this 
acid catalysed reaction of 4-carboxaldehydepyridine with methanol was investigated by 
using mass spectroscopy. Four samples of 4-carboxaldehydepyridine dissolved in 
methanol were prepared. 1 drop of concentrated sulphuric acid was added to two of 
these, then one neutral and one acidified sample was moved to an oven at 50 ºC, while 
the other two were stored at room temperature. After three days stored at the stated 
temperature, the samples were analysed by mass spectroscopy (Figure 6.42, Figure 
6.43, Figure 6.44 and Figure 6.45).  
 
Figure 6.42 ESI mass spectrum of 4-carboxaldehydepyridine in methanol stored at room temperature 
without the presence of acid.  
313 
 
Figure 6.43 ESI mass spectrum of 4-carboxaldehydepyridine in methanol stored at room temperature in 
the presence of acid. 
 
Figure 6.44 ESI mass spectrum of 4-carboxaldehydepyridine in methanol stored at 50 ºC, without the 
presence of acid. 
 
Figure 6.45 ESI mass spectrum of 4-carboxaldehydepyridine in methanol stored at 50 ºC in the presence 
of acid. 
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The significant structures observed in this experiment are detailed in Figure 6.46 and 
significant results of the experiment are outlined in Table 6.19. Four peaks of 
significance were observed. The most important of these show a mass-to-charge ratio of 
108, 140 and 154 corresponding to 4-carboxaldehydepyridine (1, 107 g/mol), the 
hemiacetal product (2, 139 g/mol) and dimethoxyacetal product (3, 154 g/mol) 
respectively. The mass spectroscopy was completed in a solvent of water and 
acetonitrile, and this led to an additional product with a mass to charge ratio of 126. 
This corresponds to a dihydroxyl product (4, 125 g/mol) produced by the same 
reversible reaction as observed with methanol, but with the solvent water molecules.  
N
O H
N
MeO OH
H
N
HO OH
H
H+
N
MeO OMe
H
a)  107.11 g/mol b)  139.15 g/mol c)  153.18 g/mol
4)  125.13 g/mol
+ methanol
- methanol + methanol
+ H2O
- H2O
 
Figure 6.46 Reaction products of 4-carboxaldehydepyridine observed in mass spectroscopy. 
In reference to Figure 6.46 Stored at room temperature Stored at 50 ºC 
No added 
acid 
1 (107.1 g/mol) 3.3 x 105 0.8 x 105 
2 (139.2 g/mol) 1.1 x 105  
3 (153.2 g/mol)  0.05 x 105 
Ratio 1 : 2 : 3 10 : 3.3 : 0 10 : 0 : 0.6 
With acid 1 (107.1 g/mol) 9.5 x 105 0.1 x 105 
2 (139.2 g/mol) 3.5 x 105  
3 (153.2 g/mol) 0.4 x 105 4.1 x 105 
Ratio 1 : 2 : 3 10 : 3.7 : 0.4 10 : 0 : 410 
Table 6.19 Collated data from mass spectroscopy study of the reaction products of 4-
carboxaldehydepyridine with methanol. The stated ratios are based on the response factors from the mass 
spectroscopy.  
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The room temperature sample with no acid showed the two expected products with no 
presence of the third. In the sample at room temperature with acid, all three products are 
observed, although the dimethoxyacetal product (3 in Figure 6.46). This suggests the 
addition of sulphuric acid catalyses the reaction to produce a dimethoxyacetal product 
(3). It was previously shown that increasing the temperature pushes the equilibrium 
from the hemiacetal (2) to 4-carboxaldehydepyridine (1), which is further proved in the 
50 ºC experiments. At this temperature no hemiacetal (2) is present in the mass spectra, 
suggesting that the dynamic equilibrium which is formed between hemiacetal (2), 4-
carboxaldehydepyridine (1) and the dimethoxyacetal (3) is not favourable towards the 
formation of hemiacetal (2). When no acid is present, there is a very small amount of 
the dimethoxyacetal (3) observed, however the addition of acid at 50 ºC has a great 
effect. The dimethoxyacetal product (3) is now in excess. This has shown that 4-
carboxaldehydepyridine does undergo a reaction similar to that reported by de la Fuente 
and Domiguez205 upon addition of sulphuric acid at 50 ºC. It was therefore thought it 
might be possible to follow the reaction through SABRE.  
6.5.4 Monitoring the acid catalysed reaction of 4-carboxaldehydepyridine with 
methanol using SABRE 
A sample of 4-carboxaldehydepyridine and IMes(a) in methanol-d4 was prepared and 
activated by the addition of hydrogen. Initial experiments with parahydrogen yielded 
the expected polarisation transfer to 4-carboxaldehydepyridine and the hemiacetal 
product. As the mass spectroscopy suggested an increase in temperature produces a 
small amount of dimethoxyacetal product (3, Figure 6.46), the sample was stored at 50 
oC for 3 days to see if it could be observed. However, this was not successful as the 
dimethoxyacetal product could not be observed in standard NMR, SABRE or mass 
spectroscopy. A small amount of concentrated sulphuric acid was added to the sample. 
This yielded the dimethoxyacetal product (3), as expected however it was not possible 
to follow this using the SABRE technique as the sulphuric acid caused the catalyst to 
severely degrade, rendering it unable to act as a polarisation transfer catalyst. This 
meant a weaker acid may be required, such as nicotinic acid. The carboxylic acid group 
of nicotinic acid has a pKa of 2
106 (and the nitrogen in the pyridyl ring has a pKa of 
4.82106), where sulphuric acid has a pKa of -9,
210 and therefore nicotinic acid is much 
weaker.   
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In a solution of 4-carboxaldehydepyridine and nicotinic acid in methanol, nicotinic acid 
is not acidic enough to promote the full reaction to the dimethoxyacetal (product 3) 
however nicotinic acid is able to bind to the SABRE catalysts. It was thought the 
proximity of both the hemiacetal product and nicotinic acid when bound to the catalyst 
might be enough to promote the reaction. A sample of IMes(a), nicotinic acid and 4-
carboxaldehydepyridine in methanol was prepared for interrogation by 1H NMR using 
method 1. The sample was activated and interrogated with the SABRE technique to 
show polarisation transfer to both substrates however no dimethoxyacetal product was 
observed. The solution was given time to react (~ 2 days) and interrogated again, 
however there was no evidence of the dimethoxyacetal by either NMR or MS.  
An acid with a pKa between that of nicotinic acid and sulphuric acid was required. P-
toluene sulphonic acid was therefore investigated, which has a pKa of -2.8.
211 A sample 
of 4-carboxaldehydepyridine with stoichiometric amount of p-toluene sulphonic acid in 
the presence of IMes(a) was prepared and interrogated by SABRE. Before the control 
experiments for this sample were completed, the reaction to the dimethoxyacetal had 
already gone to near completion. This sample was interrogated using method 1, 
however only very weak polarisation transfer is observed using the 1H OPSYdq 
sequence. This is not observable in the 1H spectra, however roughly equal signal 
intensity is observed in both the dimethoxyacetal product and p-toluene sulphonic acid 
in the 1H OPSYdq spectrum. The sample was stored at 50 ºC overnight to see if the 
weak polarisation transfer was a result of there not being enough active catalyst present 
in the sample. Weak polarisation transfer was observed in both the 1H and 1H OPSYdq 
spectra, however this did not lead to an enhancement in the 1H spectra. The transfer to 
the dimethoxyacetal was much more significant than that to the acid in the OPSYdq 
spectrum. This suggests heating the sample did have the effect to increase polarisation 
transfer to the dimethoxyacetal product however this had not led to an enhancement. A 
small amount of acetonitrile was added to the sample to promote the polarisation 
transfer to the product. Significant polarisation transfer was observed to acetonitrile 
however this again did not have the effect to increase polarisation transfer to the 
dimethoxyacetal product.  
A potential reason for this unexpectedly low level of polarisation transfer could be a 
result of the high concentration of the acid, which has been shown to exhibit 
polarisation transfer and consequently must be binding to the catalyst. The catalyst may 
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therefore be binding irreversibly to the catalyst, or in a chelating manor, both of which 
could hinder the potential for the dimethoxyacetal to bind to the catalyst. The 
experiment was repeated with 90 % less p-toluene sulphonic acid. Two samples of 4-
carboxaldehydepyridine in the presence of p-toluene sulphonic acid were prepared in 
methanol and chloroform. A small amount of protonated methanol was also added to 
the chloroform to produce the hemiacetal product. These samples were interrogated 
after an hour at room temperature to show no evidence of the dimethoxyacetal product 
by NMR. The samples were consequently left at room temperature for three days and 
interrogated again to show no evidence of the dimethoxyacetal product by 1H NMR or 
MS. IMes(a) was added to make a standard concentration sample for interrogation by 
method 1. The sample was hydrogenated and interrogated however, the dimethoxyacetal 
product was still not observed. Again, the samples were left at room temperature 
overnight however no evidence for the desired product was observed by NMR or MS.  
In summary, 4-carboxaldehydepyridine has been shown to undergo a spontaneous and 
acid catalysed reaction with alcohols. The spontaneous reaction with methanol has been 
monitored using SABRE, however so far, it has not been possible to monitor the acid 
catalysed reaction using SABRE.  
6.6 Summary 
In this chapter, significant polarisation transfer has been observed into a number of 
pyridine analogues and other related substrates. Initially investigations were completed 
to understand the functional group tolerance of SABRE. As a part of this investigation, 
it was found SABRE was tolerant to hydroxyl, carbonitrile, amino, amide, phenyl, 
aldehyde, carboxylic acid and chlorine groups, and the presence of sulphur in the ring. 
This also gave the opportunity to investigate the effect of changing the pKa on the extent 
of polarisation transfer. As an extension of this investigation, the effect of increasing the 
steric bulk of the pyridine analogues was also considered, starting from small 
substituents such as a proton or a methyl group through to bulkier substituents such as a 
phenyl ring or a benzoyl group. In all cases, a small amount of polarisation transfer is 
observed into the substituted group. Polarisation transfer was investigated to substrates 
outside of those based on pyridine, such as indole and thiazole. A series of 
commercially available drugs, provided by AstraZeneca, have also been investigated.  
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Another important consideration for the SABRE technique is the idea of competition 
within a sample, which could be either to observe a single substrate in a complex 
spectrum, or to understand the effect of polarising two substrates in one sample. The 
OPSYdq sequence has given the opportunity to successfully filter out and consequently 
only observe the substrate affected by polarisation transfer from parahydrogen. This 
means experiments can be carried out in protonated solvents, and signals deriving from 
reaction mixture impurities can be removed. Polarisation transfer to substrates 
competing for polarisation transfer was also investigated. However, a number of 
limitations must be considered. Certain combinations of substrates can have adverse 
effects (such as with 2-aminothiazole and acetonitrile, section 6.4.1.2, pg 298), and not 
all substrates have the potential to exhibit significant polarisation transfer under the 
conditions investigated here (such as for indole, section 6.3.1, pg 286).  
Some of the most significant results from this chapter are those relating to the reaction 
of 4-carboxaldehydepyridine with methanol. A literature search revealed this type of 
compound could undergo a spontaneous reaction with methanol to create a hemiacetal 
product, or an acid catalysed reaction with methanol to create a dimethoxyacetal 
product. Investigations have shown the spontaneous reaction can be observed using 
SABRE however it is too fast to monitor the transformation. It has also not yet been 
possible to hyperpolarise the acetal product produced through the addition of a strong 
acid or to monitor the reaction using SABRE. This is because the required acid degrades 
the SABRE catalyst.  
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7 Chapter 7 – Conclusions and future work 
7.1 Conclusions 
This thesis has demonstrated recent developments into the application of SABRE within 
high resolution NMR spectroscopy to characterisation of small molecules. Three 
catalytic systems were investigated, including IMes(a), SIMes(a) and ICy(a) and 
compared to the previously published PCy3 system. This comparison revealed that the 
TEP is lower for the carbenes indicating they are stronger donators compared to the 
phosphine and that the buried volumes for the carbenes are smaller in comparison. This 
is a result of the geometry of the ligands. Analysis of the rate constants and associated 
thermodynamic properties for the loss of pyridine and hydride ligands revealed the 
expected correlations to electron donation and steric bulk in that increasing electron 
donation increases the enthalpy value and increasing the steric bulk decreases the Gibbs 
free energy. Despite this, no single property can be infinitely increased or decreased to 
produce an ever increasing level of polarisation transfer into pyridine. The most 
significant factor affecting the efficiency of the polarisation transfer catalyst is the 
contact time, determined by the rate constants for both ligands. Again, there is no clear 
correlation between the observed rate constants of ligand loss with either the TEP or 
buried volume of the associated carbene/phosphine. A potential reason for this can be 
found in the structure of the carbene/phosphine itself. A methyl group in the mesitylene 
arms of IMes and SIMes are able to produce a CH-activation product, a competing 
process for the exchange of pyridine and hydride ligands loss, which may increase the 
observed rate constants. Together, these data suggest the hyperpolarisation efficiency of 
a potential SABRE catalyst cannot be predicted. The efficiency of a new catalyst must 
be decided by measurement, and can be optimised by changing the magnetic field and 
temperature of the polarisation step, and concentration of the sample. 
The effect of changing the temperature and magnetic field of the polarisation transfer 
step has been investigated for all three catalysts investigated. Changing the temperature 
of the polarisation step effects the extent of transfer observed into a substrate through 
changing the rate of exchange and therefore the contact time of the active complex. This 
has been illustrated through determination of the rate constants of the systems 
considered and is supported by the fact that increasing the temperature of the ICy(a) 
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system (with relatively slow exchange rate constants) but decreasing the temperature of 
the SIMes(a) system (with relatively fast exchange rate constants) has the effect to 
increase the extent of polarisation transfer into pyridine. Changing the magnetic field of 
polarisation affects the extent of polarisation transfer through a different process. It has 
been postulated that the extent of polarisation transfer is based on a fine balance 
between the difference in chemical shifts of the nuclei of interest and the J-coupling of 
the system59 and therefore that the extent of polarisation transfer is dependent on the 
PTF as this affects the relative chemical shifts of the nuclei. The J-coupling of the 
system does not change with external field. The observed 1H NMR signal enhancement 
for the para position increased from 38 fold at a PTF of 0 G to -103 fold at a PTF of -90 
G for SIMes(a) and from 4 fold at a PTF of 0 G to -9 fold at a PTF of -60 G for ICy(a), 
where each is quoted for the maximum PTF for the stated catalyst. This demonstrates 
that the PTF which yields the greatest extent of observed polarisation transfer changes 
for a single substrate depending on which catalyst is used. The thesis also demonstrates 
that a specific catalyst will exhibit a different PTF for maximum transfer depending on 
which substrate is investigated.  
The effects of changing the concentration and solvent on the extent of polarisation 
transfer has been investigated for IMes(a) only. It was found that maximum signal 
enhancements were observed when the concentration of the catalyst and substrate were 
dropped to 10 % of that used as standard. A possible explanation for this is the 
significantly increased proportion of parahydrogen available to the sample. Using the 
SABRE method, in a 0.6 ml sample, 0.05 µL (1 mM) of pyridine can be detected in a 
single scan producing S/N ratios of 90, 77 and 33 for the ortho, meta and para 
resonances of pyridine. This is approximately 0.05 mg of substrate, between 10 and 20 
times less than that used for 1H spectra in standard practice for NMR spectroscopy. 
Similar results were observed for the polarisation transfer to quinoline using IMes(c).  
The role of the solvent also has a significant effect on the extent of polarisation transfer 
into pyridine and quinoline. In this case, two mechanisms affect the extent of transfer. 
The relative chemical shifts of any nuclei are related to the solvent and therefore the 
chemical shift differences of the active complex are different depending on the solvent 
used. The solvent also has an effect on the exchange rates experienced by the complex 
due to differing polarities, an effect which is particularly important in charged systems 
such as those investigated here. The polarisation transfer into pyridine and quinoline 
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was investigated where methanol, ethanol, DCM, chloroform, DMSO and acetone were 
the solvents used. For pyridine, maximum signal enhancements were observed in 
ethanol, with methanol running a close second. For quinoline, significant enhancement 
is only observed in methanol and ethanol, and not the other solvents.  
During investigations of polarisation transfer into quinoline, a new catalytic complex in 
the form [Ir(carbene)(H)2(quinoline)2(NCMe)]
+ was developed, as it was found the 
complex in the form [Ir(carbene)(H)2(quinoline)3]
+ did not yield significant polarisation 
transfer into quinoline. It was found IMes(c) yielded the greatest signal enhancement of 
the three catalysts investigated. Using a 90º pulse on 1H, the maximum signal intensity 
was obtained when a PTF of 50 G is used for the 2 position with IMes(b). 
Comparing the thermodynamic data for the IMes(c)/quinoline and IMes(a)/pyridine 
systems, the rate constants for the loss of substrate ligand are very similar, as are the 
Gibbs free energies, despite significantly different enthalpy and entropy values. This 
could be because quinoline is a bulkier ligand with a lower pKa than pyridine and 
therefore a weaker Ir-N bond resulting in a lower enthalpy and entropy. The most 
significant difference is observed in the rate constants for the loss of hydride ligands, 
where the rate constant is much larger for the IMes(c)/quinoline system. This may also 
explain the lower signal enhancements observed to quinoline when compared to 
pyridine and is consistent with the effect of temperature on the extent of polarisation 
transfer.  
This thesis has also investigated the application of SABRE to standard NMR pulse 
sequences. Due to many sequences requiring phase cycling or in the case of 2D spectra, 
many increments, a new, automated flow system is required.  
Considering 1D spectra involving more complex sequences than the 90º pulse acquire 
sequence have led to the successful acquisition of a 1H NOESY NMR spectrum where 
the sample has a substrate concentration of 10 mM. A significant observation was also 
made when considering the effect of PTF on the 1H OPSYdq spectrum. It was found the 
maximum signal intensity was observed at 0 G, unlike the 90º pulse acquire which gives 
a maximum signal intensity at 50 G for quinoline. This led to all new sequences after 
this point being collected at both 0 G and 50 G.  
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Extensive work has been carried out concerning the acquisition of 1D 13C NMR spectra. 
Initially, detection of polarisation from 13C was considered. It was found that, like 1H, 
polarisation on 13C nuclei also has a dependence on the PTF used showing maximum 
signal intensity at 0 G. Owing to the addition of parahydrogen, the signals often 
presented as antiphase in the coupled 13C NMR spectrum. This therefore means a 
refocusing sequence must be completed in order for decoupling to be successful. This 
was achieved using two methods; refocusing according to J coupling evolution 
(13C{1H}_JR), and refocusing according to J coupling and chemical shift evolution 
(13C{1H}_JCSR). The addition of these refocusing sequences allowed for successful 
decoupling of the 13C spectrum however the 13C{1H}_JR sequence allowed the 
observation of the most signals and yielded the best signal intensity for those signals. 
This is thought to be due to relaxation of the hyperpolarised states during the second 
delay period of the 13C{1H}_JCSR sequence.  
Hyperpolarised 13C spectra were also investigated when considering the INEPT transfer 
sequence. This utilises the polarisation present on 1H and uses pulses to transfer this to 
13C for detection. Predictably, this yielded greater signal intensities than those observed 
when interrogating 13C magnetisation. These spectra also presented with antiphase 
peaks and therefore required a refocusing sequence to allow decoupling. This produced 
the first 13C{1H} NMR spectrum collected using SABRE which revealed all nine of the 
expected signals associated with quinoline. 
The successful acquisition of spectra resulting from both 13C and 1H polarisation in the 
form of the 13C NMR sequence and 13C{1H} INEPT NMR sequence have also allowed 
for the idea of sequential acquisition. When using method 2 to apply SABRE, the time 
required to repolarise the sample between acquisitions can be lengthy. Sequential 
interrogation of polarisation on 13C nuclei followed by polarisation on 1H nuclei in on 
hyperpolarisation step has allowed the collection of a coupled and decoupled 13C 
spectrum in one hyperpolarisation step.  
The polarisor was instrumental in the implementation of SABRE to the classic 2D 
sequences such as the COSY, HSQC, HMBC and HMQC. The use of parahydrogen has 
also allowed the application of the OPSYCOSY, which results in the crosspeaks of the 
COSY spectrum to be more intense than the diagonal. It was also found that 
development from the MKII polarisor to the MKIII polarisor decreased the amount of 
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time required for a 64 increment 2D spectrum significantly. This was reduced further by 
reducing the time of addition of parahydrogen per increment from 6 s to 2 s, resulting in 
the collection of a 2D spectrum in 16 min. This is a great improvement on 
interrogations of low concentration substrates considering 1H-13C spectra such as the 
HMBC and HMQC. The SABRE technique has also been successfully applied to the 
ufCOSY sequence by Frydman using method 1. It has therefore been possible to obtain 
a hyperpolarised COSY of 10 mM quinoline in less than a second. In the case of low 
concentration samples, information gathered from 2D spectra can also be gained much 
quicker than possible with thermally polarised samples.  
This applications based investigation was extended to include understanding the 
functional group tolerance of SABRE, increasing steric bulk of pyridine analogues, 
competition effects, and potential for transfer into commercially available drugs 
provided by AstraZeneca.  
SABRE was found to be tolerant to hydroxyl, carbonitrile, amino, amide, phenyl, 
aldehyde, carboxylic acid and chlorine groups, and the presence of sulphur in the ring. 
Investigations were also carried out into substrates which do not contain a pyridyl ring 
such as indole and thiazole analogues. The effect of increasing the steric bulk of the 
pyridine analogues was also considered, starting from small substituents such as a 
proton or a methyl group through to bulkier substituents such as a phenyl ring or a 
benzoyl group. In all cases, a small amount of polarisation transfer is observed into the 
substituted group. 
Another important consideration for the SABRE technique is the idea of competition 
within a sample, which could be either to observe a single substrate in a complex 
spectrum, or to understand the effect of polarising two substrates in one sample. The 
OPSYdq sequence has given the opportunity to successfully filter out and consequently 
only observe the substrate affected by polarisation transfer from parahydrogen. This 
means experiments can be carried out in protonated solvents, and signals deriving from 
reaction mixture impurities can be removed. Polarisation transfer to substrates 
competing for polarisation transfer was also investigated.  
Investigation also extended to the reaction of 4-carboxaldehydepyridine with methanol. 
A literature search revealed this type of compound could undergo a spontaneous 
reaction with methanol to create a hemiacetal product, or an acid catalysed reaction with 
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methanol to create a dimethoxyacetal product. Investigations have shown the 
spontaneous reaction can be followed using SABRE however this has not yet been 
possible with the acid catalysed reaction due to the effect of the acid on the SABRE 
catalyst. 
While this thesis has aimed to demonstrate the applicability of SABRE to high 
resolution NMR, it has also demonstrated some limitations. The extent of polarisation 
transfer is dependent on the lifetime of the active complex and the chemical shift 
differences and J-coupling network and as such each catalyst and substrate system 
exhibits different dependencies on the investigated variables. This therefore means the 
optimisation of polarisation transfer is difficult to predict and therefore potentially a 
lengthy process for a new catalyst or substrate. It has also been observed that the 
addition of certain substrates can cause adverse effects. For instance, it has been shown 
that SABRE is tolerant to acetonitrile and is in fact required to observe polarisation 
transfer into quinoline, however if it is added to a sample of 2-aminothiazole, the 
hyperpolarised states no longer transfer into 2-aminothiazole. Instead, they remain on 
the hydride ligands, resulting in significantly enhanced hydride signals. It should also be 
noted that not all substrates investigated have exhibited signal enhancement, however 
these have not been optimised considering all the potential variables and other SABRE 
catalysts which have not yet been discovered. 
7.2 Future work 
A number of areas for investigation in future work have been suggested below. 
1. During the course of these studies, a new catalyst type was observed in the form 
[Ir(ICy)2(COD)]Cl (Figure 7.1b) which hydrogenates to form 
[Ir(H)2(ICy)2(py)2]Cl.  
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Figure 7.1 Structures of ICy(a) and ICy2(a). 
The polarisation transfer efficiency of this catalyst was compared to that of 
ICy(a) in reference to pyridine, 3-methylpyridine, 4-methylpyridine, quinoline 
and 2-aminothiazole. [Ir(H)2(ICy)2(py)2]Cl was found to exhibit a greater signal 
enhancement than ICy(a) in all the five previously mentioned substrates. This 
therefore demonstrates a new catalyst group which warrants further 
investigation.   
2. From a technological development point of view, a new polarisor which has the 
ability to heat or cool the sample concurrently with changing the magnetic field 
of the polarisation step. This will allow a complete optimisation for each 
catalyst/substrate system. 
3. During the investigations into the effect of changing solvent on the extent of 
polarisation transfer, it was observed that [Ir(H)2(carbene)(py)3]
+ was not the 
only species present in all solvents. It has been assumed that the solvent is 
benign in our systems however it is known that acetonitrile, acetone and DMSO 
can bind to the catalysts. It is also evident in the hydride region of the resultant 
NMR spectra collected for each solvent, that a combination of active species 
may be present. An idea for future work within this project would be to 
characterise these active complexes, and compare them through measured rate 
constants for loss of substrates. 
4. Further investigations into the routes of polarisation transfer into quinoline are 
also required. This includes a revision of the theory to include the larger spin 
system and presence of acetonitrile ligand.  
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5. 2D experiments completed using the SABRE technique with the automated flow 
system are collected using one scan per increment. This significantly saves time 
of collection for each 2D spectrum however it also results in an artefact on the 
centre of the f1 direction. A potential route to overcome this artefact without 
doubling collection time required is to apply a gradient across the sample cell 
such that 2 independent scans can be collected across the height of the cell. This 
means for each transient, 2 scans can be collected, and consequently two scans 
per increment can be used for each 2D spectrum without doubling the 
experiment time. It will be interesting to develop this idea in the future. 
6. The application of SABRE to hyperpolarised 2D 1H-15N spectra is also of great 
future interest as it would provide the potential to bring 15N spectroscopy into 
the routine of a pharmaceutical chemist. 
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8 Chapter 8 – Experimental 
8.1 Instrumentation and chemical sources 
8.1.1 NMR spectrometers 
Characterisations of complexes and substrates by NMR spectroscopy have been 
completed using a number of Bruker spectrometers. These include an Avance III 400 
MHz, Avance III 500 MHz, Avance II 600 MHz and Avance II 700 MHz, where the 1H 
frequency is measured at 400.13 MHz, 500.23 MHz, 600.12 MHz and 700.13 MHz and 
13C frequency is measured at 100.62 MHz, 125.80 MHz, 150.90 MHz and 176.07 MHz. 
The aforementioned spectrometers have also been used in the calculation of 
thermodynamic parameters. When completing hyperpolarised experiments with 
SABRE, the aforementioned 400 MHz spectrometer was used. Data acquisition and 
processing is carried out using the Bruker program TopSpin. During the course of this 
PhD, versions 2.1 and 3.1 have been used.  
During the course of these experiments, six NMR solvents are used: d4-methanol is 
referenced to residual CHD2OD, d1-chloroform is referenced to residual CHCl3, d6-
ethanol is referenced to residual CHD2CD2OD, d2-dichloromethane (DCM) is 
referenced to residual CDHCl2, d6-dimethylsulphoxide (DMSO) is referenced to 
residual (OS)CD3CD2H and d6-acetone is referenced to residual (OC)CD3CD2H.   
8.1.2 Preparation of parahydrogen 
Parahydrogen was prepared by cooling hydrogen gas over Fe2O3. The first 
parahydrogen rig was made in house and the exact catalyst and temperature used in this 
system to prepare parahydrogen has changed over the course of this work. It used a 
hydrogen cylinder as a source of normal hydrogen. Towards the end of the work, a rig 
was also provided by Bruker, which used a hydrogen generator as the source of normal 
hydrogen. These changes result in the exact percentage of hydrogen in the para state 
being constant for each individual experiment, but inconsistent across the three years. 
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8.1.3 Source of solvents and chemicals 
General solvents for synthetic chemistry were dried using an Innovative Technology 
anhydrous solvent engineering system or were distilled from an appropriate drying 
agent under N2 as necessary. Deuterated solvents were obtained from Sigma-Aldrich 
and used as supplied. High purity gases were obtained from BOC and used as received. 
8.2 Standard methods 
8.2.1 Hyperpolarisation method 1 – shake method 
Samples investigated using hyperpolarisation method 1 were completed using a 5 mm 
NMR tube fitted with a J Young valve (called a Young’s Tap NMR tube from here on 
in) containing a solution of catalyst (5 mM, 3.1 x 10-6 mol), substrate (100 mM, 6.2 x 
10-5 mol) and solvent (0.6 ml), unless otherwise stated. These are standard reagent 
conditions. The sample was degassed prior to activation by hydrogen gas at a pressure 
of 3 bar.  
For each experiment, the headspace of the Young’s NMR tube was evacuated, and 
replenished with 3 bar parahydrogen. The sample was then shaken for 8 s in the desired 
magnetic field (using the fringe field of the magnet) before being rapidly transported 
into the magnet for interrogation by NMR spectroscopy. A 1H NMR spectrum was 
collected with a 90º pulse as standard. 
8.2.2 Hyperpolarisation method 2 – flow method 
Samples investigated using hyperpolarisation method 2 were completed using a 
polarisation chamber charged with a solution of catalyst (5 mM, 1.55 x 10-5 mol), 
substrate (100 mM, 3.1 x 10-4 mol) and deuterated solvent (3 ml), unless otherwise 
stated. These are standard reagent conditions. Parahydrogen was introduced to the 
solution via six inlet tubes at a pressure of 3 bar for 6 s (unless otherwise stated). This 
solution was then transferred into the Bruker Avance III series 400 MHz spectrometer 
equipped with a flow probe head (flow cell volume = 200 µl) for interrogation by NMR 
using helium as a flow gas. Unless otherwise stated, a single transient was recorded for 
the nucleus of interest. A 1H NMR spectrum was collected with a 90º pulse as standard. 
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Once interrogated, the solution was returned to the polarising chamber with a helium 
flow gas and the process repeated as required.  
It was standard to activate a sample for interrogation by method 2 in the polarisor itself 
however this was not always possible. In the case of the ICy(a) catalyst for instance, the 
sample must be pre-activated in an ampoule as it takes too long to activate in the 
polarisor. To achieve this, the sample was prepared as required, then degassed in an 
ampoule. This was then put under an atmosphere of 3 bar hydrogen gas, shaken and 
stored at room temperature until the catalyst was active. When ready, the sample was 
injected as quickly as possible into the mixing chamber of the polarisor, trying to 
minimise exposure to air as much as possible. The system was then ready for 
interrogation by NMR.  
During the progression of this thesis, the technology for the polarisation chamber was in 
development and so consequently, three polarisation chambers have been used. For the 
first polarisation chamber (MK I), the applied magnetic field was controlled by the 
position of the polarisation chamber within the fringe field of the magnet and used a 
TXO flow probe. For the second (MK II) and third (MK III, Bruker) polarisation 
chamber, the magnetic field was controlled by a coil that surrounds the reaction 
chamber such that a magnetic field can be generated in the z direction, to produce static 
DC fields in the range of −150 to 150 x10-4 T. The MK II was connected to a TXO flow 
probe and the MK III connected to a TXI flow probe.  
8.2.3 Calculation of 1H NMR enhancement factors 
For calculation of the enhancement of 1H NMR signals the following formula was used: 
E =
Spol
Sunpol  
Equation 8.1 Equation used to calculate the 1H NMR signal enhancement. 
Equation 8.1 is true where: E = enhancement, Spol = signal of polarised sample measured 
by integral and Sunpol = signal of unpolarised (thermally polarised) reference sample 
measured by integral. 
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Experimentally, reference spectra were acquired after the sample had spent 5-10 
minutes at high magnetic field to ensure it was fully equilibrated to the Boltzmann 
distribution of spins, before any parahydrogen was added to the sample. The reference 
and polarised spectra were collected using identical acquisition parameters, particularly 
the receiver gain. The raw integrals of the relevant resonances in the polarised and 
thermal spectra were used to determine the enhancement level using Equation 8.1. 
Owing to the nature of parahydrogen derived hyperpolarisation, a sample interrogated 
by NMR in the presence of parahydrogen may result in both enhanced adsorption 
signals and enhanced emission signals. Consequently, the integral for an enhanced 
emission peak is negative. This sign has been carried through in the equation to the 
resulting calculated enhancement. This means that where a negative enhancement is 
quoted, the peak was in emission. In the case of an antiphase signal, the integral of 
whole peak is taken and therefore contains a mixture of both absorption and emission 
character. The quoted enhancement is therefore lower as a result of cancellation of the 
antiphase signal. 
In some sections, the enhancement relating to the OPSYdq sequence (see Chapter 1) has 
been quoted. As an OPSY without presence of parahydrogen results in no signal, the 
enhancement of these hyperpolarised spectra are based on a standard thermal 1H NMR 
spectra of the same receiver gain (16 for the OPSYdq sequence). 
8.2.4 Considerations when discussing the effect of the magnetic field of polarisation 
on polarisation transfer efficiency 
Whenever a magnetic field in Gauss is quoted, this refers to the magnetic field present 
during the addition of parahydrogen to the sample, the polarisation transfer step. In 
method 1, the field is applied during the time the sample is shaken in the presence of 
parahydrogen. This is typically completed at two fields, Earth’s magnetic field (0.5 G) 
and a higher field measured to be around 65 G which is achieved by shaking in the stray 
field of the spectrometer. In reality, this means the higher field utilised in method 1 is 
highly variable as the shake process causes the sample to cross over a range of field 
values.  
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In method 2, the field is applied during the bubbling of parahydrogen through the 
solution. For the MK I polarisor, the field is again applied using the stray field of the 
magnet however, the chamber is now stationary so the magnetic field range experienced 
by the sample is much less than that of method 1. For the MK II and MK III polarisors, 
the magnetic field is induced by a current introduced to the coil surrounding the sample. 
The magnetic field experienced by the sample can therefore be controlled by the amount 
of current in the coil; this corresponds to the value input by the user. The coil controls 
the field experienced in the vertical (z) direction and has additional turnings at each end 
of the coil to ensure homogeneity over the length of the coil. As the chamber is not 
stored at 0 G, but as close to Earth’s magnetic field as possible considering the required 
proximity to the spectrometer, the stated value is modulated slightly. The chamber is 
used in the same position during all experiments and so this modulation is constant. The 
standard method employed to understand the effect of changing the field of polarisation 
is to take a sample of standard concentrations, and interrogate it starting at -150 G and 
increasing the field by 10 G until an experiment at +10 G has been completed, unless 
otherwise stated. For each field, six 1H NMR spectra are taken to ensure reproducibility. 
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8.2.5 Effect of changing PTF on the polarisation transfer efficiency into various 
substrates 
8.2.5.1 Effect of changing PTF on polarisation transfer efficiency into pyridine with 
SIMes(a) 
 
Figure 8.1 Effect of changing PTF on polarisation transfer efficiency into pyridine using SIMes(a). 
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Figure 8.2 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
poyridine using SIMes(a). 
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8.2.5.2 Effect of changing PTF on polarisation transfer efficiency into pyridine using 
ICy(a) 
 
Figure 8.3 Effect of changing PTF on polarisation transfer efficiency into pyridine using ICy(a). 
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Figure 8.4 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
pyridine using ICy(a). 
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8.2.5.3 Effect of changing PTF on polarisation transfer efficiency into pyridine using 
ICy2(a) 
 
Figure 8.5 Effect of changing PTF on polarisation transfer efficiency into pyridine using ICy2(a). 
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Figure 8.6 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
pyridine using ICy2(a). 
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8.2.5.4 Effect of changing PTF on polarisation transfer efficiency into 3,4,5-d3-
pyridine using SIMes(a) 
 
Figure 8.7 Effect of changing PTF on polarisation transfer efficiency into 3,4,5-d3-pyridine using 
SIMes(a). 
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Figure 8.8 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
3,4,5-d3-pyridine using SIMes(a). 
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8.2.5.5 Effect of changing PTF on polarisation transfer efficiency into quinoline using 
IMes(b) 
 
Figure 8.9 Effect of changing PTF on polarisation transfer efficiency into quinoline using IMes(b). 
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Figure 8.10 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
quinoline using IMes(b). 
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8.2.5.6 Effect of changing PTF on polarisation transfer efficiency into 4-
methylpyridine using SIMes(a) 
 
Figure 8.11 Effect of changing PTF on polarisation transfer efficiency into 4-methylpyridine using 
SIMes(a). 
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Figure 8.12 Graphical representation of the field profile of SIMes(a) with 4-methylpyridine. 
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8.2.5.7 Effect of changing PTF on polarisation transfer efficiency into 3-
methylpyridine using SIMes(a) 
 
Figure 8.13 Effect of changing PTF on polarisation transfer efficiency into 3-methylpyridine using 
SIMes(a). 
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Figure 8.14 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
3-methylpyridine using SIMes(a). 
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8.2.5.8 Effect of changing PTF on polarisation transfer efficiency into 2-aminothiazole 
using IMes(a) 
 
Figure 8.15 Effect of changing PTF on polarisation transfer efficiency into 2-aminothiazole using 
IMes(a). 
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Figure 8.16 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
2-aminothiazole using IMes(a). 
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8.2.5.9 Effect of changing PTF on polarisation transfer efficiency into 3-
phenylpyridine using IMes(a) 
 
Figure 8.17 Effect of changing PTF on polarisation transfer efficiency into 3-phenylpyridine using 
IMes(a). 
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Figure 8.18 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
3-phenylpyridine using IMes(a). 
The enhancements corresponding to the signals of protons 5 and 9 are not representative 
of the enhancement for each individual signal. The values are low as a result of the 
combination of positive and negative signals.  
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8.2.5.10 Effect of changing PTF on polarisation transfer efficiency into 4-
phenylpyridine using IMes(a) 
 
Figure 8.19 Effect of changing PTF on polarisation transfer efficiency into 4-phenylpyridine using 
IMes(a). 
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Figure 8.20 Graphical representation of the effect of changing PTF on polarisation transfer efficiency into 
4-phenylpyridine using IMes(a). 
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8.2.6 Calculation of rate constants for ligand loss and thermodynamic activation 
parameters 
A
B
C
i
ii  
Figure 8.21 The reaction co-ordinate for the dissociative reaction for loss of ligand. 
A series of 1D EXSY experiments were completed to enable the calculation of the 
pyridine and hydride ligand exchange rates in the active forms of IMes(a), SIMes(a) 
and ICy(a) as a function of temperature. The associated rates of ligand exchange were 
determined by application of the Dynafit108 programme. These data are expected to 
provide us with a better understanding of the effect the carbene ligand has on catalyst 
activity.  
In this case, the measured rate corresponds to the transformation from bound ligand 
(hydride/substrate) to free ligand, A to C in Figure 8.21, and is quoted per mole of 
iridium complex. When calculating ∆H≠, ∆S≠ and ∆G≠, the rate data used should refer 
to the rate of reaching the transition state (B) which is twice the measured rate. This is 
because once the molecule has reached point B, it is possible for it to fully disassociate 
to form C, or re-associate to form A. Consequently, the Eyring plots for activation 
parameters of both hydride ligand and pyridine loss are calculated using a graph of ln(2 
x measured rate/temperature) vs 1/temperature.109 In all cases, the raw rates are 
measured as per mole of iridium catalyst, and not per mole of hydride ligand or 
pyridine. 
8.2.7 Procedure for investigating the effect of changing temperature of polarisation on 
polarisation transfer efficiency 
The effect of changing the temperature of addition of parahydrogen to a SABRE 
catalyst was investigated using method 1. To complete these experiments the sample 
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must first be put under a parahydrogen atmosphere but not shaken. It is then stored at 
the desired temperature for three minutes with as little disturbance as possible. The 
NMR tube is then quickly wiped dry, shaken for 8 s and interrogated by NMR 
spectroscopy. Although a small amount of loss of parahydrogen will be experienced, if 
it is refreshed after the wait at the stated temperature, the sample will equilibrate 
towards room temperature. Refreshing the head space before getting the sample to the 
desired temperature minimises the loss (or gain) in temperature during the shake. It is 
also difficult to evacuate the sample ready for fresh parahydrogen when the sample is at 
an elevated temperature due to the solvent being volatile. Evacuation also has the effect 
to cool the sample. The volatility of the solvent also means the effect of increasing the 
temperature above 50 oC is not practical. 
8.3 Additional experiments 
8.3.1 Relative excess of hydrogen gas present in an NMR sample interrogated using 
method 1 
In order to fully understand the effects of changing the concentration of catalyst and 
substrate in a sample to be interrogated by method 1, it is important to understand how 
many moles of gas are present in the sample. To calculate this, a standard Youngs tap 
NMR tube was weighed when empty (29.6343 g). It was then filled with water and    
0.6 ml water was removed to allow for the space taken up by the sample. The NMR 
tube was weighed again (31.5361 g) and the two masses subtracted from each other 
(1.9018 g). As water has a density of 1 g/ml, this suggests the headspace in a typical 
NMR tube is ~1.9 ml. This value was then used in the ideal gas law to calculate the 
number of moles of hydrogen present in the headspace when 3 bar of pressure is applied 
at room temperature (293 K).  
PV = nRT, where P = 3 bar = 300, 000 Pa, V = 1.9 ml = 1.9x10-6 m3, n = x moles, R = 
8.314 JK-1mol-1 and T = 293 K. When rearranged this means the headspace contains 
2.34x10-5 mol which is equal to 0.0234 mmol. This is the number of moles of hydrogen 
present in a sample prior to activation. After activation, it is important to recognise that 
there will be an additional number of moles of hydrogen in the sample corresponding to 
those bound to the metal catalyst as hydride ligands. These must also be taken into 
account. These calculations have been presented for standard concentration samples. 
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In a standard 0.6 ml 100 mM sample, there is 0.0031 mmol of catalyst. Before 
activation, the catalyst and hydrogen are therefore present in the ratio 0.0031 : 0.0234 
which indicates that there is a 7.5 fold excess of hydrogen. After activation, each mole 
of catalyst has two hydrides and therefore a mole of hydrogen. Taking this into account, 
the catalyst and hydrogen in the sample are in the ratio 0.0031 : (0.0234 + 0.0031) 
which is equal to 0.0031 : 0.0265, giving an 8.5 fold excess of hydrogen in the sample. 
These results, together with those corresponding to other concentrations used in this 
thesis are presented in Table 8.1. 
Percent of 
std conc. 
[Cat.] 
mM 
Cat. 
mmol 
Excess of hydrogen in NMR tube 
Before activation After activation 
1000 50 0.031 0.75 1.75 
500 25 0.0155 1.51 2.5 
100 5 0.0031 7.55 8.5 
10 0.5 0.00031 75.5 76.5 
1 0.05 0.000031 755 756 
Table 8.1 The excess of hydrogen present in sample interrogated by method 1 at various levels of catalyst 
loading. 
8.3.2 Calculations relating to the solubility of hydrogen gas in methanol 
8.3.2.1 Calculations based on equations reported in Solubility of Gases in Liquids212 
The book, Solubility of Gases in Liquids, proposes that Equation 8.2 can be used to 
calculate the mole fraction of hydrogen dissolved in methanol at various temperatures, 
with a pressure of 1.013 bar.  
ln(xg)=-7.3644-(408.38/T) 
Equation 8.2 Mole fraction of hydrogen, xg, dissolved in methanol at 1.013 bar pressure of gas, where T = 
temperature in K, taken from Solubility of Gases in Liquids.212 
The mole fraction of hydrogen in methanol has been calculated according to Equation 
8.2 at the temperatures used in method 1, and presented in Table 8.2. Assuming 
hydrogen is an ideal gas, the second column shows the calculated values multiplied by 3 
to take into account the increase in pressure present in method 1 experiments. 
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T / K Mole fraction of hydrogen in methanol, xg Dissolved 
hydrogen (mmol) 1.013 bar 3 bar 
273 0.000142 0.000426 0.0000100 
293 0.000157 0.000472 0.0000110 
303 0.000165 0.000494 0.0000116 
313 0.000172 0.000515 0.0000121 
323 0.000179 0.000537 0.0000126 
Table 8.2 Amount of dissolved hydrogen (mmol) in a standard method 1 sample at various temperatures, 
predicted as by Equation 8.2. 
Table 8.2 indicates that the number of moles of dissolved H2 is very low, and the 
catalyst is predicted to be in excess by 310 fold in solution, despite the excess of 
hydrogen present in the headspace. In order for IMes(a) to fully convert into active 
catalyst, H2 must dissolve during the reaction, a process which does not happen rapidly. 
This is revealed by the fact that if a sample of IMes(a) if left to activate overnight with 
no disturbance at all, only the top ~6th of the sample is colourless and therefore active. 
The remaining ~5/6ths of the sample exhibits no colour change and remains as IMes(a). 
A paper published by Iggo et al.213 in 1998 reports similar examples of slow hydrogen 
dissolution into CDCl3 and design a high pressure flow cell to overcome this hurdle. 
Our SABRE samples are therefore vigorously shaken to force hydrogen gas into 
solution with the result that the whole sample becomes colourless and therefore active 
within 5 minutes, proven by NMR.  
8.3.2.2 Calculations based on equations reported by Liu et al.214 
The previous calculations were based on an equation which was produced for a standard 
pressure (1.013 bar). In the case that H2 is not an ideal gas, a different method was 
therefore sought to include the effect of pressure. This was based on that in a paper 
published by Liu et al.214 in which hydrogen solubility is measured over a range of 
temperatures (23.1 ºC to 140.3 ºC) and pressures (5 bar to 16 bar). These data were 
combined to produce Equation 8.3a which can be used to calculate a value for Henry’s 
law constant at a specified temperature and pressure. This is then used in Equation 8.3b 
to calculate the mole fraction of xH2 in methanol.  
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a) lnH = 122.3 - 4815.6/T - 17.5lnT + 1.4x10-7*P  
b)    H = PH2/xH2 
Equation 8.3 a) To calculate Henry’s Law constant for hydrogen dissolved in methanol, where H = 
Henry’s Law constant (MPa), T = temperature in K and P = pressure in Pa, taken from Liu et al.214 b) 
Henry’s Law correct at a specified temperature, where xH2 is the mole fraction of hydrogen dissolved in 
methanol. 
Table 8.3 presents the mole fraction of hydrogen in methanol in each temperature 
calculated according to Equation 8.3a+b. 
T/K H xH2 Dissolved hydrogen 
(mmol) 
273 689.99 0.000435 0.0000102 
293 667.46 0.000449 0.0000105 
303 638.17 0.000470 0.0000110 
313 600.73 0.000499 0.0000117 
323 557.86 0.000538 0.0000126 
Table 8.3 The amount of dissolved hydrogen (mmol) in method 1 samples at various temperatures as 
predicted by Equation 8.3a+b. 
These data matched those presented in Table 8.2 very closely. They have revealed 
therefore that H2 dissolution is a major factor when considering activation and 
polarisation transfer of method 1 samples. This explains the need for vigorous shaking 
before interrogation by NMR. The reliance of the method on the shake itself explains 
the poor reproducibility of the method as it is very difficult to shake a sample with 
exactly the same force for exactly the same time, every time the method is implemented.  
8.3.3 Calculation of estimated integrals of thermally polarised spectra for low 
concentration samples 
When investigating the effect of concentration on the extent of polarisation transfer, it 
was not possible to observe thermally polarised signals for pyridine in the low 
concentration samples in a single scan. To obtain an idea of enhancements with these 
samples, the integral of the thermally polarised signals are estimated based on 
extrapolation of the integrals of the higher pyridine concentration samples (Table 8.4). 
This was only required for sample 5 of the investigation where the ratio of catalyst and 
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substrate were kept constant as in all other cases, the hyperpolarised signals were also 
too small.  
 Absolute integral of thermally polarised spectrum 
Conc. Py (mM) 500 300 100 10 
Volume of py (µL) 25 15 5 0.5 
ortho proton 1533121 835784 276097 28628 
meta proton 1535088 832981 276110 28921 
para proton 776220 430658 138223 15485 
Table 8.4 The absolute integrals of the three positions of pyridine observed in a single scan 1H NMR 
spectrum at the indicated volumes. 
The data in Table 8.4 is presented graphically in Figure 8.22. The equations are derived 
in Excel through the trendline function and the intercept has been set to zero.  
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Figure 8.22 Graphical representation of the absolute integrals of the three positions of pyridine observed 
in a single scan 1H NMR spectrum at the indicated volumes. The equations of the trend lines are included. 
The equation for the trend line of each position is used to estimate the integral of the 
signal observed in a single 1H NMR spectrum of a pyridine sample at lower 
concentrations. The integrals of the thermally polarised signals used for calculations of 
enhancements are therefore presented in Table 8.5. 
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 Absolute integral of thermally polarised spectrum 
Conc. Py (mM) 500 300 100 10 1 
Volume of py (µL) 25 15 5 0.5 0.05 
ortho proton 1533121 835784 276097 28628 2985.4 
meta proton 1535088 832981 276110 28921 1517.5 
para proton 776220 430658 138223 15485 2985.85 
Table 8.5 The absolute integrals of the three positions of pyridine observed in a single scan 1H NMR 
spectrum at the indicated volumes. The integrals for the 1 mM (0.05 µL) sample have been calculated 
according to Figure 8.22. 
For the 1 mM sample, the enhancements for each of the three days were based on the 
calculations for day 1. This is so that deuteration of the higher concentration samples 
does not affect the predicted integral. This however means the enhancement calculation 
does not take into account any deuteration that occurred to the 1 mM sample across the 
three days.  
8.3.4 Thermally polarised spectra of quinoline using standard concentrations for 
comparison 
The 2D techniques described in Chapter 5 must be compared to thermally polarised 
spectra. To achieve this, a series of spectra have been collected using a standard 
concentration of quinoline in a sample without any catalyst present. The spectra have 
therefore been collected using a 100 mM, 10 mM and 1 mM sample of quinoline. The 
spectra have been completed in two ways. Firstly, with the same parameters as are used 
in the hyperpolarised spectrum. These are presented in Table 8.6.  Secondly, in the case 
this does not yield a spectrum with the majority of the expected correlations, the number 
of increments and/or scans per increment were increased to produce the expected 
spectrum. 
Sequence sw (ppm) centre (ppm) rg ns td aq (s) 
1H-1H COSY 3, 3 8.25, 8.25 64 1 64 0.85 
1H-13C HSQC 3, 50 8.25, 140 2050 1 64 0.85 
1H-13C HMBC 3, 50 8.25, 140 2050 1 64 0.85 
1H-13C HMQC 1.6, 40 8.2, 135 2050 1 64 0.8 
Table 8.6 Parameters used for selected 2D sequences with the flow system, where ‘sw’ is the spectral 
width, ‘centre’ is the centre of the spectral width, ‘rg’ is the receiver gain, ‘ns’ is the number of scans, ‘td’ 
is the number of increments and ‘aq’ is the acquisition time of each scan.  
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For the 100 mM quinoline sample, the spectra collected with the standard parameters 
used in the flow experiments were sufficient to gain good quality spectra in which most 
correlations were observed. To observe all correlations in the 1H-13C HMBC and 1H-13C 
HMQC NMR spectra, the number of scans was increased to 4 per 128 increments 
increasing the time of collection to 21 min and 27 sec and 20 min and 30 sec 
respectively.  
For the 10 mM quinoline sample, only the spectra collected with standard parameters 
used in the flow experiments for the 1H-1H COSY and 1H-13C HSQC NMR sequences 
contained all the expected correlations. For the 1H-13C HMBC and 1H-13C HMQC NMR 
spectra, the number of scans had to be increased to 16 per 128 increments for all 
expected correlations to be observed. This increased the collection time for each spectra 
to increase to 1 hr 23 min 47 sec for the 1H-13C HMBC NMR spectrum and 1 hr 24 min 
9 sec for the 1H-13C HMQC NMR spectrum.  
For the 1 mM quinoline sample, only the spectra collected with standard parameters 
used in the flow experiments for the 1H-1H COSY NMR sequence contained all the 
expected correlations, although the signals were weak. For the remaining 3 
heteronuclear sequences the number of scans was increased to 64 per 128 increments, 
making the collection an average to 5 hours and a half. Even after this time, none of the 
expected correlations were observed.  
8.4 Reactions  
All experimental procedures were performed under an atmosphere of either dinitrogen 
or argon, using standard Schlenk line techniques or an MBraun Unilab glovebox, unless 
otherwise stated. All NMR samples were made up in standard 5 mm NMR tubes of 
those equipped with a Young’s tap where required.  
8.4.1 [Ir(COD)Cl]2
215 
IrCl3.3H2O (2.0012 g, 352.69 g mol
-1, 5.67 mmol) was suspended in water and 2-
propanol (17 : 34 ml) in a 2-necked round bottomed flask and degassed with N2 for 20 
min. COD (6 ml, 5.292 g, 108 g mol -1, 0.0489 mol) was added under N2 and the 
mixture was heated at reflux at 100 oC for a minimum of 24 hours. The dark solution 
turned from brown to yellow with a red precipitate. After this time, the mixture was 
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allowed to cool and the red precipitate was then filtered off and washed in a minimum 
amount of cold methanol. This was further dried on the high vacuum line. A red solid 
was collected (1.1647 g, 671.34 g mol-1, 1.73 mmol, 61 %). If the mixture had an oily 
appearance after the initial cooling, it was refluxed for a further 24 hours, then allowed 
to cool again and filtered as described before. 
8.4.2 [Ir(µ-MeO)(COD)]2
216 
All the solvents used were dried and degassed before the experiment took place. The 
experiment was carried out under N2 throughout. 
KOH (0.1709 g, 56.1 g mol-1, 3 mmol) and [Ir(COD)Cl]2 (1.0183 g, 671.34 g mol
-1,   
1.5 mmol) were weighed out into separate Schlenk tubes and both were evacuated. 
Methanol (120 ml) was evacuated and degassed. This was then transferred onto the 
solids by cannula (34 ml to KOH and 68 ml to the dimer). Once the KOH had dissolved, 
the solution was transferred to the iridium solution by cannula. This was then stirred at 
room temperature for a minimum of 30 min, until the mixture had turned a golden 
yellow.  
Degassed water was then added by cannula and a yellow solid precipitated out. This 
was filtered out over a sinter glass (grade 3) immediately and dried on the high vac line. 
The yellow solid is the product (0.7621 g, 662.44 g mol-1, 1.15 mmol, 77 %). The solid 
must be filtered and dried as soon as possible as the solid can degrade in solution.   
8.4.3 [Ir(IMes)(COD)Cl]104 (IMes(a)) 
Bis-1,3-(2,4,6-trimethylphenyl) imidazole hydrochloride (IMes.HCl, 0.923 g,           
2.72 mmol) and potassium tert-butoxide (0.336 g, 3 mmol) were added to a Schlenk 
flask. . Dry THF (20 ml) was added to the flask and the reaction mixture was stirred for 
30 min. [IrCl(COD)]2 (0.915 g, 1.36 mmol) was dissolved in a minimum volume of dry 
THF and added to the first schlenk by cannula transfer and stirred for 1 hour. The 
solvent was then removed under vacuum and the resulting solid purified by column 
chromatography with an eluent of DCM:Acetone (19:1) resulting in a yellow/orange 
powder (1.12 g, 64 %). 
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8.4.4 [Ir(IMes)(COD)NCMe]PF6
80 (IMes(b)) 
A solution of [IrCl(COD)(IMes)] (0.102 g, 0.160 mmol) in dry acetone (5 ml) was 
treated with AgPF6 (46.5 mg, 0.184 mol) and stirred for 30 min at room temperature in 
the dark. This was then filtered through Celite under N2. Acetonitrile (1 ml) was then 
added to the solution and stirred under N2 for 30 min at room temperature. The solvent 
was removed under vacuum to give an orange solid (0.0977 g, 78 %).  
8.4.5 [Ir(SIMes)(COD)Cl]104 (SIMes(a)) 
Under N2, a Schlenk tube was charged with [Ir(µ-OMe)(COD)]2 (0.1416 g, 662.44 g 
mol-1, 0.21 mmol) and bis-1,3-(2,4,6-trimethylphenyl) imidazoline hydrochloride 
(SIMes.HCl, 0.139 g, 342.71 g mol-1, 0.40 mmol). Dry acetone (dried on a still over 
CaCO3, 15 ml) was added to the Schlenk tube by cannula. The bright yellow solution 
was stirred at room temperature for 30 mins, after which time it had turned a golden 
yellow colour. The solvent was removed in vacuo to give a golden yellow solid. The 
solid product was purified by flash column chromatography on silica in 19:1 
DCM:acetone. (0.1989 g, 642.28 g mol-1, 77 %).  
8.4.6 [Ir(SIMes)(COD)NCMe]PF6
80 (SIMes(b)) 
A solution of [Ir(SIMes)Cl(COD)] (0.1302 g, 642.04 g mol-1, 0.2 mmol) in acetone      
(3 ml) was treated with silver hexafluorophosphate (50 mg, 252.83 g mol-1,             
0.198 mmol) and stirred for 30 min at room temperature in the dark. This was filtered 
through celite (under a N2 atmosphere) and acetonitrile (1 ml) added. This was stirred 
for 30 min at room temperature. The solvent was evaporated under vacuum. The 
resulting orange solid was isolated (0.0534, 796.89 g mol-1, 0.067 mmol, 33 %). 
8.4.7 Bis-1,3-cyclohexyl imidazole hydrochloride (ICy.HCl)217 
A nitrogen atmosphere is required wherever possible. Cyclohexylamine (4.3 ml, 4.96 g, 
99.17 g mol-1, 50 mmol) was added to toluene (50 ml) in a 250 ml round bottomed 
flask. Under N2 and with intense stirring, paraformaldehyde (1.5 g, 50 mmol) was 
added. This was stirred intensely for 30 min at room temperature and then cooled to      
0 oC. A further portion of cyclohexylamine (4.3 ml, 4.96 g, 99.17 g mol-1 50 mmol) was 
added and the solution stirred at 0 oC for a further 10 min.  
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3.3 M HCl (15 ml, 50 mmol) was added drop-wise and the solution allowed to warm up 
to room temperature. 40 % aqueous glyoxal (72.5 ml, 50 mmol) was added slowly and 
stirred at 50 oC for 12 hours. It was then allowed to cool. Diethyl ether (50 ml) was 
added followed by saturated sodium carbonate solution (25 ml). The layers were then 
separated. 
The aqueous layer was washed with diethyl ether (3 x 50 ml) and the volatiles were 
removed under vacuum. This was then extracted with dichloromethane (75 ml), dried 
with magnesium sulphate, filtered and solvent removed under vacuum. A light brown 
solid (1.3451 g, 268.5 g mol-1, 5 mmol, 10 %) was produced which was stored under 
N2.  
8.4.8  [Ir(ICy)(COD)Cl]104 (ICy(a)) 
Bis-1,3-cyclohexyl imidazole hydrochloride (ICy.HCl, 381 mg, 1.4 mmol) and 
potassium tert-butoxide (160 mg, 1.4 mmol) were added to a Schlenk flask. Dry THF 
(20 ml) was added to the flask under an inert atmosphere and the reaction mixture was 
stirred for 30 min. [IrCl(COD)]2 (240 mg, 0.36 mmol) was dissolved in a minimum 
volume of dry THF and added to the first schlenk by cannula transfer and stirred for 1 
hour. The solvent was then removed under vacuum and the resulting solid purified by 
column chromatography with an eluent of DCM:Acetone (19:1) resulting in a 
yellow/orange powder (46 mg, 12 %). 
8.4.9 [Ir(ICy)2(COD)]Cl
104 (ICy2(a)) 
Bis-1,3-cyclohexyl imidazole hydrochloride (ICy.HCl, 381 mg, 1.4 mmol) and 
potassium tert-butoxide (160 mg, 1.4 mmol) were added to a Schlenk flask. . Dry THF 
(20 ml) was added to the flask and the reaction mixture was stirred for 30 min. 
[IrCl(COD)]2 (240 mg, 0.36 mmol) was dissolved in a minimum volume of dry THF 
and added to the first schlenk by cannula transfer and stirred for 1 hour. This produced a 
red solid which was filtered off in air (47 mg, 9 %). 
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8.5 Characterisation of catalyst precursors and active polarisation transfer 
catalysts 
A series of typical 1H and appropriate 2D data is presented in section 8.5.5 for the 
characterisation of [Ir(IMes)(quinoline)2(H)2(NCMe)]Cl as a representative example of 
the procedures used. 
8.5.1  [Ir(COD)Cl]2 
NMR matches previously reported data and the solid was the expected colour. 
8.5.2 [Ir(µ-MeO)(COD)]2 
NMR matches previously reported data and the solid was the expected colour. 
8.5.3  [Ir(IMes)(COD)Cl] (IMes(a)) 
1H NMR (MeOD, 400 MHz, 300 K): 7.22 (s, 2H, N-CH-CH-N), 7.04 (s, broad, 4H, 
CHmes), 3.99 (m, 2H, CHCOD), 3.08 (m, 2H, CHCOD), 2.36 (s, 6H, CH3
mes), 2.29 (s, 6H, 
CH3
mes), 2.18  (s, 6H, CH3
mes), 1.68 (m, 4H, CH2
COD), 1.30 (m, 4H, CH2
COD). 13C{1H} 
NMR (MeOD, 300 K): 179.3 (N-C-N), 138.5 (qCar), 136.8 (qCar), 136.2 (N-qCar), 
134.5 (qCar), 129.2 (CHar), 127.9 (CHar), 123.8 (N-CH-CH-N), 81.4 (CHcod), 51.8 
(CHcod), 32.7 (CH2
cod), 28.3 (CH2
cod), 19.8 (CH3
mes), 18.7 (CH3
mes), 17.2 (CH3
mes).  
These results are similar to those in the literature94 which were completed in 
chloroform.  
8.5.4 [Ir(IMes)(py)3(H)2]Cl 
1H NMR (MeOD, 500 MHz, 243 K): 8.58 (d, J = 4.37 Hz, 38H, oH, free py), 8.34 (d, J 
= 4.98 Hz, 4H, oH, py trans to hydride), 8.09 (d, J = 5.43 Hz, 2H, oH, py cis to 
hydride), 7.93 (tt, J = 7.67, 1.74 Hz, 18H, pH, free py), 7.79 (tt, J = 7.53, 1.46 Hz, 2H, 
pH, py trans to hydride), 7.69 (t, J = 7.67 Hz, 1H, pH, py cis to hydride), 7.51 (m, 40H, 
mH, free py), 7.18 (s, 2H, N-CH-CH-N), 7.14 (m, 4H, mH, py trans to hydride), 6.99 
(m, 2H, mH, py cis to hydride), 6.67 (s, 4H, CHmes), 2.20 (s, 6H, pCH3
mes), 2.06 (s, 
12H, oCH3
mes), -22.52 (s, 2H, hydrides). 
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13C{1H} NMR (MeOD, 243 K): Q (N-C-N), 167.5 (N-qCHar), 155.3 (oC, py cis to 
hydride), 154.3 (oC, py trans to hydride), 148.6 (oC, free py), 138.2 (qCar), 137.4 (pC, 
free py), 136.3 (pC, py cis to hydride), 135.8 (pC, py trans to hydride), 135.1 (qCar), 
128.4 (CHar), 125.3 (mC, py cis to hydride), 125.2 (mC, py trans to hydride), 124.4 
(mC, free py), 122.4 (N-CH-CH-N), 19.7 (pCH3
mes), 17.7 (σCH3
mes).  
8.5.5 [Ir(IMes)(quinoline)2(H)2(NCMe)]Cl 
It has not been possible to connect the pyridine ring to the phenyl ring in either bound 
quinoline ligands. The signals corresponding to these protons and carbons are therefore 
referred to as H-ph and C-ph respectively. ‘nbr’ means the signal is not base line 
resolved and therefore a reliable integral cannot be collected and it may have not been 
possible to ascertain correlations to this signal. A labelled chemical structure of 
quinoline is included in labels of quinoline, see section 8.7.2.1.  
1H NMR (MeOD, 400 MHz, 250 K): 9.41 (d, J = 4.83 Hz, 1H, H2 trans to hydride), 
9.36 (d, J = 9.09 Hz, 1H, H2 cis to hydride), 8.51 (d, J = 7.95 Hz, 1H, H4 trans to 
hydride), 8.29 (m, 1H, H-ph), 8.19 (d, J = 7.95 Hz, 1H, H-ph), 7.91 (t, J = 7.95 Hz, 1H, 
H3 cis to hydride), 7.84 (t, J = 7.95 Hz, nbr), 7.77 (m, nbr, H5-ph), 7.67 (nbr, H8-ph), 
7.60 (m, 1H, H3 trans to hydride), 7.28 (t, J = 7.38 Hz, 1H, H6-ph), 7.14 (s, 2H, N-CH-
CH-N), 6.96 (s, 2H, CHmes), 6.83 (m, 1H, H-ph), 6.74 (t, J = 7.95 Hz, 1H, H7-ph), 6.38 
(s, 2H, CHmes), 2.38 (s, 6H, CH3
mes), 2.10 (s, 6H, CH3
mes), 2.07 (s, 3H, bound NCCH3), 
1.71 (t, J = 3.00 Hz, 6H, CH3
mes), -20.45 (d, J = 6.55 Hz, 1H, hydride), -22.54 (d, J = 
6.19 Hz, 1H, hydride). 
13C{1H} NMR (MeOD, 250 K): 156.0 (C2 trans to hydride), 154.6 (C-ph), 149.1 (qC9), 
147.2 (qC9), 138.4 (C4 trans to hydride), 138.1 (qCar), 137.7 (C-ph), 137.3 (N-qCHar), 
135.6 (qCar), 135.3 (qCar), 129.7 (C3 cis to hydride), 129.3 (C7-ph), 128.8 (qC10), 
128.4 (CHmes), 128.3 (CHmes), 126.6 (C6-ph), 122.4 (N-CH-CH-N), 122.1 (qC10), 
121.8 (C-ph), 117.8 (NCCH3), 19.8 (CH3
mes), 17.6 (CH3
mes), 17.0 (CH3
mes), 1.93 
(NCCH3). 
Below are representative 1D and 2D spectra that are typically used in the 
characterisation of chemical structures. 
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Figure 8.23 1H NMR spectrum of [Ir(IMes)(H)2(quinoline)2(NCMe)]Cl. 
 
Figure 8.24 1H NMR spectrum of [Ir(IMes)(H)2(quinoline)2(NCMe)]Cl expanded to show the 
complicated aromatic region, including the relative integrals of the signals. 
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Figure 8.25 13C{1H} NMR spectrum of [Ir(IMes)(H)2(quinoline)2(NCMe)]Cl. 
 
Figure 8.26 1H-1H COSY NMR spectrum of [Ir(IMes)(H)2(quinoline)2(NCMe)]Cl. 
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Figure 8.27 1H-1H COSY NMR spectrum of [Ir(IMes)(H)2(quinoline)2(NCMe)]Cl expanded to 
investigate the correlations corresponding to the hydride ligands. Left shows the correlations of the 
hydride ligands to each other, and right shows the correlations of the hydride ligands to the others protons 
in the complex. 
In Figure 8.27 left, it is possible to observe not only the two doublets corresponding to 
the hydride ligands but also a singlet to the left of each. These singlets correspond to the 
two possible HD exchange products. 
1H-13C HMQC NMR spectra are also collected, optimised for one, two and three bond 
couplings. Figure 8.28 represents such a spectrum.  
 
Figure 8.28 1H-13C HMQC NMR spectrum [Ir(IMes)(H)2(quinoline)2(NCMe)]Cl optimised for 2 bond 
couplings.  
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The signal intensity of the above spectra can be altered to observe different correlations.  
8.5.6 [Ir(IMes)(COD)(NCMe)]PF6 (IMes(b)) 
1H NMR (CDCl3, 500 MHz, 298 K): 7.125 (s, 2H, N-CH-CH-N), 7.09 (s, broad, 4H, 
CHmes), 4.021 (m, 2H, CHCOD), 3.466 (m, 2H, CHCOD), 2.415 (s, 6H, CH3
mes), 2.188 (s, 
12H, CH3
mes), 1.857 (m, 2H, CH2
COD), 1.732 (m, 2H, CH2
COD), 1.573 (m, 4H, CH2
COD). 
13C{1H} NMR (CDCl3, 298 K): 213.8 (N-C-N), 173.3 (N-qC
ar), 162.6 (CHcod), 145.9 
(CHcod), 140.0 (qCar), 135.0 (qCar), 129.36 (CHar), 124.96 (q-NCCH3), 124.27 (CH
ar), 
29.0 (CH2
cod), 32.88 (CH2
cod), 32.75 (CH2
cod), 21.06 (CH3
mes), 18.35 (CH3
mes).  
8.5.7  [Ir(SIMes)(COD)Cl] (SIMes(a)) 
1H NMR (MeOD, 400 MHz, 295 K): 6.99 (s, 2H, CHmes), 6.97 (s, 2H, CHmes), 3.95 (m, 
4H, N-CH2-CH2-N), 3.94 (m, 2H, CH
COD), 3.21 (m, 2H, CHCOD), 2.51 (s, 6H, CH3
mes), 
2.38 (s, 6H, CH3
mes), 2.33  (s, 6H, CH3
mes), 1.63 (m, 4H, CH2
COD), 1.31 (m, 4H, 
CH2
COD). 13C{1H} NMR (MeOD, 295 K): 206 (N-C-N), 137.6 (qCar), 137.5 (qCar), 
136.3 (qCar), 135.4 (qCar), 129.2 (CHar), 128.2 (CHar), 82.4 (CHcod), 51.7 (CHcod), 51.5 
(N-CH2-CH2-N), 32.9 (CH2
cod), 28.15 (CH2
cod), 19.8 (CH3
mes), 18.8 (CH3
mes), 17.4 
(CH3
mes).  
MS (ESI) m/z (%): 648 (M+ -Cl + acetonitrile), 607 (M+ -Cl). 
These results are similar to those in the literature94,218 which were completed in 
chloroform.  
8.5.8 [Ir(SIMes)(py)3(H)2]Cl 
1H NMR (MeOD, 600 MHz): 8.57 (d, J = 4.31 Hz, 21H, oH, free py), 8.32 (broad, 4H, 
oH, py trans to hydride), 7.97 (d, J = 4.39 Hz, 2H, oH, py cis to hydride), 7.88 (tt, J = 
7.66, 1.39 Hz, 8H, pH, free py), 7.76 (broad, 2H, pH, py trans to hydride), 7.66 (tt, J = 
7.56, 1.64 Hz, 1H, pH, py cis to hydride), 7.46 (broad, 20H, mH, free py), 7.12 (broad, 
4H, mH, py trans to hydride), 6.97 (t, J = 6.72 Hz, 2H, mH, py cis to hydride), 6.63 (s, 
4H, CHAr, mes), 4.58 (s, 4H, free H2), 3.90 (s, 4H, N-CH2-CH2-N), 2.27 (s, 12H, 
oCH3
mes), 2.16 (s, 6H, pCH3
mes), -22.69 (s, 2H, hydrides). 
359 
13C{1H} NMR (MeOD): 208.6 (N-C-N), 179.7 (N-qCHar), 154.8 (oC, py trans to 
hydride), 154.0 (oC, py cis to hydride), 148.6 (oC, free py), 138.4 (pC, py trans to 
hydride), 137.1 (pC, free py), 136.4 (qCar), 135.9 (pC, py cis to hydride), 128.7 (CHar), 
128.4 (qCar), 125.1 (mC, py cis to hydride), 124.9 (mC, py trans to hydride), 124.4 (mC, 
free py), 50.4 (N-CH2-CH2-N), 19.4 (pCH3
mes), 17.4 (oCH3
mes).  
8.5.9 Bis-1,3-cyclohexyl imidazole hydrochloride (ICy.HCl) 
1H NMR (CDCl3, 500 MHz, 298 K): 10.97 (s, 1H, N-CH-N), 7.31 (s, 2H, N-CH-CH-
N), 4.59 (tt, J = 12.0, 3.8 Hz, 2H, CHcy), 2.24 (d, J = 11.5 Hz, 4H, CH2
cy), 1.93 (dm, J = 
13.9 Hz, 4H, CH2
cy), 1.76 (m, 4H, CH2
cy), 1.52 (qt, J = 13.2, 3.2 Hz, 4H, CH2
cy), 1.28 
(qt, J = 13.1, 3.7 Hz, 4H, CH2
cy). 13C{1H} NMR (CDCl3, 298 K): 136.6 (N-CH-N), 
119.1 (N-CH-CH-N), 59.7 (CHcy), 33.53 (CH2
cy), 24.8 (CH2
cy), 24.6 (CH2
cy). 
MS (ESI) m/z (%): 234 (ICy -Cl), 233 (ICy –Cl –H) 
8.5.10 [Ir(ICy)(COD)Cl] (ICy(a)) 
1H NMR (MeOD, 400 MHz, 300 K): 7.16 (s, 2H, N-CH-CH-N), 5.13 (m, 2H, CHCy), 
4.46 (m, 2H, CHCOD), 3.04 (m, 2H, CHCOD), 2.3 – 1.0 (m, 28H, CH2
Cy and CH2
COD). 
13C{1H} NMR (MeOD, 300 K): 176.5 (N-C-N), 117.5 (N-CH-CH-N), 82.6 (CHcod), 
59.9 (CHCy), 51.3 (CHcod), 33.7, 33.6, 33.3, 29.2, 25.8, 25.5, 24.9 (CH2
Cy and CH2
COD). 
MS (ESI) m/z (%): 531.2 (M – Cl – H), 574.3 (M – Cl +acetonitrile). 
These results are similar to those in the literature94,95 which were completed in DCM.  
8.5.11 [Ir(ICy)(py)3(H)2]Cl 
1H NMR (MeOD, 400 MHz, 280 K): 8.75 (d, J = 4.82 Hz, 4H, oH, py trans to hydride), 
8.54 (dt, J = 4.36, 1.52 Hz, 13H, oH, free py), 8.31 (d, J = 5.04 Hz, 2H, oH, py cis to 
hydride), 8.00 (tt, J = 7.69, 1.54 Hz, 2H, pH, py trans to hydride), 7.94 (tt, J = 7.69, 1.54 
Hz, 1H, pH, py cis to hydride), 7.88 (tt, J = 7.69, 1.68 Hz, 4.5H, pH, free py), 7.47 
(under free py signal, correlation observed in COSY, mH, py trans to hydride), 7.46 (m, 
16H, mH, free py), 7.27 (m, 2H, mH, py cis to hydride), 7.22 (s, 4H, N-CH-CH-N), 
4.30 (m, 2H, CHCy), 2.25-0.6 (m, 20H, CH2
Cy), -22.49 (s, 2H, hydrides). 
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13C{1H} NMR (MeOD, 280 K): 197.6 (N-C-N), 156.4 (oC, py cis to hydride), 154.7 
(oC, py trans to hydride), 148.7 (oC, free py), 137.39 (pC, py trans to hydride), 137.2 
(pC, free py), 136.8 (pC, py cis to hydride), 126.3 (mC, py trans to hydride), 125.9 
(mC, py cis to hydride), 124.3 (mC, free py), 117.7 (N-CH-CH-N), 59.2 (CHCy), 33.0 
(CH2
Cy), 25.6 (CH2
Cy), 24.8 (CH2
Cy).  
8.5.12 [Ir(ICy)2(COD)]Cl (ICy2(a), 800.58 g mol
-1) 
1H NMR (MeOD, 400 MHz, 300 K): 7.45 (s, 4H, N-CH-CH-N), 5.50 (s, 4H, CHCy), 
4.01 (m, 4H, CHCOD), 2.5 - 0.8 (m, 28H, CH2
Cy and CH2
COD). 13C{1H} NMR (MeOD, 
300 K): 174.7 (N-C-N), 119.1 (N-CH-CH-N), 74.1 (CHcod), 59.6 (CHCy), 35.3, 33.2, 
31.8, 25.3, 25.1, 24.5 (CH2
Cy and CH2
COD). 
MS (ESI) m/z (%): 765.4 (M+ -Cl). 
These results are similar to those in the literature95 which were completed in DCM.  
8.6 Acetal and hemiacetal products of 4-carboxaldehydepyridine and methanol 
4-carboxaldehydepyridine (Figure 8.29a) undergoes a spontaneous reaction with 
methanol to produce a hemiacetal product (Figure 8.29b), and upon addition of a 
suitable acid, reacts with a further equivalent of methanol to produce an acetal product 
(Figure 8.29c). 
N
O H
N
MeO OH
H
H+
N
MeO OMe
H
+ methanol
+ methanol
- methanol
 
Figure 8.29 The spontaneous and acid catalysed reactions of 4-carboxaldehydepyridine (a) with methanol 
producing a hemiacetal (b) and an acetal (c). 
The substrates presented in Figure 8.29 are characterised in the following sections. 
Mass spectrometry data for these products are presented in Chapter 6. 
361 
8.6.1 1H and 13C NMR data for 4-carboxaldehydepyridine 
N
O
H2 3
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Figure 8.30 Labelled structure of 4-carboxaldehydepyridine. 
1H NMR (d1-chloroform, 400 MHz, 298 K): 10.11 (s, 1H, H5), 8.95 (d, J = 4.5 Hz, 2H, 
H2), 7.73 (d, J = 4.47 Hz, 2H, H3). 13C{1H} NMR (d1-chloroform, 298 K): 191.6 (C5), 
151.1 (C2), 141.5 (q, C4), 122.2 (C3). 
1H NMR (d4-methanol, 400 MHz): 10.09 (s, 1H, H5), 8.82 (d, J=4.46 Hz, 2H, H2), 7.84 
(d, J=4.42 Hz, 2H, H3). 
8.6.2 1H and 13C NMR data for the hemiacetal product, NC5H4-p-CH(OMe)(OH) 
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Figure 8.31 Labelled structure of the hemiacetal product resulting from the spontaneous reaction of 4-
carboxaldehydepyridine with methanol.  
1H NMR (d1-chloroform, 400 MHz, 280 K): 8.49 (d, J = 5.86 Hz, 2H, H2), 7.45 (d, J = 
5.71 Hz, 2H, H3), 5.51 (s, 1H, H5), 3.49 (s, H7). 13C{1H} NMR (d1-chloroform, 280 
K): 150.3 (C5), 149.1 (C2), 121.5 (C3), 96.0 (qC4), 54.5 (C7).  
The signal for H7 of the CH3 isotopomer of this product is observed at 3.49 ppm and is 
nearly coincident with the signal for free methanol and its integral is therefore an 
overestimate of the number of protons present in that environment. The signal 
corresponding to C7 is however clearly observed in the 13C{1H} NMR spectrum at 54.5 
ppm. 
1H NMR (d4-methanol, 400 MHz): 8.51 (d, J = 4.68 Hz, 2H, H2), 7.52 (d, J = 4.47 Hz, 
2H, H3), 5.53 (s, 1H, H5). When this reaction was completed with deuterated methanol, 
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and therefore the methyl groups are deuterated, the signal corresponding to the methyl 
groups is not observed. 
8.6.3 1H and 13C NMR data for the acetal product, NC5H4-p-CH(OMe)2 
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Figure 8.32 Labelled structure of the acetal product resulting from the acid catalysed reaction of 4-
carboxaldehydepyridine with methanol. 
1H NMR (d4-methanol, 400 MHz): 8.87 (m, 2H, H2), 8.18 (m, 2H, H3), 5.75 (s, 1H, 
H5). When this reaction was completed with deuterated methanol, and therefore the 
methyl groups are deuterated, the 1H signal corresponding to the methyl groups (H6) is 
not observed. 
8.7 1H and 13C NMR data for substrates in methanol 
The following 1H and 13C NMR data are completed at 298 K unless otherwise stated. 
8.7.1 Substituted pyridines 
8.7.1.1 3-phenylpyridine 
N
2
3
4 5
6
7
8
8
9
9
10
 
Figure 8.33 Labelled structure of 3-phenylpyridine. 
1H NMR (d4-methanol, 500 MHz): 8.77 (dd, J = 0.75, 2.31 Hz, 1H, H2), 8.49 (dd, J = 
1.56, 4.89 Hz, 1H, H6), 8.06 (ddd, J = 1.61, 2.63, 7.95 Hz, 1H, H4), 7.63 (m, 2H, H8), 
7.49 (m, 1H, H5), 7.47 (m, 2H, H9), 7.40 (m, J = 7.40, 1H, H10). 13C{1H} NMR (d4-
methanol): 147.5 (C6), 147.1 (C2), 137.5 (qC), 137.4 (qC), 135.3 (C4), 129.0 (C9), 
128.2 (C10), 126.9 (C8), 124.2 (C5). 
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8.7.1.2 4-phenylpyridine 
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Figure 8.34 Labelled structure of 4-phenylpyridine. 
1H NMR (d4-methanol, 500 MHz): 8.56 (dd, J = 1.7, 4.59 Hz, 2H, H2), 7.74 (m, 2H, 
H6), 7.69 (dd, J = 1.63, 4.66 Hz, 2H, H3), 7.50 (m, 2H, H7), 7.45 (m, 2H, H8). 13C{1H} 
NMR (d4-methanol): 149.5 (qC), 149.3 (C2), 137.6 (qC), 129.3 (C8), 129.1 (C7), 126.8 
(C6), 121.9 (C3). 
8.7.1.3 3-benzoylpyridine 
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Figure 8.35 Labelled structure of 3-benzoylpyridine. 
1H NMR (d4-methanol, 500 MHz): 8.87 (dd, J = 0.83, 2.19 Hz, 1H, H2), 8.75 (dd, J = 
1.62, 4.93 Hz, 1H, H6), 8.17 (ddd, J = 1.73, 2.19, 7.95 Hz, 1H, H4), 7.79 (m, 2H, H9), 
7.67 (m, J = 1.28, 1H, H11), 7.58 (ddd, J = 0.91, 4.94, 7.90, 1H, H5), 7.54 (m, 2H, 
H10). 13C{1H} NMR (d4-methanol): 194.8 (q, C=O, C7), 152.2 (C6), 149.9 (C2), 137.8 
(C4), 136.7 (qC8), 133.8 (qC3), 133.2 (C11), 129.8 (C9), 128.6 (C10), 123.9 (C5).  
8.7.1.4 4-(4-chlorobenzoyl)pyridine 
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Figure 8.36 Labelled structure of 4-(4-chlorobenzoyl)pyridine. 
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1H NMR (d4-methanol, 500 MHz): 8.76 (dd, J = 1.66, 4.39 Hz, 2H, H2), 7.81 (m, J = 
9.03 Hz, 2H, H7), 7.66 (dd, J = 1.66, 4.43 Hz, 2H, H3), 7.57 (m, J = 9.09 Hz, 2H, H8). 
13C{1H} NMR (d4-methanol): 193.82 (q, C=O, C5), 149.81 (C2), 145.05 (qC4), 139.9 
(C9), 134.4 (qC6), 131.5 (C7), 128.9 (C8), 123.1 (C3). 
8.7.2 Quinoline and substituted quinolines 
8.7.2.1 Quinoline 
The spectra used in the characterisation of quinoline are shown in Chapter 5. 
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Figure 8.37 Labelled structure of quinoline. 
1H NMR (d4-methanol, 500 MHz): 8.82 (dd, J = 1.71, 4.31 Hz, 1H, H2), 8.34 (dd, J = 
0.82, 8.41 Hz, 1H, H4), 8.02 (dd, J = 0.82, 8.47 Hz, 1H, H8), 7.92 (dd, J = 1.3, 8.2 Hz, 
1H, H5), 7.76 ((m)d, J = 1.44, 6.90 Hz, 1H, H7), 7.60 ((m)d, J = 1.09, 6.97 Hz, 1H, 
H6), 7.52 (dd, J = 4.37, 8.34 Hz, 1H, H3).  
13C{1H} NMR (d4-methanol): 149.9 (dq, J = 4, 178 Hz, C2), 147.5 (qC9), 137.1 (dt, J = 
5.5, 163 Hz, C4), 129.9 (dd, J = 9.2, 161 Hz, C7), 128.7 (qC10), 128.0 (d, J = 161 Hz, 
C5), 127.8 (dd, J = 7, 161 Hz, C8), 126.8 (dd, J = 8.5, 162 Hz, C6), 121.3 (dd, J = 8.4, 
165 Hz, C3).  
8.7.2.2 Isoquinoline 
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Figure 8.38 Labelled structure of isoquinoline. 
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1H NMR (d4-methanol, 500 MHz): 9.17 (s, 1H, H1), 8.38 (d, J = 5.75 Hz, 1H, H3), 8.04 
(d, J = 8.17 Hz, 1H, H8), 7.88 (d, J = 8.57 Hz, 1H, H5), 7.76 (d, J = 5.85 Hz, 1H, H4), 
7.74 (m, J = 1.21 Hz, 1H, H6), 7.64 (m, J = 1.11 Hz, 1H, H7). 13C{1H} NMR (d4-
methanol): 151.9 (C1), 141.5 (C3), 136.2 (qC10), 131.0 (C6), 128.9 (qC9), 127.7 (C7), 
127.7 (C8), 126.4 (C5), 121.1 (C4). 
8.7.2.3 4-methylquinoline 
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Figure 8.39 Labelled structure of 4-methylquinoline. 
1H NMR (d4-methanol, 500 MHz): 8.66 (d, J = 4.51 Hz, 1H, H2), 8.10 (d, J = 8.43 Hz, 
1H, H5), 8.00 (d, J = 8.43 Hz, 1H, H8), 7.74 (m, 1H, H7), 7.62 (m, 1H, H6), 7.36 (d, J 
= 4.43 Hz, 1H, H3), 2.73 (s, 3H, H11). 13C{1H} NMR (d4-methanol): 149.6 (C2), 147.1 
(qC9), 146.1 (qC4), 129.6 (C7), 128.4 (qC10), 128.3 (C8), 126.6 (C6), 124.1 (C5), 
121.9 (C3), 17.4 (C11).  
8.7.2.4 7-methylquinoline 
N
11 2
3
45
6
7
8
9
10
 
Figure 8.40 Labelled structure of 7-methylquinoline. 
1H NMR (d4-methanol, 500 MHz): 8.76 (dd, J=4.3, 1.75 Hz, 1H, H2), 8.28 (d, J=8.33, 
1H, H4), 7.81 (m, 1H, H5), 7.79 (m, 1H, H8), 7.45 (m, 1H, H6), 7.44 (m, 1H, H3), 2.55 
(s, 3H, H11). 13C{1H} NMR (d4-methanol): 149.8 (C2), 147.7 (qC9), 140.7 (qC), 136.8 
(C4), 129.0 (C6), 127.7 (C5), 126.8 (qC), 126.6 (C8), 120.5 (C3), 20.7 (C11). 
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Figure 8.41 Labelled structure of 8-methylquinoline. 
1H NMR (d4-methanol, 400 MHz): 8.85 (dd, J = 4.21, 1.72 Hz, 1H, H2), 8.29 (d, J = 
8.28, 1H, H4), 7.75 (d, J = 8.21 Hz, H5), 7.60 (d, J = 7.1 Hz, 1H, H7), 7.50 (m, 1H, 
H3), 7.47 (m, 1H, H6), 2.75 (s, 3H, H11). 13C{1H} NMR (d4-methanol): 148.8 (C2), 
146.6 (qC9), 136.9 (C4), 136.0 (qC8), 129.8 (C7), 128.6 (q, C10), 126.2 (C6), 126.0 
(C5), 120.7 (C3), 17.0 (C11).  
8.7.3 Other substrates 
8.7.3.1 Indole 
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Figure 8.42 Labelled structure of indole. 
1H NMR (d4-methanol, 400 MHz): 10.39 (broad s, H1), 7.54 (d, J = 7.9 Hz, 1H, H7), 
7.38 (d, J = 8.23 Hz, 1H, H4), 7.22 (d, J = 3.21 Hz, 1H, H2), 7.09 (t, J = 7.6 Hz, 1H, 
H5), 6.99 (t, J = 7.5 Hz, 1H, H6), 6.43 (dd, J = 3.1, 0.8 Hz, 1H, H3). 13C{1H} NMR (d4-
methanol): 136.2 (qC), 128.0 (qC), 124.0 (C2), 120.7 (C5), 119.7 (C7), 118.5 (C6), 
110.7 (C4), 100.8 (C3). 
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8.7.3.2 2-amino-4-(4-chlorophenyl)thiazole 
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Figure 8.43 Labelled structure of 2-amino-4-(4-chlorophenyl)thiazole. 
1H NMR (d4-methanol, 500 MHz): 7.72 (d, J = 8.69 Hz, 2H, H7), 7.34 (d, J = 8.69 Hz, 
2H, H8), 6.83 (s, 1H, H5). 13C{1H} NMR (d4-methanol): 170.1 (q), 149.3 (q), 133.7 (q), 
132.9 (q), 128.3, 127.2, 102.2. 
8.7.3.3 Benzothiazole 
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Figure 8.44 Labelled structure of benzothiazole. 
1H NMR (d4-methanol, 400 MHz): 9.25 (s, 1H, H2), 8.10 (m, 1H, H7), 8.08 (m, 1H, 
H4), 7.58 (t, J = 7.44 Hz, 1H, H5) 7.51 (t, J = 7.35 Hz, 1H, H6). 13C{1H} NMR (d4-
methanol): 155.6 (C2), 152.6 (qC), 133.4 (qC), 126.1 (C5), 125.5 (C6), 122.4 (C4), 
121.9 (C7). 
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9 Chapter 9 - Appendices 
9.1 Complete data collected for the calculation of thermodynamic activation 
parameters 
This section contains all rate data collected in the calculation of thermodynamic 
parameters, to calculations to predict rates at the temperatures involved in the 
temperature dependence investigations. 
9.1.1 Collection of NMR data for the calculation of exchange rates 
A series of 1H EXSY NMR spectra were collected where the bound ligand is selectively 
excited and after a short mixing time, a NMR spectrum recorded. The mixing time 
allows for exchange and therefore the relative integrals of the bound and free ligand can 
be used to monitor the exchange process. The resultant absolute integrals of the bound 
and free ligands are turned into a percentage of each other and then plotted as a function 
of mixing time as demonstrated in Figure 9.1. 
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Figure 9.1 A plot of the percentage of bound ligands and free substrate derived from 1H EXSY NMR 
spectra against the mixing time implemented. This data was collected at 300 K and monitored the loss of 
hydride ligands from ICy(a) to free hydrogen. 
This data was then entered into Dynafit108 according to the details described below in 
section 9.1.2. The result is to gain a series of experimentally derived rate constants at a 
series of temperatures which can then be used to calculate thermodynamic parameters of 
activation as described in section 9.1.2.3. 
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9.1.2 Information pertaining to Dynafit108 
The nonlinear regression module uses the Levenberg-Marquardt algorithm.219 The time-
course of (bio)chemical reactions is computed by the numerical integration of 
simultaous first-order ordinary differential equations, using the Livermore Solver of 
ODe Systems (LSODE).220 The composition of complex mixtures at equilibrium (e.g., 
in the concentration jump experiment where a complex mixture is incubated prior to the 
addition of a reagent) is computed by solving simultaneous nonlinear algebraic 
equations, namely, the mass balance equations for the component species, by using the 
multidimensional Newton-Raphson method.221 
9.1.2.1 Data file used for the model of the determination for the rate of loss of hydride 
ligands from Carbene(a) 
Below is an example of the data file imported into Dynafit to complete calculations of 
rate of loss of hydride ligands from Carbene(a). 
[task] 
   data = progress 
   task = fit 
   model = hydrogen exchange  
[mechanism] 
IrH2 --> Ir + H2 : k1 
H2 + Ir --> IrH2 : k2 
[constants] 
;initial estimates 
   k1 = 0.11132 ??, k2 = 0.004261 ?? 
[concentrations] 
370 
   IrH2 = 100 
   H2 = 0 
[responses] 
[progress] 
   directory ./lsl275-h2/295 k/data 
   extension txt 
   file IrH2  | response IrH2 = 1 
   file H2 | response H2 = 1 
[output] 
   directory ./lsl275-h2/295 K/output/fit 
[end] 
Dynafit uses the following equations in the calculation (Equation 9.1). 
REACTION MECHANISM   IrH2 <===> Ir + H2 : k1  k2  
DIFERENTIAL EQUATIONS  d[IrH2]/dt =  -k1[IrH2]+k2[Ir][H2] 
d[Ir]/dt =  +k1[IrH2]-k2[Ir][H2] 
d[H2]/dt =  +k1[IrH2]-k2[Ir][H2] 
Equation 9.1 Reaction mechanism and differential equations used by Dynafit together with user data to 
calculate the rate of loss of hydride ligands from a catalyst. 
9.1.2.2 Data file used for the model of the determination for the rate of loss of 
substrate from Carbene(a) 
Below is an example of the data file imported into Dynafit to complete calculations of 
rate of loss of substrate ligands from Carbene(a). In all following calculations, the 
substrate ligand always refers to that bound trans to the hydride ligands. 
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[task] 
   data = progress 
   task = fit 
   model = pyridine exchange  
[mechanism] 
Irpy --> Ir + py : k1 
py + Ir --> Irpy : k2 
[constants] 
;initial estimates 
   k1 = 0.801 ??, k2 = 0.7 ?? 
[concentrations] 
   Irpy = 100 
   py = 0 
[responses] 
[progress] 
   directory ./lsl275-py/295 k/data 
   extension txt 
   file Irpy  | response Irpy = 1 
   file py | response py = 1 
[output] 
   directory ./lsl275-py/295 K/output/fit 
[end] 
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Dynafit uses the following equations in the calculation (Equation 9.2). 
REACTION MECHANISM   Irpy <===> Ir + py : k1  k2  
DIFERENTIAL EQUATIONS  d[Irpy]/dt =  -k1[Irpy]+k2[Ir][py] 
d[Ir]/dt =  +k1[Irpy]-k2[Ir][py] 
d[py]/dt =  +k1[Irpy]-k2[Ir][py] 
Equation 9.2 Reaction mechanism and differential equations used by Dynafit together with user data to 
calculate the rate of loss of substrate ligands from a catalyst, with pyridine used as an example. 
9.1.2.3 Data file used for the model of the determination for the rate of loss of hydride 
ligands from IMes(c) and SIMes(c) 
Below is an example of the data file imported into Dynafit to complete calculations of 
rate of loss of hydride ligands from IMes(c) and SIMes(c) when activated in the 
presence of quinoline. This complex results in two hydride resonances, one 
corresponding to the hydride ligands trans to quinoline, and one corresponding to the 
hydride ligand trans to acetonitrile. The data was therefore measured by exciting just 
one resonance however this lead to the complication that the rate of interconversion of 
the two hydride ligands also had to be taken into account. This was completed using the 
following file.  
[task] 
   data = progress 
   task = fit 
   model = hydrogen exchange  
[mechanism] 
IrH2 --> Ir + H2 : k1 
H2 + Ir --> IrH2 : k2 
IrH2 --> Ir2H : k3 
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Ir2H --> IrH2 : k4 
[constants] 
   k1 = 0.72328 ??, k2 = 0.004261 ??, k3 = 0.2  ??, k4 = 0.3  ?? 
[concentrations] 
   IrH2 = 100 
   H2 = 0 
   Ir2H = 0 
[responses] 
[progress] 
   directory ./lsl258-h2/268 k/data 
   extension txt 
   file IrH2  | response IrH2 = 1 
   file H2 | response H2 = 1 
   file Ir2H  | response Ir2H = 1 
[output] 
   directory ./lsl258-h2/268 K/output/fit 
[end] 
Dynafit uses the following equations in the calculation (Equation 9.3). 
REACTION MECHANISM   IrH2 <===> Ir + H2 : k1  k2  
IrH2 <===> Ir2H : k3  k4  
DIFERENTIAL EQUATIONS 
d[IrH2]/dt =  -k1[IrH2]+k2[Ir][H2]-k3[IrH2]+k4[Ir2H] 
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d[Ir]/dt =  +k1[IrH2]-k2[Ir][H2] 
d[H2]/dt =  +k1[IrH2]-k2[Ir][H2] 
d[Ir2H]/dt =  +k3[IrH2]-k4[Ir2H] 
Equation 9.3 Reaction mechanism and differential equations used by Dynafit together with user data to 
calculate the rate of loss of hydride ligands from IMes(c) activated in the presence of quinoline.  
9.1.3 Calculation of thermodynamic activation parameters  
The thermodynamic parameters of activation for each catalytic system were calculated 
through using the Eyring method. This involves plotting a graph of (1/T) vs ln(2k/T) 
where T is temperature in Kelvin and k is the experimentally measured rate constants in 
s-1. This produces a straight line, the gradient and intercept of which can be used to 
derive the ∆Hǂ and ∆Sǂ according to Equation 9.4. 
y=           mx               +c 
ln(k/T)=(-∆Hǂ/RT)+ln(kb/h)+(∆S
ǂ/R) 
Equation 9.4 Eyring equation. 
9.1.4 Treatment of errors 
The errors quoted by Dynafit are calculated to be correct to a 95 % confidence level. 
The standard errors have not been used as it has been published that the underestimate 
the error,222 and therefore the ‘exact interval’ lower and upper limits have been 
presented. 
When considering the calculation of thermodynamic activation parameters of loss of 
pyridine or hydride ligands, the errors are presented as standard errors correct to a 95 % 
confidence level.  
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9.1.5 Collected rate constants and thermodynamic activation parameters for a sample 
of SIMes(a) hydrogenated in the presence of pyridine 
T / K Observed rate constant from DynaFit / s-1 
Loss of hydride ligands Loss of pyridine ligands 
261 0.360   (0.345 – 0.377) 0.429   (0.423 – 0.436) 
263 0.460   (0.446 – 0.476) 0.541   (0.535 – 0.549) 
268 0.889   (0.874 – 0.907) 1.067   (1.060 – 1.077) 
272 1.444   (1.422 – 1.472) 1.843   (1.825 – 1.861) 
276 2.423   (2.403 – 2.443) 3.126   (3.086 – 3.167) 
280 4.016   (3.959 – 4.077) 4.864   (4.823 – 4.907) 
284 6.309   (6.256 – 6.385) 7.447   (7.198 – 7.893) 
Table 9.1 Rate constants (quoted to 3 d.p.) for the loss of pyridine and hydride ligands from SIMes(a) in 
the presence of pyridine at the indicated temperatures, with corresponding lower and upper limits to a 95 
% confidence level.  
The data in Table 9.1 was used to produce the Eyring plots shown in Figure 9.2. 
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Figure 9.2  The Eyring plots derived for the loss of hydride ligands and pyridine ligands from SIMes(a) 
in the presence of pyridine with associated equations, produced from the data presented in Table 9.1. 
Figure 9.2 displays the equations which can be used to calculate the thermodynamic 
parameters presented in Table 9.2. 
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Thermodynamic 
parameters 
For ligand loss  
Hydride Pyridine 
∆Hǂ (kJ mol-1) 74.9 ± 0.2 (0.3 %) 75.6 ± 0.4 (0.5 %) 
∆Sǂ (J K-1 mol-1) 40.3 ± 0.7 (1.7 %) 44.6 ± 1.5 (3.4 %) 
∆G300
ǂ (kJ mol-1) 62.8 ± 0.02 (0.03 %) 62.3 ± 0.05 (0.08 %) 
Table 9.2 The thermodynamic parameters of activation for the loss of hydride ligands and pyridine 
ligands from SIMes(a) in the presence of pyridine. 
The data presented in the above section has also been used to predict the rate of loss of 
pyridine and hydride ligands from SIMes(a) at the temperatures investigated by method 
1 and 300 K for comparison purposes. The results are presented in Table 9.3. 
Temperature Predicted rate of loss of ligand from SIMes(a) 
ºC K Hydride ligand Pyridine ligand 
0 273 1.68 2.05 
20 293 17.19 21.37 
30 303 49.04 61.53 
40 313 130.99 165.74 
50 323 329.56 420.29 
27 300 36.06 45.13 
Table 9.3 Predicted rates loss of pyridine and hydride ligands from SIMes(a) at the specified 
temperatures. 
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9.1.6 Collected rate constants and thermodynamic activation parameters for a sample 
of ICy(a) hydrogenated in the presence of pyridine 
T / K Observed rate constant from DynaFit / s-1 
Loss of hydride ligands Loss of pyridine ligands 
285 N/C 0.204   (0.189 – 0.225) 
290.1 N/C 0.308   (0.302 – 0.318) 
295 0.112   (0.107 – 0.117) 0.769   (0.728 – 0.813) 
300 0.213   (0.209 – 0.218) 1.129   (1.062 – 1.202) 
305 0.371   (0.362 – 0.382) 2.175   (1.964 – 2.421) 
310 0.632   (0.619 – 0.646) 5.069   (4.549 – 5.681) 
315 1.141   (1.121 – 1.170) 8.489   (7.601 – 9.520) 
320 1.980   (1.908 – 2.109) 16.34   (12.79 – 21.45) 
325 3.665   (3.544 – 3.979) N/C 
Table 9.4 Rate constants (quoted to 3 d.p.) for the loss of pyridine and hydride ligands from ICy(a) in the 
presence of pyridine at the indicated temperatures, with corresponding lower and upper limits to a 95 % 
confidence level. 
The data in Table 9.4 was used to produce the Eyring plots shown in Figure 9.3. 
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Figure 9.3 The Eyring plots derived for the loss of hydride ligands and pyridine ligands from ICy(a) in 
the presence of pyridine with associated equations, produced from the data presented in Table 9.4. 
Figure 9.3 displays the equations which can be used to calculate the thermodynamic 
parameters presented in Table 9.5. 
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Thermodynamic 
parameters 
For ligand loss 
Hydride Pyridine 
∆Hǂ (kJ mol-1) 88.7 ± 0.6 (0.7 %) 94.3 ± 1.1 (1.2 %) 
∆Sǂ (J K-1 mol-1) 43.4 ± 2.0 (4.7 %) 77.6 ± 3.7 (4.8 %) 
∆G300
ǂ (kJ mol-1) 75.7 ± 0.02 (0.02 %) 71.1 ± 0.04 (0.06 %) 
Table 9.5 The thermodynamic parameters of activation for the loss of hydride ligands and pyridine 
ligands from ICy(a) in the presence of pyridine. 
The data presented in the above section has also been used to predict the rate of loss of 
pyridine and hydride ligands from ICy(a) at the temperatures investigated by method 1 
and 300 K for comparison purposes. The results are presented in Table 9.6. 
Temperature Predicted rate of loss of ligand from ICy(a) 
ºC K Hydride ligand Pyridine ligand 
0 273 0.0055 0.028 
20 293 0.085 0.53 
30 303 0.29 1.95 
40 313 0.94 6.67 
50 323 2.79 21.1 
27 300 0.21 1.33 
Table 9.6 Predicted rates loss of pyridine and hydride ligands from ICy(a) at the specified temperatures. 
9.1.7 Collected rate constants and thermodynamic activation parameters for a sample 
of IMes(c) hydrogenated in the presence of quinoline 
Rate of loss of hydride ligands Rate of loss of quinoline ligands 
T / K Observed rate constant / s-1 T/ K Observed rate constant / s-1 
268 0.723   (0.674 – 0.778) 255 0.152   (0.145 – 0.161) 
273 1.560   (1.496 – 1.632) 260 0.276   (0.264 – 0.294) 
278 2.841   (2.733 – 2.965) 265 0.539   (0.523 – 0.557) 
283 5.188   (5.000 – 5.415) 270 0.981   (0.957 – 1.010) 
288 8.691   (8.442 – 9.013) 275 1.744   (1.683 – 1.824) 
293 15.254 (14.694 – 15.840)  
298 25.533 (24.307 – 26.864) 
300 35.591 (34.057 – 37.898) 
Table 9.7 Rate constants (quoted to 3 d.p.) for the loss of quinoline and hydride ligands from IMes(c) in 
the presence of quinoline at the indicated temperatures, with corresponding lower and upper limits to a 95 
% confidence level.  
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The data in Table 9.7 was used to produce the Eyring plots shown in Figure 9.4. 
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Figure 9.4 The Eyring plots derived for the loss of hydride ligands and quinoline ligands from IMes(c) in 
the presence of quinoline with associated equations, produced from the data presented in Table 9.7. 
Figure 9.4 displays the equations which can be used to calculate the thermodynamic 
parameters presented in Table 9.8. 
Thermodynamic 
parameters 
For ligand loss 
Hydride Quinoline 
∆Hǂ (kJ mol-1) 76.3 ± 0.5 (0.7 %) 69.5 ± 0.6 (0.9 %) 
∆Sǂ (J K-1 mol-1) 44.3 ± 1.8 (4 %) 19.0 ± 2.2 (11.7 %) 
∆G300
ǂ (kJ mol-1) 63.0 ± 0.03 (0.05 %) 63.8 ± 0.07 (0.1 %) 
Table 9.8 The thermodynamic parameters of activation for the loss of hydride ligands and quinoline 
ligands from IMes(c) in the presence of quinoline. 
The data presented in the above section has also been used to predict the rate of loss of 
quinoline and hydride ligands from IMes(c) at the temperatures investigated by method 
1 and 300 K for comparison purposes. The results are presented in Table 9.9. 
Temperature Predicted rate of loss of ligand from IMes(c) 
ºC K Hydride ligand Quinoline ligand 
0 273 1.47 1.39 
20 293 19.59 14.65 
30 303 45.78 31.77 
40 313 124.56 79.15 
50 323 318.88 186.53 
27 300 33.47 23.88 
Table 9.9 Predicted rates loss of quinoline and hydride ligands from IMes(c) at the specified 
temperatures. 
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9.1.8 Collected rate constant data for a sample of SIMes(c) hydrogenated in the 
presence of quinoline 
Rate of loss of hydride ligands Rate of loss of quinoline ligands 
T / K Observed rate constant / s-1 T/ K Observed rate constant / s-1 
273 2.86   (2.786 – 2.962) 275 0.214   (0.200 – 0.229) 
Table 9.10 Rate constants (quoted to 3 d.p.) for the loss of quinoline and hydride ligands from SIMes(c) 
in the presence of quinoline at the indicated temperatures, with corresponding lower and upper limits to a 
95 % confidence level. 
9.2 Product operators of INEPT NMR experiments prior to FID acquisition 
These final product operators are the result of the stated were calculated by Richard 
Green as part of a review publication of parahydrogen derived hyperpolarisation.151 
Various stating states have been considered for each sequence. In each case, I and S are 
parahydrogen and R is a heteronucleus such as 13C. Only the states which can be 
observed are included together with information about which nuclei they are observed 
on. 
9.2.1 Product operators of the INEPTnd NMR sequence 
9.2.1.1 Starting with Iz 
Observable on I 
Iycos[2πτ(J12)]cos[2πτ(J13)] 
Observable on S 
IzSx2cos[2πτ(J13)]sin[2πτ(J12)] 
Observable on R 
-IzRy2cos[2πτ(J12)]sin[2πτ(J13)] 
Plus non-observable states 
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9.2.1.2 Starting with IzSz 
No observables on I, S or R. 
9.2.1.3 Starting with IzRz 
No observables on I, S or R. 
9.2.1.4 Starting with IxSx 
No observables on I, S or R. 
9.2.2 Product operators of the INEPT_phase NMR sequence with a 45º initial pulse  
9.2.2.1 Starting with Iz 
Observable on I 
Ix(1/√2) 
No other states are observable 
9.2.2.2 Starting with IzSz 
Observable on I 
-Iy1/4cos[2πτ(J13)]sin[2πτ(J12)] + IxSz1/2cos[2πτ(J12)]cos[2πτ(J23)] 
Observable on S 
-IzSx1/2cos[2πτ(J12)]cos[2πτ(J13)] – Sy1/4cos[2πτ(J23)]sin[2πτ(J12)] 
Observable on R 
IzRy1/2sin[2πτ(J12)]sin[2πτ(J13)] + SzRy1/2cos[2πτ(J12)]sin[2πτ(J23)] 
Plus non-observable states 
382 
9.2.2.3 Starting with IzRz 
Observable on I 
-Iy(1/√2)cos[2πτ(J12)]sin[2πτ(J13)] 
Observable on S 
-IzSx(1/√2)sin[2πτ(J12)]sin[2πτ(J13)] 
Observable on R 
-IzRy(1/√2)cos[2πτ(J12)]cos[2πτ(J13)] 
Plus non-observable states 
9.2.3 Product operators of the INEPT_phase NMR sequence with a 90º initial pulse 
9.2.3.1 Starting with Iz 
No observables on I, S or R. 
9.2.3.2 Starting with IzSz 
No observables on I, S or R. 
9.2.3.3 Starting with IzRz 
Observable on I 
-Iy(1/2)cos[2πτ(J12)]sin[2πτ(J13)] 
Observable on S 
-IzSxsin[2πτ(J12)]sin[2πτ(J13)] 
Observable on R 
-IzRycos[2πτ(J12)]cos[2πτ(J13)] 
Plus non-observable states 
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9.3 Adapted pulse sequences used within this thesis 
During the development of standard sequences for use with the method 2, a series of 
new sequences had to be written to incorporate the commands associated with the 
polarisor. These are prefixed with ‘ph_’. 
9.3.1 Standard 90º pulse acquire sequence – ph_zg 
This sequence completes a single 90º pulse followed by acquisition. It has been used for 
both 1H and 13C acqusitions. 
;ph_zg 
;zg for use with parahydrogen polariser 
 
#include <Avance.incl> 
#include <Polariser.incl> 
 
1 ze 
2 1u 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 d1 
  p0 ph1 
  go=3 ph31 
  30m wr #0 
  TOPOL             ;transfer sample to polariser 
  lo to 2 times l0 
  POLPOS            ;wait for sample in polariser 
exit 
 
ph1=0 2 2 0 1 3 3 1 
ph31=0 2 2 0 1 3 3 1 
  
 
;d1 : relaxation delay; set to very short for hyperpolarisation 
experiments  
;ns : number of scans: set to = 1 for hyperpolarisation 
experiments 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans; re-polarising between scans 
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9.3.2 1H OPSYdq NMR pulse sequence – ph_OPSYdq 
This sequence filters the double quantum magnetic states using gradients and transforms 
them into observable magnetisation. It can be altered to achieve zero quantum or single 
quantum filtration by changing the proportions of the gradients used.  
;;start 
 
;ph_OPSYdq 
;OPSY with double quantum filter modified for use with the 
parahydrogen polariser 
 
#include <Avance.incl> 
#include <Grad.incl> 
#include <Polariser.incl> 
 
 
1 ze 
2 d1 
 subr POLARISE( d20, d21, d24 ) 
3 30m 
  d1 
  p1 ph1             ; pH MODIFIED 
  50u UNBLKGRAD 
  p16:gp1*-1 
  d16 
  20u BLKGRAD 
  p1 ph2             ; pH MODIFIED 
  50u UNBLKGRAD 
  p16:gp1 
  d16 
  p16:gp1 
  d16 
  20u BLKGRAD 
  go=3 ph31 
  30m wr #0 
  TOPOL ;transfer sample to polariser 
  20u ze 
  lo to 2 times l0 
  ;POLPOS ;wait for sample in poariser 
exit 
 
ph1=1 1 1 1 0 0 0 0 
ph2=0 0 0 0 1 1 1 1 
ph31=0 0 0 0 1 1 1 1 
 
 
;d1 : relaxation delay; set to very short for hyperpolarisation 
experiments  
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
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;l0 : accumulate L0 scans 
;pl1 : f1 channel - power level for pulse (default) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p16: homospoil/gradient pulse 
;d16: delay for homospoil/gradient recovery 
;NS: 1 * n, total number of scans: NS * TD0 
;use gradient ratio:     gpz1= from 80 to 100 % 
;p16= 1-3 ms 
; increase gpz1 and/or p16 to improve the signal suppression. 
;use gradient files: 
;gpnam1: SINE.100 
 
;Ralph Adams 12MAY2009 
 
;;stop 
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9.3.3 Selective OPSYdq sequence – OPSYdq_2shaped90_mkIII 
This sequence applies an OPSYdq filter to two selected resonances. It is designed to 
give an idea of the coupling relationship between the two resonances. 
;;start 
;OPSYdq_2shaped90_mkIII 
;OPSY with double quantum filter modified for use with the 
parahydrogen polariser 
#include <Avance.incl> 
#include <Grad.incl> 
#include <Polariser3.incl> 
1 ze 
2 d1 
        subr POLARISE( d20, d21, d24 ) 
3 30m pl1:f1 pl2:f2 
  d1 
  (center 
  (p12:sp1 ph1):f1 
  (p12:sp2 ph1):f2 
  ) 
  50u UNBLKGRAD 
  p16:gp1*-1 
  d16 pl1:f1 pl2:f2 
  20u BLKGRAD 
  (center 
  (p12:sp3 ph2):f1 
  (p12:sp4 ph2):f2 
  ) 
  50u UNBLKGRAD 
  p16:gp1 
  d16 
  p16:gp1 
  d16 
  20u BLKGRAD 
  go=3 ph31 
  30m wr #0 
  TOPOL ;transfer sample to polariser 
  20u ze 
  lo to 2 times l0 
  POLPOS ;wait for sample in poariser 
exit 
ph1=1 1 1 1 0 0 0 0 
ph2=0 0 0 0 1 1 1 1 
ph3=1 1 1 1 0 0 0 0 
ph31=0 0 0 0 1 1 1 1 
;d1 : relaxation delay; set to very short for hyperpolarisation 
experiments 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans 
;p16: homospoil/gradient pulse 
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;d16: delay for homospoil/gradient recovery 
;NS: 1 * n, total number of scans: NS * TD0 
;use gradient ratio:     gpz1= from 80 to 100 % 
;p16= 1-3 ms 
; increase gpz1 and/or p16 to improve the signal suppression. 
;use gradient files: 
;gpnam1: SINE.100 
;phcor 1 : phasedifference between power levels sp1 and pl1 
;choose p11 according to desired selectivity 
;the flip-angle is determined by the amplitude 
;set O1 on resonance on the multiplet to be excited or use 
spoffs 
;;stop 
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9.3.4 1D 1H NOESY NMR pulse sequence – ph_selnogp 
This is the standard 1D 1H NOESY NMR pulse sequence from Bruker adapted for use 
with the polarisor. 
;selnogp 
;avance-version (07/06/20) 
;1D NOESY using selective refocussing with a shaped pulse 
;dipolar coupling may be due to noe or chemical exchange. 
; 
;H. Kessler, H. Oschkinat, C. Griesinger & W. Bermel, 
;   J. Magn. Reson. 70, 106 (1986) 
;J. Stonehouse, P. Adell, J. Keeler & A.J. Shaka,  
;   J. Am. Chem. Soc 116, 6037 (1994) 
;K. Stott, J. Stonehouse, J. Keeler, T.L. Hwang & A.J. Shaka,  
;   J. Am. Chem. Soc 117, 4199-4200 (1995) 
; 
;$CLASS=HighRes 
;$DIM=1D 
;$TYPE= 
;$SUBTYPE= 
;$COMMENT= 
 
 
#include <Avance.incl> 
#include <Grad.incl> 
#include <Polariser.incl> 
 
 
"p2=p1*2" 
 
 
"d19=d8*0.5-p16-d16" 
 
 
"acqt0=-p1*2/3.1416-4u" 
 
 
1 ze 
2 30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 30m 
  20u pl1:f1 
  d1 
  50u UNBLKGRAD 
  (p1 ph1):f1 
  3u 
  p16:gp1 
  d16 pl0:f1 
  p12:sp2:f1 ph2:r 
  3u 
  p16:gp1 
  d16 pl1:f1 
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  (p1 ph3):f1 
  d19 
  p16:gp2 
  d16 
  3u 
  (p2 ph4):f1 
  3u 
  p16:gp2*-1 
  d16 
  d19 
  (p1 ph5):f1 
  4u BLKGRAD 
  go=3 ph31 
  TOPOL             ;transfer sample to polariser 
  30m mc #0 to 2 F0(zd) 
exit 
 
 
ph1=0 2  
ph2=0 0 1 1 2 2 3 3 
ph3=0 
ph4=0 
ph5=0 
ph31=0 2 2 0  
 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;sp2: f1 channel - shaped pulse 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p12: f1 channel - 180 degree shaped pulse 
;p16: homospoil/gradient pulse                            [1 
msec] 
;d1 : relaxation delay; 1-5 * T1 
;d8 : mixing time 
;d16: delay for homospoil/gradient recovery 
;d19: d8*0.5 - p16 - d16 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;NS: 2 * n, total number of scans: NS * TD0 
;DS: 4 
 
 
;phcor 2 : phasedifference between power levels sp1 and pl1 
 
;choose p12 according to desired selectivity 
;the flip-angle is determined by the amplitude 
;set O1 on resonance on the multiplet to be excited or use 
spoffs 
 
 
;use gradient ratio:    gp 1 : gp 2 
;                         15 :   40 
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;for z-only gradients: 
;gpz1: 15% 
;gpz2: 40% 
 
;use gradient files:    
;gpnam1: SINE.100 
;gpnam2: SINE.100 
 
 
 
;$Id: selnogp,v 1.15.6.1 2007/07/04 13:41:19 ber Exp $ 
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9.3.5 1D 1H NOESY NMR pulse sequence – ph_selnogp_noloopdummy 
This 1D 1H NOESY NMR pulse sequence has been adapted from the sequence by 
Bruker to force the phase cycle to be implemented. 
;ph_selnogp_noloopdummy 
;avance-version (07/06/20) 
;1D NOESY using selective refocussing with a shaped pulse 
;dipolar coupling may be due to noe or chemical exchange. 
; 
;H. Kessler, H. Oschkinat, C. Griesinger & W. Bermel, 
;   J. Magn. Reson. 70, 106 (1986) 
;J. Stonehouse, P. Adell, J. Keeler & A.J. Shaka,  
;   J. Am. Chem. Soc 116, 6037 (1994) 
;K. Stott, J. Stonehouse, J. Keeler, T.L. Hwang & A.J. Shaka,  
;   J. Am. Chem. Soc 117, 4199-4200 (1995) 
; 
;$CLASS=HighRes 
;$DIM=1D 
;$TYPE= 
;$SUBTYPE= 
;$COMMENT= 
 
 
#include <Avance.incl> 
#include <Grad.incl> 
#include <Polariser3.incl> 
 
 
"p2=p1*2" 
 
 
"d19=d8*0.5-p16-d16" 
 
 
"acqt0=-p1*2/3.1416-4u" 
 
 
1 ze 
2 30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 30m 
  20u pl1:f1 
  d1 
  50u UNBLKGRAD 
  (p1 ph1):f1 
  3u 
  p16:gp1 
  d16 pl0:f1 
  p12:sp2:f1 ph2:r 
  3u 
  p16:gp1 
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  d16 pl1:f1 
  (p1 ph3):f1 
  d19 
  p16:gp2 
  d16 
  3u 
  (p2 ph4):f1 
  3u 
  p16:gp2*-1 
  d16 
  d19 
  (p1 ph5):f1 
  4u BLKGRAD 
  go=3 ph31  
4 TOPOL             ;transfer sample to polariser 
5 30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
6 30m 
  20u pl1:f1 
  d1 
  50u UNBLKGRAD 
  (p1 ph1):f1 
  3u 
  p16:gp1 
  d16 pl0:f1 
  p12:sp2:f1 ph2:r 
  3u 
  p16:gp1 
  d16 pl1:f1 
  (p1 ph3):f1 
  d19 
  p16:gp2 
  d16 
  3u 
  (p2 ph4):f1 
  3u 
  p16:gp2*-1 
  d16 
  d19 
  (p1 ph5):f1 
  4u BLKGRAD 
  go=3 ph31  
7 30m ze 
8 TOPOL             ;transfer sample to polariser 
  30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
9 30m 
  20u pl1:f1 
  d1 
  50u UNBLKGRAD 
  (p1 ph1):f1 
  3u 
  p16:gp1 
  d16 pl0:f1 
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  p12:sp2:f1 ph2:r 
  3u 
  p16:gp1 
  d16 pl1:f1 
  (p1 ph3):f1 
  d19 
  p16:gp2 
  d16 
  3u 
  (p2 ph4):f1 
  3u 
  p16:gp2*-1 
  d16 
  d19 
  (p1 ph5):f1 
  4u BLKGRAD 
  go=3 ph31  
10 TOPOL             ;transfer sample to polariser 
11 30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
12 30m 
  20u pl1:f1 
  d1 
  50u UNBLKGRAD 
  (p1 ph1):f1 
  3u 
  p16:gp1 
  d16 pl0:f1 
  p12:sp2:f1 ph2:r 
  3u 
  p16:gp1 
  d16 pl1:f1 
  (p1 ph3):f1 
  d19 
  p16:gp2 
  d16 
  3u 
  (p2 ph4):f1 
  3u 
  p16:gp2*-1 
  d16 
  d19 
  (p1 ph5):f1 
  4u BLKGRAD 
  go=3 ph31  
13 TOPOL             ;transfer sample to polariser 
 
  30m mc #0 to 3 F0(zd) 
exit 
 
 
ph1=0 2  
ph2=0 0 1 1 2 2 3 3 
ph3=0 
ph4=0 
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ph5=0 
ph31=0 2 2 0  
 
 
;pl0 : 120dB 
;pl1 : f1 channel - power level for pulse (default) 
;sp2: f1 channel - shaped pulse 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p12: f1 channel - 180 degree shaped pulse 
;p16: homospoil/gradient pulse                            [1 
msec] 
;d1 : relaxation delay; 1-5 * T1 
;d8 : mixing time 
;d16: delay for homospoil/gradient recovery 
;d19: d8*0.5 - p16 - d16 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;NS: 2 * n, total number of scans: NS * TD0 
;DS: 4 
 
 
;phcor 2 : phasedifference between power levels sp1 and pl1 
 
;choose p12 according to desired selectivity 
;the flip-angle is determined by the amplitude 
;set O1 on resonance on the multiplet to be excited or use 
spoffs 
 
 
;use gradient ratio:    gp 1 : gp 2 
;                         15 :   40 
 
;for z-only gradients: 
;gpz1: 15% 
;gpz2: 40% 
 
;use gradient files:    
;gpnam1: SINE.100 
;gpnam2: SINE.100 
 
 
 
;$Id: selnogp,v 1.15.6.1 2007/07/04 13:41:19 ber Exp $ 
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9.3.6 1D refocused 13C{1H} NMR pulse sequence (13C{1H}_JR) – ph_zg_refocus 
This is the standard 1D 13C NMR pulse sequence from Bruker adapted to include a 
delay between the pulse and acquisition, and for use with the polarisor. 
;ph_zg_refocus 
;zg for use with parahydrogen polariser 
 
#include <Avance.incl> 
#include <Polariser.incl> 
 
"d3=1/(2*cnst2)" 
 
1 ze 
2 1u 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 d1 pl12:f2 
  p0 ph1 
  d3 do:f2 
  go=3 ph31 cpd2:f2 
  30m wr #0 do:f2 
  TOPOL             ;transfer sample to polariser 
  lo to 2 times l0  
  POLPOS            ;wait for sample in polariser 
exit 
 
ph1=0 2 2 0 1 3 3 1 
ph31=0 2 2 0 1 3 3 1 
  
 
;d1 : relaxation delay; set to very short for hyperpolarisation 
experiments  
;ns : number of scans: set to = 1 for hyperpolarisation 
experiments 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans; re-polarising between scans 
;cpd2: decoupling according to sequence defined by cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for decoupling sequence 
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9.3.7 1D 13C{1H} NMR pulse sequence refocused for both J coupling and chemical 
shift evolution (13C{1H}_JCSR) – ph_zg_refocused_J+CS 
This is the standard 1D 13C{1H} NMR pulse sequence from Bruker adapted to include a 
refocusing section allowing both J coupling and chemical shift evolution, and for use 
with the polarisor. 
;ph_zg_refocus 
;zg for use with parahydrogen polariser 
 
#include <Avance.incl> 
#include <Polariser3.incl> 
 
"d3=1/(2*cnst2)" 
 
1 ze 
2 1u 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 d1 pl12:f2 
  p0 ph1 
  d3 do:f2 
  (center (p4 ph2):f2 (p2 ph3) ) 
  d3 
  go=3 ph31 cpd2:f2 
  30m wr #0 do:f2 
  TOPOL             ;transfer sample to polariser 
  lo to 2 times l0  
  POLPOS            ;wait for sample in polariser 
exit 
 
ph1=0 2 2 0 1 3 3 1 
ph2=0 2  
ph3=0 2 
ph31=0 2 2 0 1 3 3 1 
  
 
;pl12 : f2 channel - power level for pulse (default) 
;p0 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  180 degree high power pulse 
;d1 : relaxation delay; set to very short for hyperpolarisation 
experiments  
;ns : number of scans: set to = 1 for hyperpolarisation 
experiments 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans; re-polarising between scans 
;cpd2: decoupling according to sequence defined by cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for decoupling sequence 
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9.3.8 1D 13C INEPT NMR pulse sequence – ph_ineptnd 
This is the standard 1D 13C INEPTnd NMR pulse sequence from Bruker adapted for use 
with the polarisor. 
;ph_ineptnd_mkIII 
;avance-version (02/05/31) 
;INEPT for non-selective polarization transfer 
;no decoupling during acquisition 
;modified for use with the polariser mkII by REM and LSL 
;$CLASS=HighRes 
;$DIM=1D 
;$TYPE= 
;$SUBTYPE= 
;$COMMENT= 
 
 
#include <Avance.incl> 
#include <Polariser3.incl> 
 
 
"p2=p1*2" 
"p4=p3*2" 
"d4=1s/(cnst2*4)" 
 
 
1 ze  
2 30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 d1  
  (p5 ph1):f2  
  d4 
  (center (p4 ph2):f2 (p2 ph4) ) 
  d4 
  (p3 ph3):f2 (p1 ph5)  
  go=3 ph31 
  30m mc #0 to 2 F0(zd) 
  TOPOL             ;transfer sample to polariser 
  lo to 2 times l0 
  POLPOS            ;wait for sample in polariser and set to 
manuel mode 
exit 
 
ph1=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph2=0 2  
ph3=1 1 3 3 
ph4=0 2  
ph5=0 0 0 0 1 1 1 1 2 2 2 2 3 3 3 3 
ph31=0 0 2 2 1 1 3 3 
 
 
;pl1 : f1 channel - power level for pulse (default) 
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;pl2 : f2 channel - power level for pulse (default) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p5 : f2 channel - 90 or 45 degree pulse as desired 
;d1 : relaxation delay; 1-5 * T1 
;d4 : 1/(4J(XH)) 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans; re-polarising between scans 
;cnst2: = J(XH) 
;NS: 4 * n, total number of scans: NS * TD0 
;DS: 16 
 
 
 
;$Id: ineptnd,v 1.9 2005/11/10 12:17:00 ber Exp $ 
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9.3.9 1D 13C INEPT NMR pulse sequence with phase change – ph_inept_phase 
This is the standard 1D 13C INEPTnd NMR pulse sequence from Bruker adapted for 
PHIP protocols according to Haake et al.150 for use with the polarisor. 
;ph_ineptrd 
;avance-version (02/05/31) 
;INEPT for non-selective polarization transfer 
;with decoupling during acquisition 
;Modified for use with the polariser mkII 
;$CLASS=HighRes 
;$DIM=1D 
;$TYPE= 
;$SUBTYPE= 
;$COMMENT= 
 
 
#include <Avance.incl> 
#include <Polariser.incl> 
 
 
"p2=p1*2" 
"p4=p3*2" 
"d3=1s/(cnst2*cnst11)" 
"d4=1s/(cnst2*4)" 
"d12=20u" 
 
 
1 ze  
2 30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 30m do:f2  
  d1 
  d12 pl2:f2  
  (p5 ph1):f2  
  d4 
  (center (p4 ph2):f2 (p2 ph4) ) 
  d4 
  (p3 ph3):f2 (p1 ph5)  
  d3 
  (center (p4 ph2):f2 (p2 ph6) ) 
  d3 pl12:f2 
  go=3 ph31 cpd2:f2 
  30m do:f2 mc #0 to 2 F0(zd) 
  TOPOL             ;transfer sample to polariser 
  lo to 2 times l0 
  POLPOS            ;wait for sample in polariser and set to 
manuel mode 
exit 
 
 
ph1=1 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph2=0 2  
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ph3=1 1 3 3 
ph4=0 2  
ph5=0 0 0 0 1 1 1 1 2 2 2 2 3 3 3 3 
ph6=0 2 0 2 1 3 1 3 
ph31=0 0 2 2 1 1 3 3 
 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB decoupling 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p5 : f2 channel - 90 or 45 degree high power pulse 
;d1 : relaxation delay; 1-5 * T1 
;d3 : 1/(6J(XH))  XH, XH2, XH3 positive 
;     1/(4J(XH))  XH only 
;     1/(3J(XH))  XH, XH3 positive, XH2 negative 
;d4 : 1/(4J(XH)) 
;d12: delay for power switching                      [20 usec] 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans; re-polarising between scans 
;cnst2: = J(XH) 
;cnst11: 6  XH, XH2, XH3 positive 
;        4  XH only 
;        3  XH, XH3 positive, XH2 negative 
;NS: 4 * n, total number of scans: NS * TD0 
;DS: 16 
;cpd2: decoupling according to sequence defined by cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for decoupling sequence 
 
 
 
;$Id: ineptrd,v 1.9 2005/11/10 12:17:00 ber Exp $ 
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9.3.10 1D 13C{1H} INEPT NMR pulse sequence – ph_ineptrd 
This is the standard 1D 13C{1H} INEPTrd NMR pulse sequence from Bruker adapted 
for use with the polarisor. 
;ph_ineptrd_mkIII 
;avance-version (02/05/31) 
;INEPT for non-selective polarization transfer 
;with decoupling during acquisition 
;Modified for use with the polariser mkII 
;$CLASS=HighRes 
;$DIM=1D 
;$TYPE= 
;$SUBTYPE= 
;$COMMENT= 
 
 
#include <Avance.incl> 
#include <Polariser3.incl> 
 
 
"p2=p1*2" 
"p4=p3*2" 
"d3=1s/(cnst2*cnst11)" 
"d4=1s/(cnst2*4)" 
"d12=20u" 
 
 
1 ze  
2 30m 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 30m do:f2  
  d1 
  d12 pl2:f2  
  (p5 ph1):f2  
  d4 
  (center (p4 ph2):f2 (p2 ph4) ) 
  d4 
  (p3 ph3):f2 (p1 ph5)  
  d3 
  (center (p4 ph2):f2 (p2 ph6) ) 
  d3 pl12:f2 
  go=3 ph31 cpd2:f2 
  30m do:f2 mc #0 to 2 F0(zd) 
  TOPOL             ;transfer sample to polariser 
  lo to 2 times l0 
  POLPOS            ;wait for sample in polariser and set to 
manuel mode 
exit 
 
 
ph1=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 
ph2=0 2  
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ph3=1 1 3 3 
ph4=0 2  
ph5=0 0 0 0 1 1 1 1 2 2 2 2 3 3 3 3 
ph6=0 2 0 2 1 3 1 3 
ph31=0 0 2 2 1 1 3 3 
 
 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB decoupling 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p4 : f2 channel - 180 degree high power pulse 
;p5 : f2 channel - 90 or 45 degree high power pulse 
;d1 : relaxation delay; 1-5 * T1 
;d3 : 1/(6J(XH))  XH, XH2, XH3 positive 
;     1/(4J(XH))  XH only 
;     1/(3J(XH))  XH, XH3 positive, XH2 negative 
;d4 : 1/(4J(XH)) 
;d12: delay for power switching                      [20 usec] 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans; re-polarising between scans 
;cnst2: = J(XH) 
;cnst11: 6  XH, XH2, XH3 positive 
;        4  XH only 
;        3  XH, XH3 positive, XH2 negative 
;NS: 4 * n, total number of scans: NS * TD0 
;DS: 16 
;cpd2: decoupling according to sequence defined by cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for decoupling sequence 
 
 
 
;$Id: ineptrd,v 1.9 2005/11/10 12:17:00 ber Exp $ 
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9.3.11 2D 1H-1H OPSYdq-COSY NMR pulse sequence – ph_OPSYdq_2D 
In this sequence, the first 90º pulse of the COSY sequence is replaced by an OPSYdq 
sequence such that only double quantum states are filtered for use in the COSY section 
of the sequence.  
;;start 
 
;ph_OPSYdq_2D 
;OPSY with double quantum filter modified for use with the 
parahydrogen polariser 
;Modified to work like a COSYgpqf but by selecting only two spin 
order terms 
 
#include <Avance.incl> 
#include <Grad.incl> 
#include <Polariser.incl> 
 
"d0=3u" 
 
"d13=4u" 
"in0=inf1" 
 
1 ze 
2 d1 
 subr POLARISE( d20, d21, d24 ) 
3 30m 
  d1 
  p1 ph1             ; pH MODIFIED 
  50u UNBLKGRAD 
  p16:gp1*-1 
  d16 
  20u BLKGRAD 
  p1 ph2             ; pH MODIFIED 
  50u UNBLKGRAD 
  p16:gp1 
  d16 
  p16:gp1 
  d16 
  20u BLKGRAD 
  d0 
  50u UNBLKGRAD 
  p19:gp2 
  d16 
  p0 ph2 
  d13 
  p19:gp2 
  d16 
  4u BLKGRAD 
  go=3 ph31 
  TOPOL ;transfer sample to polariser   
  d1 mc #0 to 2 F1QF(id0) 
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  POLPOS ;wait for sample in poariser 
exit 
 
ph1=0 2 
ph2=0 0 2 2 
ph3=0 2 
ph31=0 2 
 
 
;d1 : relaxation delay; set to very short for hyperpolarisation 
experiments  
;d13: short delay [4 usec] 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans 
;pl1 : f1 channel - power level for pulse (default) 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p16: homospoil/gradient pulse 
;p19: gradient pulse for single quantum filter 
;d16: delay for homospoil/gradient recovery 
;NS: 1 * n, total number of scans: NS * TD0 
;in0: 1/(1 * SW) = 2 * DW 
;use gradient ratio:     gpz1= 70%   gpz2=10% 
;p16= 1-3 ms 
;p19= 600 us 
; increase gpz1 and/or p16 to improve the signal suppression. 
;use gradient files: 
;gpnam1: SINE.100 
;gpz1 70% refers to the gradient filter used to select double 
quantum coherences 
;gpz2 10% refers to the single quantum filter (used in the last 
90) 
 
;Ralph Adams 12MAY2009 
 
;;stop 
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9.3.12 2D NMR pulse sequences 
This has been completed through the addition of an ‘include’ file to correspond to the 
commands for the polarisor to be used, and three subroutines relating to control of the 
polarisor. These additions have been made to all the standard 2D sequences used for 
hyperpolarisation via SABRE using method 2. This has been exemplified through the 
adaptation of the standard 2D 1H-1H COSY NMR pulse sequence from Bruker for use 
with the polarisor. 
;COSY using gradient pulse 
;ph_cosygpqf 
;For use with the parahydrogen polariser 
 
#include <Avance.incl> 
#include <Grad.incl> 
#include <Polariser.incl> 
 
"d13=4u" 
"in0=inf1" 
"d0=3u" 
"d27=50m" 
 
1 ze 
2 d1 
  subr POLARISE( d20, d21, d24 ) ;wait for sample and polarise; 
transfer when done 
3 p1 ph1 
  d0 
  50u UNBLKGRAD 
  p16:gp1 
  d16 
  p0 ph2 
  d13 
  p16:gp1 
  d16 
  4u BLKGRAD 
  go=3 ph31 
  TOPOL ;transfer sample to polariser 
  d1 mc #0 to 2 F1QF(id0) 
  POLPOS ;wait for sample in polariser 
exit 
 
ph1=0 2  
ph2=0 0 2 2 
ph31=0 2  
  
 
;d1 : relaxation delay; set to very short for hyperpolarisation 
experiments  
;d13: short delay [4 usec] 
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;d16: delay for gradient recovery 
;d20: bubble time for polarisation 
;d21: stop bubbling, wait before transfering the sample 
;d24: settling after transfer 
;l0 : accumulate L0 scans; re-polarising between scans 
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9.4 X-ray crystallography data for [Ir(SIMes)(COD)(2-methylpyridine)]PF6 
Single crystals of C37HN22F11PIr were grown in methanol in the freezer. A suitable 
crystal was selected, extracted using oil on a loop and interrogated on an Oxford 
Diffraction SuperNova diffractometer. The crystal was kept at 110.00(10) K during data 
collection. Using Olex2,223 the structure was solved with the XS structure solution 
program using Direct Methods and refined with the XL224 refinement package using 
Least Squares minimisation. 
 
Figure 9.5 X-ray crystallography structure of [Ir(SIMes)(COD)(2-methylpyridine)]PF6. 
Identification code  sbd1108  
Empirical formula  C37HN22F11PIr  
Formula weight  1184.76  
Temperature/K  110.00(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  9.7857(4)  
b/Å  21.6745(10)  
c/Å  16.1768(6)  
α/°  90.00  
β/°  95.804(4)  
γ/°  90.00  
Volume/Å3  3413.5(2)  
Z  4  
ρcalcmg/mm
3  2.305  
m/mm-1  4.094  
F(000)  2268.0  
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Crystal size/mm3  0.1709 × 0.1563 × 0.121  
2Θ range for data collection  5.62 to 64.26°  
Index ranges  -6 ≤ h ≤ 13, -30 ≤ k ≤ 24, -23 ≤ l ≤ 24 
Reflections collected  20731  
Independent reflections  10763[R(int) = 0.0333]  
Data/restraints/parameters  10763/0/422  
Goodness-of-fit on F2  1.035  
Final R indexes [I>=2σ (I)]  R1 = 0.0337, wR2 = 0.0734  
Final R indexes [all data]  R1 = 0.0468, wR2 = 0.0809  
Largest diff. peak/hole / e Å-3 1.78/-1.31 
 
Atom x y z U(eq) 
Ir36 3098.58(11) 5960.80(5) 1899.39(7) 17.99(4) 
P41 9057.7(10) 6753.5(5) 5839.0(6) 30.6(2) 
F42 8334(3) 6106.7(14) 5577.6(17) 64.2(8) 
F43 8825(3) 6964.3(14) 4896.8(14) 60.1(8) 
F44 9802(3) 7380.4(11) 6118.8(18) 57.8(7) 
F45 10504(2) 6458.0(12) 5687.7(15) 46.9(6) 
F4 7613(2) 7051.3(15) 5989.5(17) 65.1(8) 
N40 4454(3) 5653.4(13) 2918.4(16) 23.1(5) 
F38 9246(3) 6518.5(13) 6781.6(14) 55.4(7) 
C24 1549(3) 5778.2(16) 912(2) 23.9(6) 
N25 462(3) 6424.2(12) 2628.3(16) 21.9(5) 
C0AA 2114(3) 6361.3(16) 776.5(19) 23.9(6) 
N8 2199(3) 7041.8(13) 2889.1(16) 21.6(5) 
C1AA 4271(3) 7188.3(15) 3838.5(19) 24.1(6) 
C10 3568(3) 7287.7(15) 3051.6(19) 22.1(6) 
C11 4787(3) 5937.2(14) 1158(2) 21.6(6) 
C12 7498(4) 8155.4(18) 3664(3) 35.4(8) 
C13 -1344(3) 5790.7(15) 1896(2) 21.0(6) 
C14 4123(3) 7654.5(15) 2459.0(19) 22.9(6) 
C15 1819(3) 5191.2(17) 461(2) 27.8(7) 
C16 -155(3) 6959.8(16) 3025(2) 29.6(7) 
C17 -2061(3) 5233.4(15) 1830.4(19) 21.9(6) 
C27 -1813(3) 4765.7(15) 2407(2) 24.2(6) 
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C28 1820(3) 6488.9(15) 2567.6(18) 20.6(6) 
C5 4228(3) 5338.4(15) 1145.3(19) 22.1(6) 
C3 5550(3) 7468.8(16) 4025(2) 26.1(7) 
C35 -840(3) 4863.0(16) 3085(2) 26.4(7) 
C32 -315(3) 5861.7(14) 2555(2) 20.5(6) 
C4AA 6136(3) 7835.9(16) 3441(2) 27.7(7) 
C19 4319(4) 5093.7(17) 3259(2) 30.2(7) 
C1 3083(3) 6478.3(17) 113(2) 28.6(7) 
C2 -2599(4) 4165.4(17) 2320(3) 35.9(8) 
C29 3364(3) 5081.1(16) 390(2) 25.5(7) 
C2AA 4600(3) 6392.9(16) 448(2) 25.6(7) 
C3AA 1054(3) 7404.7(16) 3180(2) 28.9(7) 
C23 5565(3) 6007.1(17) 3189(2) 28.7(7) 
C48 -1686(3) 6297.3(15) 1266(2) 25.5(7) 
C33 -88(3) 5410.6(15) 3174(2) 23.8(6) 
C34 5417(3) 7913.8(15) 2669(2) 25.6(7) 
C37 5274(4) 4890(2) 3902(2) 39.4(9) 
C30 6529(4) 5825(2) 3819(2) 37.7(9) 
C4 3357(4) 7775.4(16) 1619(2) 28.4(7) 
C51 3708(4) 6776.3(17) 4473(2) 30.4(7) 
C52 6376(4) 5262(2) 4184(2) 43.4(10) 
C5AA 3179(4) 4683.0(17) 2913(2) 34.4(8) 
C49 890(3) 5514.6(18) 3944(2) 30.6(7) 
 Table 9.11 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement Parameters 
(Å2×103) for sbd1108. Ueq is defined as 1/3 of of the trace of the orthogonalised UIJ tensor. 
 
Atom U11 U22 U33 U23 
Ir36 17.75(6) 16.45(6) 19.75(6) -2.59(5) 
P41 36.7(5) 28.7(5) 25.9(4) -0.9(4) 
F42 83(2) 55.4(18) 51.6(16) -2.9(14) 
F43 73.9(18) 72(2) 33.7(13) 19.5(13) 
F44 59.3(16) 24.5(12) 89(2) -11.5(14) 
F45 45.4(13) 39.7(14) 56.5(15) -6.7(12) 
F4 40.0(14) 95(2) 60.9(17) -3.5(17) 
N40 23.5(13) 23.5(14) 22.4(12) -3.8(11) 
F38 81.0(19) 55.3(18) 29.1(12) 2.9(12) 
C24 18.2(14) 27.6(17) 25.9(15) -5.1(14) 
N25 21.7(12) 15.2(12) 29.7(13) -4.2(11) 
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C0AA 21.9(15) 26.5(17) 22.7(14) -3.0(13) 
N8 20.7(12) 20.5(13) 23.8(12) -5.0(11) 
C1AA 26.2(15) 22.9(16) 23.0(14) -3.5(13) 
C10 22.2(14) 19.8(15) 24.3(14) -6.2(13) 
C11 19.0(14) 21.6(15) 24.5(14) -3.5(13) 
C12 28.6(18) 26.3(18) 50(2) -6.5(17) 
C13 19.2(14) 20.0(14) 24.7(15) 1.1(12) 
C14 26.4(15) 18.7(15) 23.8(14) -5.5(13) 
C15 22.9(15) 29.4(18) 31.0(17) -10.8(15) 
C16 26.1(16) 22.4(17) 41.8(19) -9.9(15) 
C17 21.0(14) 20.1(15) 25.1(15) -2.0(13) 
C27 28.3(16) 17.1(15) 28.1(15) -0.6(13) 
C28 23.8(15) 18.5(15) 19.3(13) -0.2(12) 
C5 20.2(14) 22.7(16) 23.8(14) -4.4(13) 
C3 26.4(16) 24.9(17) 26.2(15) -5.7(14) 
C35 29.5(17) 23.5(17) 26.3(15) 3.3(14) 
C32 19.5(14) 16.5(14) 26.4(15) -2.4(12) 
C4AA 25.0(16) 19.5(16) 38.4(18) -7.0(15) 
C19 36.1(19) 28.6(18) 27.1(16) 1.4(15) 
C1 31.4(17) 31.4(19) 23.5(15) 3.2(14) 
C2 48(2) 20.8(17) 40(2) -0.5(16) 
C29 21.5(15) 25.7(17) 29.4(16) -11.4(14) 
C2AA 24.7(15) 23.3(16) 29.5(16) 1.4(14) 
C3AA 25.3(16) 23.0(17) 39.0(19) -9.4(15) 
C23 24.4(16) 34(2) 27.2(16) -9.2(15) 
C48 22.6(15) 21.7(16) 32.0(17) 3.5(14) 
C33 25.5(15) 21.4(16) 24.8(15) -0.2(13) 
C34 28.5(16) 19.5(15) 29.4(16) -2.8(14) 
C37 51(2) 40(2) 28.2(18) 7.2(17) 
C30 30.0(18) 57(3) 25.5(17) -10.6(18) 
C4 37.1(18) 20.6(16) 27.0(16) -0.7(14) 
C51 36.7(18) 30.6(19) 24.2(15) -3.2(15) 
C52 39(2) 63(3) 26.9(18) -1(2) 
C5AA 40(2) 24.6(18) 41(2) 2.1(16) 
C49 30.3(17) 35(2) 25.5(16) 1.1(15) 
Table 9.12 Anisotropic Displacement Parameters (Å2×103) for sbd1108. The Anisotropic displacement 
factor exponent takes the form: -2π2[h2a*2U11+...+2hka×b×U12]. 
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 Atom Atom Length/Å   Atom Atom Length/Å 
Ir36 N40 2.116(3)   C10 C14 1.397(4) 
Ir36 C24 2.125(3)   C11 C5 1.408(4) 
Ir36 C0AA 2.151(3)   C11 C2AA 1.512(5) 
Ir36 C11 2.138(3)   C12 C4AA 1.514(5) 
Ir36 C28 2.078(3)   C13 C17 1.396(4) 
Ir36 C5 2.192(3)   C13 C32 1.400(4) 
P41 F42 1.608(3)   C13 C48 1.512(4) 
P41 F43 1.585(2)   C14 C34 1.396(4) 
P41 F44 1.586(3)   C14 C4 1.507(4) 
P41 F45 1.595(2)   C15 C29 1.546(4) 
P41 F4 1.595(3)   C16 C3AA 1.528(5) 
P41 F38 1.601(2)   C17 C27 1.383(4) 
N40 C19 1.345(4)   C27 C35 1.394(5) 
N40 C23 1.365(4)   C27 C2 1.511(5) 
C24 C0AA 1.406(5)   C5 C29 1.520(4) 
C24 C15 1.503(5)   C3 C4AA 1.402(5) 
N25 C16 1.484(4)   C35 C33 1.396(5) 
N25 C28 1.349(4)   C32 C33 1.401(4) 
N25 C32 1.435(4)   C4AA C34 1.379(5) 
C0AA C1 1.523(4)   C19 C37 1.397(5) 
N8 C10 1.441(4)   C19 C5AA 1.492(5) 
N8 C28 1.343(4)   C1 C2AA 1.539(4) 
N8 C3AA 1.484(4)   C23 C30 1.375(5) 
C1AA C10 1.401(4)   C33 C49 1.508(4) 
C1AA C3 1.397(4)   C37 C52 1.386(6) 
C1AA C51 1.506(5)   C30 C52 1.372(6) 
Table 9.13 Bond Lengths for sbd1108.  
  
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
N40 Ir36 C24 150.47(13)   C1AA C10 N8 118.1(3) 
N40 Ir36 C0AA 167.61(11)   C14 C10 N8 120.3(3) 
N40 Ir36 C11 88.29(11)   C14 C10 C1AA 121.5(3) 
N40 Ir36 C5 85.87(11)   C5 C11 Ir36 73.12(17) 
C24 Ir36 C0AA 38.37(13)   C5 C11 C2AA 125.0(3) 
412 
C24 Ir36 C11 96.17(12)   C2AA C11 Ir36 111.7(2) 
C24 Ir36 C5 80.16(12)   C17 C13 C32 118.1(3) 
C0AA Ir36 C5 89.23(12)   C17 C13 C48 120.1(3) 
C11 Ir36 C0AA 80.89(12)   C32 C13 C48 121.8(3) 
C11 Ir36 C5 37.92(11)   C10 C14 C4 121.7(3) 
C28 Ir36 N40 97.55(11)   C34 C14 C10 117.9(3) 
C28 Ir36 C24 94.12(12)   C34 C14 C4 120.4(3) 
C28 Ir36 C0AA 88.57(12)   C24 C15 C29 112.8(3) 
C28 Ir36 C11 147.68(12)   N25 C16 C3AA 102.8(2) 
C28 Ir36 C5 173.13(12)   C27 C17 C13 122.1(3) 
F43 P41 F42 88.96(16)   C17 C27 C35 118.6(3) 
F43 P41 F44 92.55(16)   C17 C27 C2 121.0(3) 
F43 P41 F45 90.65(14)   C35 C27 C2 120.3(3) 
F43 P41 F4 89.26(15)   N25 C28 Ir36 129.0(2) 
F43 P41 F38 177.62(17)   N8 C28 Ir36 122.4(2) 
F44 P41 F42 178.19(17)   N8 C28 N25 107.4(3) 
F44 P41 F45 89.94(14)   C11 C5 Ir36 68.96(17) 
F44 P41 F4 89.90(16)   C11 C5 C29 122.3(3) 
F44 P41 F38 89.74(16)   C29 C5 Ir36 113.7(2) 
F45 P41 F42 89.05(16)   C1AA C3 C4AA 121.3(3) 
F45 P41 F4 179.81(18)   C27 C35 C33 121.4(3) 
F45 P41 F38 89.98(14)   C13 C32 N25 119.4(3) 
F4 P41 F42 91.11(18)   C13 C32 C33 121.2(3) 
F4 P41 F38 90.12(15)   C33 C32 N25 119.3(3) 
F38 P41 F42 88.76(15)   C3 C4AA C12 120.6(3) 
C19 N40 Ir36 121.6(2)   C34 C4AA C12 121.1(3) 
C19 N40 C23 118.9(3)   C34 C4AA C3 118.3(3) 
C23 N40 Ir36 119.3(2)   N40 C19 C37 120.2(4) 
C0AA C24 Ir36 71.80(18)   N40 C19 C5AA 119.0(3) 
C0AA C24 C15 126.4(3)   C37 C19 C5AA 120.6(4) 
C15 C24 Ir36 112.0(2)   C0AA C1 C2AA 112.3(3) 
C28 N25 C16 113.4(3)   C5 C29 C15 110.7(2) 
C28 N25 C32 126.8(3)   C11 C2AA C1 112.6(3) 
C32 N25 C16 117.7(2)   N8 C3AA C16 102.2(3) 
C24 C0AA Ir36 69.82(19)   N40 C23 C30 122.8(4) 
C24 C0AA C1 122.9(3)   C35 C33 C32 118.4(3) 
C1 C0AA Ir36 113.8(2)   C35 C33 C49 119.7(3) 
C10 N8 C3AA 117.6(3)   C32 C33 C49 121.8(3) 
413 
C28 N8 C10 128.0(3)   C4AA C34 C14 122.5(3) 
C28 N8 C3AA 114.1(3)   C52 C37 C19 120.1(4) 
C10 C1AA C51 122.0(3)   C52 C30 C23 118.5(4) 
C3 C1AA C10 118.4(3)   C30 C52 C37 119.4(4) 
C3 C1AA C51 119.5(3)           
Table 9.14 Bond angles for sbd1108 
 
Atom x y z U(eq) 
H24 598 5801 1087 29 
H0AA 1491 6715 869 29 
H11 5702 5969 1492 26 
H12A 7341 8555 3921 53 
H12B 7958 8219 3160 53 
H12C 8078 7899 4056 53 
H15A 1326 5207 -104 33 
H15B 1449 4839 758 33 
H16A -514 6839 3553 35 
H16B -909 7144 2651 35 
H17 -2741 5173 1375 26 
H5 4811 5026 1471 27 
H3 6033 7410 4559 31 
H35 -684 4550 3495 32 
H1A 2945 6904 -100 34 
H1B 2856 6191 -356 34 
H2A -3115 4108 2802 54 
H2B -1953 3823 2288 54 
H2C -3237 4176 1813 54 
H29A 3538 4633 344 31 
H29B 3629 5283 -118 31 
H2AA 5121 6247 -8 31 
H2AB 4985 6797 639 31 
H3AA 891 7789 2855 35 
H3AB 1236 7509 3777 35 
H23 5675 6395 2932 34 
H48A -2072 6115 739 38 
H48B -850 6527 1179 38 
414 
H48C -2360 6578 1472 38 
H34 5819 8153 2265 31 
H37 5167 4497 4146 47 
H30 7285 6084 3998 45 
H4A 3512 7434 1243 43 
H4B 3687 8160 1391 43 
H4C 2372 7811 1675 43 
H51A 2836 6945 4620 46 
H51B 4366 6754 4970 46 
H51C 3556 6362 4239 46 
H52 7020 5127 4626 52 
H5AA 2424 4934 2650 52 
H5AB 2849 4439 3363 52 
H5AC 3514 4406 2499 52 
H49A 556 5857 4265 46 
H49B 1803 5615 3783 46 
H49C 946 5139 4283 46 
Table 9.15 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters (Å2×103) for 
sbd1108. 
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10 Abbreviations 
%Vbur  : per cent buried volume 
Å  : angstrom 
ALTADENA : Adiabatic Longitudinal Transport After Dissociation Engenders 
Nuclear Alignment 
av.  : average 
BBI  : Broadband inverse probe 
cat   : catalyst 
CDCl3  : deuterated chloroform 
CIDNP : Chemically Induced Dynamic Nuclear Polarisation 
COD  : 1,5-cyclooctadiene 
COE  : cyclooctene 
conc.  : concentration 
COSY  : Correlation Spectroscopy 
Cy  : cyclohexyl 
D  : deuterium 
DCM  : Dichloromethane 
DFT  : Density Functional Theory 
DMSO  : Dimethylsulphoxide 
DNP  : Dynamic Nuclear Polarisation 
dq  : double quantum 
E  : enhancement 
420 
eq.  : equivalent(s) 
ESI  : electrospray ionisation 
Et  : ethyl 
EXSY  : Exchange spectroscopy 
FID  : Free Induction Decay 
G  : Gauss 
GI50  : A quantitative measure of how much of a compound is required to 
cause a 50 % reduction in proliferation of cancer cells 
H  : Proton (and Henry’s Law constant in Experimental) 
HMBC : Heteronuclear multiple-bond correlation spectroscopy 
HMQC : Heteronuclear multiple-quantum correlation spectroscopy 
HSQC  : Heteronuclear single-quantum correlation spectroscopy 
IC50  : A quantitative measure of how much of a compound is required to             
inhibit a given biological process by half 
ICy  : Bis-1,3-cyclohexyl imidazole hydrochloride 
IMe  : Bis-1,3-methyl imidazole hydrochloride 
IMes  : Bis-1,3-(2,4,6-trimethylphenyl) imidazole hydrochloride 
INEPT  : Insensitive Nuclei Enhanced by Polarisation Transfer 
iPr  : isopropyl 
IR  : infrared 
K  : Kelvin 
L  : ligand 
421 
M  : metal 
Me  : methyl 
MeO  : methoxy ligand 
MeOD  : deuterated methanol 
MIC  : minimum inhibitory concentration 
MKI/II/III : referring to the first (Mark1), second (Mark 2) and third (mark 3) 
generation mixing chamber 
MRI  : Magnetic Resonance Imaging 
MS  : Mass spectroscopy 
NCMe  : Acetonitrile 
nd  : Not decoupled, in reference to the INEPT pulse sequence 
NH-PHIP : Non-hydrogenative parahydrogen induced polarisation 
NHC  : N-heterocyclic carbene 
NMR  : Nuclear Magnetic Resonance 
NOESY : nuclear Overhauser effect spectroscopy 
obs.  : observed 
OPSY  : Only parahydrogen spectroscopy 
OPSYdq : Only parahydrogen spectroscopy optimised for double quantum states 
ORTEP : Oak Ridge Thermal Ellipsoid Plot 
PASADENA : Parahydrogen And Synthesis Allow Dramatically Enhanced Nuclear 
Alignment 
PCy3  : tricyclohexyl phosphine 
422 
Ph  : Phenyl 
pH2  : parahydrogen 
PHIP  : Parahydrogen induced polarisation 
PPh3  : triphenyl phosphine 
ppm  : parts per million 
PTF  : polarisation transfer field 
py  : pyridine 
q  : quinoline 
r  : repulsivity factor 
R  : any group 
rd   : refocused and decoupled, in reference to the INEPT pulse sequence 
rel.  : relative 
RF  : radio frequency  
S/N  : signal to noise ratio 
SABRE : Signal Amplification By Reversible Exchange 
SIMes  : bis-1,3-(2,4,6-trimethylphenyl) imidazoline hydrochloride 
Sub  : substrate 
T  : tesla 
tBu  : tert-butyl 
TEP  : Tolman’s Electronic Parameter 
THF  : tetrahydrofuran 
TOCSY : Total correlation spectroscopy 
423 
TXI  : Triple Resonance Inverse Probe 
TXO  : Triple Resonances Obverse Probe 
ufCOSY : ultrafast COSY 
UV  : ultraviolet 
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